BindingDB Reactant_set_id,Ligand SMILES,Ligand InChI,Ligand InChI Key,BindingDB MonomerID,BindingDB Ligand Name,Target Name,Target Source Organism According to Curator or DataSource,IC50 (nM)
2,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(C\C=C\c2cn[nH]c2)C(=O)N(C\C=C\c2cn[nH]c2)[C@@H]1Cc1ccccc1,"InChI=1S/C31H34N6O3/c38-29-27(17-23-9-3-1-4-10-23)36(15-7-13-25-19-32-33-20-25)31(40)37(16-8-14-26-21-34-35-22-26)28(30(29)39)18-24-11-5-2-6-12-24/h1-14,19-22,27-30,38-39H,15-18H2,(H,32,33)(H,34,35)/b13-7+,14-8+/t27-,28-,29+,30+/m1/s1",UZLMEAPBHYEHAC-UNTBESQGSA-N,22,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[(2E)-3-(1H-pyrazol-4-yl)prop-2-en-1-yl]-1,3-diazepan-2-one::DMPC Cyclic Urea 2",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
3,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CC2)C(=O)N(C\C=C\c2cn[nH]c2)[C@@H]1Cc1ccccc1,"InChI=1S/C29H34N4O3/c34-27-25(16-21-8-3-1-4-9-21)32(15-7-12-24-18-30-31-19-24)29(36)33(20-23-13-14-23)26(28(27)35)17-22-10-5-2-6-11-22/h1-12,18-19,23,25-28,34-35H,13-17,20H2,(H,30,31)/b12-7+/t25-,26-,27+,28+/m1/s1",HYNYUFZPPJMPOB-UTWJFGBXSA-N,23,"(4R,5S,6S,7R)-4,7-dibenzyl-1-(cyclopropylmethyl)-5,6-dihydroxy-3-[(2E)-3-(1H-pyrazol-4-yl)prop-2-en-1-yl]-1,3-diazepan-2-one::DMPC Cyclic Urea 3",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
4,OCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CC2)C1=O,"InChI=1S/C29H40N2O4/c32-18-10-2-1-9-17-30-25(19-22-11-5-3-6-12-22)27(33)28(34)26(20-23-13-7-4-8-14-23)31(29(30)35)21-24-15-16-24/h3-8,11-14,24-28,32-34H,1-2,9-10,15-21H2/t25-,26-,27+,28+/m1/s1",YXVAZXDWVZTGGD-VIJSPRBVSA-N,24,"(4R,5S,6S,7R)-4,7-dibenzyl-1-(cyclopropylmethyl)-5,6-dihydroxy-3-(6-hydroxyhexyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 4",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
5,OCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CC2)C1=O,"InChI=1S/C28H38N2O4/c31-17-9-3-8-16-29-24(18-21-10-4-1-5-11-21)26(32)27(33)25(19-22-12-6-2-7-13-22)30(28(29)34)20-23-14-15-23/h1-2,4-7,10-13,23-27,31-33H,3,8-9,14-20H2/t24-,25-,26+,27+/m1/s1",WWTSWTPNILRSJX-XDZXDJIYSA-N,25,"(4R,5S,6S,7R)-4,7-dibenzyl-1-(cyclopropylmethyl)-5,6-dihydroxy-3-(5-hydroxypentyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 5",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
6,CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CC2)C1=O,"InChI=1S/C27H36N2O3/c1-2-3-16-28-23(17-20-10-6-4-7-11-20)25(30)26(31)24(18-21-12-8-5-9-13-21)29(27(28)32)19-22-14-15-22/h4-13,22-26,30-31H,2-3,14-19H2,1H3/t23-,24-,25+,26+/m1/s1",QDUGHFLRTUTUJH-XPGKHFPBSA-N,26,"(4R,5S,6S,7R)-4,7-dibenzyl-1-butyl-3-(cyclopropylmethyl)-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 6",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
7,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CCC2)C(=O)N(CC2CCC2)[C@@H]1Cc1ccccc1,"InChI=1S/C29H38N2O3/c32-27-25(17-21-9-3-1-4-10-21)30(19-23-13-7-14-23)29(34)31(20-24-15-8-16-24)26(28(27)33)18-22-11-5-2-6-12-22/h1-6,9-12,23-28,32-33H,7-8,13-20H2/t25-,26-,27+,28+/m1/s1",ACIVSSKFPCODPQ-VIJSPRBVSA-N,27,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(cyclobutylmethyl)-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL287355::DMPC Cyclic Urea 7",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
8,OCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCO)C1=O,"InChI=1S/C29H42N2O5/c32-19-11-3-9-17-30-25(21-23-13-5-1-6-14-23)27(34)28(35)26(22-24-15-7-2-8-16-24)31(29(30)36)18-10-4-12-20-33/h1-2,5-8,13-16,25-28,32-35H,3-4,9-12,17-22H2/t25-,26-,27+,28+/m1/s1",IXMFJRZMSUIMQY-VIJSPRBVSA-N,28,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(5-hydroxypentyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 8",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
9,CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCC)C1=O,"InChI=1S/C27H38N2O3/c1-3-5-17-28-23(19-21-13-9-7-10-14-21)25(30)26(31)24(20-22-15-11-8-12-16-22)29(27(28)32)18-6-4-2/h7-16,23-26,30-31H,3-6,17-20H2,1-2H3/t23-,24-,25+,26+/m1/s1",USVBEQBEZXWMMT-XPGKHFPBSA-N,29,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-dibutyl-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL284472::DMPC Cyclic Urea 9",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
10,CC(C)=CCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC=C(C)C)C1=O,"InChI=1S/C29H38N2O3/c1-21(2)15-17-30-25(19-23-11-7-5-8-12-23)27(32)28(33)26(20-24-13-9-6-10-14-24)31(29(30)34)18-16-22(3)4/h5-16,25-28,32-33H,17-20H2,1-4H3/t25-,26-,27+,28+/m1/s1",AJMLQZYOPGTFTI-VIJSPRBVSA-N,30,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(3-methylbut-2-en-1-yl)-1,3-diazepan-2-one::DMPC Cyclic Urea 10",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
11,CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC=C(C)C)C1=O,"InChI=1S/C28H38N2O3/c1-4-5-17-29-24(19-22-12-8-6-9-13-22)26(31)27(32)25(20-23-14-10-7-11-15-23)30(28(29)33)18-16-21(2)3/h6-16,24-27,31-32H,4-5,17-20H2,1-3H3/t24-,25-,26+,27+/m1/s1",BBKCIKXZHYLMAG-XDZXDJIYSA-N,31,"(4R,5S,6S,7R)-4,7-dibenzyl-1-butyl-5,6-dihydroxy-3-(3-methylbut-2-en-1-yl)-1,3-diazepan-2-one::DMPC Cyclic Urea 11",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
12,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CC2)C(=O)N(CC2CC2)[C@@H]1Cc1ccccc1,"InChI=1S/C27H34N2O3/c30-25-23(15-19-7-3-1-4-8-19)28(17-21-11-12-21)27(32)29(18-22-13-14-22)24(26(25)31)16-20-9-5-2-6-10-20/h1-10,21-26,30-31H,11-18H2/t23-,24-,25+,26+/m1/s1",YMTOUOZOBVYCFQ-XPGKHFPBSA-N,32,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(cyclopropylmethyl)-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL431306::DMPC Cyclic Urea 12",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
13,OCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCCO)C1=O,"InChI=1S/C31H46N2O5/c34-21-13-3-1-11-19-32-27(23-25-15-7-5-8-16-25)29(36)30(37)28(24-26-17-9-6-10-18-26)33(31(32)38)20-12-2-4-14-22-35/h5-10,15-18,27-30,34-37H,1-4,11-14,19-24H2/t27-,28-,29+,30+/m1/s1",LUWZWPBFBGGXGY-XAZDILKDSA-N,33,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(6-hydroxyhexyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 13",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
14,CC(C)=CCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CC2)C1=O,"InChI=1S/C28H36N2O3/c1-20(2)15-16-29-24(17-21-9-5-3-6-10-21)26(31)27(32)25(18-22-11-7-4-8-12-22)30(28(29)33)19-23-13-14-23/h3-12,15,23-27,31-32H,13-14,16-19H2,1-2H3/t24-,25-,26+,27+/m1/s1",UKDOJLFAHNAKJI-XDZXDJIYSA-N,34,"(4R,5S,6S,7R)-4,7-dibenzyl-1-(cyclopropylmethyl)-5,6-dihydroxy-3-(3-methylbut-2-en-1-yl)-1,3-diazepan-2-one::DMPC Cyclic Urea 14",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
15,OC(Br)CCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCC(O)Br)C1=O,"InChI=1S/C31H44Br2N2O5/c32-27(36)17-9-3-11-19-34-25(21-23-13-5-1-6-14-23)29(38)30(39)26(22-24-15-7-2-8-16-24)35(31(34)40)20-12-4-10-18-28(33)37/h1-2,5-8,13-16,25-30,36-39H,3-4,9-12,17-22H2/t25-,26-,27?,28?,29+,30+/m1/s1",JHBZEJFCXWXNHI-FGNRRAGXSA-N,35,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(6-bromo-6-hydroxyhexyl)-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 15",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
16,CS(=O)(=O)CCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCO)C1=O,"InChI=1S/C30H44N2O6S/c1-39(37,38)21-13-5-11-19-32-27(23-25-16-8-3-9-17-25)29(35)28(34)26(22-24-14-6-2-7-15-24)31(30(32)36)18-10-4-12-20-33/h2-3,6-9,14-17,26-29,33-35H,4-5,10-13,18-23H2,1H3/t26-,27-,28+,29+/m1/s1",WOSXSJHAZUAABD-GKQHHHCTSA-N,36,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(5-hydroxypentyl)-1-(5-methanesulfonylpentyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 16",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
17,OCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCO)C1=O,"InChI=1S/C30H44N2O5/c33-20-12-2-1-10-18-31-26(22-24-14-6-3-7-15-24)28(35)29(36)27(23-25-16-8-4-9-17-25)32(30(31)37)19-11-5-13-21-34/h3-4,6-9,14-17,26-29,33-36H,1-2,5,10-13,18-23H2/t26-,27-,28+,29+/m1/s1",DDHHIIFVUPKDPX-GKQHHHCTSA-N,37,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1-(6-hydroxyhexyl)-3-(5-hydroxypentyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 17",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
18,CC(C)=CCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC=C)C1=O,"InChI=1S/C27H34N2O3/c1-4-16-28-23(18-21-11-7-5-8-12-21)25(30)26(31)24(19-22-13-9-6-10-14-22)29(27(28)32)17-15-20(2)3/h4-15,23-26,30-31H,1,16-19H2,2-3H3/t23-,24-,25+,26+/m1/s1",ZGQLVQGAMZWRQZ-XPGKHFPBSA-N,38,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(3-methylbut-2-en-1-yl)-1-(prop-2-en-1-yl)-1,3-diazepan-2-one::DMPC Cyclic Urea 18",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
19,CC(O)CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCC(C)O)C1=O,"InChI=1S/C31H46N2O5/c1-23(34)13-9-11-19-32-27(21-25-15-5-3-6-16-25)29(36)30(37)28(22-26-17-7-4-8-18-26)33(31(32)38)20-12-10-14-24(2)35/h3-8,15-18,23-24,27-30,34-37H,9-14,19-22H2,1-2H3/t23?,24?,27-,28-,29+,30+/m1/s1",AKQNCFFQZVSLCC-RNKQMKKOSA-N,39,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(5-hydroxyhexyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 19",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
20,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CCCC2)C(=O)N(CC=C)[C@@H]1Cc1ccccc1,"InChI=1S/C28H36N2O3/c1-2-17-29-24(18-21-11-5-3-6-12-21)26(31)27(32)25(19-22-13-7-4-8-14-22)30(28(29)33)20-23-15-9-10-16-23/h2-8,11-14,23-27,31-32H,1,9-10,15-20H2/t24-,25-,26+,27+/m1/s1",KCFMBKBBZJZMLP-XDZXDJIYSA-N,40,"(4R,5S,6S,7R)-4,7-dibenzyl-1-(cyclopentylmethyl)-5,6-dihydroxy-3-(prop-2-en-1-yl)-1,3-diazepan-2-one::DMPC Cyclic Urea 20",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
21,CS(=O)CCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCO)C1=O,"InChI=1S/C30H44N2O5S/c1-38(37)21-13-5-11-19-32-27(23-25-16-8-3-9-17-25)29(35)28(34)26(22-24-14-6-2-7-15-24)31(30(32)36)18-10-4-12-20-33/h2-3,6-9,14-17,26-29,33-35H,4-5,10-13,18-23H2,1H3/t26-,27-,28+,29+,38?/m1/s1",BSTHIZRFCYURQH-KRMPQFPOSA-N,41,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(5-hydroxypentyl)-1-(5-methanesulfinylpentyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 21",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
22,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CC2)C(=O)N(CC=C)[C@@H]1Cc1ccccc1,"InChI=1S/C26H32N2O3/c1-2-15-27-22(16-19-9-5-3-6-10-19)24(29)25(30)23(17-20-11-7-4-8-12-20)28(26(27)31)18-21-13-14-21/h2-12,21-25,29-30H,1,13-18H2/t22-,23-,24+,25+/m1/s1",MLILSMSYLHSTCQ-NGSHPTGOSA-N,42,"(4R,5S,6S,7R)-4,7-dibenzyl-1-(cyclopropylmethyl)-5,6-dihydroxy-3-(prop-2-en-1-yl)-1,3-diazepan-2-one::DMPC Cyclic Urea 22",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
23,OCC(O)CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCC(O)CO)C1=O,"InChI=1S/C31H46N2O7/c34-21-25(36)15-7-9-17-32-27(19-23-11-3-1-4-12-23)29(38)30(39)28(20-24-13-5-2-6-14-24)33(31(32)40)18-10-8-16-26(37)22-35/h1-6,11-14,25-30,34-39H,7-10,15-22H2/t25?,26?,27-,28-,29+,30+/m1/s1",MHPLIQPYLFRDSQ-TXAUPYHESA-N,43,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(5,6-dihydroxyhexyl)-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 23",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
24,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CCCC2)C(=O)N(CC2CCCC2)[C@@H]1Cc1ccccc1,"InChI=1S/C31H42N2O3/c34-29-27(19-23-11-3-1-4-12-23)32(21-25-15-7-8-16-25)31(36)33(22-26-17-9-10-18-26)28(30(29)35)20-24-13-5-2-6-14-24/h1-6,11-14,25-30,34-35H,7-10,15-22H2/t27-,28-,29+,30+/m1/s1",QZTNLTALZBMNPA-XAZDILKDSA-N,44,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(cyclopentylmethyl)-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL287274::DMPC Cyclic Urea 24",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
25,CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC=C)C1=O,"InChI=1S/C26H34N2O3/c1-3-5-17-28-23(19-21-14-10-7-11-15-21)25(30)24(29)22(27(16-4-2)26(28)31)18-20-12-8-6-9-13-20/h4,6-15,22-25,29-30H,2-3,5,16-19H2,1H3/t22-,23-,24+,25+/m1/s1",RBIWFYGQJSVKBO-NGSHPTGOSA-N,45,"(4R,5S,6S,7R)-4,7-dibenzyl-1-butyl-5,6-dihydroxy-3-(prop-2-en-1-yl)-1,3-diazepan-2-one::DMPC Cyclic Urea 25",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
26,CCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCC)C1=O,"InChI=1S/C29H42N2O3/c1-3-5-13-19-30-25(21-23-15-9-7-10-16-23)27(32)28(33)26(22-24-17-11-8-12-18-24)31(29(30)34)20-14-6-4-2/h7-12,15-18,25-28,32-33H,3-6,13-14,19-22H2,1-2H3/t25-,26-,27+,28+/m1/s1",MQXUJTOWJYVUBG-VIJSPRBVSA-N,46,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-dipentyl-1,3-diazepan-2-one::CHEMBL420054::DMPC Cyclic Urea 26",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
27,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CCCC2)C(=O)N(CC2CC2)[C@@H]1Cc1ccccc1,"InChI=1S/C29H38N2O3/c32-27-25(17-21-9-3-1-4-10-21)30(19-23-13-7-8-14-23)29(34)31(20-24-15-16-24)26(28(27)33)18-22-11-5-2-6-12-22/h1-6,9-12,23-28,32-33H,7-8,13-20H2/t25-,26-,27+,28+/m1/s1",ZVCYAYFZGSWKCW-VIJSPRBVSA-N,47,"(4R,5S,6S,7R)-4,7-dibenzyl-1-(cyclopentylmethyl)-3-(cyclopropylmethyl)-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 27",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
28,COC(=O)CCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCC(O)=O)C1=O,"InChI=1S/C32H44N2O7/c1-41-29(37)19-11-5-13-21-34-27(23-25-16-8-3-9-17-25)31(39)30(38)26(22-24-14-6-2-7-15-24)33(32(34)40)20-12-4-10-18-28(35)36/h2-3,6-9,14-17,26-27,30-31,38-39H,4-5,10-13,18-23H2,1H3,(H,35,36)/t26-,27-,30+,31+/m1/s1",UOQMTCQFQIUGCW-MLHYWSLVSA-N,48,"6-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(6-methoxy-6-oxohexyl)-2-oxo-1,3-diazepan-1-yl]hexanoic acid::DMPC Cyclic Urea 28",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
29,CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CCCC2)C1=O,"InChI=1S/C29H40N2O3/c1-2-3-18-30-25(19-22-12-6-4-7-13-22)27(32)28(33)26(20-23-14-8-5-9-15-23)31(29(30)34)21-24-16-10-11-17-24/h4-9,12-15,24-28,32-33H,2-3,10-11,16-21H2,1H3/t25-,26-,27+,28+/m1/s1",DUDCFZLRJBOUDU-VIJSPRBVSA-N,49,"(4R,5S,6S,7R)-4,7-dibenzyl-1-butyl-3-(cyclopentylmethyl)-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 29",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
30,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC=C)C(=O)N(CC=C)[C@@H]1Cc1ccccc1,"InChI=1S/C25H30N2O3/c1-3-15-26-21(17-19-11-7-5-8-12-19)23(28)24(29)22(27(16-4-2)25(26)30)18-20-13-9-6-10-14-20/h3-14,21-24,28-29H,1-2,15-18H2/t21-,22-,23+,24+/m1/s1",IWJSQELMWLOYSO-LWSSLDFYSA-N,152,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(prop-2-en-1-yl)-1,3-diazepan-2-one::CHEMBL284314::XK216",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
31,CCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCC)C1=O,"InChI=1S/C31H46N2O3/c1-3-5-7-15-21-32-27(23-25-17-11-9-12-18-25)29(34)30(35)28(24-26-19-13-10-14-20-26)33(31(32)36)22-16-8-6-4-2/h9-14,17-20,27-30,34-35H,3-8,15-16,21-24H2,1-2H3/t27-,28-,29+,30+/m1/s1",YKPHAYCUAMAQPA-XAZDILKDSA-N,51,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-dihexyl-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL314052::DMPC Cyclic Urea 31",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
32,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CC2)C(=O)N(C\C=C\c2ccccc2)[C@@H]1Cc1ccccc1,"InChI=1S/C32H36N2O3/c35-30-28(21-25-13-6-2-7-14-25)33(20-10-17-24-11-4-1-5-12-24)32(37)34(23-27-18-19-27)29(31(30)36)22-26-15-8-3-9-16-26/h1-17,27-31,35-36H,18-23H2/b17-10+/t28-,29-,30+,31+/m1/s1",JQIJRUHAAZUJCS-QFUXTDBTSA-N,52,"(4R,5S,6S,7R)-4,7-dibenzyl-1-(cyclopropylmethyl)-5,6-dihydroxy-3-[(2E)-3-phenylprop-2-en-1-yl]-1,3-diazepan-2-one::DMPC Cyclic Urea 32",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
33,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(C\C=C\c2ccccc2)C(=O)N(C\C=C\c2ccccc2)[C@@H]1Cc1ccccc1,"InChI=1S/C37H38N2O3/c40-35-33(27-31-19-9-3-10-20-31)38(25-13-23-29-15-5-1-6-16-29)37(42)39(26-14-24-30-17-7-2-8-18-30)34(36(35)41)28-32-21-11-4-12-22-32/h1-24,33-36,40-41H,25-28H2/b23-13+,24-14+/t33-,34-,35+,36+/m1/s1",PQAGQBVFTNIPFE-IKDXNIPKSA-N,53,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[(2E)-3-phenylprop-2-en-1-yl]-1,3-diazepan-2-one::DMPC Cyclic Urea 33",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
34,CNC(=O)OCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCCO)C1=O,"InChI=1S/C33H49N3O6/c1-34-32(40)42-23-15-5-3-13-21-36-29(25-27-18-10-7-11-19-27)31(39)30(38)28(24-26-16-8-6-9-17-26)35(33(36)41)20-12-2-4-14-22-37/h6-11,16-19,28-31,37-39H,2-5,12-15,20-25H2,1H3,(H,34,40)/t28-,29-,30+,31+/m1/s1",ZCPUINNVBUMJTM-VKONIRKNSA-N,54,"6-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(6-hydroxyhexyl)-2-oxo-1,3-diazepan-1-yl]hexyl N-methylcarbamate::DMPC Cyclic Urea 34",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
35,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,"InChI=1S/C28H39N3O7S/c1-3-19(2)16-31(39(34,35)22-11-9-21(29)10-12-22)17-25(32)24(15-20-7-5-4-6-8-20)30-28(33)38-26-18-37-27-23(26)13-14-36-27/h4-12,19,23-27,32H,3,13-18,29H2,1-2H3,(H,30,33)/t19-,23-,24-,25+,26-,27+/m0/s1",NKLRQHQHYBFPSD-DRMLODCJSA-N,112654,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-((S)-2-methylbutyl)phenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (10a)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]",Human immunodeficiency virus,
36,CNC(=O)n1cc(C=CCN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(CC=Cc3cnn(c3)C(=O)NC)C2=O)cn1,"InChI=1S/C35H40N8O5/c1-36-33(46)42-23-27(21-38-42)15-9-17-40-29(19-25-11-5-3-6-12-25)31(44)32(45)30(20-26-13-7-4-8-14-26)41(35(40)48)18-10-16-28-22-39-43(24-28)34(47)37-2/h3-16,21-24,29-32,44-45H,17-20H2,1-2H3,(H,36,46)(H,37,47)/t29-,30-,31+,32+/m1/s1",IKEFCSLYZCHDLJ-ZRTHHSRSSA-N,56,"4-[(1E)-3-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-[(2E)-3-[1-(methylcarbamoyl)-1H-pyrazol-4-yl]prop-2-en-1-yl]-2-oxo-1,3-diazepan-1-yl]prop-1-en-1-yl]-N-methyl-1H-pyrazole-1-carboxamide::DMPC Cyclic Urea 36",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
37,CC(C)CCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCC(C)C)C1=O,"InChI=1S/C31H46N2O3/c1-23(2)13-11-19-32-27(21-25-15-7-5-8-16-25)29(34)30(35)28(22-26-17-9-6-10-18-26)33(31(32)36)20-12-14-24(3)4/h5-10,15-18,23-24,27-30,34-35H,11-14,19-22H2,1-4H3/t27-,28-,29+,30+/m1/s1",LYOGIXRQACPKHV-XAZDILKDSA-N,57,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(4-methylpentyl)-1,3-diazepan-2-one::CHEMBL314984::DMPC Cyclic Urea 37",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
38,COCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCO)C1=O,"InChI=1S/C30H44N2O5/c1-37-21-13-5-11-19-32-27(23-25-16-8-3-9-17-25)29(35)28(34)26(22-24-14-6-2-7-15-24)31(30(32)36)18-10-4-12-20-33/h2-3,6-9,14-17,26-29,33-35H,4-5,10-13,18-23H2,1H3/t26-,27-,28+,29+/m1/s1",KSJSYHIMFKBWLA-GKQHHHCTSA-N,58,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(5-hydroxypentyl)-1-(5-methoxypentyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 38",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
39,CCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCC)C1=O,"InChI=1S/C25H34N2O3/c1-3-15-26-21(17-19-11-7-5-8-12-19)23(28)24(29)22(27(16-4-2)25(26)30)18-20-13-9-6-10-14-20/h5-14,21-24,28-29H,3-4,15-18H2,1-2H3/t21-,22-,23+,24+/m1/s1",KVURTRGFRUMHJA-LWSSLDFYSA-N,59,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-dipropyl-1,3-diazepan-2-one::CHEMBL32733::DMPC Cyclic Urea 39",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
40,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)OCc2cccnc2)C(=O)N(CCCCCNC(=O)OCc2cccnc2)[C@@H]1Cc1ccccc1,"InChI=1S/C43H54N6O7/c50-39-37(27-33-15-5-1-6-16-33)48(25-11-3-9-23-46-41(52)55-31-35-19-13-21-44-29-35)43(54)49(38(40(39)51)28-34-17-7-2-8-18-34)26-12-4-10-24-47-42(53)56-32-36-20-14-22-45-30-36/h1-2,5-8,13-22,29-30,37-40,50-51H,3-4,9-12,23-28,31-32H2,(H,46,52)(H,47,53)/t37-,38-,39+,40+/m1/s1",FESAQXBIUJPCIL-WESAGZJESA-N,60,"DMPC Cyclic Urea 40::pyridin-3-ylmethyl N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-(5-{[(pyridin-3-ylmethoxy)carbonyl]amino}pentyl)-1,3-diazepan-1-yl]pentyl}carbamate dihydrate dihydrochloride",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
41,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCC=C)C(=O)N(CCCCC=C)[C@@H]1Cc1ccccc1,"InChI=1S/C31H42N2O3/c1-3-5-7-15-21-32-27(23-25-17-11-9-12-18-25)29(34)30(35)28(24-26-19-13-10-14-20-26)33(31(32)36)22-16-8-6-4-2/h3-4,9-14,17-20,27-30,34-35H,1-2,5-8,15-16,21-24H2/t27-,28-,29+,30+/m1/s1",BTUVWXBOQBUYMH-XAZDILKDSA-N,61,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(hex-5-en-1-yl)-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 41",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
42,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)Oc2ccc(cc2)[N+]([O-])=O)C(=O)N(CCCCCNC(=O)OCc2ccncc2)[C@@H]1Cc1ccccc1,"InChI=1S/C43H52N6O9/c50-39-37(29-32-13-5-1-6-14-32)47(27-11-3-9-23-45-41(52)57-31-34-21-25-44-26-22-34)43(54)48(38(40(39)51)30-33-15-7-2-8-16-33)28-12-4-10-24-46-42(53)58-36-19-17-35(18-20-36)49(55)56/h1-2,5-8,13-22,25-26,37-40,50-51H,3-4,9-12,23-24,27-31H2,(H,45,52)(H,46,53)/t37-,38-,39+,40+/m1/s1",LEMVHGOJSMIBIE-WESAGZJESA-N,62,"4-nitrophenyl N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-(5-{[(pyridin-4-ylmethoxy)carbonyl]amino}pentyl)-1,3-diazepan-1-yl]pentyl}carbamate::DMPC Cyclic Urea 42",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
43,CC(C)CCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCC(C)C)C1=O,"InChI=1S/C29H42N2O3/c1-21(2)15-17-30-25(19-23-11-7-5-8-12-23)27(32)28(33)26(20-24-13-9-6-10-14-24)31(29(30)34)18-16-22(3)4/h5-14,21-22,25-28,32-33H,15-20H2,1-4H3/t25-,26-,27+,28+/m1/s1",VNWDQLNHUXTPLV-VIJSPRBVSA-N,63,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(3-methylbutyl)-1,3-diazepan-2-one::CHEMBL284491::DMPC Cyclic Urea 43",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
44,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCC2CO2)C(=O)N(CCCCC2CO2)[C@@H]1Cc1ccccc1,"InChI=1S/C31H42N2O5/c34-29-27(19-23-11-3-1-4-12-23)32(17-9-7-15-25-21-37-25)31(36)33(18-10-8-16-26-22-38-26)28(30(29)35)20-24-13-5-2-6-14-24/h1-6,11-14,25-30,34-35H,7-10,15-22H2/t25?,26?,27-,28-,29+,30+/m1/s1",MUTHQDJRBVUBPD-TXAUPYHESA-N,64,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[4-(oxiran-2-yl)butyl]-1,3-diazepan-2-one::DMPC Cyclic Urea 44",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
45,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)c2cccc(c2)C(F)(F)F)C(=O)N(CCCCCNC(=O)c2cccc(c2)C(F)(F)F)[C@@H]1Cc1ccccc1,"InChI=1S/C45H50F6N4O5/c46-44(47,48)35-21-13-19-33(29-35)41(58)52-23-9-3-11-25-54-37(27-31-15-5-1-6-16-31)39(56)40(57)38(28-32-17-7-2-8-18-32)55(43(54)60)26-12-4-10-24-53-42(59)34-20-14-22-36(30-34)45(49,50)51/h1-2,5-8,13-22,29-30,37-40,56-57H,3-4,9-12,23-28H2,(H,52,58)(H,53,59)/t37-,38-,39+,40+/m1/s1",VDZJTPNTOORHAL-WESAGZJESA-N,65,"DMPC Cyclic Urea 45::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-(5-{[3-(trifluoromethyl)phenyl]formamido}pentyl)-1,3-diazepan-1-yl]pentyl}-3-(trifluoromethyl)benzamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
46,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)Nc2ccccc2)C(=O)N(CCCCCNC(=O)Nc2ccccc2)[C@@H]1Cc1ccccc1,"InChI=1S/C43H54N6O5/c50-39-37(31-33-19-7-1-8-20-33)48(29-17-5-15-27-44-41(52)46-35-23-11-3-12-24-35)43(54)49(38(40(39)51)32-34-21-9-2-10-22-34)30-18-6-16-28-45-42(53)47-36-25-13-4-14-26-36/h1-4,7-14,19-26,37-40,50-51H,5-6,15-18,27-32H2,(H2,44,46,52)(H2,45,47,53)/t37-,38-,39+,40+/m1/s1",VYJOVOPANSNQSP-WESAGZJESA-N,66,"1-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-{5-[(phenylcarbamoyl)amino]pentyl}-1,3-diazepan-1-yl]pentyl}-3-phenylurea::DMPC Cyclic Urea 46",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
47,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)c2cccc(F)c2)C(=O)N(CCCCCNC(=O)c2cccc(F)c2)[C@@H]1Cc1ccccc1,"InChI=1S/C43H50F2N4O5/c44-35-21-13-19-33(29-35)41(52)46-23-9-3-11-25-48-37(27-31-15-5-1-6-16-31)39(50)40(51)38(28-32-17-7-2-8-18-32)49(43(48)54)26-12-4-10-24-47-42(53)34-20-14-22-36(45)30-34/h1-2,5-8,13-22,29-30,37-40,50-51H,3-4,9-12,23-28H2,(H,46,52)(H,47,53)/t37-,38-,39+,40+/m1/s1",SXZREBMMGUVYHI-WESAGZJESA-N,67,"DMPC Cyclic Urea 47::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-3-{5-[(3-fluorophenyl)formamido]pentyl}-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]pentyl}-3-fluorobenzamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
48,CC(CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCC(C)N=O)C1=O)N=O,"InChI=1S/C31H44N4O5/c1-23(32-39)13-9-11-19-34-27(21-25-15-5-3-6-16-25)29(36)30(37)28(22-26-17-7-4-8-18-26)35(31(34)38)20-12-10-14-24(2)33-40/h3-8,15-18,23-24,27-30,36-37H,9-14,19-22H2,1-2H3/t23?,24?,27-,28-,29+,30+/m1/s1",YVKOJOJTEOMSCG-RNKQMKKOSA-N,68,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[(5Z)-5-(hydroxyimino)hexyl]-1,3-diazepan-2-one::DMPC Cyclic Urea 48",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
49,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)c2ccncc2)C(=O)N(CCCCCNC(=O)c2ccncc2)[C@@H]1Cc1ccccc1,"InChI=1S/C41H50N6O5/c48-37-35(29-31-13-5-1-6-14-31)46(27-11-3-9-21-44-39(50)33-17-23-42-24-18-33)41(52)47(36(38(37)49)30-32-15-7-2-8-16-32)28-12-4-10-22-45-40(51)34-19-25-43-26-20-34/h1-2,5-8,13-20,23-26,35-38,48-49H,3-4,9-12,21-22,27-30H2,(H,44,50)(H,45,51)/t35-,36-,37+,38+/m1/s1",QUUQERMKKZCHEO-RNATXAOGSA-N,69,"CHEMBL282395::DMPC Cyclic Urea 49::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-[5-(pyridin-4-ylformamido)pentyl]-1,3-diazepan-1-yl]pentyl}pyridine-4-carboxamide dihydrochloride",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
50,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)c2ccc(F)cc2)C(=O)N(CCCCCNC(=O)c2ccc(F)cc2)[C@@H]1Cc1ccccc1,"InChI=1S/C43H50F2N4O5/c44-35-21-17-33(18-22-35)41(52)46-25-9-3-11-27-48-37(29-31-13-5-1-6-14-31)39(50)40(51)38(30-32-15-7-2-8-16-32)49(43(48)54)28-12-4-10-26-47-42(53)34-19-23-36(45)24-20-34/h1-2,5-8,13-24,37-40,50-51H,3-4,9-12,25-30H2,(H,46,52)(H,47,53)/t37-,38-,39+,40+/m1/s1",VMAACENPBLBGNM-WESAGZJESA-N,70,"DMPC Cyclic Urea 50::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-3-{5-[(4-fluorophenyl)formamido]pentyl}-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]pentyl}-4-fluorobenzamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
51,OCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCCCl)C1=O,"InChI=1S/C31H45ClN2O4/c32-19-11-1-2-12-20-33-27(23-25-15-7-5-8-16-25)29(36)30(37)28(24-26-17-9-6-10-18-26)34(31(33)38)21-13-3-4-14-22-35/h5-10,15-18,27-30,35-37H,1-4,11-14,19-24H2/t27-,28-,29+,30+/m1/s1",UJPXEKCVJBRCHQ-XAZDILKDSA-N,71,"(4R,5S,6S,7R)-4,7-dibenzyl-1-(6-chlorohexyl)-5,6-dihydroxy-3-(6-hydroxyhexyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 51",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
52,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)c2cc(F)cc(F)c2)C(=O)N(CCCCCNC(=O)c2cc(F)cc(F)c2)[C@@H]1Cc1ccccc1,"InChI=1S/C43H48F4N4O5/c44-33-23-31(24-34(45)27-33)41(54)48-17-9-3-11-19-50-37(21-29-13-5-1-6-14-29)39(52)40(53)38(22-30-15-7-2-8-16-30)51(43(50)56)20-12-4-10-18-49-42(55)32-25-35(46)28-36(47)26-32/h1-2,5-8,13-16,23-28,37-40,52-53H,3-4,9-12,17-22H2,(H,48,54)(H,49,55)/t37-,38-,39+,40+/m1/s1",QGUANZMTSJRLAD-WESAGZJESA-N,72,"DMPC Cyclic Urea 52::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-3-{5-[(3,5-difluorophenyl)formamido]pentyl}-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]pentyl}-3,5-difluorobenzamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
53,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCC(Br)Br)C(=O)N(CCCCCC(Br)Br)[C@@H]1Cc1ccccc1,"InChI=1S/C31H42Br4N2O3/c32-27(33)17-9-3-11-19-36-25(21-23-13-5-1-6-14-23)29(38)30(39)26(22-24-15-7-2-8-16-24)37(31(36)40)20-12-4-10-18-28(34)35/h1-2,5-8,13-16,25-30,38-39H,3-4,9-12,17-22H2/t25-,26-,29+,30+/m1/s1",ICZAKUIGRWRENM-HHGOQMMWSA-N,73,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(6,6-dibromohexyl)-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 53",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
54,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(C\C=C\c2ccccc2O)C(=O)N(C\C=C\c2ccccc2O)[C@@H]1Cc1ccccc1,"InChI=1S/C37H38N2O5/c40-33-21-9-7-17-29(33)19-11-23-38-31(25-27-13-3-1-4-14-27)35(42)36(43)32(26-28-15-5-2-6-16-28)39(37(38)44)24-12-20-30-18-8-10-22-34(30)41/h1-22,31-32,35-36,40-43H,23-26H2/b19-11+,20-12+/t31-,32-,35+,36+/m1/s1",GRMLFZVLLOPZDI-AFASWRATSA-N,74,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[(2E)-3-(2-hydroxyphenyl)prop-2-en-1-yl]-1,3-diazepan-2-one::DMPC Cyclic Urea 54",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
55,CSCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCO)C1=O,"InChI=1S/C30H44N2O4S/c1-37-21-13-5-11-19-32-27(23-25-16-8-3-9-17-25)29(35)28(34)26(22-24-14-6-2-7-15-24)31(30(32)36)18-10-4-12-20-33/h2-3,6-9,14-17,26-29,33-35H,4-5,10-13,18-23H2,1H3/t26-,27-,28+,29+/m1/s1",MCFIUZLETGOEDA-GKQHHHCTSA-N,75,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1-(5-hydroxypentyl)-3-[5-(methylsulfanyl)pentyl]-1,3-diazepan-2-one::DMPC Cyclic Urea 55",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
56,COC(=O)CCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCC(=O)OC)C1=O,"InChI=1S/C33H46N2O7/c1-41-29(36)19-11-5-13-21-34-27(23-25-15-7-3-8-16-25)31(38)32(39)28(24-26-17-9-4-10-18-26)35(33(34)40)22-14-6-12-20-30(37)42-2/h3-4,7-10,15-18,27-28,31-32,38-39H,5-6,11-14,19-24H2,1-2H3/t27-,28-,31+,32+/m1/s1",BVXWMYQTUQMUTR-CKROWEISSA-N,76,"DMPC Cyclic Urea 56::methyl 6-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(6-methoxy-6-oxohexyl)-2-oxo-1,3-diazepan-1-yl]hexanoate",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
57,CC(C)CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCC(C)C)C1=O,"InChI=1S/C33H50N2O3/c1-25(2)15-11-13-21-34-29(23-27-17-7-5-8-18-27)31(36)32(37)30(24-28-19-9-6-10-20-28)35(33(34)38)22-14-12-16-26(3)4/h5-10,17-20,25-26,29-32,36-37H,11-16,21-24H2,1-4H3/t29-,30-,31+,32+/m1/s1",DRAQQTVGOMUDKD-ZRTHHSRSSA-N,77,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(5-methylhexyl)-1,3-diazepan-2-one::CHEMBL316256::DMPC Cyclic Urea 57",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
58,CNS(=O)(=O)OCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCCO)C1=O,"InChI=1S/C32H49N3O7S/c1-33-43(40,41)42-23-15-5-3-13-21-35-29(25-27-18-10-7-11-19-27)31(38)30(37)28(24-26-16-8-6-9-17-26)34(32(35)39)20-12-2-4-14-22-36/h6-11,16-19,28-31,33,36-38H,2-5,12-15,20-25H2,1H3/t28-,29-,30+,31+/m1/s1",MLADZSJIDPANMX-VKONIRKNSA-N,78,"6-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(6-hydroxyhexyl)-2-oxo-1,3-diazepan-1-yl]hexyl N-methylsulfamate::DMPC Cyclic Urea 58",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
59,CC(=O)OCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCCO)C1=O,"InChI=1S/C33H48N2O6/c1-26(37)41-23-15-5-3-13-21-35-30(25-28-18-10-7-11-19-28)32(39)31(38)29(24-27-16-8-6-9-17-27)34(33(35)40)20-12-2-4-14-22-36/h6-11,16-19,29-32,36,38-39H,2-5,12-15,20-25H2,1H3/t29-,30-,31+,32+/m1/s1",WYVYCMXAYLZDQL-ZRTHHSRSSA-N,79,"6-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(6-hydroxyhexyl)-2-oxo-1,3-diazepan-1-yl]hexyl acetate::DMPC Cyclic Urea 59",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
60,OCC1CC1CN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CC2CO)C1=O,"InChI=1S/C29H38N2O5/c32-17-23-13-21(23)15-30-25(11-19-7-3-1-4-8-19)27(34)28(35)26(12-20-9-5-2-6-10-20)31(29(30)36)16-22-14-24(22)18-33/h1-10,21-28,32-35H,11-18H2/t21?,22?,23?,24?,25-,26-,27+,28+/m1/s1",HSLUVHJCBOAUDF-GJKVBGLZSA-N,80,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({[2-(hydroxymethyl)cyclopropyl]methyl})-1,3-diazepan-2-one::DMPC Cyclic Urea 60",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
61,OCCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCCCO)C1=O,"InChI=1S/C33H50N2O5/c36-23-15-5-1-3-13-21-34-29(25-27-17-9-7-10-18-27)31(38)32(39)30(26-28-19-11-8-12-20-28)35(33(34)40)22-14-4-2-6-16-24-37/h7-12,17-20,29-32,36-39H,1-6,13-16,21-26H2/t29-,30-,31+,32+/m1/s1",ULBYZNDXPCBOLF-ZRTHHSRSSA-N,81,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(7-hydroxyheptyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 61",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
62,CNC(=O)CCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCC(=O)NC)C1=O,"InChI=1S/C33H48N4O5/c1-34-29(38)19-11-5-13-21-36-27(23-25-15-7-3-8-16-25)31(40)32(41)28(24-26-17-9-4-10-18-26)37(33(36)42)22-14-6-12-20-30(39)35-2/h3-4,7-10,15-18,27-28,31-32,40-41H,5-6,11-14,19-24H2,1-2H3,(H,34,38)(H,35,39)/t27-,28-,31+,32+/m1/s1",IGFDAOYJCCNRSG-CKROWEISSA-N,82,"6-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-[5-(methylcarbamoyl)pentyl]-2-oxo-1,3-diazepan-1-yl]-N-methylhexanamide::DMPC Cyclic Urea 62",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
63,CC(C)(C)CCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCC(C)(C)C)C1=O,"InChI=1S/C31H46N2O3/c1-30(2,3)17-19-32-25(21-23-13-9-7-10-14-23)27(34)28(35)26(22-24-15-11-8-12-16-24)33(29(32)36)20-18-31(4,5)6/h7-16,25-28,34-35H,17-22H2,1-6H3/t25-,26-,27+,28+/m1/s1",VYSKDMAUVBQCBE-VIJSPRBVSA-N,83,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(3,3-dimethylbutyl)-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL315381::DMPC Cyclic Urea 63",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
64,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC2CCCCC2)C(=O)N(CC2CCCCC2)[C@@H]1Cc1ccccc1,"InChI=1S/C33H46N2O3/c36-31-29(21-25-13-5-1-6-14-25)34(23-27-17-9-3-10-18-27)33(38)35(24-28-19-11-4-12-20-28)30(32(31)37)22-26-15-7-2-8-16-26/h1-2,5-8,13-16,27-32,36-37H,3-4,9-12,17-24H2/t29-,30-,31+,32+/m1/s1",FADBDGCGGLEUOC-ZRTHHSRSSA-N,84,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(cyclohexylmethyl)-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL32828::DMPC Cyclic Urea 64",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
65,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCc2ccccc2)C(=O)N(CCCc2ccccc2)[C@@H]1Cc1ccccc1,"InChI=1S/C37H42N2O3/c40-35-33(27-31-19-9-3-10-20-31)38(25-13-23-29-15-5-1-6-16-29)37(42)39(26-14-24-30-17-7-2-8-18-30)34(36(35)41)28-32-21-11-4-12-22-32/h1-12,15-22,33-36,40-41H,13-14,23-28H2/t33-,34-,35+,36+/m1/s1",IISGOMXPTXBGKW-NWJWHWDBSA-N,85,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(3-phenylpropyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 65",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
66,COCCOCn1cc(\C=C\CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(C\C=C\c3cnn(COCCOC)c3)C2=O)cn1,"InChI=1S/C39H50N6O7/c1-49-19-21-51-29-42-27-33(25-40-42)15-9-17-44-35(23-31-11-5-3-6-12-31)37(46)38(47)36(24-32-13-7-4-8-14-32)45(39(44)48)18-10-16-34-26-41-43(28-34)30-52-22-20-50-2/h3-16,25-28,35-38,46-47H,17-24,29-30H2,1-2H3/b15-9+,16-10+/t35-,36-,37+,38+/m1/s1",GMCPYLZPVZCQFF-BWYNHLEOSA-N,86,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[(2E)-3-{1-[(2-methoxyethoxy)methyl]-1H-pyrazol-4-yl}prop-2-en-1-yl]-1,3-diazepan-2-one::DMPC Cyclic Urea 66",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
67,OCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCO)C1=O,"InChI=1S/C27H38N2O5/c30-17-9-7-15-28-23(19-21-11-3-1-4-12-21)25(32)26(33)24(20-22-13-5-2-6-14-22)29(27(28)34)16-8-10-18-31/h1-6,11-14,23-26,30-33H,7-10,15-20H2/t23-,24-,25+,26+/m1/s1",QNAMUDMCVZGMML-XPGKHFPBSA-N,87,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(4-hydroxybutyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 67",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
68,CNC(=O)OCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCCOC(=O)NC)C1=O,"InChI=1S/C35H52N4O7/c1-36-33(42)45-23-15-5-3-13-21-38-29(25-27-17-9-7-10-18-27)31(40)32(41)30(26-28-19-11-8-12-20-28)39(35(38)44)22-14-4-6-16-24-46-34(43)37-2/h7-12,17-20,29-32,40-41H,3-6,13-16,21-26H2,1-2H3,(H,36,42)(H,37,43)/t29-,30-,31+,32+/m1/s1",FZEYSAKGSQEVKR-ZRTHHSRSSA-N,88,"6-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{6-[(methylcarbamoyl)oxy]hexyl}-2-oxo-1,3-diazepan-1-yl]hexyl N-methylcarbamate::DMPC Cyclic Urea 68",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
69,CC(C)(O)CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCC(C)(C)O)C1=O,"InChI=1S/C33H50N2O5/c1-32(2,39)19-11-13-21-34-27(23-25-15-7-5-8-16-25)29(36)30(37)28(24-26-17-9-6-10-18-26)35(31(34)38)22-14-12-20-33(3,4)40/h5-10,15-18,27-30,36-37,39-40H,11-14,19-24H2,1-4H3/t27-,28-,29+,30+/m1/s1",UVMQENHVXVZWQX-XAZDILKDSA-N,89,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(5-hydroxy-5-methylhexyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 69",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
70,C\C(=C/CN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(C\C=C(/C)C(O)=O)C1=O)C(O)=O,"InChI=1S/C29H34N2O7/c1-19(27(34)35)13-15-30-23(17-21-9-5-3-6-10-21)25(32)26(33)24(18-22-11-7-4-8-12-22)31(29(30)38)16-14-20(2)28(36)37/h3-14,23-26,32-33H,15-18H2,1-2H3,(H,34,35)(H,36,37)/b19-13+,20-14+/t23-,24-,25+,26+/m1/s1",ANMQVZAKIUOCAR-ZTLIVNGJSA-N,90,"(2E)-4-[(4R,5S,6S,7R)-4,7-dibenzyl-3-[(2E)-3-carboxy-3-methylprop-2-en-1-yl]-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]-2-methylbut-2-enoic acid::DMPC Cyclic Urea 70",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
71,CC(C)CN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC(C)C)C1=O,"InChI=1S/C27H38N2O3/c1-19(2)17-28-23(15-21-11-7-5-8-12-21)25(30)26(31)24(16-22-13-9-6-10-14-22)29(27(28)32)18-20(3)4/h5-14,19-20,23-26,30-31H,15-18H2,1-4H3/t23-,24-,25+,26+/m1/s1",FTNYZEKSGWZDIC-XPGKHFPBSA-N,91,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(2-methylpropyl)-1,3-diazepan-2-one::CHEMBL86874::DMPC Cyclic Urea 71",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
72,OCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCO)C1=O,"InChI=1S/C25H34N2O5/c28-15-7-13-26-21(17-19-9-3-1-4-10-19)23(30)24(31)22(18-20-11-5-2-6-12-20)27(25(26)32)14-8-16-29/h1-6,9-12,21-24,28-31H,7-8,13-18H2/t21-,22-,23+,24+/m1/s1",IJCXSYFOPRLLCZ-LWSSLDFYSA-N,92,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(3-hydroxypropyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 72",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
73,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)c2ccccc2)C(=O)N(CCCCCNC(=O)c2ccccc2)[C@@H]1Cc1ccccc1,"InChI=1S/C43H52N4O5/c48-39-37(31-33-19-7-1-8-20-33)46(29-17-5-15-27-44-41(50)35-23-11-3-12-24-35)43(52)47(38(40(39)49)32-34-21-9-2-10-22-34)30-18-6-16-28-45-42(51)36-25-13-4-14-26-36/h1-4,7-14,19-26,37-40,48-49H,5-6,15-18,27-32H2,(H,44,50)(H,45,51)/t37-,38-,39+,40+/m1/s1",HVCGCQVDUHANJA-WESAGZJESA-N,93,"DMPC Cyclic Urea 73::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-[5-(phenylformamido)pentyl]-1,3-diazepan-1-yl]pentyl}benzamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
74,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCOC=C)C(=O)N(CCOC=C)[C@@H]1Cc1ccccc1,"InChI=1S/C27H34N2O5/c1-3-33-17-15-28-23(19-21-11-7-5-8-12-21)25(30)26(31)24(20-22-13-9-6-10-14-22)29(27(28)32)16-18-34-4-2/h3-14,23-26,30-31H,1-2,15-20H2/t23-,24-,25+,26+/m1/s1",VYANBIBLIUKGJH-XPGKHFPBSA-N,94,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis[2-(ethenyloxy)ethyl]-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL313599::DMPC Cyclic Urea 74",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
75,CC(=O)CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCC(C)=O)C1=O,"InChI=1S/C31H42N2O5/c1-23(34)13-9-11-19-32-27(21-25-15-5-3-6-16-25)29(36)30(37)28(22-26-17-7-4-8-18-26)33(31(32)38)20-12-10-14-24(2)35/h3-8,15-18,27-30,36-37H,9-14,19-22H2,1-2H3/t27-,28-,29+,30+/m1/s1",QEYSIQWBPKNYHP-XAZDILKDSA-N,95,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(5-oxohexyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 75",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
76,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCC#N)C(=O)N(CCCCC#N)[C@@H]1Cc1ccccc1,"InChI=1S/C29H36N4O3/c30-17-9-3-11-19-32-25(21-23-13-5-1-6-14-23)27(34)28(35)26(22-24-15-7-2-8-16-24)33(29(32)36)20-12-4-10-18-31/h1-2,5-8,13-16,25-28,34-35H,3-4,9-12,19-22H2/t25-,26-,27+,28+/m1/s1",YHBNJXDOWCKLMO-VIJSPRBVSA-N,96,"5-[(4R,5S,6S,7R)-4,7-dibenzyl-3-(4-cyanobutyl)-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]pentanenitrile::DMPC Cyclic Urea 76",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
77,CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCc2ccccc2)C1=O,"InChI=1S/C31H38N2O3/c1-2-3-20-32-27(22-25-15-9-5-10-16-25)29(34)30(35)28(23-26-17-11-6-12-18-26)33(31(32)36)21-19-24-13-7-4-8-14-24/h4-18,27-30,34-35H,2-3,19-23H2,1H3/t27-,28-,29+,30+/m1/s1",APTPAWBYQDCQND-XAZDILKDSA-N,97,"(4R,5S,6S,7R)-4,7-dibenzyl-1-butyl-5,6-dihydroxy-3-(2-phenylethyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 77",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
78,COCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCOC)C1=O,"InChI=1S/C31H46N2O5/c1-37-21-13-5-11-19-32-27(23-25-15-7-3-8-16-25)29(34)30(35)28(24-26-17-9-4-10-18-26)33(31(32)36)20-12-6-14-22-38-2/h3-4,7-10,15-18,27-30,34-35H,5-6,11-14,19-24H2,1-2H3/t27-,28-,29+,30+/m1/s1",HIMYXPUMLAHVRJ-XAZDILKDSA-N,98,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(5-methoxypentyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 78",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
79,CCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC)C1=O,"InChI=1S/C23H30N2O3/c1-3-24-19(15-17-11-7-5-8-12-17)21(26)22(27)20(25(4-2)23(24)28)16-18-13-9-6-10-14-18/h5-14,19-22,26-27H,3-4,15-16H2,1-2H3/t19-,20-,21+,22+/m1/s1",ITHMKJIOEXGHDG-CZYKHXBRSA-N,99,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-diethyl-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL329184::DMPC Cyclic Urea 79",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
80,CC(C)CCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCC(C)C)C1=O,"InChI=1S/C35H54N2O3/c1-27(2)17-9-7-15-23-36-31(25-29-19-11-5-12-20-29)33(38)34(39)32(26-30-21-13-6-14-22-30)37(35(36)40)24-16-8-10-18-28(3)4/h5-6,11-14,19-22,27-28,31-34,38-39H,7-10,15-18,23-26H2,1-4H3/t31-,32-,33+,34+/m1/s1",LKCCOVZVNWPCLW-WZJLIZBTSA-N,100,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(6-methylheptyl)-1,3-diazepan-2-one::CHEMBL420042::DMPC Cyclic Urea 80",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
81,CNC(=O)OCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCOC(=O)NC)C1=O,"InChI=1S/C33H48N4O7/c1-34-31(40)43-21-13-5-11-19-36-27(23-25-15-7-3-8-16-25)29(38)30(39)28(24-26-17-9-4-10-18-26)37(33(36)42)20-12-6-14-22-44-32(41)35-2/h3-4,7-10,15-18,27-30,38-39H,5-6,11-14,19-24H2,1-2H3,(H,34,40)(H,35,41)/t27-,28-,29+,30+/m1/s1",YETCRWADEIUMHR-XAZDILKDSA-N,101,"5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{5-[(methylcarbamoyl)oxy]pentyl}-2-oxo-1,3-diazepan-1-yl]pentyl N-methylcarbamate::DMPC Cyclic Urea 81",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
82,CNC(=S)NCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=S)NC)C1=O,"InChI=1S/C33H50N6O3S2/c1-34-31(43)36-19-11-5-13-21-38-27(23-25-15-7-3-8-16-25)29(40)30(41)28(24-26-17-9-4-10-18-26)39(33(38)42)22-14-6-12-20-37-32(44)35-2/h3-4,7-10,15-18,27-30,40-41H,5-6,11-14,19-24H2,1-2H3,(H2,34,36,43)(H2,35,37,44)/t27-,28-,29+,30+/m1/s1",VZSDXHRHGMNLAN-XAZDILKDSA-N,102,"1-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{5-[(methylcarbamothioyl)amino]pentyl}-2-oxo-1,3-diazepan-1-yl]pentyl}-3-methylthiourea::DMPC Cyclic Urea 82",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
83,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC=C)C(=O)N(CCCN2C(=O)c3ccccc3C2=O)[C@@H]1Cc1ccccc1,"InChI=1S/C33H35N3O5/c1-2-18-34-27(21-23-12-5-3-6-13-23)29(37)30(38)28(22-24-14-7-4-8-15-24)35(33(34)41)19-11-20-36-31(39)25-16-9-10-17-26(25)32(36)40/h2-10,12-17,27-30,37-38H,1,11,18-22H2/t27-,28-,29+,30+/m1/s1",YXKFPFQIDHAWAU-XAZDILKDSA-N,103,"2-{3-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-(prop-2-en-1-yl)-1,3-diazepan-1-yl]propyl}-2,3-dihydro-1H-isoindole-1,3-dione::DMPC Cyclic Urea 83",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
84,CC(C)(CO)CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCC(C)(C)CO)C1=O,"InChI=1S/C35H54N2O5/c1-34(2,25-38)19-11-13-21-36-29(23-27-15-7-5-8-16-27)31(40)32(41)30(24-28-17-9-6-10-18-28)37(33(36)42)22-14-12-20-35(3,4)26-39/h5-10,15-18,29-32,38-41H,11-14,19-26H2,1-4H3/t29-,30-,31+,32+/m1/s1",HWTLVUXMVFQBIM-ZRTHHSRSSA-N,104,"2-amino-1-piperonyl-N-sec-butyl-pyrrolo[3,2-b]quinoxaline-3-carboxamide::DMPC Cyclic Urea 84",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
85,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCC(N=O)c2ccc(F)cc2)C(=O)N(CCCC(N=O)c2ccc(F)cc2)[C@@H]1Cc1ccccc1,"InChI=1S/C39H42F2N4O5/c40-31-19-15-29(16-20-31)33(42-49)13-7-23-44-35(25-27-9-3-1-4-10-27)37(46)38(47)36(26-28-11-5-2-6-12-28)45(39(44)48)24-8-14-34(43-50)30-17-21-32(41)22-18-30/h1-6,9-12,15-22,33-38,46-47H,7-8,13-14,23-26H2/t33?,34?,35-,36-,37+,38+/m1/s1",KDIGFCCJEDREMI-BCJJHTAHSA-N,105,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis[4-(4-fluorophenyl)-4-(hydroxyimino)butyl]-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 85",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
86,CNC(=O)OCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCCOC(C)=O)C1=O,"InChI=1S/C35H51N3O7/c1-27(39)44-23-15-5-3-13-21-37-30(25-28-17-9-7-10-18-28)32(40)33(41)31(26-29-19-11-8-12-20-29)38(35(37)43)22-14-4-6-16-24-45-34(42)36-2/h7-12,17-20,30-33,40-41H,3-6,13-16,21-26H2,1-2H3,(H,36,42)/t30-,31-,32+,33+/m1/s1",DFDROWKHHMKEAZ-FYZVQMPESA-N,106,"6-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{6-[(methylcarbamoyl)oxy]hexyl}-2-oxo-1,3-diazepan-1-yl]hexyl acetate::DMPC Cyclic Urea 86",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
87,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)CN2CCOCC2)C(=O)N(CCCCCNC(=O)CN2CCOCC2)[C@@H]1Cc1ccccc1,"InChI=1S/C41H62N6O7/c48-37(31-44-21-25-53-26-22-44)42-17-9-3-11-19-46-35(29-33-13-5-1-6-14-33)39(50)40(51)36(30-34-15-7-2-8-16-34)47(41(46)52)20-12-4-10-18-43-38(49)32-45-23-27-54-28-24-45/h1-2,5-8,13-16,35-36,39-40,50-51H,3-4,9-12,17-32H2,(H,42,48)(H,43,49)/t35-,36-,39+,40+/m1/s1",GDJYGAPASBSKFB-JFDQHVTASA-N,107,"DMPC Cyclic Urea 87::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{5-[1-(morpholin-4-yl)acetamido]pentyl}-2-oxo-1,3-diazepan-1-yl]pentyl}-2-(morpholin-4-yl)acetamide tetrahydrate dihydrochloride",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
88,CS(=O)(=O)NCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNS(C)(=O)=O)C1=O,"InChI=1S/C31H48N4O7S2/c1-43(39,40)32-19-11-5-13-21-34-27(23-25-15-7-3-8-16-25)29(36)30(37)28(24-26-17-9-4-10-18-26)35(31(34)38)22-14-6-12-20-33-44(2,41)42/h3-4,7-10,15-18,27-30,32-33,36-37H,5-6,11-14,19-24H2,1-2H3/t27-,28-,29+,30+/m1/s1",SPFDDOLVNJYPAH-XAZDILKDSA-N,108,"DMPC Cyclic Urea 88::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(5-methanesulfonamidopentyl)-2-oxo-1,3-diazepan-1-yl]pentyl}methanesulfonamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
89,CNCC(=O)NCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)CNC)C1=O,"InChI=1S/C35H54N6O5/c1-36-25-31(42)38-19-11-5-13-21-40-29(23-27-15-7-3-8-16-27)33(44)34(45)30(24-28-17-9-4-10-18-28)41(35(40)46)22-14-6-12-20-39-32(43)26-37-2/h3-4,7-10,15-18,29-30,33-34,36-37,44-45H,5-6,11-14,19-26H2,1-2H3,(H,38,42)(H,39,43)/t29-,30-,33+,34+/m1/s1",HXYGSLWOJMYBHA-LQKJHIRSSA-N,109,"DMPC Cyclic Urea 89::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{5-[2-(methylamino)acetamido]pentyl}-2-oxo-1,3-diazepan-1-yl]pentyl}-2-(methylamino)acetamide dihydrochloride",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
90,Cc1ccc(cc1)S(=O)(=O)NCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNS(=O)(=O)c2ccc(C)cc2)C1=O,"InChI=1S/C43H56N4O7S2/c1-33-19-23-37(24-20-33)55(51,52)44-27-11-5-13-29-46-39(31-35-15-7-3-8-16-35)41(48)42(49)40(32-36-17-9-4-10-18-36)47(43(46)50)30-14-6-12-28-45-56(53,54)38-25-21-34(2)22-26-38/h3-4,7-10,15-26,39-42,44-45,48-49H,5-6,11-14,27-32H2,1-2H3/t39-,40-,41+,42+/m1/s1",XSRRECGJLGJUCI-GLGKVNTQSA-N,110,"DMPC Cyclic Urea 90::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{5-[(4-methylbenzene)sulfonamido]pentyl}-2-oxo-1,3-diazepan-1-yl]pentyl}-4-methylbenzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
91,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)c2ccccc2F)C(=O)N(CCCCCNC(=O)c2ccccc2F)[C@@H]1Cc1ccccc1,"InChI=1S/C43H50F2N4O5/c44-35-23-11-9-21-33(35)41(52)46-25-13-3-15-27-48-37(29-31-17-5-1-6-18-31)39(50)40(51)38(30-32-19-7-2-8-20-32)49(43(48)54)28-16-4-14-26-47-42(53)34-22-10-12-24-36(34)45/h1-2,5-12,17-24,37-40,50-51H,3-4,13-16,25-30H2,(H,46,52)(H,47,53)/t37-,38-,39+,40+/m1/s1",ZZGWYXUTFLRGQD-WESAGZJESA-N,111,"DMPC Cyclic Urea 91::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-3-{5-[(2-fluorophenyl)formamido]pentyl}-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]pentyl}-2-fluorobenzamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
92,CCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCCC)C1=O,"InChI=1S/C33H50N2O3/c1-3-5-7-9-17-23-34-29(25-27-19-13-11-14-20-27)31(36)32(37)30(26-28-21-15-12-16-22-28)35(33(34)38)24-18-10-8-6-4-2/h11-16,19-22,29-32,36-37H,3-10,17-18,23-26H2,1-2H3/t29-,30-,31+,32+/m1/s1",FSHUUSFSAWCFAT-ZRTHHSRSSA-N,112,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-diheptyl-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL432190::DMPC Cyclic Urea 92",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
93,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=S)Nc2ccccc2)C(=O)N(CCCCCNC(=S)Nc2ccccc2)[C@@H]1Cc1ccccc1,"InChI=1S/C43H54N6O3S2/c50-39-37(31-33-19-7-1-8-20-33)48(29-17-5-15-27-44-41(53)46-35-23-11-3-12-24-35)43(52)49(38(40(39)51)32-34-21-9-2-10-22-34)30-18-6-16-28-45-42(54)47-36-25-13-4-14-26-36/h1-4,7-14,19-26,37-40,50-51H,5-6,15-18,27-32H2,(H2,44,46,53)(H2,45,47,54)/t37-,38-,39+,40+/m1/s1",ATXKYIYRLJEGQW-WESAGZJESA-N,113,"1-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-{5-[(phenylcarbamothioyl)amino]pentyl}-1,3-diazepan-1-yl]pentyl}-3-phenylthiourea::DMPC Cyclic Urea 93",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
94,CNC(=O)NCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)NC)C1=O,"InChI=1S/C33H50N6O5/c1-34-31(42)36-19-11-5-13-21-38-27(23-25-15-7-3-8-16-25)29(40)30(41)28(24-26-17-9-4-10-18-26)39(33(38)44)22-14-6-12-20-37-32(43)35-2/h3-4,7-10,15-18,27-30,40-41H,5-6,11-14,19-24H2,1-2H3,(H2,34,36,42)(H2,35,37,43)/t27-,28-,29+,30+/m1/s1",OYNFRQIQIBKTHH-XAZDILKDSA-N,114,"1-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{5-[(methylcarbamoyl)amino]pentyl}-2-oxo-1,3-diazepan-1-yl]pentyl}-3-methylurea::DMPC Cyclic Urea 94",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
95,CSc1nnc(NCC=CCN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(CC=CCNc3nnc(SC)[nH]3)C2=O)[nH]1,"InChI=1S/C33H42N10O3S2/c1-47-31-36-29(38-40-31)34-17-9-11-19-42-25(21-23-13-5-3-6-14-23)27(44)28(45)26(22-24-15-7-4-8-16-24)43(33(42)46)20-12-10-18-35-30-37-32(48-2)41-39-30/h3-16,25-28,44-45H,17-22H2,1-2H3,(H2,34,36,38,40)(H2,35,37,39,41)/t25-,26-,27+,28+/m1/s1",MOIWHGXXTVBMPC-VIJSPRBVSA-N,115,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[(2E)-4-{[5-(methylsulfanyl)-1H-1,2,4-triazol-3-yl]amino}but-2-en-1-yl]-1,3-diazepan-2-one::DMPC Cyclic Urea 95",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
96,COC(=O)NCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)OC)C1=O,"InChI=1S/C33H48N4O7/c1-43-31(40)34-19-11-5-13-21-36-27(23-25-15-7-3-8-16-25)29(38)30(39)28(24-26-17-9-4-10-18-26)37(33(36)42)22-14-6-12-20-35-32(41)44-2/h3-4,7-10,15-18,27-30,38-39H,5-6,11-14,19-24H2,1-2H3,(H,34,40)(H,35,41)/t27-,28-,29+,30+/m1/s1",YGCQZFGUBAXOFA-XAZDILKDSA-N,116,"DMPC Cyclic Urea 96::methyl N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{5-[(methoxycarbonyl)amino]pentyl}-2-oxo-1,3-diazepan-1-yl]pentyl}carbamate",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
97,CC(=O)NCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(C)=O)C1=O,"InChI=1S/C33H48N4O5/c1-25(38)34-19-11-5-13-21-36-29(23-27-15-7-3-8-16-27)31(40)32(41)30(24-28-17-9-4-10-18-28)37(33(36)42)22-14-6-12-20-35-26(2)39/h3-4,7-10,15-18,29-32,40-41H,5-6,11-14,19-24H2,1-2H3,(H,34,38)(H,35,39)/t29-,30-,31+,32+/m1/s1",CFFYNIWNUKREJO-ZRTHHSRSSA-N,117,"DMPC Cyclic Urea 97::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-3-(5-acetamidopentyl)-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]pentyl}acetamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
98,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(C[C@@H]2CC2(c2ccccc2)c2ccccc2)C(=O)N(C[C@@H]2CC2(c2ccccc2)c2ccccc2)[C@@H]1Cc1ccccc1,"InChI=1S/C51H50N2O3/c54-47-45(31-37-19-7-1-8-20-37)52(35-43-33-50(43,39-23-11-3-12-24-39)40-25-13-4-14-26-40)49(56)53(46(48(47)55)32-38-21-9-2-10-22-38)36-44-34-51(44,41-27-15-5-16-28-41)42-29-17-6-18-30-42/h1-30,43-48,54-55H,31-36H2/t43-,44-,45+,46+,47-,48-/m0/s1",FWJQTCWGFAHKFZ-XKKFLGBRSA-N,118,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis({[(1R)-2,2-diphenylcyclopropyl]methyl})-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 98",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
99,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(C[C@@H]2C[C@H]2c2ccccc2)C(=O)N(C[C@H]2C[C@@H]2c2ccccc2)[C@@H]1Cc1ccccc1,"InChI=1S/C39H42N2O3/c42-37-35(21-27-13-5-1-6-14-27)40(25-31-23-33(31)29-17-9-3-10-18-29)39(44)41(26-32-24-34(32)30-19-11-4-12-20-30)36(38(37)43)22-28-15-7-2-8-16-28/h1-20,31-38,42-43H,21-26H2/t31-,32+,33-,34+,35-,36-,37+,38+/m1/s1",DXYJAAZPNMQYKU-ACYUNPMUSA-N,119,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{[(1R,2R)-2-phenylcyclopropyl]methyl}-1-{[(1S,2S)-2-phenylcyclopropyl]methyl}-1,3-diazepan-2-one::DMPC Cyclic Urea 99",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
100,OCCCCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCCCCO)C1=O,"InChI=1S/C35H54N2O5/c38-25-17-7-3-1-5-15-23-36-31(27-29-19-11-9-12-20-29)33(40)34(41)32(28-30-21-13-10-14-22-30)37(35(36)42)24-16-6-2-4-8-18-26-39/h9-14,19-22,31-34,38-41H,1-8,15-18,23-28H2/t31-,32-,33+,34+/m1/s1",HSHYCDVIHVMARS-WZJLIZBTSA-N,120,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(8-hydroxyoctyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 100",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
101,COCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCOC)C1=O,"InChI=1S/C25H34N2O5/c1-31-15-13-26-21(17-19-9-5-3-6-10-19)23(28)24(29)22(18-20-11-7-4-8-12-20)27(25(26)30)14-16-32-2/h3-12,21-24,28-29H,13-18H2,1-2H3/t21-,22-,23+,24+/m1/s1",MFPWTYXTECUSIK-LWSSLDFYSA-N,121,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(2-methoxyethyl)-1,3-diazepan-2-one::CHEMBL423500::DMPC Cyclic Urea 101",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
102,CN(C)CCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCN(C)C)C1=O,"InChI=1S/C31H48N4O3/c1-32(2)19-11-13-21-34-27(23-25-15-7-5-8-16-25)29(36)30(37)28(24-26-17-9-6-10-18-26)35(31(34)38)22-14-12-20-33(3)4/h5-10,15-18,27-30,36-37H,11-14,19-24H2,1-4H3/t27-,28-,29+,30+/m1/s1",OJXDVNXJVASQNH-XAZDILKDSA-N,122,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis[4-(dimethylamino)butyl]-5,6-dihydroxy-1,3-diazepan-2-one dihydrochloride::DMPC Cyclic Urea 102",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
103,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCC23CC4CC(CC(C4)C2)C3)C(=O)N(CCC23CC4CC(CC(C4)C2)C3)[C@@H]1Cc1ccccc1,"InChI=1S/C43H58N2O3/c46-39-37(21-29-7-3-1-4-8-29)44(13-11-42-23-31-15-32(24-42)17-33(16-31)25-42)41(48)45(38(40(39)47)22-30-9-5-2-6-10-30)14-12-43-26-34-18-35(27-43)20-36(19-34)28-43/h1-10,31-40,46-47H,11-28H2/t31?,32?,33?,34?,35?,36?,37-,38-,39+,40+,42?,43?/m1/s1",YYENRTDDXNTDMK-LSHQIPOWSA-N,123,"(4R,5S,6S,7R)-1,3-bis[2-(adamantan-1-yl)ethyl]-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 103",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
104,O[C@@H](CCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCC[C@@H](O)c2ccc(F)cc2)C1=O)c1ccc(F)cc1,"InChI=1S/C39H44F2N2O5/c40-31-19-15-29(16-20-31)35(44)13-7-23-42-33(25-27-9-3-1-4-10-27)37(46)38(47)34(26-28-11-5-2-6-12-28)43(39(42)48)24-8-14-36(45)30-17-21-32(41)22-18-30/h1-6,9-12,15-22,33-38,44-47H,7-8,13-14,23-26H2/t33-,34-,35-,36+,37+,38+/m1/s1",UHZHRHOHEJRMEP-BKXLAGIUSA-N,124,"(4R,5S,6S,7R)-4,7-dibenzyl-1-[(4R)-4-(4-fluorophenyl)-4-hydroxybutyl]-3-[(4S)-4-(4-fluorophenyl)-4-hydroxybutyl]-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 104",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
105,CCOCCN1[C@@H](Cc2ccccc2)[C@@H](O)[C@H](O)[C@H](Cc2ccccc2)N(CCOCC)C1=O,"InChI=1S/C27H38N2O5/c1-3-33-17-15-28-23(19-21-11-7-5-8-12-21)25(30)26(31)24(20-22-13-9-6-10-14-22)29(27(28)32)16-18-34-4-2/h5-14,23-26,30-31H,3-4,15-20H2,1-2H3/t23-,24-,25+,26+/m0/s1",MPOLZPRZMBTQLP-QEGGNFSNSA-N,125,"(4S,5R,6R,7S)-4,7-dibenzyl-1,3-bis(2-ethoxyethyl)-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 105",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
106,OC(CN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC(O)Cc2ccccc2)C1=O)Cc1ccccc1,"InChI=1S/C37H42N2O5/c40-31(21-27-13-5-1-6-14-27)25-38-33(23-29-17-9-3-10-18-29)35(42)36(43)34(24-30-19-11-4-12-20-30)39(37(38)44)26-32(41)22-28-15-7-2-8-16-28/h1-20,31-36,40-43H,21-26H2/t31?,32?,33-,34-,35+,36+/m1/s1",BJYHOXNNFLNKLG-LMLRNAOASA-N,126,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(2-hydroxy-3-phenylpropyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 106",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
107,NCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCN)C1=O,"InChI=1S/C29H44N4O3/c30-17-9-3-11-19-32-25(21-23-13-5-1-6-14-23)27(34)28(35)26(22-24-15-7-2-8-16-24)33(29(32)36)20-12-4-10-18-31/h1-2,5-8,13-16,25-28,34-35H,3-4,9-12,17-22,30-31H2/t25-,26-,27+,28+/m1/s1",BIEJTDFFXMXWIH-VIJSPRBVSA-N,127,"(4R,5S,6S,7R)-1,3-bis(5-aminopentyl)-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 107",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
108,NCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCN)C1=O,"InChI=1S/C27H40N4O3/c28-15-7-9-17-30-23(19-21-11-3-1-4-12-21)25(32)26(33)24(20-22-13-5-2-6-14-22)31(27(30)34)18-10-8-16-29/h1-6,11-14,23-26,32-33H,7-10,15-20,28-29H2/t23-,24-,25+,26+/m1/s1",TXGJUFAVGDYSPH-XPGKHFPBSA-N,128,"(4R,5S,6S,7R)-1,3-bis(4-aminobutyl)-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one dihydrate dihydrochloride::CHEMBL28470::DMPC Cyclic Urea 108",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
109,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCNC(=O)c2cnccn2)C(=O)N(CCCCCNC(=O)c2cnccn2)[C@@H]1Cc1ccccc1,"InChI=1S/C39H48N8O5/c48-35-33(25-29-13-5-1-6-14-29)46(23-11-3-9-17-44-37(50)31-27-40-19-21-42-31)39(52)47(34(36(35)49)26-30-15-7-2-8-16-30)24-12-4-10-18-45-38(51)32-28-41-20-22-43-32/h1-2,5-8,13-16,19-22,27-28,33-36,48-49H,3-4,9-12,17-18,23-26H2,(H,44,50)(H,45,51)/t33-,34-,35+,36+/m1/s1",KVUSMJLYIOAOHQ-NWJWHWDBSA-N,129,"DMPC Cyclic Urea 109::N-{5-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-[5-(pyrazin-2-ylformamido)pentyl]-1,3-diazepan-1-yl]pentyl}pyrazine-2-carboxamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
110,NC(CCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCC(N)c2ccc(F)cc2)C1=O)c1ccc(F)cc1,"InChI=1S/C39H46F2N4O3/c40-31-19-15-29(16-20-31)33(42)13-7-23-44-35(25-27-9-3-1-4-10-27)37(46)38(47)36(26-28-11-5-2-6-12-28)45(39(44)48)24-8-14-34(43)30-17-21-32(41)22-18-30/h1-6,9-12,15-22,33-38,46-47H,7-8,13-14,23-26,42-43H2/t33?,34?,35-,36-,37+,38+/m1/s1",CWRJATMIQRJWLU-BCJJHTAHSA-N,130,"(4R,5S,6S,7R)-1,3-bis[4-amino-4-(4-fluorophenyl)butyl]-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 110",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
111,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCn2cccn2)C(=O)N(CCCCCn2cccn2)[C@@H]1Cc1ccccc1,"InChI=1S/C35H46N6O3/c42-33-31(27-29-15-5-1-6-16-29)40(25-11-3-9-21-38-23-13-19-36-38)35(44)41(26-12-4-10-22-39-24-14-20-37-39)32(34(33)43)28-30-17-7-2-8-18-30/h1-2,5-8,13-20,23-24,31-34,42-43H,3-4,9-12,21-22,25-28H2/t31-,32-,33+,34+/m1/s1",MHAOCEHEZYLDEO-WZJLIZBTSA-N,131,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[5-(1H-pyrazol-1-yl)pentyl]-1,3-diazepan-2-one::DMPC Cyclic Urea 111",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
112,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC#Cc2ccccc2)C(=O)N(CC#Cc2ccccc2)[C@@H]1Cc1ccccc1,"InChI=1S/C37H34N2O3/c40-35-33(27-31-19-9-3-10-20-31)38(25-13-23-29-15-5-1-6-16-29)37(42)39(26-14-24-30-17-7-2-8-18-30)34(36(35)41)28-32-21-11-4-12-22-32/h1-12,15-22,33-36,40-41H,25-28H2/t33-,34-,35+,36+/m1/s1",HGZAFFDUYZNFNL-NWJWHWDBSA-N,132,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(3-phenylprop-2-yn-1-yl)-1,3-diazepan-2-one::DMPC Cyclic Urea 112",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
113,[NH3+]CCCCCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCC[NH3+])C1=O,"InChI=1S/C31H48N4O3/c32-19-11-1-3-13-21-34-27(23-25-15-7-5-8-16-25)29(36)30(37)28(24-26-17-9-6-10-18-26)35(31(34)38)22-14-4-2-12-20-33/h5-10,15-18,27-30,36-37H,1-4,11-14,19-24,32-33H2/p+2/t27-,28-,29+,30+/m1/s1",VZUHWGBQQIOAGX-XAZDILKDSA-P,133,"6-[(4R,5S,6S,7R)-3-(6-aminiumylhexyl)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]hexan-1-aminium dichloride::DMPC Cyclic Urea 113",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
114,Cc1cc(C)cc(NC\C=C\CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(C\C=C\CNc3cc(C)cc(C)c3)C2=O)c1,"InChI=1S/C43H52N4O3/c1-31-23-32(2)26-37(25-31)44-19-11-13-21-46-39(29-35-15-7-5-8-16-35)41(48)42(49)40(30-36-17-9-6-10-18-36)47(43(46)50)22-14-12-20-45-38-27-33(3)24-34(4)28-38/h5-18,23-28,39-42,44-45,48-49H,19-22,29-30H2,1-4H3/b13-11+,14-12+/t39-,40-,41+,42+/m1/s1",FSMRXXHDZHZEOZ-XQUPZXFPSA-N,134,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis[(2E)-4-[(3,5-dimethylphenyl)amino]but-2-en-1-yl]-5,6-dihydroxy-1,3-diazepan-2-one dihydrochloride::DMPC Cyclic Urea 114",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
115,OCCOCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCOCCO)C1=O,"InChI=1S/C27H38N2O7/c30-13-17-35-15-11-28-23(19-21-7-3-1-4-8-21)25(32)26(33)24(20-22-9-5-2-6-10-22)29(27(28)34)12-16-36-18-14-31/h1-10,23-26,30-33H,11-20H2/t23-,24-,25+,26+/m1/s1",KDNCODBZLKVUEM-XPGKHFPBSA-N,135,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[2-(2-hydroxyethoxy)ethyl]-1,3-diazepan-2-one::DMPC Cyclic Urea 115",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
116,CN(C)CCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCN(C)C)C1=O,"InChI=1S/C27H40N4O3/c1-28(2)15-17-30-23(19-21-11-7-5-8-12-21)25(32)26(33)24(20-22-13-9-6-10-14-22)31(27(30)34)18-16-29(3)4/h5-14,23-26,32-33H,15-20H2,1-4H3/t23-,24-,25+,26+/m1/s1",YHIYCMLSRJCVBV-XPGKHFPBSA-N,136,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis[2-(dimethylamino)ethyl]-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 116",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
117,CC(O)CC1C(CCN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(CCC3C(CC(C)O)C3(C)C)C2=O)C1(C)C,"InChI=1S/C39H58N2O5/c1-25(42)21-31-29(38(31,3)4)17-19-40-33(23-27-13-9-7-10-14-27)35(44)36(45)34(24-28-15-11-8-12-16-28)41(37(40)46)20-18-30-32(22-26(2)43)39(30,5)6/h7-16,25-26,29-36,42-45H,17-24H2,1-6H3/t25?,26?,29?,30?,31?,32?,33-,34-,35+,36+/m1/s1",JNHYHLHMBTYIMN-IQVGKYBMSA-N,137,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({2-[3-(2-hydroxypropyl)-2,2-dimethylcyclopropyl]ethyl})-1,3-diazepan-2-one::DMPC Cyclic Urea 117",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
118,C[NH+](C)CCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC[NH+](C)C)C1=O,"InChI=1S/C27H40N4O3/c1-28(2)15-17-30-23(19-21-11-7-5-8-12-21)25(32)26(33)24(20-22-13-9-6-10-14-22)31(27(30)34)18-16-29(3)4/h5-14,23-26,32-33H,15-20H2,1-4H3/p+2/t23-,24-,25+,26+/m1/s1",YHIYCMLSRJCVBV-XPGKHFPBSA-P,138,"DMPC Cyclic Urea 118::{2-[(4R,5S,6S,7R)-4,7-dibenzyl-3-[2-(dimethylaminiumyl)ethyl]-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]ethyl}dimethylazanium diiodide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
119,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCC(=O)c2ccc(F)cc2)C(=O)N(CCCC(=O)c2ccc(F)cc2)[C@@H]1Cc1ccccc1,"InChI=1S/C39H40F2N2O5/c40-31-19-15-29(16-20-31)35(44)13-7-23-42-33(25-27-9-3-1-4-10-27)37(46)38(47)34(26-28-11-5-2-6-12-28)43(39(42)48)24-8-14-36(45)30-17-21-32(41)22-18-30/h1-6,9-12,15-22,33-34,37-38,46-47H,7-8,13-14,23-26H2/t33-,34-,37+,38+/m1/s1",DDJAJENDNFYDNC-HVYOWVPISA-N,139,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis[4-(4-fluorophenyl)-4-oxobutyl]-5,6-dihydroxy-1,3-diazepan-2-one::DMPC Cyclic Urea 119",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
120,CC1=NOC(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(CC3CC(C)=NO3)C2=O)C1,"InChI=1S/C29H36N4O5/c1-19-13-23(37-30-19)17-32-25(15-21-9-5-3-6-10-21)27(34)28(35)26(16-22-11-7-4-8-12-22)33(29(32)36)18-24-14-20(2)31-38-24/h3-12,23-28,34-35H,13-18H2,1-2H3/t23?,24?,25-,26-,27+,28+/m1/s1",VFROLCJFXPJAHV-QPOYVEKMSA-N,140,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[(3-methyl-4,5-dihydro-1,2-oxazol-5-yl)methyl]-1,3-diazepan-2-one::DMPC Cyclic Urea 120",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
121,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCN2CCOCC2)C(=O)N(CCN2CCOCC2)[C@@H]1Cc1ccccc1,"InChI=1S/C31H44N4O5/c36-29-27(23-25-7-3-1-4-8-25)34(13-11-32-15-19-39-20-16-32)31(38)35(14-12-33-17-21-40-22-18-33)28(30(29)37)24-26-9-5-2-6-10-26/h1-10,27-30,36-37H,11-24H2/t27-,28-,29+,30+/m1/s1",XFJDWPUDCKDRDP-XAZDILKDSA-N,141,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[2-(morpholin-4-yl)ethyl]-1,3-diazepan-2-one::DMPC Cyclic Urea 121",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
122,CCC(O)CN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC(O)CC)C1=O,"InChI=1S/C27H38N2O5/c1-3-21(30)17-28-23(15-19-11-7-5-8-12-19)25(32)26(33)24(16-20-13-9-6-10-14-20)29(27(28)34)18-22(31)4-2/h5-14,21-26,30-33H,3-4,15-18H2,1-2H3/t21?,22?,23-,24-,25+,26+/m1/s1",BUZLNNRMOXQFFF-BQXPWZCYSA-N,142,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(2-hydroxybutyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 122",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
123,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCC2CCNCC2)C(=O)N(CCC2CCNCC2)[C@@H]1Cc1ccccc1,"InChI=1S/C33H48N4O3/c38-31-29(23-27-7-3-1-4-8-27)36(21-15-25-11-17-34-18-12-25)33(40)37(22-16-26-13-19-35-20-14-26)30(32(31)39)24-28-9-5-2-6-10-28/h1-10,25-26,29-32,34-35,38-39H,11-24H2/t29-,30-,31+,32+/m1/s1",QCFLNAJMYWWHRE-ZRTHHSRSSA-N,143,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[2-(piperidin-4-yl)ethyl]-1,3-diazepan-2-one::DMPC Cyclic Urea 123",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
124,CC(=O)NCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCNC(C)=O)C1=O,"InChI=1S/C27H36N4O5/c1-19(32)28-13-15-30-23(17-21-9-5-3-6-10-21)25(34)26(35)24(18-22-11-7-4-8-12-22)31(27(30)36)16-14-29-20(2)33/h3-12,23-26,34-35H,13-18H2,1-2H3,(H,28,32)(H,29,33)/t23-,24-,25+,26+/m1/s1",WQKFMDZPKVSKRJ-XPGKHFPBSA-N,144,"DMPC Cyclic Urea 124::N-{2-[(4R,5S,6S,7R)-4,7-dibenzyl-3-(2-acetamidoethyl)-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]ethyl}acetamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
125,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCNC(=O)Cc2ccccn2)C(=O)N(CCNC(=O)Cc2ccccn2)[C@@H]1Cc1ccccc1,"InChI=1S/C37H42N6O5/c44-33(25-29-15-7-9-17-38-29)40-19-21-42-31(23-27-11-3-1-4-12-27)35(46)36(47)32(24-28-13-5-2-6-14-28)43(37(42)48)22-20-41-34(45)26-30-16-8-10-18-39-30/h1-18,31-32,35-36,46-47H,19-26H2,(H,40,44)(H,41,45)/t31-,32-,35+,36+/m1/s1",HYSMBISRTLFRJM-VPZGHRDASA-N,145,"DMPC Cyclic Urea 125::N-{2-[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-{2-[1-(pyridin-2-yl)acetamido]ethyl}-1,3-diazepan-1-yl]ethyl}-2-(pyridin-2-yl)acetamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
126,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCn2ccnc2)C(=O)N(CCCCCn2ccnc2)[C@@H]1Cc1ccccc1,"InChI=1S/C35H46N6O3/c42-33-31(25-29-13-5-1-6-14-29)40(21-11-3-9-19-38-23-17-36-27-38)35(44)41(22-12-4-10-20-39-24-18-37-28-39)32(34(33)43)26-30-15-7-2-8-16-30/h1-2,5-8,13-18,23-24,27-28,31-34,42-43H,3-4,9-12,19-22,25-26H2/t31-,32-,33+,34+/m1/s1",FDSAKCUNWBEMES-WZJLIZBTSA-N,146,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[5-(1H-imidazol-1-yl)pentyl]-1,3-diazepan-2-one dihydrochloride::DMPC Cyclic Urea 126",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
127,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CCCCCN2CCOCC2)C(=O)N(CCCCCN2CCOCC2)[C@@H]1Cc1ccccc1,"InChI=1S/C37H56N4O5/c42-35-33(29-31-13-5-1-6-14-31)40(19-11-3-9-17-38-21-25-45-26-22-38)37(44)41(20-12-4-10-18-39-23-27-46-28-24-39)34(36(35)43)30-32-15-7-2-8-16-32/h1-2,5-8,13-16,33-36,42-43H,3-4,9-12,17-30H2/t33-,34-,35+,36+/m1/s1",PBVNYQZSCJHDJA-NWJWHWDBSA-N,147,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[5-(morpholin-4-yl)pentyl]-1,3-diazepan-2-one dihydrochloride::DMPC Cyclic Urea 127",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
128,CC(C)(C)C(O)CN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CC(O)C(C)(C)C)C1=O,"InChI=1S/C31H46N2O5/c1-30(2,3)25(34)19-32-23(17-21-13-9-7-10-14-21)27(36)28(37)24(18-22-15-11-8-12-16-22)33(29(32)38)20-26(35)31(4,5)6/h7-16,23-28,34-37H,17-20H2,1-6H3/t23-,24-,25?,26?,27+,28+/m1/s1",HKNHBWLAUQVXRL-RZIVHCQRSA-N,148,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(2-hydroxy-3,3-dimethylbutyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 128",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
129,OCCN1[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N(CCO)C1=O,"InChI=1S/C23H30N2O5/c26-13-11-24-19(15-17-7-3-1-4-8-17)21(28)22(29)20(25(12-14-27)23(24)30)16-18-9-5-2-6-10-18/h1-10,19-22,26-29H,11-16H2/t19-,20-,21+,22+/m1/s1",QIJKJRUCFPJJJX-CZYKHXBRSA-N,149,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(2-hydroxyethyl)-1,3-diazepan-2-one::DMPC Cyclic Urea 129",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
130,OCc1ccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3ccc(CO)cc3)C2=O)cc1,"InChI=1S/C35H38N2O5/c38-23-29-15-11-27(12-16-29)21-36-31(19-25-7-3-1-4-8-25)33(40)34(41)32(20-26-9-5-2-6-10-26)37(35(36)42)22-28-13-17-30(24-39)18-14-28/h1-18,31-34,38-41H,19-24H2/t31-,32-,33+,34+/m1/s1",XCVGQMUMMDXKCY-WZJLIZBTSA-N,150,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({[4-(hydroxymethyl)phenyl]methyl})-1,3-diazepan-2-one::DMP323",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
131,Nc1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(N)c3)C2=O)c1,"InChI=1S/C33H36N4O3/c34-27-15-7-13-25(17-27)21-36-29(19-23-9-3-1-4-10-23)31(38)32(39)30(20-24-11-5-2-6-12-24)37(33(36)40)22-26-14-8-16-28(35)18-26/h1-18,29-32,38-39H,19-22,34-35H2/t29-,30-,31+,32+/m1/s1",KYRSNWPSSXSNEP-ZRTHHSRSSA-N,151,"(4R,5S,6S,7R)-1,3-bis[(3-aminophenyl)methyl]-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL223824::DMP450",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
132,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(CC=C)C(=O)N(CC=C)[C@@H]1Cc1ccccc1,"InChI=1S/C25H30N2O3/c1-3-15-26-21(17-19-11-7-5-8-12-19)23(28)24(29)22(27(16-4-2)25(26)30)18-20-13-9-6-10-14-20/h3-14,21-24,28-29H,1-2,15-18H2/t21-,22-,23+,24+/m1/s1",IWJSQELMWLOYSO-LWSSLDFYSA-N,152,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(prop-2-en-1-yl)-1,3-diazepan-2-one::CHEMBL284314::XK216",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
133,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2ccc3ccccc3c2)C(=O)N(Cc2ccc3ccccc3c2)[C@@H]1Cc1ccccc1,"InChI=1S/C41H38N2O3/c44-39-37(25-29-11-3-1-4-12-29)42(27-31-19-21-33-15-7-9-17-35(33)23-31)41(46)43(38(40(39)45)26-30-13-5-2-6-14-30)28-32-20-22-34-16-8-10-18-36(34)24-32/h1-24,37-40,44-45H,25-28H2/t37-,38-,39+,40+/m1/s1",VUYPJDFAKYXJEV-WESAGZJESA-N,153,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(naphthalen-2-ylmethyl)-1,3-diazepan-2-one::CHEMBL33647::XK263",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
134,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)C(=O)Nc2nccs2)C(=O)N(Cc2cccc(c2)C(=O)Nc2nccs2)[C@@H]1Cc1ccccc1,"InChI=1S/C41H38N6O5S2/c48-35-33(23-27-9-3-1-4-10-27)46(25-29-13-7-15-31(21-29)37(50)44-39-42-17-19-53-39)41(52)47(34(36(35)49)24-28-11-5-2-6-12-28)26-30-14-8-16-32(22-30)38(51)45-40-43-18-20-54-40/h1-22,33-36,48-49H,23-26H2,(H,42,44,50)(H,43,45,51)/t33-,34-,35+,36+/m1/s1",JDALSSGOBMTZEP-NWJWHWDBSA-N,154,"3-{[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-{[3-(1,3-thiazol-2-ylcarbamoyl)phenyl]methyl}-1,3-diazepan-1-yl]methyl}-N-(1,3-thiazol-2-yl)benzamide::CHEMBL57375::XV638",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
135,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)C(=O)Nc2nc3ccccc3[nH]2)C(=O)N(Cc2cccc(c2)C(=O)Nc2nc3ccccc3[nH]2)[C@@H]1Cc1ccccc1,"InChI=1S/C49H44N8O5/c58-43-41(27-31-13-3-1-4-14-31)56(29-33-17-11-19-35(25-33)45(60)54-47-50-37-21-7-8-22-38(37)51-47)49(62)57(42(44(43)59)28-32-15-5-2-6-16-32)30-34-18-12-20-36(26-34)46(61)55-48-52-39-23-9-10-24-40(39)53-48/h1-26,41-44,58-59H,27-30H2,(H2,50,51,54,60)(H2,52,53,55,61)/t41-,42-,43+,44+/m1/s1",UWSVAGUSMAEUKO-QHQGJXSCSA-N,155,"CHEMBL11266::N-(1H-1,3-benzodiazol-2-yl)-3-{[(4R,5S,6S,7R)-3-{[3-(1H-1,3-benzodiazol-2-ylcarbamoyl)phenyl]methyl}-4,7-dibenzyl-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]methyl}benzamide::SD146",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
136,NC(=O)c1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(c3)C(N)=O)C2=O)c1,"InChI=1S/C35H36N4O5/c36-33(42)27-15-7-13-25(17-27)21-38-29(19-23-9-3-1-4-10-23)31(40)32(41)30(20-24-11-5-2-6-12-24)39(35(38)44)22-26-14-8-16-28(18-26)34(37)43/h1-18,29-32,40-41H,19-22H2,(H2,36,42)(H2,37,43)/t29-,30-,31+,32+/m1/s1",XVBGKELHGBXFDC-ZRTHHSRSSA-N,156,"3-{[(4R,5S,6S,7R)-4,7-dibenzyl-3-[(3-carbamoylphenyl)methyl]-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]methyl}benzamide::CHEMBL311499::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
137,CNC(=O)c1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(c3)C(=O)NC)C2=O)c1,"InChI=1S/C37H40N4O5/c1-38-35(44)29-17-9-15-27(19-29)23-40-31(21-25-11-5-3-6-12-25)33(42)34(43)32(22-26-13-7-4-8-14-26)41(37(40)46)24-28-16-10-18-30(20-28)36(45)39-2/h3-20,31-34,42-43H,21-24H2,1-2H3,(H,38,44)(H,39,45)/t31-,32-,33+,34+/m1/s1",LTVYROXJAPCACF-WZJLIZBTSA-N,157,"3-{[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{[3-(methylcarbamoyl)phenyl]methyl}-2-oxo-1,3-diazepan-1-yl]methyl}-N-methylbenzamide::CHEMBL82606::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
138,CCNC(=O)c1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(c3)C(=O)NCC)C2=O)c1,"InChI=1S/C39H44N4O5/c1-3-40-37(46)31-19-11-17-29(21-31)25-42-33(23-27-13-7-5-8-14-27)35(44)36(45)34(24-28-15-9-6-10-16-28)43(39(42)48)26-30-18-12-20-32(22-30)38(47)41-4-2/h5-22,33-36,44-45H,3-4,23-26H2,1-2H3,(H,40,46)(H,41,47)/t33-,34-,35+,36+/m1/s1",NHEIBOKBLUFHEF-NWJWHWDBSA-N,158,"3-{[(4R,5S,6S,7R)-4,7-dibenzyl-3-{[3-(ethylcarbamoyl)phenyl]methyl}-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]methyl}-N-ethylbenzamide::CHEMBL81396::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
139,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)C(=O)Nc2ccccn2)C(=O)N(Cc2cccc(c2)C(=O)Nc2ccccn2)[C@@H]1Cc1ccccc1,"InChI=1S/C45H42N6O5/c52-41-37(27-31-13-3-1-4-14-31)50(29-33-17-11-19-35(25-33)43(54)48-39-21-7-9-23-46-39)45(56)51(38(42(41)53)28-32-15-5-2-6-16-32)30-34-18-12-20-36(26-34)44(55)49-40-22-8-10-24-47-40/h1-26,37-38,41-42,52-53H,27-30H2,(H,46,48,54)(H,47,49,55)/t37-,38-,41+,42+/m1/s1",CTTYWAAVPCSYCV-VNXDFUDDSA-N,159,"3-{[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-{[3-(pyridin-2-ylcarbamoyl)phenyl]methyl}-1,3-diazepan-1-yl]methyl}-N-(pyridin-2-yl)benzamide::CHEMBL81383::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
140,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)C(=O)Nc2ncc[nH]2)C(=O)N(Cc2cccc(c2)C(=O)Nc2ncc[nH]2)[C@@H]1Cc1ccccc1,"InChI=1S/C41H40N8O5/c50-35-33(23-27-9-3-1-4-10-27)48(25-29-13-7-15-31(21-29)37(52)46-39-42-17-18-43-39)41(54)49(34(36(35)51)24-28-11-5-2-6-12-28)26-30-14-8-16-32(22-30)38(53)47-40-44-19-20-45-40/h1-22,33-36,50-51H,23-26H2,(H2,42,43,46,52)(H2,44,45,47,53)/t33-,34-,35+,36+/m1/s1",XFNBBSJRWLSLFP-NWJWHWDBSA-N,160,"3-{[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{[3-(1H-imidazol-2-ylcarbamoyl)phenyl]methyl}-2-oxo-1,3-diazepan-1-yl]methyl}-N-(1H-imidazol-2-yl)benzamide::CHEMBL291677::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
141,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2ccc3[nH]ncc3c2)C(=O)N(Cc2ccc3[nH]ncc3c2)[C@@H]1Cc1ccccc1,"InChI=1S/C35H34N6O3/c42-33-31(17-23-7-3-1-4-8-23)40(21-25-11-13-29-27(15-25)19-36-38-29)35(44)41(22-26-12-14-30-28(16-26)20-37-39-30)32(34(33)43)18-24-9-5-2-6-10-24/h1-16,19-20,31-34,42-43H,17-18,21-22H2,(H,36,38)(H,37,39)/t31-,32-,33+,34+/m1/s1",QMCVFDPMIZPVDS-WZJLIZBTSA-N,161,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(1H-indazol-5-ylmethyl)-1,3-diazepan-2-one::CHEMBL78671::Cyclic Urea::Indazole, 1",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
142,ONC(=N)c1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(c3)C(=N)NO)C2=O)c1,"InChI=1S/C35H38N6O5/c36-33(38-45)27-15-7-13-25(17-27)21-40-29(19-23-9-3-1-4-10-23)31(42)32(43)30(20-24-11-5-2-6-12-24)41(35(40)44)22-26-14-8-16-28(18-26)34(37)39-46/h1-18,29-32,42-43,45-46H,19-22H2,(H2,36,38)(H2,37,39)/t29-,30-,31+,32+/m1/s1",CVCBZRCJISTSIN-ZRTHHSRSSA-N,162,"3-{[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{[3-(N'-hydroxycarbamimidoyl)phenyl]methyl}-2-oxo-1,3-diazepan-1-yl]methyl}-N'-hydroxybenzene-1-carboximidamide::Cyclic Urea::[4R-(4,5,6,7)]-3,3-[[Tetrahydro-5,6-dihydroxy-2-oxo-4,7-bis(phenylmethyl)-1H-1,3-diazepine-1,3(2H)-diyl]bis(methylene)]bis[N-hydroxybenzenecarboximidamide]",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
143,Cc1nc(CN2CCN(CC2)c2c(Cl)cnc3[nH]c(nc23)-c2cn(C)nc2C)no1,"InChI=1S/C19H22ClN9O/c1-11-13(9-27(3)25-11)18-23-16-17(14(20)8-21-19(16)24-18)29-6-4-28(5-7-29)10-15-22-12(2)30-26-15/h8-9H,4-7,10H2,1-3H3,(H,21,23,24)",ZYQKMYRXVHUATB-UHFFFAOYSA-N,247370,"US9447092, 3",Cytochrome P450 3A4,Homo sapiens,>50000
144,O[C@@H]1[C@@H](CCc2ccccc2)N(Cc2ccc3[nH]ncc3c2)C(=O)N(Cc2ccc3[nH]ncc3c2)[C@@H]1Cc1ccccc1,"InChI=1S/C35H34N6O2/c42-34-32(16-13-24-7-3-1-4-8-24)40(22-26-11-14-30-28(17-26)20-36-38-30)35(43)41(33(34)19-25-9-5-2-6-10-25)23-27-12-15-31-29(18-27)21-37-39-31/h1-12,14-15,17-18,20-21,32-34,42H,13,16,19,22-23H2,(H,36,38)(H,37,39)/t32-,33-,34-/m1/s1",XYUHJAIPECDEBR-CKOYEXALSA-N,164,"(4R,5R,6R)-4-benzyl-5-hydroxy-1,3-bis(1H-indazol-5-ylmethyl)-6-(2-phenylethyl)-1,3-diazinan-2-one::CHEMBL288254::Cyclic Urea::[4R-(4,5,6)]-Tetrahydro-5-hydroxy-1,3-bis(1H-indazol-5-ylmethyl)-4-(2-phenylethyl)-6-(phenylmethyl)-2(1H)-pyrimidinone",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
145,O=C1CCCC2=C1C1(CCS(=O)(=O)C1)N=C(Nc1nc3ccccc3o1)N2,"InChI=1S/C25H28Cl2O6/c1-6-7-8-9-10-17(15-11-18(24(28)32-4)22(30-2)20(26)13-15)16-12-19(25(29)33-5)23(31-3)21(27)14-16/h10-14H,6-9H2,1-5H3",BLBHGUJDTWXHFE-UHFFFAOYSA-N,2764,"2-(benzo[d]oxazol-2-ylamino)-4',5',7,8-tetrahydro-1H,2'H-spiro[quinazoline-4,3'-thiophen-1,1-dioxide]-5(6H)-one::US9447087, 24",Galactokinase,, 6676.9
146,O[C@H]1[C@@H](Cc2ccccc2)NC(=O)N(Cc2ccc3[nH]ncc3c2)[C@H](Cc2ccccc2)[C@@H]1O,"InChI=1S/C27H28N4O3/c32-25-23(14-18-7-3-1-4-8-18)29-27(34)31(17-20-11-12-22-21(13-20)16-28-30-22)24(26(25)33)15-19-9-5-2-6-10-19/h1-13,16,23-26,32-33H,14-15,17H2,(H,28,30)(H,29,34)/t23-,24-,25+,26+/m1/s1",RHDRKQCNNGBNHC-XPGKHFPBSA-N,166,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1-(1H-indazol-5-ylmethyl)-1,3-diazepan-2-one::CHEMBL311496::Cyclic Urea::[4R-(4,5,6,7)]-Hexahydro-5,6-dihydroxy-1-(1H-indazol-5-ylmethyl)-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
147,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2ccc3[nH]ncc3c2)C(=O)N(Cc2cccc(c2)C(O)=O)[C@@H]1Cc1ccccc1,"InChI=1S/C35H34N4O5/c40-32-30(18-23-8-3-1-4-9-23)38(21-25-12-7-13-27(16-25)34(42)43)35(44)39(22-26-14-15-29-28(17-26)20-36-37-29)31(33(32)41)19-24-10-5-2-6-11-24/h1-17,20,30-33,40-41H,18-19,21-22H2,(H,36,37)(H,42,43)/t30-,31-,32+,33+/m1/s1",IPSNCGJWCSQSPB-FYZVQMPESA-N,167,"3-{[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(1H-indazol-5-ylmethyl)-2-oxo-1,3-diazepan-1-yl]methyl}benzoic acid::CHEMBL310124::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
148,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2ccc3[nH]ncc3c2)C(=O)N(Cc2cccc(O)c2)[C@@H]1Cc1ccccc1,"InChI=1S/C34H34N4O4/c39-28-13-7-12-25(17-28)21-37-30(18-23-8-3-1-4-9-23)32(40)33(41)31(19-24-10-5-2-6-11-24)38(34(37)42)22-26-14-15-29-27(16-26)20-35-36-29/h1-17,20,30-33,39-41H,18-19,21-22H2,(H,35,36)/t30-,31-,32+,33+/m1/s1",HMBROJULWCDLQT-FYZVQMPESA-N,168,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-[(3-hydroxyphenyl)methyl]-1-(1H-indazol-5-ylmethyl)-1,3-diazepan-2-one::CHEMBL433136::Cyclic Urea::[4R-(4,5,6,7)]-Hexahydro-5,6-dihydroxy-1-[(3-hydroxyphenyl)methyl]-3-(1H-indazol-5-ylmethyl)-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
149,OCCc1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3ccc4[nH]ncc4c3)C2=O)c1,"InChI=1S/C36H38N4O4/c41-17-16-27-12-7-13-28(18-27)23-39-32(20-25-8-3-1-4-9-25)34(42)35(43)33(21-26-10-5-2-6-11-26)40(36(39)44)24-29-14-15-31-30(19-29)22-37-38-31/h1-15,18-19,22,32-35,41-43H,16-17,20-21,23-24H2,(H,37,38)/t32-,33-,34+,35+/m1/s1",PHJUBIAVEOBIMZ-WDKGQIBQSA-N,169,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-{[3-(2-hydroxyethyl)phenyl]methyl}-1-(1H-indazol-5-ylmethyl)-1,3-diazepan-2-one::CHEMBL312358::Cyclic Urea::[4R-(4,5,6,7)]-Hexahydro-5,6-dihydroxy-1-[[3-(2-hydroxyethyl)phenyl]methyl]-3-(1H-indazol-5-ylmethyl)-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
150,COC(=O)Cc1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3ccc4[nH]ncc4c3)C2=O)c1,"InChI=1S/C37H38N4O5/c1-46-34(42)21-27-13-8-14-28(17-27)23-40-32(19-25-9-4-2-5-10-25)35(43)36(44)33(20-26-11-6-3-7-12-26)41(37(40)45)24-29-15-16-31-30(18-29)22-38-39-31/h2-18,22,32-33,35-36,43-44H,19-21,23-24H2,1H3,(H,38,39)/t32-,33-,35+,36+/m1/s1",NFLSBSNFRZFUJE-IHIHPJAWSA-N,170,"CHEMBL309557::Cyclic Urea::[4R-(4,5,6,7)]-Methyl 3-[[Hexahydro-5,6-dihyroxy-3-(1H-indazol-5-ylmethyl)-2-oxo-4,7-bis(phenylmethyl)-1H-1,3-diazepin-1-yl]methyl]benzeneacetate::methyl 2-(3-{[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-(1H-indazol-5-ylmethyl)-2-oxo-1,3-diazepan-1-yl]methyl}phenyl)acetate",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
151,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(C=O)c2)C(=O)N(Cc2cccc(C=O)c2)[C@@H]1Cc1ccccc1,"InChI=1S/C35H34N2O5/c38-23-29-15-7-13-27(17-29)21-36-31(19-25-9-3-1-4-10-25)33(40)34(41)32(20-26-11-5-2-6-12-26)37(35(36)42)22-28-14-8-16-30(18-28)24-39/h1-18,23-24,31-34,40-41H,19-22H2/t31-,32-,33+,34+/m1/s1",SCAKARIEFOIUDT-WZJLIZBTSA-N,171,"3-{[(4R,5S,6S,7R)-4,7-dibenzyl-3-[(3-formylphenyl)methyl]-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]methyl}benzaldehyde::CHEMBL294331::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
152,CC(=O)c1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(c3)C(C)=O)C2=O)c1,"InChI=1S/C37H38N2O5/c1-25(40)31-17-9-15-29(19-31)23-38-33(21-27-11-5-3-6-12-27)35(42)36(43)34(22-28-13-7-4-8-14-28)39(37(38)44)24-30-16-10-18-32(20-30)26(2)41/h3-20,33-36,42-43H,21-24H2,1-2H3/t33-,34-,35+,36+/m1/s1",GNWGNQFZTKCMNP-NWJWHWDBSA-N,172,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis[(3-acetylphenyl)methyl]-5,6-dihydroxy-1,3-diazepan-2-one::(4R,5S,6S,7R)-Hexahydro-5,6-dihydroxy-1,3-bis[(3-acetylphenyl)methyl]-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one::CHEMBL289473::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
153,CCC(=O)c1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(c3)C(=O)CC)C2=O)c1,"InChI=1S/C39H42N2O5/c1-3-35(42)31-19-11-17-29(21-31)25-40-33(23-27-13-7-5-8-14-27)37(44)38(45)34(24-28-15-9-6-10-16-28)41(39(40)46)26-30-18-12-20-32(22-30)36(43)4-2/h5-22,33-34,37-38,44-45H,3-4,23-26H2,1-2H3/t33-,34-,37+,38+/m1/s1",QHMOOLGACYFYIQ-HVYOWVPISA-N,173,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[(3-propanoylphenyl)methyl]-1,3-diazepan-2-one::CHEMBL291814::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
154,CCCC(=O)c1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(c3)C(=O)CCC)C2=O)c1,"InChI=1S/C41H46N2O5/c1-3-13-37(44)33-21-11-19-31(23-33)27-42-35(25-29-15-7-5-8-16-29)39(46)40(47)36(26-30-17-9-6-10-18-30)43(41(42)48)28-32-20-12-22-34(24-32)38(45)14-4-2/h5-12,15-24,35-36,39-40,46-47H,3-4,13-14,25-28H2,1-2H3/t35-,36-,39+,40+/m1/s1",CUSSQSVURRNYDL-JFDQHVTASA-N,174,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis[(3-butanoylphenyl)methyl]-5,6-dihydroxy-1,3-diazepan-2-one::CHEMBL304411::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
155,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)C(=O)C(F)(F)F)C(=O)N(Cc2cccc(c2)C(=O)C(F)(F)F)[C@@H]1Cc1ccccc1,"InChI=1S/C37H32F6N2O5/c38-36(39,40)33(48)27-15-7-13-25(17-27)21-44-29(19-23-9-3-1-4-10-23)31(46)32(47)30(20-24-11-5-2-6-12-24)45(35(44)50)22-26-14-8-16-28(18-26)34(49)37(41,42)43/h1-18,29-32,46-47H,19-22H2/t29-,30-,31+,32+/m1/s1",AMNCJZAOSZGEBS-ZRTHHSRSSA-N,175,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({[3-(2,2,2-trifluoroacetyl)phenyl]methyl})-1,3-diazepan-2-one::(4R,5S,6S,7R)-Hexahydro-5,6-dihydroxy-1,3-bis[[3-(trifluoroacetyl)phenyl]methyl]-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one::CHEMBL292631::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
156,CC(C)(C)C(=O)c1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(c3)C(=O)C(C)(C)C)C2=O)c1,"InChI=1S/C43H50N2O5/c1-42(2,3)39(48)33-21-13-19-31(23-33)27-44-35(25-29-15-9-7-10-16-29)37(46)38(47)36(26-30-17-11-8-12-18-30)45(41(44)50)28-32-20-14-22-34(24-32)40(49)43(4,5)6/h7-24,35-38,46-47H,25-28H2,1-6H3/t35-,36-,37+,38+/m1/s1",IXHSGRWAMNNNRD-RNATXAOGSA-N,176,"(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis({[3-(2,2-dimethylpropanoyl)phenyl]methyl})-5,6-dihydroxy-1,3-diazepan-2-one::(4R,5S,6S,7R)-Hexahydro-5,6-dihydroxy-1,3-bis[(3-pivaloylphenyl)methyl]-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one::CHEMBL304410::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
157,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(CN=O)c2)C(=O)N(Cc2cccc(CN=O)c2)[C@@H]1Cc1ccccc1,"InChI=1S/C35H36N4O5/c40-33-31(19-25-9-3-1-4-10-25)38(23-29-15-7-13-27(17-29)21-36-43)35(42)39(24-30-16-8-14-28(18-30)22-37-44)32(34(33)41)20-26-11-5-2-6-12-26/h1-18,31-34,40-41H,19-24H2/t31-,32-,33+,34+/m1/s1",PMVSRYIVLLIFPU-WZJLIZBTSA-N,177,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({3-[(hydroxyimino)methyl]phenyl}methyl)-1,3-diazepan-2-one::CHEMBL305125::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
158,CC(N=O)c1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(c3)C(C)N=O)C2=O)c1,"InChI=1S/C37H40N4O5/c1-25(38-45)31-17-9-15-29(19-31)23-40-33(21-27-11-5-3-6-12-27)35(42)36(43)34(22-28-13-7-4-8-14-28)41(37(40)44)24-30-16-10-18-32(20-30)26(2)39-46/h3-20,25-26,33-36,42-43H,21-24H2,1-2H3/t25?,26?,33-,34-,35+,36+/m1/s1",FHCPILNSLQORSE-OHHGTCQSSA-N,178,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({3-[1-(hydroxyimino)ethyl]phenyl}methyl)-1,3-diazepan-2-one::4R,5S,6S,7R)-Hexahydro-5,6-dihydroxy-1,3-bis[[3-[1-(hydroxyimino)ethyl]phenyl]methyl]-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one::CHEMBL431174::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
159,CCC(N=O)c1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(c3)C(CC)N=O)C2=O)c1,"InChI=1S/C39H44N4O5/c1-3-33(40-47)31-19-11-17-29(21-31)25-42-35(23-27-13-7-5-8-14-27)37(44)38(45)36(24-28-15-9-6-10-16-28)43(39(42)46)26-30-18-12-20-32(22-30)34(4-2)41-48/h5-22,33-38,44-45H,3-4,23-26H2,1-2H3/t33?,34?,35-,36-,37+,38+/m1/s1",XZYUSIKLNDYKKU-BCJJHTAHSA-N,179,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({3-[1-(hydroxyimino)propyl]phenyl}methyl)-1,3-diazepan-2-one::CHEMBL303128::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
160,CCCC(N=O)c1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3cccc(c3)C(CCC)N=O)C2=O)c1,"InChI=1S/C41H48N4O5/c1-3-13-35(42-49)33-21-11-19-31(23-33)27-44-37(25-29-15-7-5-8-16-29)39(46)40(47)38(26-30-17-9-6-10-18-30)45(41(44)48)28-32-20-12-22-34(24-32)36(43-50)14-4-2/h5-12,15-24,35-40,46-47H,3-4,13-14,25-28H2,1-2H3/t35?,36?,37-,38-,39+,40+/m1/s1",QHWBHDVXWOSETP-SQLYEEAASA-N,180,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({3-[1-(hydroxyimino)butyl]phenyl}methyl)-1,3-diazepan-2-one::CHEMBL292858::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
161,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)C(N=O)C(F)(F)F)C(=O)N(Cc2cccc(c2)C(N=O)C(F)(F)F)[C@@H]1Cc1ccccc1,"InChI=1S/C37H34F6N4O5/c38-36(39,40)33(44-51)27-15-7-13-25(17-27)21-46-29(19-23-9-3-1-4-10-23)31(48)32(49)30(20-24-11-5-2-6-12-24)47(35(46)50)22-26-14-8-16-28(18-26)34(45-52)37(41,42)43/h1-18,29-34,48-49H,19-22H2/t29-,30-,31+,32+,33?,34?/m1/s1",WCAGFROALOKRDR-UIQKQUQUSA-N,181,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({3-[2,2,2-trifluoro-1-(hydroxyimino)ethyl]phenyl}methyl)-1,3-diazepan-2-one::CHEMBL294295::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
162,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)-c2cc[nH]n2)C(=O)N(Cc2cccc(c2)-c2cc[nH]n2)[C@@H]1Cc1ccccc1,"InChI=1S/C39H38N6O3/c46-37-35(23-27-9-3-1-4-10-27)44(25-29-13-7-15-31(21-29)33-17-19-40-42-33)39(48)45(36(38(37)47)24-28-11-5-2-6-12-28)26-30-14-8-16-32(22-30)34-18-20-41-43-34/h1-22,35-38,46-47H,23-26H2,(H,40,42)(H,41,43)/t35-,36-,37+,38+/m1/s1",SREQXWNZQCXRIR-RNATXAOGSA-N,182,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({[3-(1H-pyrazol-3-yl)phenyl]methyl})-1,3-diazepan-2-one::(4R,5S,6S,7R)-Hexahydro-5,6-dihydroxy-1,3-bis[[3-(1H-pyrazol-3-yl)phenyl]methyl]-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one::CHEMBL38314::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
163,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)-c2cn[nH]c2)C(=O)N(Cc2cccc(c2)-c2cn[nH]c2)[C@@H]1Cc1ccccc1,"InChI=1S/C39H38N6O3/c46-37-35(19-27-9-3-1-4-10-27)44(25-29-13-7-15-31(17-29)33-21-40-41-22-33)39(48)45(36(38(37)47)20-28-11-5-2-6-12-28)26-30-14-8-16-32(18-30)34-23-42-43-24-34/h1-18,21-24,35-38,46-47H,19-20,25-26H2,(H,40,41)(H,42,43)/t35-,36-,37+,38+/m1/s1",USPVZNGEOQQYLK-RNATXAOGSA-N,183,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({[3-(1H-pyrazol-4-yl)phenyl]methyl})-1,3-diazepan-2-one::(4R,5S,6S,7R)-Hexahydro-5,6-dihydroxy-1,3-bis[[3-(1H-prazol-4-yl)phenyl]methyl]-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one::CHEMBL304491::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
164,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)-c2ncc[nH]2)C(=O)N(Cc2cccc(c2)-c2ncc[nH]2)[C@@H]1Cc1ccccc1,"InChI=1S/C39H38N6O3/c46-35-33(23-27-9-3-1-4-10-27)44(25-29-13-7-15-31(21-29)37-40-17-18-41-37)39(48)45(34(36(35)47)24-28-11-5-2-6-12-28)26-30-14-8-16-32(22-30)38-42-19-20-43-38/h1-22,33-36,46-47H,23-26H2,(H,40,41)(H,42,43)/t33-,34-,35+,36+/m1/s1",LTSTXUQEHQNBBZ-NWJWHWDBSA-N,184,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({[3-(1H-imidazol-2-yl)phenyl]methyl})-1,3-diazepan-2-one::(4R,5S,6S,7R)-Hexahydro-5,6-dihydroxy-1,3-bis[[3-(1H-imidazol-2-yl)phenyl]methyl]-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one::CHEMBL434019::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
165,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)-c2c[nH]cn2)C(=O)N(Cc2cccc(c2)-c2c[nH]cn2)[C@@H]1Cc1ccccc1,"InChI=1S/C39H38N6O3/c46-37-35(19-27-9-3-1-4-10-27)44(23-29-13-7-15-31(17-29)33-21-40-25-42-33)39(48)45(36(38(37)47)20-28-11-5-2-6-12-28)24-30-14-8-16-32(18-30)34-22-41-26-43-34/h1-18,21-22,25-26,35-38,46-47H,19-20,23-24H2,(H,40,42)(H,41,43)/t35-,36-,37+,38+/m1/s1",LGCLJPYTRGJXHK-RNATXAOGSA-N,185,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({[3-(1H-imidazol-4-yl)phenyl]methyl})-1,3-diazepan-2-one::CHEMBL291621::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
166,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)-c2c[nH]nn2)C(=O)N(Cc2cccc(c2)-c2c[nH]nn2)[C@@H]1Cc1ccccc1,"InChI=1S/C37H36N8O3/c46-35-33(19-25-9-3-1-4-10-25)44(23-27-13-7-15-29(17-27)31-21-38-42-40-31)37(48)45(34(36(35)47)20-26-11-5-2-6-12-26)24-28-14-8-16-30(18-28)32-22-39-43-41-32/h1-18,21-22,33-36,46-47H,19-20,23-24H2,(H,38,40,42)(H,39,41,43)/t33-,34-,35+,36+/m1/s1",RDGHXKOZJGWPHA-NWJWHWDBSA-N,186,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({[3-(2H-1,2,3-triazol-4-yl)phenyl]methyl})-1,3-diazepan-2-one::CHEMBL444038::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
167,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)-c2nnc[nH]2)C(=O)N(Cc2cccc(c2)-c2nnc[nH]2)[C@@H]1Cc1ccccc1,"InChI=1S/C37H36N8O3/c46-33-31(19-25-9-3-1-4-10-25)44(21-27-13-7-15-29(17-27)35-38-23-40-42-35)37(48)45(32(34(33)47)20-26-11-5-2-6-12-26)22-28-14-8-16-30(18-28)36-39-24-41-43-36/h1-18,23-24,31-34,46-47H,19-22H2,(H,38,40,42)(H,39,41,43)/t31-,32-,33+,34+/m1/s1",JJPAWNWDPWKLCQ-WZJLIZBTSA-N,187,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({[3-(1H-1,2,4-triazol-3-yl)phenyl]methyl})-1,3-diazepan-2-one::CHEMBL293654::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
168,O[C@@H]1[C@@H](O)[C@@H](Cc2ccccc2)N(Cc2cccc(c2)-c2nnn[nH]2)C(=O)N(Cc2cccc(c2)-c2nnn[nH]2)[C@@H]1Cc1ccccc1,"InChI=1S/C35H34N10O3/c46-31-29(19-23-9-3-1-4-10-23)44(21-25-13-7-15-27(17-25)33-36-40-41-37-33)35(48)45(30(32(31)47)20-24-11-5-2-6-12-24)22-26-14-8-16-28(18-26)34-38-42-43-39-34/h1-18,29-32,46-47H,19-22H2,(H,36,37,40,41)(H,38,39,42,43)/t29-,30-,31+,32+/m1/s1",VONDGXFKSSKVJE-ZRTHHSRSSA-N,188,"(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({[3-(2H-1,2,3,4-tetrazol-5-yl)phenyl]methyl})-1,3-diazepan-2-one::CHEMBL302864::Cyclic Urea",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
169,OCc1ccc(CN2[C@H](Cc3ccccc3)[C@H](O)CN(Cc3ccccc3)N(Cc3ccc(CO)cc3)C2=O)cc1,"InChI=1S/C34H37N3O4/c38-24-30-15-11-28(12-16-30)21-36-32(19-26-7-3-1-4-8-26)33(40)23-35(20-27-9-5-2-6-10-27)37(34(36)41)22-29-13-17-31(25-39)18-14-29/h1-18,32-33,38-40H,19-25H2/t32-,33-/m1/s1",ZGLNLADIKLQLDI-CZNDPXEESA-N,189,"(5R,6R)-1,5-dibenzyl-6-hydroxy-2,4-bis({[4-(hydroxymethyl)phenyl]methyl})-1,2,4-triazepan-3-one::(5R,6R)-2,4-Bis[(hydroxymethyl)benzyl]-1,5-dibenzyl-6-hydroxy-3-oxo-1,2,4-triazacycloheptane::Azacyclic Urea::Unnamed azacyclic urea",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
170,OCc1ccc(CN2[C@H](Cc3ccccc3)[C@H](O)CN(Cc3ccoc3)N(Cc3ccc(CO)cc3)C2=O)cc1,"InChI=1S/C32H35N3O5/c36-21-27-10-6-25(7-11-27)18-34-30(16-24-4-2-1-3-5-24)31(38)20-33(17-29-14-15-40-23-29)35(32(34)39)19-26-8-12-28(22-37)13-9-26/h1-15,23,30-31,36-38H,16-22H2/t30-,31-/m1/s1",FVXGZVWGOFVUIM-FIRIVFDPSA-N,190,"(5R,6R)-2,4-Bis[4-(hydroxymethyl)benzyl]-1-(3-furanylmethyl)-5-benzyl-6-hydroxy-3-oxo-1,2,4-triazacycloheptane::(5R,6R)-5-benzyl-1-(furan-3-ylmethyl)-6-hydroxy-2,4-bis({[4-(hydroxymethyl)phenyl]methyl})-1,2,4-triazepan-3-one::Azacyclic Urea::Unnamed azacyclic urea",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
171,O[C@@H]1CN(Cc2ccccc2)N(Cc2ccccc2)C(=O)N(Cc2ccccc2)[C@@H]1Cc1ccccc1,"InChI=1S/C32H33N3O2/c36-31-25-33(22-27-15-7-2-8-16-27)35(24-29-19-11-4-12-20-29)32(37)34(23-28-17-9-3-10-18-28)30(31)21-26-13-5-1-6-14-26/h1-20,30-31,36H,21-25H2/t30-,31-/m1/s1",GURZXAWQZSNWCW-FIRIVFDPSA-N,191,"(5R,6R)-1,2,4,5-tetrabenzyl-6-hydroxy-1,2,4-triazepan-3-one::5R,6R)-1,2,4,5-Tetrabenzyl-6-hydroxy-3-oxo-1,2,4-triazacycloheptane::Azacyclic Urea::Unnamed azacyclic urea",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
172,O[C@@H]1CN(Cc2ccccc2)N(Cc2ccc(O)cc2)C(=O)N(Cc2ccc(O)cc2)[C@@H]1Cc1ccccc1,"InChI=1S/C32H33N3O4/c36-28-15-11-26(12-16-28)21-34-30(19-24-7-3-1-4-8-24)31(38)23-33(20-25-9-5-2-6-10-25)35(32(34)39)22-27-13-17-29(37)18-14-27/h1-18,30-31,36-38H,19-23H2/t30-,31-/m1/s1",SQFKCAMRRRAISM-FIRIVFDPSA-N,192,"(5R,6R)-1,5-dibenzyl-6-hydroxy-2,4-bis[(4-hydroxyphenyl)methyl]-1,2,4-triazepan-3-one::(5R,6R)-2,4-Bis(4-hydroxybenzyl)-1,5-dibenzyl-6-hydroxy-3-oxo-1,2,4-triazacycloheptane::CHEMBL130078::Unnamed azacyclic urea",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
173,COc1cccc(CN2[C@H](Cc3ccccc3)[C@H](O)CN(Cc3ccccc3)N(Cc3cccc(OC)c3)C2=O)c1,"InChI=1S/C34H37N3O4/c1-40-30-17-9-15-28(19-30)23-36-32(21-26-11-5-3-6-12-26)33(38)25-35(22-27-13-7-4-8-14-27)37(34(36)39)24-29-16-10-18-31(20-29)41-2/h3-20,32-33,38H,21-25H2,1-2H3/t32-,33-/m1/s1",POTVKRBLAIMCGT-CZNDPXEESA-N,193,"(5R,6R)-1,5-dibenzyl-6-hydroxy-2,4-bis[(3-methoxyphenyl)methyl]-1,2,4-triazepan-3-one::Azacyclic Urea::Unnamed azacyclic urea",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
174,COc1cc(CN2[C@H](Cc3ccccc3)[C@H](O)CN(Cc3ccccc3)N(Cc3ccc(O)c(OC)c3)C2=O)ccc1O,"InChI=1S/C34H37N3O6/c1-42-32-18-26(13-15-29(32)38)21-36-28(17-24-9-5-3-6-10-24)31(40)23-35(20-25-11-7-4-8-12-25)37(34(36)41)22-27-14-16-30(39)33(19-27)43-2/h3-16,18-19,28,31,38-40H,17,20-23H2,1-2H3/t28-,31-/m1/s1",PMBZSBGCSQGJAQ-GRKNLSHJSA-N,194,"(5R,6R)-1,5-dibenzyl-6-hydroxy-2,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-1,2,4-triazepan-3-one::(5r,6r)-2,4-bis-(4-hydroxy-3-methoxybenzyl)-1,5- dibenzyl-3-oxo-6-hydroxy-1,2,4-triazacycloheptane::A-98881",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
175,COc1cc(CN2[C@H](Cc3ccccc3)[C@H](O)CN(Cc3ccccc3)N(CC3CC3)C2=O)ccc1O,"InChI=1S/C30H35N3O4/c1-37-29-17-25(14-15-27(29)34)19-32-26(16-22-8-4-2-5-9-22)28(35)21-31(18-23-10-6-3-7-11-23)33(30(32)36)20-24-12-13-24/h2-11,14-15,17,24,26,28,34-35H,12-13,16,18-21H2,1H3/t26-,28-/m1/s1",ZXMNXYSILSXVSY-IXCJQBJRSA-N,195,"(5R,6R)-1,5-dibenzyl-2-(cyclopropylmethyl)-6-hydroxy-4-[(4-hydroxy-3-methoxyphenyl)methyl]-1,2,4-triazepan-3-one::Azacyclic Urea::Unnamed azacyclic urea",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
176,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C,"InChI=1S/C43H52N4O7/c1-29(2)37(46-42(51)53-27-33-21-13-7-14-22-33)40(49)44-35(25-31-17-9-5-10-18-31)39(48)36(26-32-19-11-6-12-20-32)45-41(50)38(30(3)4)47-43(52)54-28-34-23-15-8-16-24-34/h5-24,29-30,35-39,48H,25-28H2,1-4H3,(H,44,49)(H,45,50)(H,46,51)(H,47,52)/t35-,36-,37-,38-/m0/s1",GEANBHANAKKWSL-ZQWQDMLBSA-N,196,"A-74704::CHEMBL307193::benzyl N-[(1S)-1-{[(2S,4S)-4-[(2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanamido]-3-hydroxy-1,5-diphenylpentan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
177,CC(C)[C@H](NC(=O)N(C)Cc1ccccn1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)N(C)Cc1ccccn1)C(C)C,"InChI=1S/C44H58N8O6/c1-29(2)37(49-43(57)51(5)27-33-21-13-15-23-45-33)41(55)47-35(25-31-17-9-7-10-18-31)39(53)40(54)36(26-32-19-11-8-12-20-32)48-42(56)38(30(3)4)50-44(58)52(6)28-34-22-14-16-24-46-34/h7-24,29-30,35-40,53-54H,25-28H2,1-6H3,(H,47,55)(H,48,56)(H,49,57)(H,50,58)/t35-,36-,37-,38-,39+,40+/m0/s1",QPVWMQXBTCSLCB-RRUVMKMCSA-N,197,"(2S)-N-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[(2S)-3-methyl-2-{[methyl(pyridin-2-ylmethyl)carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]-3-methyl-2-{[methyl(pyridin-2-ylmethyl)carbamoyl]amino}butanamide::A-76889::CHEMBL43294",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
178,CC(C)[C@H](NC(=O)N(C)Cc1ccccn1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)N(C)Cc1ccccn1)C(C)C,"InChI=1S/C44H58N8O6/c1-29(2)37(49-43(57)51(5)27-33-21-13-15-23-45-33)41(55)47-35(25-31-17-9-7-10-18-31)39(53)40(54)36(26-32-19-11-8-12-20-32)48-42(56)38(30(3)4)50-44(58)52(6)28-34-22-14-16-24-46-34/h7-24,29-30,35-40,53-54H,25-28H2,1-6H3,(H,47,55)(H,48,56)(H,49,57)(H,50,58)/t35-,36-,37-,38-,39-,40-/m0/s1",QPVWMQXBTCSLCB-UNHORJANSA-N,198,"(2S)-N-[(2S,3S,4S,5S)-3,4-dihydroxy-5-[(2S)-3-methyl-2-{[methyl(pyridin-2-ylmethyl)carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]-3-methyl-2-{[methyl(pyridin-2-ylmethyl)carbamoyl]amino}butanamide::A-76928::JMC51852 Inhibitor PP",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
179,CC(C)[C@H](NC(=O)N(C)Cc1ccccn1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)N(C)Cc1ccccn1)C(C)C,"InChI=1S/C44H58N8O6/c1-29(2)37(49-43(57)51(5)27-33-21-13-15-23-45-33)41(55)47-35(25-31-17-9-7-10-18-31)39(53)40(54)36(26-32-19-11-8-12-20-32)48-42(56)38(30(3)4)50-44(58)52(6)28-34-22-14-16-24-46-34/h7-24,29-30,35-40,53-54H,25-28H2,1-6H3,(H,47,55)(H,48,56)(H,49,57)(H,50,58)/t35-,36-,37-,38-,39-,40+/m0/s1",QPVWMQXBTCSLCB-BYAJYZPISA-N,199,"(2S)-N-[(2S,3R,4S,5S)-3,4-dihydroxy-5-[(2S)-3-methyl-2-{[methyl(pyridin-2-ylmethyl)carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]-3-methyl-2-{[methyl(pyridin-2-ylmethyl)carbamoyl]amino}butanamide::A-77003::[2PyridCH2NCH3CO-Val-NHCH(Bz)]CHOHCHOH",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
180,CC(C)[C@H](NC(=O)N(C)Cc1ccccn1)C(=O)N[C@H](C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)N(C)Cc1ccccn1)C(C)C)Cc1ccccc1,"InChI=1S/C44H58N8O5/c1-30(2)39(49-43(56)51(5)28-34-21-13-15-23-45-34)41(54)47-36(25-32-17-9-7-10-18-32)27-38(53)37(26-33-19-11-8-12-20-33)48-42(55)40(31(3)4)50-44(57)52(6)29-35-22-14-16-24-46-35/h7-24,30-31,36-40,53H,25-29H2,1-6H3,(H,47,54)(H,48,55)(H,49,56)(H,50,57)/t36-,37-,38+,39-,40-/m0/s1",KTXGTJRUYOGULA-FFDWOFMBSA-N,200,"(2S)-N-[(2S,3R,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl(pyridin-2-ylmethyl)carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]-3-methyl-2-{[methyl(pyridin-2-ylmethyl)carbamoyl]amino}butanamide::A-78791",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
181,CC(C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(CC1CCCCC1)NC(=O)[C@@H](NC(C)=O)C(C)C,"InChI=1S/C31H51N5O5/c1-20(2)28(32-22(5)37)30(40)34-26(17-24-13-9-7-10-14-24)27(39)19-36(18-25-15-11-8-12-16-25)35-31(41)29(21(3)4)33-23(6)38/h7,9-10,13-14,20-21,25-29,39H,8,11-12,15-19H2,1-6H3,(H,32,37)(H,33,38)(H,34,40)(H,35,41)/t26-,27-,28-,29-/m0/s1",JNBVLGDICHLLTN-DZUOILHNSA-N,201,"(2S)-N-[(2S,3S)-4-[(2S)-N'-(cyclohexylmethyl)-2-acetamido-3-methylbutanehydrazido]-3-hydroxy-1-phenylbutan-2-yl]-2-acetamido-3-methylbutanamide::CGP 53820",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 8.5
182,CCOC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(CC1CCCCC1)NC(=O)[C@@H](NC(=O)OCC)C(C)C,"InChI=1S/C33H55N5O7/c1-7-44-32(42)35-28(22(3)4)30(40)34-26(19-24-15-11-9-12-16-24)27(39)21-38(20-25-17-13-10-14-18-25)37-31(41)29(23(5)6)36-33(43)45-8-2/h9,11-12,15-16,22-23,25-29,39H,7-8,10,13-14,17-21H2,1-6H3,(H,34,40)(H,35,42)(H,36,43)(H,37,41)/t26-,27-,28-,29-/m0/s1",WEFMCBSODKDJFB-DZUOILHNSA-N,202,"CGP 53820 analog::CHEMBL324572::ethyl N-[(1S)-1-{[(2S,3S)-4-[(2S)-N'-(cyclohexylmethyl)-2-[(ethoxycarbonyl)amino]-3-methylbutanehydrazido]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 177
183,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(OC)cc1,"InChI=1S/C29H40N2O8S/c1-4-20(2)17-31(40(34,35)23-12-10-22(36-3)11-13-23)18-26(32)25(16-21-8-6-5-7-9-21)30-29(33)39-27-19-38-28-24(27)14-15-37-28/h5-13,20,24-28,32H,4,14-19H2,1-3H3,(H,30,33)/t20-,24-,25-,26+,27-,28+/m0/s1",CXUFZTSMYKDYRK-QKULBLGOSA-N,112655,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-3-hydroxy-4-(4-methoxy-N-((S)-2-methylbutyl)phenylsulfonamido)-1-phenylbutan-2-yl)carbamate (10b)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]",Human immunodeficiency virus,
184,COCCOC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(CC1CCCCC1)NC(=O)[C@@H](NC(=O)OCCOC)C(C)C,"InChI=1S/C35H59N5O9/c1-24(2)30(37-34(44)48-19-17-46-5)32(42)36-28(21-26-13-9-7-10-14-26)29(41)23-40(22-27-15-11-8-12-16-27)39-33(43)31(25(3)4)38-35(45)49-20-18-47-6/h7,9-10,13-14,24-25,27-31,41H,8,11-12,15-23H2,1-6H3,(H,36,42)(H,37,44)(H,38,45)(H,39,43)/t28-,29-,30-,31-/m0/s1",XEBVQLCYEMXQLM-ORYMTKCHSA-N,204,"2-methoxyethyl N-[(1S)-1-{[(2S,3S)-4-[(2S)-N'-(cyclohexylmethyl)-2-{[(2-methoxyethoxy)carbonyl]amino}-3-methylbutanehydrazido]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-methylpropyl]carbamate::CGP 53820 analog",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 164
185,COCCOCCOC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(CC1CCCCC1)NC(=O)[C@@H](NC(=O)OCCOCCOC)C(C)C,"InChI=1S/C39H67N5O11/c1-28(2)34(41-38(48)54-23-21-52-19-17-50-5)36(46)40-32(25-30-13-9-7-10-14-30)33(45)27-44(26-31-15-11-8-12-16-31)43-37(47)35(29(3)4)42-39(49)55-24-22-53-20-18-51-6/h7,9-10,13-14,28-29,31-35,45H,8,11-12,15-27H2,1-6H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t32-,33-,34-,35-/m0/s1",OLBLSEVYAPOMFN-BBACVFHCSA-N,205,"2-(2-methoxyethoxy)ethyl N-[(1S)-1-{[(2S,3S)-4-[(2S)-N'-(cyclohexylmethyl)-3-methyl-2-(2-oxo-3,6,9-trioxa-1-azadecan-1-yl)butanehydrazido]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-methylpropyl]carbamate::CGP 53820 analog",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 67
186,COC(=O)N[C@@H](C(C)C)C(=O)NN(C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)CC1CCCCC1,"InChI=1S/C38H51N7O7/c1-24(2)34(43-38(51)52-3)37(50)44-45(22-26-14-8-5-9-15-26)23-32(46)30(20-25-12-6-4-7-13-25)41-36(49)31(21-33(39)47)42-35(48)29-19-18-27-16-10-11-17-28(27)40-29/h4,6-7,10-13,16-19,24,26,30-32,34,46H,5,8-9,14-15,20-23H2,1-3H3,(H2,39,47)(H,41,49)(H,42,48)(H,43,51)(H,44,50)/t30-,31-,32-,34-/m0/s1",VUMKXPNJDITTGF-SUGCFTRWSA-N,206,"1-Cyclohexyl-2-N-[[(methoxycarbonyl)-L-valinyl]amino]-4(S)-hydroxy-5(S)-[[N-(quinolin-2-ylcarbonyl)-L-asparaginyl]amino]-6-phenyl-2-azahexane::CGP 53820 analog::methyl N-[(1S)-1-[N'-(cyclohexylmethyl)-N'-[(2S,3S)-2-hydroxy-4-phenyl-3-[(2S)-2-(quinolin-2-ylformamido)butanediamido]butyl]hydrazinecarbonyl]-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 27
187,CCOC(=O)N[C@@H](C(C)C)C(=O)NN(C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC)C(C)C)CC1CCCCC1,"InChI=1S/C32H53N5O7/c1-7-44-32(42)35-28(22(4)5)30(40)36-37(19-24-16-12-9-13-17-24)20-26(38)25(18-23-14-10-8-11-15-23)33-29(39)27(21(2)3)34-31(41)43-6/h8,10-11,14-15,21-22,24-28,38H,7,9,12-13,16-20H2,1-6H3,(H,33,39)(H,34,41)(H,35,42)(H,36,40)/t25-,26-,27-,28-/m0/s1",MPCIOBADQADHMQ-LJWNLINESA-N,207,"1-Cyclohexyl-2-[[N-(ethoxycarbonyl)-L-valinyl]amino]-4(S)-hydroxy-5(S)-[[N-(methoxycarbonyl)-L-valinyl]amino]-6-phenyl-2-azahexane::CGP 53820 analog::methyl N-[(1S)-1-{[(2S,3S)-4-[(2S)-N'-(cyclohexylmethyl)-2-[(ethoxycarbonyl)amino]-3-methylbutanehydrazido]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 56
188,COCCOC(=O)N[C@@H](C(C)C)C(=O)NN(C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC)C(C)C)CC1CCCCC1,"InChI=1S/C33H55N5O8/c1-22(2)28(35-32(42)45-6)30(40)34-26(19-24-13-9-7-10-14-24)27(39)21-38(20-25-15-11-8-12-16-25)37-31(41)29(23(3)4)36-33(43)46-18-17-44-5/h7,9-10,13-14,22-23,25-29,39H,8,11-12,15-21H2,1-6H3,(H,34,40)(H,35,42)(H,36,43)(H,37,41)/t26-,27-,28-,29-/m0/s1",TUOHGYWWSZWQKZ-DZUOILHNSA-N,208,"CGP 53820 analog::methyl N-[(1S)-1-{[(2S,3S)-4-[(2S)-N'-(cyclohexylmethyl)-2-{[(2-methoxyethoxy)carbonyl]amino}-3-methylbutanehydrazido]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 67
189,CCOC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(CC1CCCCC1)NC(=O)[C@@H](NC(=O)OC)C(C)C,"InChI=1S/C32H53N5O7/c1-7-44-32(42)35-27(21(2)3)29(39)33-25(18-23-14-10-8-11-15-23)26(38)20-37(19-24-16-12-9-13-17-24)36-30(40)28(22(4)5)34-31(41)43-6/h8,10-11,14-15,21-22,24-28,38H,7,9,12-13,16-20H2,1-6H3,(H,33,39)(H,34,41)(H,35,42)(H,36,40)/t25-,26-,27-,28-/m0/s1",HHZVZJSOAPPIMO-LJWNLINESA-N,209,"CGP 53820 analog::ethyl N-[(1S)-1-{[(2S,3S)-4-[(2S)-N'-(cyclohexylmethyl)-2-[(methoxycarbonyl)amino]-3-methylbutanehydrazido]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 76
190,CCOC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(CC1CCCCC1)NC(=O)[C@@H](NC(=O)OCCOC)C(C)C,"InChI=1S/C34H57N5O8/c1-7-46-33(43)36-29(23(2)3)31(41)35-27(20-25-14-10-8-11-15-25)28(40)22-39(21-26-16-12-9-13-17-26)38-32(42)30(24(4)5)37-34(44)47-19-18-45-6/h8,10-11,14-15,23-24,26-30,40H,7,9,12-13,16-22H2,1-6H3,(H,35,41)(H,36,43)(H,37,44)(H,38,42)/t27-,28-,29-,30-/m0/s1",SMVHNFHQIVWIBA-KRCBVYEFSA-N,210,"CGP 53820 analog::ethyl N-[(1S)-1-{[(2S,3S)-4-[(2S)-N'-(cyclohexylmethyl)-2-{[(2-methoxyethoxy)carbonyl]amino}-3-methylbutanehydrazido]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 150
191,COCCOC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(CC1CCCCC1)NC(=O)[C@@H](NC(=O)OC)C(C)C,"InChI=1S/C33H55N5O8/c1-22(2)28(36-33(43)46-18-17-44-5)30(40)34-26(19-24-13-9-7-10-14-24)27(39)21-38(20-25-15-11-8-12-16-25)37-31(41)29(23(3)4)35-32(42)45-6/h7,9-10,13-14,22-23,25-29,39H,8,11-12,15-21H2,1-6H3,(H,34,40)(H,35,42)(H,36,43)(H,37,41)/t26-,27-,28-,29-/m0/s1",RIZULOWDBGNKDX-DZUOILHNSA-N,211,"2-methoxyethyl N-[(1S)-1-{[(2S,3S)-4-[(2S)-N'-(cyclohexylmethyl)-2-[(methoxycarbonyl)amino]-3-methylbutanehydrazido]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-methylpropyl]carbamate::CGP 53820 analog",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 62
192,CCOC(=O)N[C@@H](C(C)C)C(=O)NN(C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCCOC)C(C)C)CC1CCCCC1,"InChI=1S/C34H57N5O8/c1-7-46-33(43)37-30(24(4)5)32(42)38-39(21-26-16-12-9-13-17-26)22-28(40)27(20-25-14-10-8-11-15-25)35-31(41)29(23(2)3)36-34(44)47-19-18-45-6/h8,10-11,14-15,23-24,26-30,40H,7,9,12-13,16-22H2,1-6H3,(H,35,41)(H,36,44)(H,37,43)(H,38,42)/t27-,28-,29-,30-/m0/s1",VSYJBWZQJDHWCZ-KRCBVYEFSA-N,212,"2-methoxyethyl N-[(1S)-1-{[(2S,3S)-4-[(2S)-N'-(cyclohexylmethyl)-2-[(ethoxycarbonyl)amino]-3-methylbutanehydrazido]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-methylpropyl]carbamate::CGP 53820 analog",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 134
193,COC(=O)N[C@@H](C(C)C)C(=O)NN(CC(C)C)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,"InChI=1S/C35H47N7O7/c1-21(2)19-42(41-34(47)31(22(3)4)40-35(48)49-5)20-29(43)27(17-23-11-7-6-8-12-23)38-33(46)28(18-30(36)44)39-32(45)26-16-15-24-13-9-10-14-25(24)37-26/h6-16,21-22,27-29,31,43H,17-20H2,1-5H3,(H2,36,44)(H,38,46)(H,39,45)(H,40,48)(H,41,47)/t27-,28-,29-,31-/m0/s1",MWAWRNNBGQOTJY-KECWCRPSSA-N,213,"2-Methyl-4-[[N-(methoxycarbonyl)-L-valinyl]amino]-6(S)-hydroxy-7(S)-[[N-(quinolin-2-ylcarbonyl)-L-asparaginyl]amino]-8-phenyl-4-azaoctane::CGP 53820 analog::methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-4-phenyl-3-[(2S)-2-(quinolin-2-ylformamido)butanediamido]butyl]-N'-(2-methylpropyl)hydrazinecarbonyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 23
194,COC(=O)N[C@@H](C(C)C)C(=O)NN(C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)Cc1ccc(OC)cc1,"InChI=1S/C39H47N7O8/c1-24(2)35(44-39(52)54-4)38(51)45-46(22-26-14-17-28(53-3)18-15-26)23-33(47)31(20-25-10-6-5-7-11-25)42-37(50)32(21-34(40)48)43-36(49)30-19-16-27-12-8-9-13-29(27)41-30/h5-19,24,31-33,35,47H,20-23H2,1-4H3,(H2,40,48)(H,42,50)(H,43,49)(H,44,52)(H,45,51)/t31-,32-,33-,35-/m0/s1",FRIPPNBCKDHEHW-TUCRWICHSA-N,214,"1-(4-Methoxyphenyl)-2-[[N-(methoxycarbonyl)-L-valinyl]amino]-4(S)-hydroxy-5(S)-[[N-(quinolin-2-ylcarbonyl)-L-asparaginyl]amino]-6-phenyl-2-azahexane::CGP 53820 analog::methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-4-phenyl-3-[(2S)-2-(quinolin-2-ylformamido)butanediamido]butyl]-N'-[(4-methoxyphenyl)methyl]hydrazinecarbonyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 31
195,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NN(C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)CC1CCCCC1,"InChI=1S/C44H55N7O7/c1-29(2)40(49-44(57)58-28-32-18-10-5-11-19-32)43(56)50-51(26-31-16-8-4-9-17-31)27-38(52)36(24-30-14-6-3-7-15-30)47-42(55)37(25-39(45)53)48-41(54)35-23-22-33-20-12-13-21-34(33)46-35/h3,5-7,10-15,18-23,29,31,36-38,40,52H,4,8-9,16-17,24-28H2,1-2H3,(H2,45,53)(H,47,55)(H,48,54)(H,49,57)(H,50,56)/t36-,37-,38-,40-/m0/s1",RTLNCIKDZUJCAQ-UNOODAFMSA-N,215,"1-Cyclohexyl-2-[[N-(benzyloxycarbonyl)-L-valinyl]amino]-4(S)-hydroxy-5(S)-[[N-(quinolin-2-ylcarbonyl)-L-asparaginyl]amino]-6-phenyl-2-azahexane::CGP 53820 analog::benzyl N-[(1S)-1-[N'-(cyclohexylmethyl)-N'-[(2S,3S)-2-hydroxy-4-phenyl-3-[(2S)-2-(quinolin-2-ylformamido)butanediamido]butyl]hydrazinecarbonyl]-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 41
196,CC(C)CN(C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C,"InChI=1S/C41H51N7O7/c1-26(2)23-48(47-40(53)37(27(3)4)46-41(54)55-25-29-15-9-6-10-16-29)24-35(49)33(21-28-13-7-5-8-14-28)44-39(52)34(22-36(42)50)45-38(51)32-20-19-30-17-11-12-18-31(30)43-32/h5-20,26-27,33-35,37,49H,21-25H2,1-4H3,(H2,42,50)(H,44,52)(H,45,51)(H,46,54)(H,47,53)/t33-,34-,35-,37-/m0/s1",FKWYXAHMWIBZLY-SZHYKVQFSA-N,216,"2-Methyl-4-[[N-(benzyloxycarbonyl)-L-valinyl]amino]-6(S)-hydroxy-7(S)-[[N-(quinolin-2-ylcarbonyl)-L-asparaginyl]amino]-8-phenyl-4-azaoctane::CGP 53820 analog::benzyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-4-phenyl-3-[(2S)-2-(quinolin-2-ylformamido)butanediamido]butyl]-N'-(2-methylpropyl)hydrazinecarbonyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 37
197,COc1ccc(CN(C[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)c2ccc3ccccc3n2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)C)cc1,"InChI=1S/C45H51N7O8/c1-29(2)41(50-45(58)60-28-32-14-8-5-9-15-32)44(57)51-52(26-31-18-21-34(59-3)22-19-31)27-39(53)37(24-30-12-6-4-7-13-30)48-43(56)38(25-40(46)54)49-42(55)36-23-20-33-16-10-11-17-35(33)47-36/h4-23,29,37-39,41,53H,24-28H2,1-3H3,(H2,46,54)(H,48,56)(H,49,55)(H,50,58)(H,51,57)/t37-,38-,39-,41-/m0/s1",KJHOFIHBRJXADK-MJSJRNKMSA-N,217,"1-(4-Methoxyphenyl)-2-[[N-(benzyloxycarbonyl)-L-valinyl]amino]-4(S)-hydroxy-5(S)-[[N-(quinolin-2-ylcarbonyl)-L-asparaginyl]amino]-6-phenyl-2-azahexane::CGP 53820 analog::benzyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-4-phenyl-3-[(2S)-2-(quinolin-2-ylformamido)butanediamido]butyl]-N'-[(4-methoxyphenyl)methyl]hydrazinecarbonyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 49
198,CCOC(=O)N[C@@H](C(C)C)C(=O)NN(C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)CC1CCCCC1,"InChI=1S/C39H53N7O7/c1-4-53-39(52)44-35(25(2)3)38(51)45-46(23-27-15-9-6-10-16-27)24-33(47)31(21-26-13-7-5-8-14-26)42-37(50)32(22-34(40)48)43-36(49)30-20-19-28-17-11-12-18-29(28)41-30/h5,7-8,11-14,17-20,25,27,31-33,35,47H,4,6,9-10,15-16,21-24H2,1-3H3,(H2,40,48)(H,42,50)(H,43,49)(H,44,52)(H,45,51)/t31-,32-,33-,35-/m0/s1",HFUNMZASCGNINT-TUCRWICHSA-N,218,"1-Cyclohexyl-2-[[N-(ethoxycarbonyl)-L-valinyl]amino]-4(S)-hydroxy-5(S)-[[N-(quinolin-2-ylcarbonyl)-L-asparaginyl]amino]-6-phenyl-2-azahexane::CGP 53820 analog::ethyl N-[(1S)-1-[N'-(cyclohexylmethyl)-N'-[(2S,3S)-2-hydroxy-4-phenyl-3-[(2S)-2-(quinolin-2-ylformamido)butanediamido]butyl]hydrazinecarbonyl]-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 126
199,CN(Cc1ccc(s1)C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl)Cc1ccc(O)c(c1)C(O)=O,"InChI=1S/C27H27ClN2O7S2/c1-30(12-16-6-8-22(31)19(10-16)27(36)37)13-18-7-9-24(39-18)26(35)29-21(11-25(33)34)23(32)15-38-14-17-4-2-3-5-20(17)28/h2-10,21,31H,11-15H2,1H3,(H,29,35)(H,33,34)(H,36,37)/t21-/m0/s1",FIEQQFOHZKVJLV-NRFANRHFSA-N,219,5-({[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl](methyl)amino}methyl)-2-hydroxybenzoic acid::Inhibitor 47c::Thiophene Scaffold 47c,Caspase-3,Homo sapiens,
200,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cc1)C=O,"InChI=1S/C19H18N2O9S/c22-10-13(7-17(24)25)21-18(26)12-3-1-11(2-4-12)9-20-31(29,30)14-5-6-16(23)15(8-14)19(27)28/h1-6,8,10,13,20,23H,7,9H2,(H,21,26)(H,24,25)(H,27,28)/t13-/m0/s1",FMTZTJFXNZOBIQ-ZDUSSCGKSA-N,220,5-{[(4-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}phenyl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 3,Caspase-1,Homo sapiens,
201,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C=O,"InChI=1S/C18H17N3O9S/c22-9-12(5-16(24)25)21-17(26)10-1-2-11(19-7-10)8-20-31(29,30)13-3-4-15(23)14(6-13)18(27)28/h1-4,6-7,9,12,20,23H,5,8H2,(H,21,26)(H,24,25)(H,27,28)/t12-/m0/s1",BZEURKGKCWHMON-LBPRGKRZSA-N,221,5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 4::Pyridine Scaffold 4,Caspase-1,Homo sapiens,
202,CN(Cc1ccc(s1)C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl)Cc1ccc(O)c(c1)C(O)=O,"InChI=1S/C27H27ClN2O7S2/c1-30(12-16-6-8-22(31)19(10-16)27(36)37)13-18-7-9-24(39-18)26(35)29-21(11-25(33)34)23(32)15-38-14-17-4-2-3-5-20(17)28/h2-10,21,31H,11-15H2,1H3,(H,29,35)(H,33,34)(H,36,37)/t21-/m0/s1",FIEQQFOHZKVJLV-NRFANRHFSA-N,219,5-({[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl](methyl)amino}methyl)-2-hydroxybenzoic acid::Inhibitor 47c::Thiophene Scaffold 47c,Caspase-1,Homo sapiens,
203,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H24ClN3O9S2/c27-20-4-2-1-3-16(20)13-40-14-23(32)21(10-24(33)34)30-25(35)15-5-6-17(28-11-15)12-29-41(38,39)18-7-8-22(31)19(9-18)26(36)37/h1-9,11,21,29,31H,10,12-14H2,(H,30,35)(H,33,34)(H,36,37)/t21-/m0/s1",AYQUXMOMSNPZEF-NRFANRHFSA-N,222,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyridin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Pyridine Scaffold 59,Caspase-1,Homo sapiens,
204,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN4O9S2/c26-18-4-2-1-3-14(18)12-40-13-21(32)19(8-23(33)34)30-24(35)15-9-27-22(28-10-15)11-29-41(38,39)16-5-6-20(31)17(7-16)25(36)37/h1-7,9-10,19,29,31H,8,11-13H2,(H,30,35)(H,33,34)(H,36,37)/t19-/m0/s1",NAJZBQCCBCKDIT-IBGZPJMESA-N,223,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyrimidin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyrimidin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 62b::Inhibitor 62b,Caspase-1,Homo sapiens,
205,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C24H22ClN3O9S3/c25-16-4-2-1-3-13(16)11-38-12-19(30)17(8-22(31)32)28-23(33)20-9-26-21(39-20)10-27-40(36,37)14-5-6-18(29)15(7-14)24(34)35/h1-7,9,17,27,29H,8,10-12H2,(H,28,33)(H,31,32)(H,34,35)/t17-/m0/s1",VCWYKJKQZUPTQP-KRWDZBQOSA-N,224,"(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiazol-2-hydroxy-benzoic Acidylmethyl}sulfamoyl)-2-::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-1,3-thiazol-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 64b::Inhibitor 64b",Caspase-1,Homo sapiens,
206,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C=O,"InChI=1S/C17H16N2O9S2/c20-8-9(5-15(22)23)19-16(24)14-4-1-10(29-14)7-18-30(27,28)11-2-3-13(21)12(6-11)17(25)26/h1-4,6,8-9,18,21H,5,7H2,(H,19,24)(H,22,23)(H,25,26)/t9-/m0/s1",VUJHWZDCLPHWMO-VIFPVBQESA-N,225,(S)-5-5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-thiophen-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66a::Thiophene Scaffold 66a,Caspase-1,Homo sapiens,
207,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O9S3/c26-18-4-2-1-3-14(18)12-38-13-21(30)19(10-23(31)32)28-24(33)22-8-5-15(39-22)11-27-40(36,37)16-6-7-20(29)17(9-16)25(34)35/h1-9,19,27,29H,10-13H2,(H,28,33)(H,31,32)(H,34,35)/t19-/m0/s1",ZOVHWLRITDMPBF-IBGZPJMESA-N,226,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66b::Thiophene Scaffold 66b,Caspase-1,Homo sapiens,
208,Cc1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)sc1C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H25ClN2O9S3/c1-14-8-16(11-28-41(37,38)17-6-7-21(30)18(9-17)26(35)36)40-24(14)25(34)29-20(10-23(32)33)22(31)13-39-12-15-4-2-3-5-19(15)27/h2-9,20,28,30H,10-13H2,1H3,(H,29,34)(H,32,33)(H,35,36)/t20-/m0/s1",PZMBYHSWPUMKMR-FQEVSTJZSA-N,227,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]-4-methyl-thiophen-2-ylmethyl}-sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-4-methylthiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 69b::Inhibitor 69b,Caspase-1,Homo sapiens,
209,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cc1)C=O,"InChI=1S/C19H18N2O9S/c22-10-13(7-17(24)25)21-18(26)12-3-1-11(2-4-12)9-20-31(29,30)14-5-6-16(23)15(8-14)19(27)28/h1-6,8,10,13,20,23H,7,9H2,(H,21,26)(H,24,25)(H,27,28)/t13-/m0/s1",FMTZTJFXNZOBIQ-ZDUSSCGKSA-N,220,5-{[(4-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}phenyl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 3,Caspase-4,Homo sapiens,
210,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C=O,"InChI=1S/C18H17N3O9S/c22-9-12(5-16(24)25)21-17(26)10-1-2-11(19-7-10)8-20-31(29,30)13-3-4-15(23)14(6-13)18(27)28/h1-4,6-7,9,12,20,23H,5,8H2,(H,21,26)(H,24,25)(H,27,28)/t12-/m0/s1",BZEURKGKCWHMON-LBPRGKRZSA-N,221,5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 4::Pyridine Scaffold 4,Caspase-4,Homo sapiens,
211,CN(Cc1ccc(s1)C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl)Cc1ccc(O)c(c1)C(O)=O,"InChI=1S/C27H27ClN2O7S2/c1-30(12-16-6-8-22(31)19(10-16)27(36)37)13-18-7-9-24(39-18)26(35)29-21(11-25(33)34)23(32)15-38-14-17-4-2-3-5-20(17)28/h2-10,21,31H,11-15H2,1H3,(H,29,35)(H,33,34)(H,36,37)/t21-/m0/s1",FIEQQFOHZKVJLV-NRFANRHFSA-N,219,5-({[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl](methyl)amino}methyl)-2-hydroxybenzoic acid::Inhibitor 47c::Thiophene Scaffold 47c,Caspase-4,Homo sapiens,
212,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H24ClN3O9S2/c27-20-4-2-1-3-16(20)13-40-14-23(32)21(10-24(33)34)30-25(35)15-5-6-17(28-11-15)12-29-41(38,39)18-7-8-22(31)19(9-18)26(36)37/h1-9,11,21,29,31H,10,12-14H2,(H,30,35)(H,33,34)(H,36,37)/t21-/m0/s1",AYQUXMOMSNPZEF-NRFANRHFSA-N,222,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyridin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Pyridine Scaffold 59,Caspase-4,Homo sapiens,
213,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN4O9S2/c26-18-4-2-1-3-14(18)12-40-13-21(32)19(8-23(33)34)30-24(35)15-9-27-22(28-10-15)11-29-41(38,39)16-5-6-20(31)17(7-16)25(36)37/h1-7,9-10,19,29,31H,8,11-13H2,(H,30,35)(H,33,34)(H,36,37)/t19-/m0/s1",NAJZBQCCBCKDIT-IBGZPJMESA-N,223,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyrimidin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyrimidin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 62b::Inhibitor 62b,Caspase-4,Homo sapiens,
214,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C24H22ClN3O9S3/c25-16-4-2-1-3-13(16)11-38-12-19(30)17(8-22(31)32)28-23(33)20-9-26-21(39-20)10-27-40(36,37)14-5-6-18(29)15(7-14)24(34)35/h1-7,9,17,27,29H,8,10-12H2,(H,28,33)(H,31,32)(H,34,35)/t17-/m0/s1",VCWYKJKQZUPTQP-KRWDZBQOSA-N,224,"(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiazol-2-hydroxy-benzoic Acidylmethyl}sulfamoyl)-2-::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-1,3-thiazol-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 64b::Inhibitor 64b",Caspase-4,Homo sapiens,
215,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C=O,"InChI=1S/C17H16N2O9S2/c20-8-9(5-15(22)23)19-16(24)14-4-1-10(29-14)7-18-30(27,28)11-2-3-13(21)12(6-11)17(25)26/h1-4,6,8-9,18,21H,5,7H2,(H,19,24)(H,22,23)(H,25,26)/t9-/m0/s1",VUJHWZDCLPHWMO-VIFPVBQESA-N,225,(S)-5-5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-thiophen-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66a::Thiophene Scaffold 66a,Caspase-4,Homo sapiens,
216,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O9S3/c26-18-4-2-1-3-14(18)12-38-13-21(30)19(10-23(31)32)28-24(33)22-8-5-15(39-22)11-27-40(36,37)16-6-7-20(29)17(9-16)25(34)35/h1-9,19,27,29H,10-13H2,(H,28,33)(H,31,32)(H,34,35)/t19-/m0/s1",ZOVHWLRITDMPBF-IBGZPJMESA-N,226,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66b::Thiophene Scaffold 66b,Caspase-4,Homo sapiens,
217,Cc1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)sc1C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H25ClN2O9S3/c1-14-8-16(11-28-41(37,38)17-6-7-21(30)18(9-17)26(35)36)40-24(14)25(34)29-20(10-23(32)33)22(31)13-39-12-15-4-2-3-5-19(15)27/h2-9,20,28,30H,10-13H2,1H3,(H,29,34)(H,32,33)(H,35,36)/t20-/m0/s1",PZMBYHSWPUMKMR-FQEVSTJZSA-N,227,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]-4-methyl-thiophen-2-ylmethyl}-sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-4-methylthiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 69b::Inhibitor 69b,Caspase-4,Homo sapiens,
218,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN4O9S2/c26-18-4-2-1-3-14(18)12-40-13-21(32)19(8-23(33)34)30-24(35)15-9-27-22(28-10-15)11-29-41(38,39)16-5-6-20(31)17(7-16)25(36)37/h1-7,9-10,19,29,31H,8,11-13H2,(H,30,35)(H,33,34)(H,36,37)/t19-/m0/s1",NAJZBQCCBCKDIT-IBGZPJMESA-N,223,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyrimidin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyrimidin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 62b::Inhibitor 62b,Caspase-3,Homo sapiens,
219,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cn1)C=O,"InChI=1S/C17H16N4O9S/c22-8-9(3-15(24)25)21-16(26)13-7-18-10(5-19-13)6-20-31(29,30)11-1-2-14(23)12(4-11)17(27)28/h1-2,4-5,7-9,20,23H,3,6H2,(H,21,26)(H,24,25)(H,27,28)/t9-/m0/s1",WZOPGEGZMUAACK-VIFPVBQESA-N,228,(S)-5-{[5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-pyrazin-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pyrazin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 63a::Inhibitor 63a,Caspase-3,Homo sapiens,
220,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cn1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN4O9S2/c26-18-4-2-1-3-14(18)12-40-13-22(32)19(8-23(33)34)30-24(35)20-11-27-15(9-28-20)10-29-41(38,39)16-5-6-21(31)17(7-16)25(36)37/h1-7,9,11,19,29,31H,8,10,12-13H2,(H,30,35)(H,33,34)(H,36,37)/t19-/m0/s1",QGUFFLIQTMLQTG-IBGZPJMESA-N,229,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyrazin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyrazin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 63b::Inhibitor 63b,Caspase-3,Homo sapiens,
221,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C=O,"InChI=1S/C16H15N3O9S2/c20-7-8(3-14(22)23)19-15(24)12-5-17-13(29-12)6-18-30(27,28)9-1-2-11(21)10(4-9)16(25)26/h1-2,4-5,7-8,18,21H,3,6H2,(H,19,24)(H,22,23)(H,25,26)/t8-/m0/s1",ZCWWDSIBHPKSBQ-QMMMGPOBSA-N,230,"(S)-5-{[5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-thiazol-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-1,3-thiazol-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 64a::Inhibitor 64a",Caspase-3,Homo sapiens,
222,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C24H22ClN3O9S3/c25-16-4-2-1-3-13(16)11-38-12-19(30)17(8-22(31)32)28-23(33)20-9-26-21(39-20)10-27-40(36,37)14-5-6-18(29)15(7-14)24(34)35/h1-7,9,17,27,29H,8,10-12H2,(H,28,33)(H,31,32)(H,34,35)/t17-/m0/s1",VCWYKJKQZUPTQP-KRWDZBQOSA-N,224,"(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiazol-2-hydroxy-benzoic Acidylmethyl}sulfamoyl)-2-::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-1,3-thiazol-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 64b::Inhibitor 64b",Caspase-3,Homo sapiens,
223,OC(=O)C[C@H](NC(=O)c1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)on1)C=O,"InChI=1S/C16H15N3O10S/c20-7-8(3-14(22)23)18-15(24)12-4-9(29-19-12)6-17-30(27,28)10-1-2-13(21)11(5-10)16(25)26/h1-2,4-5,7-8,17,21H,3,6H2,(H,18,24)(H,22,23)(H,25,26)/t8-/m0/s1",JETOFKFBJLQWCA-QMMMGPOBSA-N,231,"(S)-5-{[3-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)is-oxazol-5-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(3-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-1,2-oxazol-5-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 65a::Inhibitor 65a",Caspase-3,Homo sapiens,
224,OC(=O)C[C@H](NC(=O)c1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)on1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C24H22ClN3O10S2/c25-17-4-2-1-3-13(17)11-39-12-21(30)18(9-22(31)32)27-23(33)19-7-14(38-28-19)10-26-40(36,37)15-5-6-20(29)16(8-15)24(34)35/h1-8,18,26,29H,9-12H2,(H,27,33)(H,31,32)(H,34,35)/t18-/m0/s1",WMIODZZRGICKHN-SFHVURJKSA-N,232,"(S)-5-({3-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]isoxazol-5-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(3-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-1,2-oxazol-5-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 65b::Inhibitor 65b",Caspase-3,Homo sapiens,
225,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C=O,"InChI=1S/C17H16N2O9S2/c20-8-9(5-15(22)23)19-16(24)14-4-1-10(29-14)7-18-30(27,28)11-2-3-13(21)12(6-11)17(25)26/h1-4,6,8-9,18,21H,5,7H2,(H,19,24)(H,22,23)(H,25,26)/t9-/m0/s1",VUJHWZDCLPHWMO-VIFPVBQESA-N,225,(S)-5-5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-thiophen-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66a::Thiophene Scaffold 66a,Caspase-3,Homo sapiens,
226,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O9S3/c26-18-4-2-1-3-14(18)12-38-13-21(30)19(10-23(31)32)28-24(33)22-8-5-15(39-22)11-27-40(36,37)16-6-7-20(29)17(9-16)25(34)35/h1-9,19,27,29H,10-13H2,(H,28,33)(H,31,32)(H,34,35)/t19-/m0/s1",ZOVHWLRITDMPBF-IBGZPJMESA-N,226,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66b::Thiophene Scaffold 66b,Caspase-3,Homo sapiens,
227,OC(=O)C[C@H](NC(=O)c1csc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)c1)C=O,"InChI=1S/C17H16N2O9S2/c20-7-10(4-15(22)23)19-16(24)9-3-11(29-8-9)6-18-30(27,28)12-1-2-14(21)13(5-12)17(25)26/h1-3,5,7-8,10,18,21H,4,6H2,(H,19,24)(H,22,23)(H,25,26)/t10-/m0/s1",XXUAWKHXQZNZAZ-JTQLQIEISA-N,233,(S)-5-{[4-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-thiophen-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(4-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 67a::Inhibitor 67a,Caspase-3,Homo sapiens,
228,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(CO)cc1,"InChI=1S/C29H40N2O8S/c1-3-20(2)16-31(40(35,36)23-11-9-22(18-32)10-12-23)17-26(33)25(15-21-7-5-4-6-8-21)30-29(34)39-27-19-38-28-24(27)13-14-37-28/h4-12,20,24-28,32-33H,3,13-19H2,1-2H3,(H,30,34)/t20-,24-,25-,26+,27-,28+/m0/s1",ALWBGUNCNDFMFE-QKULBLGOSA-N,112656,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-3-hydroxy-4-(4-(hydroxymethyl)-N-((S)-2-methylbutyl)phenylsulfonamido)-1-phenylbutan-2-yl)carbamate (10c)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]",Human immunodeficiency virus,
229,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc2OCOc2c1,"InChI=1S/C29H38N2O9S/c1-3-19(2)15-31(41(34,35)21-9-10-25-26(14-21)39-18-38-25)16-24(32)23(13-20-7-5-4-6-8-20)30-29(33)40-27-17-37-28-22(27)11-12-36-28/h4-10,14,19,22-24,27-28,32H,3,11-13,15-18H2,1-2H3,(H,30,33)/t19-,22-,23-,24+,27-,28+/m0/s1",QQGKYOUYWIXTAU-VGOMVBHOSA-N,112657,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-3-hydroxy-4-(N-((S)-2-methylbutyl)benzo[d][1,3]dioxole-5-sulfonamido)-1-phenylbutan-2-yl)carbamate (10d)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]",Human immunodeficiency virus,
230,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc2ncsc2c1,"InChI=1S/C29H37N3O7S2/c1-3-19(2)15-32(41(35,36)21-9-10-23-27(14-21)40-18-30-23)16-25(33)24(13-20-7-5-4-6-8-20)31-29(34)39-26-17-38-28-22(26)11-12-37-28/h4-10,14,18-19,22,24-26,28,33H,3,11-13,15-17H2,1-2H3,(H,31,34)/t19-,22-,24-,25+,26-,28+/m0/s1",COTBSCQKHDXTHH-RPEWIUDZSA-N,112658,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-3-hydroxy-4-(N-((S)-2-methylbutyl)benzo[d]thiazole-6-sulfonamido)-1-phenylbutan-2-yl)carbamate (10e)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]",Human immunodeficiency virus,
231,CCC(CC)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,"InChI=1S/C29H41N3O7S/c1-3-20(4-2)17-32(40(35,36)23-12-10-22(30)11-13-23)18-26(33)25(16-21-8-6-5-7-9-21)31-29(34)39-27-19-38-28-24(27)14-15-37-28/h5-13,20,24-28,33H,3-4,14-19,30H2,1-2H3,(H,31,34)/t24-,25-,26+,27-,28+/m0/s1",GEBDYIIQOXRGOM-AJIIGFCHSA-N,112659,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-(2-ethylbutyl)phenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (11a)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]",Human immunodeficiency virus,
232,CCC(CC)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(OC)cc1,"InChI=1S/C30H42N2O8S/c1-4-21(5-2)18-32(41(35,36)24-13-11-23(37-3)12-14-24)19-27(33)26(17-22-9-7-6-8-10-22)31-30(34)40-28-20-39-29-25(28)15-16-38-29/h6-14,21,25-29,33H,4-5,15-20H2,1-3H3,(H,31,34)/t25-,26-,27+,28-,29+/m0/s1",NTULOPNXUZKLEA-WNJKUOTESA-N,112660,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(N-(2-ethylbutyl)-4-methoxyphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (11b)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]",Human immunodeficiency virus,
233,CCC(CC)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(CO)cc1,"InChI=1S/C30H42N2O8S/c1-3-21(4-2)17-32(41(36,37)24-12-10-23(19-33)11-13-24)18-27(34)26(16-22-8-6-5-7-9-22)31-30(35)40-28-20-39-29-25(28)14-15-38-29/h5-13,21,25-29,33-34H,3-4,14-20H2,1-2H3,(H,31,35)/t25-,26-,27+,28-,29+/m0/s1",KOYHHSRUNXTXFB-WNJKUOTESA-N,112661,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(N-(2-ethylbutyl)-4-(hydroxymethyl)phenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (11c)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]",Human immunodeficiency virus,
234,CCC(CC)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc2OCOc2c1,"InChI=1S/C30H40N2O9S/c1-3-20(4-2)16-32(42(35,36)22-10-11-26-27(15-22)40-19-39-26)17-25(33)24(14-21-8-6-5-7-9-21)31-30(34)41-28-18-38-29-23(28)12-13-37-29/h5-11,15,20,23-25,28-29,33H,3-4,12-14,16-19H2,1-2H3,(H,31,34)/t23-,24-,25+,28-,29+/m0/s1",ZLBAIBYBEYCDIE-KTJDEMTHSA-N,112662,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(N-(2-ethylbutyl)benzo[d][1,3]dioxole-5-sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (11d)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]",Human immunodeficiency virus,
235,CCC(CC)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc2ncsc2c1,"InChI=1S/C30H39N3O7S2/c1-3-20(4-2)16-33(42(36,37)22-10-11-24-28(15-22)41-19-31-24)17-26(34)25(14-21-8-6-5-7-9-21)32-30(35)40-27-18-39-29-23(27)12-13-38-29/h5-11,15,19-20,23,25-27,29,34H,3-4,12-14,16-18H2,1-2H3,(H,32,35)/t23-,25-,26+,27-,29+/m0/s1",RAFDIRILGICCDS-OPUPNEDUSA-N,112663,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(N-(2-ethylbutyl)benzo[d]thiazole-6-sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (11e)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]",Human immunodeficiency virus,
236,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,"InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1",CJBJHOAVZSMMDJ-HEXNFIEUSA-N,8125,"(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate::CHEMBL1323::Darunavir::Darunavir (DRV)::TMC-114::UIC-94017::US10806794, Compound Darunavir","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]",Human immunodeficiency virus,
237,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,"InChI=1S/C28H39N3O7S/c1-3-19(2)16-31(39(34,35)22-11-9-21(29)10-12-22)17-25(32)24(15-20-7-5-4-6-8-20)30-28(33)38-26-18-37-27-23(26)13-14-36-27/h4-12,19,23-27,32H,3,13-18,29H2,1-2H3,(H,30,33)/t19-,23-,24-,25+,26-,27+/m0/s1",NKLRQHQHYBFPSD-DRMLODCJSA-N,112654,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-((S)-2-methylbutyl)phenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (10a)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]",Human immunodeficiency virus,
238,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(OC)cc1,"InChI=1S/C29H40N2O8S/c1-4-20(2)17-31(40(34,35)23-12-10-22(36-3)11-13-23)18-26(32)25(16-21-8-6-5-7-9-21)30-29(33)39-27-19-38-28-24(27)14-15-37-28/h5-13,20,24-28,32H,4,14-19H2,1-3H3,(H,30,33)/t20-,24-,25-,26+,27-,28+/m0/s1",CXUFZTSMYKDYRK-QKULBLGOSA-N,112655,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-3-hydroxy-4-(4-methoxy-N-((S)-2-methylbutyl)phenylsulfonamido)-1-phenylbutan-2-yl)carbamate (10b)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]",Human immunodeficiency virus,
239,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(CO)cc1,"InChI=1S/C29H40N2O8S/c1-3-20(2)16-31(40(35,36)23-11-9-22(18-32)10-12-23)17-26(33)25(15-21-7-5-4-6-8-21)30-29(34)39-27-19-38-28-24(27)13-14-37-28/h4-12,20,24-28,32-33H,3,13-19H2,1-2H3,(H,30,34)/t20-,24-,25-,26+,27-,28+/m0/s1",ALWBGUNCNDFMFE-QKULBLGOSA-N,112656,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-3-hydroxy-4-(4-(hydroxymethyl)-N-((S)-2-methylbutyl)phenylsulfonamido)-1-phenylbutan-2-yl)carbamate (10c)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]",Human immunodeficiency virus,
240,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc2OCOc2c1,"InChI=1S/C29H38N2O9S/c1-3-19(2)15-31(41(34,35)21-9-10-25-26(14-21)39-18-38-25)16-24(32)23(13-20-7-5-4-6-8-20)30-29(33)40-27-17-37-28-22(27)11-12-36-28/h4-10,14,19,22-24,27-28,32H,3,11-13,15-18H2,1-2H3,(H,30,33)/t19-,22-,23-,24+,27-,28+/m0/s1",QQGKYOUYWIXTAU-VGOMVBHOSA-N,112657,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-3-hydroxy-4-(N-((S)-2-methylbutyl)benzo[d][1,3]dioxole-5-sulfonamido)-1-phenylbutan-2-yl)carbamate (10d)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]",Human immunodeficiency virus,
241,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc2ncsc2c1,"InChI=1S/C29H37N3O7S2/c1-3-19(2)15-32(41(35,36)21-9-10-23-27(14-21)40-18-30-23)16-25(33)24(13-20-7-5-4-6-8-20)31-29(34)39-26-17-38-28-22(26)11-12-37-28/h4-10,14,18-19,22,24-26,28,33H,3,11-13,15-17H2,1-2H3,(H,31,34)/t19-,22-,24-,25+,26-,28+/m0/s1",COTBSCQKHDXTHH-RPEWIUDZSA-N,112658,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-3-hydroxy-4-(N-((S)-2-methylbutyl)benzo[d]thiazole-6-sulfonamido)-1-phenylbutan-2-yl)carbamate (10e)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]",Human immunodeficiency virus,
242,CCC(CC)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,"InChI=1S/C29H41N3O7S/c1-3-20(4-2)17-32(40(35,36)23-12-10-22(30)11-13-23)18-26(33)25(16-21-8-6-5-7-9-21)31-29(34)39-27-19-38-28-24(27)14-15-37-28/h5-13,20,24-28,33H,3-4,14-19,30H2,1-2H3,(H,31,34)/t24-,25-,26+,27-,28+/m0/s1",GEBDYIIQOXRGOM-AJIIGFCHSA-N,112659,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-(2-ethylbutyl)phenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (11a)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]",Human immunodeficiency virus,
243,CCC(CC)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(OC)cc1,"InChI=1S/C30H42N2O8S/c1-4-21(5-2)18-32(41(35,36)24-13-11-23(37-3)12-14-24)19-27(33)26(17-22-9-7-6-8-10-22)31-30(34)40-28-20-39-29-25(28)15-16-38-29/h6-14,21,25-29,33H,4-5,15-20H2,1-3H3,(H,31,34)/t25-,26-,27+,28-,29+/m0/s1",NTULOPNXUZKLEA-WNJKUOTESA-N,112660,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(N-(2-ethylbutyl)-4-methoxyphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (11b)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]",Human immunodeficiency virus,
244,CCC(CC)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(CO)cc1,"InChI=1S/C30H42N2O8S/c1-3-21(4-2)17-32(41(36,37)24-12-10-23(19-33)11-13-24)18-27(34)26(16-22-8-6-5-7-9-22)31-30(35)40-28-20-39-29-25(28)14-15-38-29/h5-13,21,25-29,33-34H,3-4,14-20H2,1-2H3,(H,31,35)/t25-,26-,27+,28-,29+/m0/s1",KOYHHSRUNXTXFB-WNJKUOTESA-N,112661,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(N-(2-ethylbutyl)-4-(hydroxymethyl)phenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (11c)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]",Human immunodeficiency virus,
245,CCC(CC)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc2OCOc2c1,"InChI=1S/C30H40N2O9S/c1-3-20(4-2)16-32(42(35,36)22-10-11-26-27(15-22)40-19-39-26)17-25(33)24(14-21-8-6-5-7-9-21)31-30(34)41-28-18-38-29-23(28)12-13-37-29/h5-11,15,20,23-25,28-29,33H,3-4,12-14,16-19H2,1-2H3,(H,31,34)/t23-,24-,25+,28-,29+/m0/s1",ZLBAIBYBEYCDIE-KTJDEMTHSA-N,112662,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(N-(2-ethylbutyl)benzo[d][1,3]dioxole-5-sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (11d)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]",Human immunodeficiency virus,
246,CCC(CC)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc2ncsc2c1,"InChI=1S/C30H39N3O7S2/c1-3-20(4-2)16-33(42(36,37)22-10-11-24-28(15-22)41-19-31-24)17-26(34)25(14-21-8-6-5-7-9-21)32-30(35)40-27-18-39-29-23(27)12-13-38-29/h5-11,15,19-20,23,25-27,29,34H,3-4,12-14,16-18H2,1-2H3,(H,32,35)/t23-,25-,26+,27-,29+/m0/s1",RAFDIRILGICCDS-OPUPNEDUSA-N,112663,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(N-(2-ethylbutyl)benzo[d]thiazole-6-sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (11e)","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]",Human immunodeficiency virus,
247,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,"InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1",CJBJHOAVZSMMDJ-HEXNFIEUSA-N,8125,"(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate::CHEMBL1323::Darunavir::Darunavir (DRV)::TMC-114::UIC-94017::US10806794, Compound Darunavir","Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]",Human immunodeficiency virus,
248,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)c1ncc(o1)-c1c(Cl)cccc1Cl,"InChI=1S/C26H19Cl2N3O10S2/c27-15-2-1-3-16(28)22(15)19-11-29-25(41-19)23(35)17(9-21(33)34)31-24(36)20-7-4-12(42-20)10-30-43(39,40)13-5-6-18(32)14(8-13)26(37)38/h1-8,11,17,30,32H,9-10H2,(H,31,36)(H,33,34)(H,37,38)/t17-/m0/s1",ACBRCEPZVPRKPJ-KRWDZBQOSA-N,247,"5-[(5-{1-Carboxymethyl-2-[5-(2,6-dichloro-phenyl)-oxazol-2-yl]-2-oxo-ethylcarbamoyl}thiophen-2-ylmethyl)-sulfamoyl]-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-3-carboxy-1-[5-(2,6-dichlorophenyl)-1,3-oxazol-2-yl]-1-oxopropan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 41b::Thiophene Scaffold 41b",Caspase-3,Homo sapiens,
249,COc1cccc2nc(oc12)C(=O)[C@H](CC(O)=O)NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1,"InChI=1S/C25H21N3O11S2/c1-38-18-4-2-3-15-22(18)39-24(28-15)21(32)16(10-20(30)31)27-23(33)19-8-5-12(40-19)11-26-41(36,37)13-6-7-17(29)14(9-13)25(34)35/h2-9,16,26,29H,10-11H2,1H3,(H,27,33)(H,30,31)(H,34,35)/t16-/m0/s1",GGYJPVNQLXYGOZ-INIZCTEOSA-N,248,"5-({5-[1-Carboxymethyl-2-(7-methyl-benzoxazol-2-yl)-2-oxo-ethylcarbamoyl]thiophen-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-3-carboxy-1-(7-methoxy-1,3-benzoxazol-2-yl)-1-oxopropan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 42b::Thiophene Scaffold 42b",Caspase-3,Homo sapiens,
250,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccccc2)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C24H23ClN2O6S3/c25-19-9-5-4-6-16(19)14-34-15-21(28)20(12-23(29)30)27-24(31)22-11-10-17(35-22)13-26-36(32,33)18-7-2-1-3-8-18/h1-11,20,26H,12-15H2,(H,27,31)(H,29,30)/t20-/m0/s1",OEBJUDGECLJUTH-FQEVSTJZSA-N,249,(3S)-3-{[5-(benzenesulfonamidomethyl)thiophen-2-yl]formamido}-5-{[(2-chlorophenyl)methyl]sulfanyl}-4-oxopentanoic acid::(S)-3-{[5-(Benzenesulfonylamino-methyl)thiophene-2-carbonyl]amino}-5-(2-chloro-benzylsulfanyl)-4-oxo-pentanoic Acid::Inhibitor 74::Thiophene Scaffold 74,Caspase-3,Homo sapiens,
251,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)cc2)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C24H23ClN2O7S3/c25-19-4-2-1-3-15(19)13-35-14-21(29)20(11-23(30)31)27-24(32)22-10-7-17(36-22)12-26-37(33,34)18-8-5-16(28)6-9-18/h1-10,20,26,28H,11-14H2,(H,27,32)(H,30,31)/t20-/m0/s1",HHAHHFFADDXEEC-FQEVSTJZSA-N,250,(3S)-5-{[(2-chlorophenyl)methyl]sulfanyl}-3-({5-[(4-hydroxybenzene)sulfonamidomethyl]thiophen-2-yl}formamido)-4-oxopentanoic acid::(S)-5-(2-Chloro-benzylsulfanyl)-3-({5-[(4-hydroxy-ben-zenesulfonylamino)methyl]thiophene-2-carbonyl}amino)-4-oxo-pentanoic Acid::Inhibitor 75::Thiophene Scaffold 75,Caspase-3,Homo sapiens,
252,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2cccc(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O8S3/c26-19-7-2-1-4-16(19)13-37-14-21(29)20(11-23(30)31)28-24(32)22-9-8-17(38-22)12-27-39(35,36)18-6-3-5-15(10-18)25(33)34/h1-10,20,27H,11-14H2,(H,28,32)(H,30,31)(H,33,34)/t20-/m0/s1",MSOSPLTZVVLJDB-FQEVSTJZSA-N,251,(S)-3-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}sulfamoyl)-benzoic Acid::3-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}benzoic acid::Inhibitor 76::Thiophene Scaffold 76,Caspase-3,Homo sapiens,
253,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2cccc(c2)-c2nc(=O)o[nH]2)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H23ClN4O8S3/c27-19-7-2-1-4-16(19)13-40-14-21(32)20(11-23(33)34)29-25(35)22-9-8-17(41-22)12-28-42(37,38)18-6-3-5-15(10-18)24-30-26(36)39-31-24/h1-10,20,28H,11-14H2,(H,29,35)(H,33,34)(H,30,31,36)/t20-/m0/s1",USVOMZAPZHSFMM-FQEVSTJZSA-N,252,"(3S)-5-{[(2-chlorophenyl)methyl]sulfanyl}-4-oxo-3-[(5-{[3-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)benzene]sulfonamidomethyl}thiophen-2-yl)formamido]pentanoic acid::(S)-5-(2-Chloro-benzylsulfanyl)-4-oxo-3-[(5-{[3-(5-oxo-4,5-dihydro[1,2,4]oxadiazol-3-yl)benzenesulfonylamino]-methyl}thiophene-2-carbonyl)amino]pentanoic Acid::Inhibitor 77::Thiophene Scaffold 77",Caspase-3,Homo sapiens,
254,CN(Cc1ccc(s1)C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl)S(=O)(=O)c1ccc(O)c(c1)C(O)=O,"InChI=1S/C26H25ClN2O9S3/c1-29(41(37,38)17-7-8-21(30)18(10-17)26(35)36)12-16-6-9-23(40-16)25(34)28-20(11-24(32)33)22(31)14-39-13-15-4-2-3-5-19(15)27/h2-10,20,30H,11-14H2,1H3,(H,28,34)(H,32,33)(H,35,36)/t20-/m0/s1",MKCPZCBJTCEQFQ-FQEVSTJZSA-N,253,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}methyl-sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl](methyl)sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 78::Thiophene Scaffold 78,Caspase-3,Homo sapiens,
255,OC(=O)C[C@H](NC(=O)c1ccc(s1)S(=O)(=O)NCc1ccc(O)c(c1)C(O)=O)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O9S3/c26-17-4-2-1-3-15(17)12-38-13-20(30)18(10-22(31)32)28-24(33)21-7-8-23(39-21)40(36,37)27-11-14-5-6-19(29)16(9-14)25(34)35/h1-9,18,27,29H,10-13H2,(H,28,33)(H,31,32)(H,34,35)/t18-/m0/s1",MTYPWYNHRRSEAM-SFHVURJKSA-N,254,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophene-2-sulfonylamino}-methyl)-2-hydroxy-benzoic Acid::5-[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophene-2-)sulfonamidomethyl]-2-hydroxybenzoic acid::Inhibitor 79::Thiophene Scaffold 79,Caspase-3,Homo sapiens,
256,OC(=O)C[C@H](NC(=O)c1ccc(CNCc2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H25ClN2O7S2/c27-19-4-2-1-3-16(19)13-37-14-22(31)20(10-24(32)33)29-25(34)23-8-6-17(38-23)12-28-11-15-5-7-21(30)18(9-15)26(35)36/h1-9,20,28,30H,10-14H2,(H,29,34)(H,32,33)(H,35,36)/t20-/m0/s1",AZTLWCKQYIECGA-FQEVSTJZSA-N,255,(S)-5-[({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}amino)-methyl]-2-hydroxy-benzoic Acid::5-({[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]amino}methyl)-2-hydroxybenzoic acid::Inhibitor 47a::Thiophene Scaffold 47a,Caspase-3,Homo sapiens,
257,CC(=O)N(Cc1ccc(s1)C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl)Cc1ccc(O)c(c1)C(O)=O,"InChI=1S/C28H27ClN2O8S2/c1-16(32)31(12-17-6-8-23(33)20(10-17)28(38)39)13-19-7-9-25(41-19)27(37)30-22(11-26(35)36)24(34)15-40-14-18-4-2-3-5-21(18)29/h2-10,22,33H,11-15H2,1H3,(H,30,37)(H,35,36)(H,38,39)/t22-/m0/s1",LOAXHXWQPLWYQU-QFIPXVFZSA-N,256,(S)-5-[(Acetyl-{5-[1-carboxymethyl-3-(2-chloro-benzyl-sulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}-amino)methyl]-2-hydroxy-benzoic Acid::5-({N-[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]acetamido}methyl)-2-hydroxybenzoic acid::Inhibitor 47b::Thiophene Scaffold 47b,Caspase-3,Homo sapiens,
258,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cc1)C=O,"InChI=1S/C19H18N2O9S/c22-10-13(7-17(24)25)21-18(26)12-3-1-11(2-4-12)9-20-31(29,30)14-5-6-16(23)15(8-14)19(27)28/h1-6,8,10,13,20,23H,7,9H2,(H,21,26)(H,24,25)(H,27,28)/t13-/m0/s1",FMTZTJFXNZOBIQ-ZDUSSCGKSA-N,220,5-{[(4-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}phenyl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 3,Caspase-7,Homo sapiens,
259,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C=O,"InChI=1S/C18H17N3O9S/c22-9-12(5-16(24)25)21-17(26)10-1-2-11(19-7-10)8-20-31(29,30)13-3-4-15(23)14(6-13)18(27)28/h1-4,6-7,9,12,20,23H,5,8H2,(H,21,26)(H,24,25)(H,27,28)/t12-/m0/s1",BZEURKGKCWHMON-LBPRGKRZSA-N,221,5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 4::Pyridine Scaffold 4,Caspase-7,Homo sapiens,
260,CN(Cc1ccc(s1)C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl)Cc1ccc(O)c(c1)C(O)=O,"InChI=1S/C27H27ClN2O7S2/c1-30(12-16-6-8-22(31)19(10-16)27(36)37)13-18-7-9-24(39-18)26(35)29-21(11-25(33)34)23(32)15-38-14-17-4-2-3-5-20(17)28/h2-10,21,31H,11-15H2,1H3,(H,29,35)(H,33,34)(H,36,37)/t21-/m0/s1",FIEQQFOHZKVJLV-NRFANRHFSA-N,219,5-({[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl](methyl)amino}methyl)-2-hydroxybenzoic acid::Inhibitor 47c::Thiophene Scaffold 47c,Caspase-7,Homo sapiens,
261,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H24ClN3O9S2/c27-20-4-2-1-3-16(20)13-40-14-23(32)21(10-24(33)34)30-25(35)15-5-6-17(28-11-15)12-29-41(38,39)18-7-8-22(31)19(9-18)26(36)37/h1-9,11,21,29,31H,10,12-14H2,(H,30,35)(H,33,34)(H,36,37)/t21-/m0/s1",AYQUXMOMSNPZEF-NRFANRHFSA-N,222,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyridin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Pyridine Scaffold 59,Caspase-7,Homo sapiens,
262,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN4O9S2/c26-18-4-2-1-3-14(18)12-40-13-21(32)19(8-23(33)34)30-24(35)15-9-27-22(28-10-15)11-29-41(38,39)16-5-6-20(31)17(7-16)25(36)37/h1-7,9-10,19,29,31H,8,11-13H2,(H,30,35)(H,33,34)(H,36,37)/t19-/m0/s1",NAJZBQCCBCKDIT-IBGZPJMESA-N,223,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyrimidin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyrimidin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 62b::Inhibitor 62b,Caspase-7,Homo sapiens,
263,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C24H22ClN3O9S3/c25-16-4-2-1-3-13(16)11-38-12-19(30)17(8-22(31)32)28-23(33)20-9-26-21(39-20)10-27-40(36,37)14-5-6-18(29)15(7-14)24(34)35/h1-7,9,17,27,29H,8,10-12H2,(H,28,33)(H,31,32)(H,34,35)/t17-/m0/s1",VCWYKJKQZUPTQP-KRWDZBQOSA-N,224,"(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiazol-2-hydroxy-benzoic Acidylmethyl}sulfamoyl)-2-::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-1,3-thiazol-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 64b::Inhibitor 64b",Caspase-7,Homo sapiens,
264,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C=O,"InChI=1S/C17H16N2O9S2/c20-8-9(5-15(22)23)19-16(24)14-4-1-10(29-14)7-18-30(27,28)11-2-3-13(21)12(6-11)17(25)26/h1-4,6,8-9,18,21H,5,7H2,(H,19,24)(H,22,23)(H,25,26)/t9-/m0/s1",VUJHWZDCLPHWMO-VIFPVBQESA-N,225,(S)-5-5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-thiophen-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66a::Thiophene Scaffold 66a,Caspase-7,Homo sapiens,
265,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O9S3/c26-18-4-2-1-3-14(18)12-38-13-21(30)19(10-23(31)32)28-24(33)22-8-5-15(39-22)11-27-40(36,37)16-6-7-20(29)17(9-16)25(34)35/h1-9,19,27,29H,10-13H2,(H,28,33)(H,31,32)(H,34,35)/t19-/m0/s1",ZOVHWLRITDMPBF-IBGZPJMESA-N,226,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66b::Thiophene Scaffold 66b,Caspase-7,Homo sapiens,
266,Cc1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)sc1C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H25ClN2O9S3/c1-14-8-16(11-28-41(37,38)17-6-7-21(30)18(9-17)26(35)36)40-24(14)25(34)29-20(10-23(32)33)22(31)13-39-12-15-4-2-3-5-19(15)27/h2-9,20,28,30H,10-13H2,1H3,(H,29,34)(H,32,33)(H,35,36)/t20-/m0/s1",PZMBYHSWPUMKMR-FQEVSTJZSA-N,227,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]-4-methyl-thiophen-2-ylmethyl}-sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-4-methylthiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 69b::Inhibitor 69b,Caspase-7,Homo sapiens,
267,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cc1)C=O,"InChI=1S/C19H18N2O9S/c22-10-13(7-17(24)25)21-18(26)12-3-1-11(2-4-12)9-20-31(29,30)14-5-6-16(23)15(8-14)19(27)28/h1-6,8,10,13,20,23H,7,9H2,(H,21,26)(H,24,25)(H,27,28)/t13-/m0/s1",FMTZTJFXNZOBIQ-ZDUSSCGKSA-N,220,5-{[(4-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}phenyl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 3,Caspase-6,Homo sapiens,
268,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C=O,"InChI=1S/C18H17N3O9S/c22-9-12(5-16(24)25)21-17(26)10-1-2-11(19-7-10)8-20-31(29,30)13-3-4-15(23)14(6-13)18(27)28/h1-4,6-7,9,12,20,23H,5,8H2,(H,21,26)(H,24,25)(H,27,28)/t12-/m0/s1",BZEURKGKCWHMON-LBPRGKRZSA-N,221,5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 4::Pyridine Scaffold 4,Caspase-6,Homo sapiens,
269,CN(Cc1ccc(s1)C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl)Cc1ccc(O)c(c1)C(O)=O,"InChI=1S/C27H27ClN2O7S2/c1-30(12-16-6-8-22(31)19(10-16)27(36)37)13-18-7-9-24(39-18)26(35)29-21(11-25(33)34)23(32)15-38-14-17-4-2-3-5-20(17)28/h2-10,21,31H,11-15H2,1H3,(H,29,35)(H,33,34)(H,36,37)/t21-/m0/s1",FIEQQFOHZKVJLV-NRFANRHFSA-N,219,5-({[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl](methyl)amino}methyl)-2-hydroxybenzoic acid::Inhibitor 47c::Thiophene Scaffold 47c,Caspase-6,Homo sapiens,
270,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H24ClN3O9S2/c27-20-4-2-1-3-16(20)13-40-14-23(32)21(10-24(33)34)30-25(35)15-5-6-17(28-11-15)12-29-41(38,39)18-7-8-22(31)19(9-18)26(36)37/h1-9,11,21,29,31H,10,12-14H2,(H,30,35)(H,33,34)(H,36,37)/t21-/m0/s1",AYQUXMOMSNPZEF-NRFANRHFSA-N,222,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyridin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Pyridine Scaffold 59,Caspase-6,Homo sapiens,
271,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN4O9S2/c26-18-4-2-1-3-14(18)12-40-13-21(32)19(8-23(33)34)30-24(35)15-9-27-22(28-10-15)11-29-41(38,39)16-5-6-20(31)17(7-16)25(36)37/h1-7,9-10,19,29,31H,8,11-13H2,(H,30,35)(H,33,34)(H,36,37)/t19-/m0/s1",NAJZBQCCBCKDIT-IBGZPJMESA-N,223,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyrimidin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyrimidin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 62b::Inhibitor 62b,Caspase-6,Homo sapiens,
272,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C24H22ClN3O9S3/c25-16-4-2-1-3-13(16)11-38-12-19(30)17(8-22(31)32)28-23(33)20-9-26-21(39-20)10-27-40(36,37)14-5-6-18(29)15(7-14)24(34)35/h1-7,9,17,27,29H,8,10-12H2,(H,28,33)(H,31,32)(H,34,35)/t17-/m0/s1",VCWYKJKQZUPTQP-KRWDZBQOSA-N,224,"(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiazol-2-hydroxy-benzoic Acidylmethyl}sulfamoyl)-2-::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-1,3-thiazol-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 64b::Inhibitor 64b",Caspase-6,Homo sapiens,
273,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C=O,"InChI=1S/C17H16N2O9S2/c20-8-9(5-15(22)23)19-16(24)14-4-1-10(29-14)7-18-30(27,28)11-2-3-13(21)12(6-11)17(25)26/h1-4,6,8-9,18,21H,5,7H2,(H,19,24)(H,22,23)(H,25,26)/t9-/m0/s1",VUJHWZDCLPHWMO-VIFPVBQESA-N,225,(S)-5-5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-thiophen-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66a::Thiophene Scaffold 66a,Caspase-6,Homo sapiens,
274,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O9S3/c26-18-4-2-1-3-14(18)12-38-13-21(30)19(10-23(31)32)28-24(33)22-8-5-15(39-22)11-27-40(36,37)16-6-7-20(29)17(9-16)25(34)35/h1-9,19,27,29H,10-13H2,(H,28,33)(H,31,32)(H,34,35)/t19-/m0/s1",ZOVHWLRITDMPBF-IBGZPJMESA-N,226,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66b::Thiophene Scaffold 66b,Caspase-6,Homo sapiens,
275,Cc1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)sc1C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H25ClN2O9S3/c1-14-8-16(11-28-41(37,38)17-6-7-21(30)18(9-17)26(35)36)40-24(14)25(34)29-20(10-23(32)33)22(31)13-39-12-15-4-2-3-5-19(15)27/h2-9,20,28,30H,10-13H2,1H3,(H,29,34)(H,32,33)(H,35,36)/t20-/m0/s1",PZMBYHSWPUMKMR-FQEVSTJZSA-N,227,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]-4-methyl-thiophen-2-ylmethyl}-sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-4-methylthiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 69b::Inhibitor 69b,Caspase-6,Homo sapiens,
276,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cc1)C=O,"InChI=1S/C19H18N2O9S/c22-10-13(7-17(24)25)21-18(26)12-3-1-11(2-4-12)9-20-31(29,30)14-5-6-16(23)15(8-14)19(27)28/h1-6,8,10,13,20,23H,7,9H2,(H,21,26)(H,24,25)(H,27,28)/t13-/m0/s1",FMTZTJFXNZOBIQ-ZDUSSCGKSA-N,220,5-{[(4-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}phenyl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 3,Caspase-5,Homo sapiens,
277,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C=O,"InChI=1S/C18H17N3O9S/c22-9-12(5-16(24)25)21-17(26)10-1-2-11(19-7-10)8-20-31(29,30)13-3-4-15(23)14(6-13)18(27)28/h1-4,6-7,9,12,20,23H,5,8H2,(H,21,26)(H,24,25)(H,27,28)/t12-/m0/s1",BZEURKGKCWHMON-LBPRGKRZSA-N,221,5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 4::Pyridine Scaffold 4,Caspase-5,Homo sapiens,
278,CN(Cc1ccc(s1)C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl)Cc1ccc(O)c(c1)C(O)=O,"InChI=1S/C27H27ClN2O7S2/c1-30(12-16-6-8-22(31)19(10-16)27(36)37)13-18-7-9-24(39-18)26(35)29-21(11-25(33)34)23(32)15-38-14-17-4-2-3-5-20(17)28/h2-10,21,31H,11-15H2,1H3,(H,29,35)(H,33,34)(H,36,37)/t21-/m0/s1",FIEQQFOHZKVJLV-NRFANRHFSA-N,219,5-({[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl](methyl)amino}methyl)-2-hydroxybenzoic acid::Inhibitor 47c::Thiophene Scaffold 47c,Caspase-5,Homo sapiens,
279,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H24ClN3O9S2/c27-20-4-2-1-3-16(20)13-40-14-23(32)21(10-24(33)34)30-25(35)15-5-6-17(28-11-15)12-29-41(38,39)18-7-8-22(31)19(9-18)26(36)37/h1-9,11,21,29,31H,10,12-14H2,(H,30,35)(H,33,34)(H,36,37)/t21-/m0/s1",AYQUXMOMSNPZEF-NRFANRHFSA-N,222,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyridin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Pyridine Scaffold 59,Caspase-5,Homo sapiens,
280,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN4O9S2/c26-18-4-2-1-3-14(18)12-40-13-21(32)19(8-23(33)34)30-24(35)15-9-27-22(28-10-15)11-29-41(38,39)16-5-6-20(31)17(7-16)25(36)37/h1-7,9-10,19,29,31H,8,11-13H2,(H,30,35)(H,33,34)(H,36,37)/t19-/m0/s1",NAJZBQCCBCKDIT-IBGZPJMESA-N,223,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyrimidin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyrimidin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 62b::Inhibitor 62b,Caspase-5,Homo sapiens,
281,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C24H22ClN3O9S3/c25-16-4-2-1-3-13(16)11-38-12-19(30)17(8-22(31)32)28-23(33)20-9-26-21(39-20)10-27-40(36,37)14-5-6-18(29)15(7-14)24(34)35/h1-7,9,17,27,29H,8,10-12H2,(H,28,33)(H,31,32)(H,34,35)/t17-/m0/s1",VCWYKJKQZUPTQP-KRWDZBQOSA-N,224,"(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiazol-2-hydroxy-benzoic Acidylmethyl}sulfamoyl)-2-::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-1,3-thiazol-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 64b::Inhibitor 64b",Caspase-5,Homo sapiens,
282,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C=O,"InChI=1S/C17H16N2O9S2/c20-8-9(5-15(22)23)19-16(24)14-4-1-10(29-14)7-18-30(27,28)11-2-3-13(21)12(6-11)17(25)26/h1-4,6,8-9,18,21H,5,7H2,(H,19,24)(H,22,23)(H,25,26)/t9-/m0/s1",VUJHWZDCLPHWMO-VIFPVBQESA-N,225,(S)-5-5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-thiophen-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66a::Thiophene Scaffold 66a,Caspase-5,Homo sapiens,
283,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O9S3/c26-18-4-2-1-3-14(18)12-38-13-21(30)19(10-23(31)32)28-24(33)22-8-5-15(39-22)11-27-40(36,37)16-6-7-20(29)17(9-16)25(34)35/h1-9,19,27,29H,10-13H2,(H,28,33)(H,31,32)(H,34,35)/t19-/m0/s1",ZOVHWLRITDMPBF-IBGZPJMESA-N,226,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66b::Thiophene Scaffold 66b,Caspase-5,Homo sapiens,
284,Cc1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)sc1C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H25ClN2O9S3/c1-14-8-16(11-28-41(37,38)17-6-7-21(30)18(9-17)26(35)36)40-24(14)25(34)29-20(10-23(32)33)22(31)13-39-12-15-4-2-3-5-19(15)27/h2-9,20,28,30H,10-13H2,1H3,(H,29,34)(H,32,33)(H,35,36)/t20-/m0/s1",PZMBYHSWPUMKMR-FQEVSTJZSA-N,227,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]-4-methyl-thiophen-2-ylmethyl}-sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-4-methylthiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 69b::Inhibitor 69b,Caspase-5,Homo sapiens,
285,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cc1)C=O,"InChI=1S/C19H18N2O9S/c22-10-13(7-17(24)25)21-18(26)12-3-1-11(2-4-12)9-20-31(29,30)14-5-6-16(23)15(8-14)19(27)28/h1-6,8,10,13,20,23H,7,9H2,(H,21,26)(H,24,25)(H,27,28)/t13-/m0/s1",FMTZTJFXNZOBIQ-ZDUSSCGKSA-N,220,5-{[(4-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}phenyl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 3,Caspase-8,Homo sapiens,
286,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C=O,"InChI=1S/C18H17N3O9S/c22-9-12(5-16(24)25)21-17(26)10-1-2-11(19-7-10)8-20-31(29,30)13-3-4-15(23)14(6-13)18(27)28/h1-4,6-7,9,12,20,23H,5,8H2,(H,21,26)(H,24,25)(H,27,28)/t12-/m0/s1",BZEURKGKCWHMON-LBPRGKRZSA-N,221,5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 4::Pyridine Scaffold 4,Caspase-8,Homo sapiens,
287,CN(Cc1ccc(s1)C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl)Cc1ccc(O)c(c1)C(O)=O,"InChI=1S/C27H27ClN2O7S2/c1-30(12-16-6-8-22(31)19(10-16)27(36)37)13-18-7-9-24(39-18)26(35)29-21(11-25(33)34)23(32)15-38-14-17-4-2-3-5-20(17)28/h2-10,21,31H,11-15H2,1H3,(H,29,35)(H,33,34)(H,36,37)/t21-/m0/s1",FIEQQFOHZKVJLV-NRFANRHFSA-N,219,5-({[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl](methyl)amino}methyl)-2-hydroxybenzoic acid::Inhibitor 47c::Thiophene Scaffold 47c,Caspase-8,Homo sapiens,
288,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H24ClN3O9S2/c27-20-4-2-1-3-16(20)13-40-14-23(32)21(10-24(33)34)30-25(35)15-5-6-17(28-11-15)12-29-41(38,39)18-7-8-22(31)19(9-18)26(36)37/h1-9,11,21,29,31H,10,12-14H2,(H,30,35)(H,33,34)(H,36,37)/t21-/m0/s1",AYQUXMOMSNPZEF-NRFANRHFSA-N,222,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyridin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Pyridine Scaffold 59,Caspase-8,Homo sapiens,
289,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN4O9S2/c26-18-4-2-1-3-14(18)12-40-13-21(32)19(8-23(33)34)30-24(35)15-9-27-22(28-10-15)11-29-41(38,39)16-5-6-20(31)17(7-16)25(36)37/h1-7,9-10,19,29,31H,8,11-13H2,(H,30,35)(H,33,34)(H,36,37)/t19-/m0/s1",NAJZBQCCBCKDIT-IBGZPJMESA-N,223,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyrimidin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyrimidin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 62b::Inhibitor 62b,Caspase-8,Homo sapiens,
290,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C24H22ClN3O9S3/c25-16-4-2-1-3-13(16)11-38-12-19(30)17(8-22(31)32)28-23(33)20-9-26-21(39-20)10-27-40(36,37)14-5-6-18(29)15(7-14)24(34)35/h1-7,9,17,27,29H,8,10-12H2,(H,28,33)(H,31,32)(H,34,35)/t17-/m0/s1",VCWYKJKQZUPTQP-KRWDZBQOSA-N,224,"(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiazol-2-hydroxy-benzoic Acidylmethyl}sulfamoyl)-2-::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-1,3-thiazol-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 64b::Inhibitor 64b",Caspase-8,Homo sapiens,
291,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C=O,"InChI=1S/C17H16N2O9S2/c20-8-9(5-15(22)23)19-16(24)14-4-1-10(29-14)7-18-30(27,28)11-2-3-13(21)12(6-11)17(25)26/h1-4,6,8-9,18,21H,5,7H2,(H,19,24)(H,22,23)(H,25,26)/t9-/m0/s1",VUJHWZDCLPHWMO-VIFPVBQESA-N,225,(S)-5-5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-thiophen-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66a::Thiophene Scaffold 66a,Caspase-8,Homo sapiens,
292,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O9S3/c26-18-4-2-1-3-14(18)12-38-13-21(30)19(10-23(31)32)28-24(33)22-8-5-15(39-22)11-27-40(36,37)16-6-7-20(29)17(9-16)25(34)35/h1-9,19,27,29H,10-13H2,(H,28,33)(H,31,32)(H,34,35)/t19-/m0/s1",ZOVHWLRITDMPBF-IBGZPJMESA-N,226,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66b::Thiophene Scaffold 66b,Caspase-8,Homo sapiens,
293,Cc1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)sc1C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H25ClN2O9S3/c1-14-8-16(11-28-41(37,38)17-6-7-21(30)18(9-17)26(35)36)40-24(14)25(34)29-20(10-23(32)33)22(31)13-39-12-15-4-2-3-5-19(15)27/h2-9,20,28,30H,10-13H2,1H3,(H,29,34)(H,32,33)(H,35,36)/t20-/m0/s1",PZMBYHSWPUMKMR-FQEVSTJZSA-N,227,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]-4-methyl-thiophen-2-ylmethyl}-sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-4-methylthiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 69b::Inhibitor 69b,Caspase-8,Homo sapiens,
294,OC(=O)C[C@H](NC(=O)c1csc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)c1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O9S3/c26-19-4-2-1-3-14(19)11-38-13-22(30)20(9-23(31)32)28-24(33)15-7-16(39-12-15)10-27-40(36,37)17-5-6-21(29)18(8-17)25(34)35/h1-8,12,20,27,29H,9-11,13H2,(H,28,33)(H,31,32)(H,34,35)/t20-/m0/s1",GLQGBIUHNGLPEY-FQEVSTJZSA-N,257,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-3-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(4-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 67b::Inhibitor 67b,Caspase-3,Homo sapiens,
295,OC(=O)C[C@H](NC(=O)c1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cs1)C=O,"InChI=1S/C17H16N2O9S2/c20-7-10(4-15(22)23)19-16(24)14-3-9(8-29-14)6-18-30(27,28)11-1-2-13(21)12(5-11)17(25)26/h1-3,5,7-8,10,18,21H,4,6H2,(H,19,24)(H,22,23)(H,25,26)/t10-/m0/s1",XTYAXJSXJWVVFZ-JTQLQIEISA-N,258,(S)-5-{[5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-thiophen-3-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}thiophen-3-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 68a::Inhibitor 68a,Caspase-3,Homo sapiens,
296,OC(=O)C[C@H](NC(=O)c1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cs1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O9S3/c26-18-4-2-1-3-15(18)12-38-13-21(30)19(9-23(31)32)28-24(33)22-7-14(11-39-22)10-27-40(36,37)16-5-6-20(29)17(8-16)25(34)35/h1-8,11,19,27,29H,9-10,12-13H2,(H,28,33)(H,31,32)(H,34,35)/t19-/m0/s1",UVOJEXKUDHCDHQ-IBGZPJMESA-N,259,(S)-4-[(4-Hydroxy-3-methyl-benzenesulfonylamino)-methyl]thiophene-2-carboxylic Acid [3-(2-Chloro-benz-ylsulfanyl)-1-ethyl-2-oxo-propyl]amide::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-3-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 68b::Inhibitor 68b,Caspase-3,Homo sapiens,
297,Cc1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)sc1C(=O)N[C@@H](CC(O)=O)C=O,"InChI=1S/C18H18N2O9S2/c1-9-4-11(30-16(9)17(25)20-10(8-21)5-15(23)24)7-19-31(28,29)12-2-3-14(22)13(6-12)18(26)27/h2-4,6,8,10,19,22H,5,7H2,1H3,(H,20,25)(H,23,24)(H,26,27)/t10-/m0/s1",IEEBOWICSGFLHF-JTQLQIEISA-N,260,(S)-5-{[5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-4-methyl-thiophen-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-4-methylthiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 69a::Inhibitor 69a,Caspase-3,Homo sapiens,
298,Cc1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)sc1C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H25ClN2O9S3/c1-14-8-16(11-28-41(37,38)17-6-7-21(30)18(9-17)26(35)36)40-24(14)25(34)29-20(10-23(32)33)22(31)13-39-12-15-4-2-3-5-19(15)27/h2-9,20,28,30H,10-13H2,1H3,(H,29,34)(H,32,33)(H,35,36)/t20-/m0/s1",PZMBYHSWPUMKMR-FQEVSTJZSA-N,227,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]-4-methyl-thiophen-2-ylmethyl}-sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-4-methylthiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 69b::Inhibitor 69b,Caspase-3,Homo sapiens,
299,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)o1)C=O,"InChI=1S/C17H16N2O10S/c20-8-9(5-15(22)23)19-16(24)14-4-1-10(29-14)7-18-30(27,28)11-2-3-13(21)12(6-11)17(25)26/h1-4,6,8-9,18,21H,5,7H2,(H,19,24)(H,22,23)(H,25,26)/t9-/m0/s1",LKRGLBXFALOHLE-VIFPVBQESA-N,261,(S)-5-{[5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-furan-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}furan-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 70a::Inhibitor 70a,Caspase-3,Homo sapiens,
300,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)o1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O10S2/c26-18-4-2-1-3-14(18)12-39-13-21(30)19(10-23(31)32)28-24(33)22-8-5-15(38-22)11-27-40(36,37)16-6-7-20(29)17(9-16)25(34)35/h1-9,19,27,29H,10-13H2,(H,28,33)(H,31,32)(H,34,35)/t19-/m0/s1",KCYRHEUMORWGHJ-IBGZPJMESA-N,262,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]furan-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}furan-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 70b::Inhibitor 70b,Caspase-3,Homo sapiens,
301,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1cccnc1,"InChI=1S/C24H23N3O9S3/c28-19-5-4-16(8-17(19)24(33)34)39(35,36)26-11-15-3-6-21(38-15)23(32)27-18(9-22(30)31)20(29)13-37-12-14-2-1-7-25-10-14/h1-8,10,18,26,28H,9,11-13H2,(H,27,32)(H,30,31)(H,33,34)/t18-/m0/s1",QHKQIPCBIONNNA-SFHVURJKSA-N,263,(S)-5-({5-[1-Carboxymethyl-2-oxo-3-(pyridin-3-ylmeth-ylsulfanyl)propylcarbamoyl]thiophen-2-ylmethyl}-sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxo-4-[(pyridin-3-ylmethyl)sulfanyl]butan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 71::Thiophene Scaffold 71,Caspase-3,Homo sapiens,
302,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccncc1,"InChI=1S/C24H23N3O9S3/c28-19-3-2-16(9-17(19)24(33)34)39(35,36)26-11-15-1-4-21(38-15)23(32)27-18(10-22(30)31)20(29)13-37-12-14-5-7-25-8-6-14/h1-9,18,26,28H,10-13H2,(H,27,32)(H,30,31)(H,33,34)/t18-/m0/s1",YRPYWPSDJUJBQH-SFHVURJKSA-N,264,(S)-5-({5-[1-Carboxymethyl-2-oxo-3-(pyridin-4-ylmeth-ylsulfanyl)propylcarbamoyl]thiophen-2-ylmethyl}-sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxo-4-[(pyridin-4-ylmethyl)sulfanyl]butan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 72::Thiophene Scaffold 72,Caspase-3,Homo sapiens,
303,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CCCc1ccccc1,"InChI=1S/C26H26N2O9S2/c29-21-11-10-18(13-19(21)26(34)35)39(36,37)27-15-17-9-12-23(38-17)25(33)28-20(14-24(31)32)22(30)8-4-7-16-5-2-1-3-6-16/h1-3,5-6,9-13,20,27,29H,4,7-8,14-15H2,(H,28,33)(H,31,32)(H,34,35)/t20-/m0/s1",IAZHUZNOJTUKSY-FQEVSTJZSA-N,265,(S)-5-({5-[1-Carboxymethyl-5-(2-chloro-phenyl)-2-oxo-pentylcarbamoyl]thiophen-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxo-6-phenylhexan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 73::Thiophene Scaffold 73,Caspase-3,Homo sapiens,
304,CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(C)=O)C(=O)N[C@@H](CC(O)=O)C=O,"InChI=1S/C20H30N4O11/c1-9(2)17(20(35)22-11(8-25)6-15(29)30)24-18(33)12(4-5-14(27)28)23-19(34)13(7-16(31)32)21-10(3)26/h8-9,11-13,17H,4-7H2,1-3H3,(H,21,26)(H,22,35)(H,23,34)(H,24,33)(H,27,28)(H,29,30)(H,31,32)/t11-,12-,13-,17-/m0/s1",UMBVAPCONCILTL-MRHIQRDNSA-N,10246,(4S)-4-{[(1S)-1-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-2-methylpropyl]carbamoyl}-4-[(3S)-3-acetamido-3-formamidopropanoic acid]butanoic acid::Ac-DEVD-CHO::CHEMBL417149,Caspase-3,Homo sapiens,
305,CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(C)=O)C(=O)N[C@@H](CC(O)=O)C=O,"InChI=1S/C20H30N4O11/c1-9(2)17(20(35)22-11(8-25)6-15(29)30)24-18(33)12(4-5-14(27)28)23-19(34)13(7-16(31)32)21-10(3)26/h8-9,11-13,17H,4-7H2,1-3H3,(H,21,26)(H,22,35)(H,23,34)(H,24,33)(H,27,28)(H,29,30)(H,31,32)/t11-,12-,13-,17-/m0/s1",UMBVAPCONCILTL-MRHIQRDNSA-N,10246,(4S)-4-{[(1S)-1-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-2-methylpropyl]carbamoyl}-4-[(3S)-3-acetamido-3-formamidopropanoic acid]butanoic acid::Ac-DEVD-CHO::CHEMBL417149,Caspase-1,Homo sapiens,
306,OC(=O)C[C@H](NC(=O)CCCCCNS(=O)(=O)c1ccc(O)c(c1)C(O)=O)C=O,"InChI=1S/C17H22N2O9S/c20-10-11(8-16(23)24)19-15(22)4-2-1-3-7-18-29(27,28)12-5-6-14(21)13(9-12)17(25)26/h5-6,9-11,18,21H,1-4,7-8H2,(H,19,22)(H,23,24)(H,25,26)/t11-/m0/s1",PLGQJIHCXVKCOL-NSHDSACASA-N,266,5-[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pentyl)sulfamoyl]-2-hydroxybenzoic acid::inhibitor 2::sulfonamide analog 1,Caspase-3,Homo sapiens,
307,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cc1)C=O,"InChI=1S/C19H18N2O9S/c22-10-13(7-17(24)25)21-18(26)12-3-1-11(2-4-12)9-20-31(29,30)14-5-6-16(23)15(8-14)19(27)28/h1-6,8,10,13,20,23H,7,9H2,(H,21,26)(H,24,25)(H,27,28)/t13-/m0/s1",FMTZTJFXNZOBIQ-ZDUSSCGKSA-N,220,5-{[(4-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}phenyl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 3,Caspase-3,Homo sapiens,
308,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C=O,"InChI=1S/C18H17N3O9S/c22-9-12(5-16(24)25)21-17(26)10-1-2-11(19-7-10)8-20-31(29,30)13-3-4-15(23)14(6-13)18(27)28/h1-4,6-7,9,12,20,23H,5,8H2,(H,21,26)(H,24,25)(H,27,28)/t12-/m0/s1",BZEURKGKCWHMON-LBPRGKRZSA-N,221,5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 4::Pyridine Scaffold 4,Caspase-3,Homo sapiens,
309,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccccc2)nc1)C=O,"InChI=1S/C17H17N3O6S/c21-11-14(8-16(22)23)20-17(24)12-6-7-13(18-9-12)10-19-27(25,26)15-4-2-1-3-5-15/h1-7,9,11,14,19H,8,10H2,(H,20,24)(H,22,23)/t14-/m0/s1",OKXHJSNMCKNGQC-AWEZNQCLSA-N,267,(3S)-3-{[6-(benzenesulfonamidomethyl)pyridin-3-yl]formamido}-4-oxobutanoic acid::(S)-3-{[6-(Benzenesulfonylamino-methyl)pyridine-3-carbonyl]amino}-4-oxo-butyric Acid Trifluoroacetate::Inhibitor 48::Pyridine Scaffold 48,Caspase-3,Homo sapiens,
310,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)cc2)nc1)C=O,"InChI=1S/C17H17N3O7S/c21-10-13(7-16(23)24)20-17(25)11-1-2-12(18-8-11)9-19-28(26,27)15-5-3-14(22)4-6-15/h1-6,8,10,13,19,22H,7,9H2,(H,20,25)(H,23,24)/t13-/m0/s1",PQNSMYHJDHIPKV-ZDUSSCGKSA-N,268,(3S)-3-({6-[(4-hydroxybenzene)sulfonamidomethyl]pyridin-3-yl}formamido)-4-oxobutanoic acid::(S)-3-({6-[(4-Hydroxy-benzenesulfonylamino)methyl]-pyridine-3-carbonyl}amino)-4-oxo-butyric Acid Trifluoroacetate::Inhibitor 49::Pyridine Scaffold 49,Caspase-3,Homo sapiens,
311,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2cccc(c2)C(O)=O)nc1)C=O,"InChI=1S/C18H17N3O8S/c22-10-14(7-16(23)24)21-17(25)12-4-5-13(19-8-12)9-20-30(28,29)15-3-1-2-11(6-15)18(26)27/h1-6,8,10,14,20H,7,9H2,(H,21,25)(H,23,24)(H,26,27)/t14-/m0/s1",MENAYYMPBRSAAE-AWEZNQCLSA-N,269,(S)-3-{[5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-pyridin-2-ylmethyl]sulfamoyl}benzoic Acid Trifluoroacetate::3-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}benzoic acid::Inhibitor 50::Pyridine Scaffold 50,Caspase-3,Homo sapiens,
312,CS(=O)(=O)c1cccc(c1)S(=O)(=O)NCc1ccc(cn1)C(=O)N[C@@H](CC(O)=O)C=O,"InChI=1S/C18H19N3O8S2/c1-30(26,27)15-3-2-4-16(8-15)31(28,29)20-10-13-6-5-12(9-19-13)18(25)21-14(11-22)7-17(23)24/h2-6,8-9,11,14,20H,7,10H2,1H3,(H,21,25)(H,23,24)/t14-/m0/s1",IVOJLNSQLGMYAO-AWEZNQCLSA-N,270,(3S)-3-({6-[(3-methanesulfonylbenzene)sulfonamidomethyl]pyridin-3-yl}formamido)-4-oxobutanoic acid::(S)-3-({6-[(3-Methanesulfonyl-benzenesulfonylamino)-methyl]pyridine-3-carbonyl}amino)-4-oxo-butyric Acid Trifluoroacetate::Inhibitor 51::Pyridine Scaffold 51,Caspase-3,Homo sapiens,
313,CS(=O)(=O)Nc1cccc(c1)S(=O)(=O)NCc1ccc(cn1)C(=O)N[C@@H](CC(O)=O)C=O,"InChI=1S/C18H20N4O8S2/c1-31(27,28)22-13-3-2-4-16(7-13)32(29,30)20-10-14-6-5-12(9-19-14)18(26)21-15(11-23)8-17(24)25/h2-7,9,11,15,20,22H,8,10H2,1H3,(H,21,26)(H,24,25)/t15-/m0/s1",YSLPNYJYCBRIOX-HNNXBMFYSA-N,271,(3S)-3-({6-[(3-methanesulfonamidobenzene)sulfonamidomethyl]pyridin-3-yl}formamido)-4-oxobutanoic acid::(S)-3-({6-[(4-Methanesulfonylamino-benzenesulfon-ylamino)methyl]pyridine-3-carbonyl}amino)-4-oxo-butyricAcid Trifluoroacetate::Inhibitor 52::Pyridine Scaffold 52,Caspase-3,Homo sapiens,
314,CS(=O)(=O)Nc1ccc(cc1)S(=O)(=O)NCc1ccc(cn1)C(=O)N[C@@H](CC(O)=O)C=O,"InChI=1S/C18H20N4O8S2/c1-31(27,28)22-13-4-6-16(7-5-13)32(29,30)20-10-14-3-2-12(9-19-14)18(26)21-15(11-23)8-17(24)25/h2-7,9,11,15,20,22H,8,10H2,1H3,(H,21,26)(H,24,25)/t15-/m0/s1",UMHYHMWMJNTZIX-HNNXBMFYSA-N,272,(3S)-3-({6-[(4-methanesulfonamidobenzene)sulfonamidomethyl]pyridin-3-yl}formamido)-4-oxobutanoic acid::(S)-3-({6-[(3-Methanesulfonylamino-benzenesulfon-ylamino)methyl]pyridine-3-carbonyl}amino)-4-oxo-butyricAcid Trifluoroacetate::Inhibitor 53::Pyridine Scaffold 53,Caspase-3,Homo sapiens,
315,CS(=O)(=O)NC(=O)c1cccc(c1)S(=O)(=O)NCc1ccc(cn1)C(=O)N[C@@H](CC(O)=O)C=O,"InChI=1S/C19H20N4O9S2/c1-33(29,30)23-19(28)12-3-2-4-16(7-12)34(31,32)21-10-14-6-5-13(9-20-14)18(27)22-15(11-24)8-17(25)26/h2-7,9,11,15,21H,8,10H2,1H3,(H,22,27)(H,23,28)(H,25,26)/t15-/m0/s1",XJBQVBPGIOOPMP-HNNXBMFYSA-N,273,(3S)-3-[(6-{[3-(methanesulfonylcarbamoyl)benzene]sulfonamidomethyl}pyridin-3-yl)formamido]-4-oxobutanoic acid::(S)-3-({6-[(3-Methanesulfonylaminocarbonyl-benzene-sulfonylamino)methyl]-pyridine-3-carbonyl}amino)-4-oxo-butyric Acid Trifluoroacetate::Inhibitor 54::Pyridine Scaffold 54,Caspase-3,Homo sapiens,
316,CC(=O)NS(=O)(=O)c1cccc(c1)S(=O)(=O)NCc1ccc(cn1)C(=O)N[C@@H](CC(O)=O)C=O,"InChI=1S/C19H20N4O9S2/c1-12(25)23-34(31,32)17-4-2-3-16(8-17)33(29,30)21-10-14-6-5-13(9-20-14)19(28)22-15(11-24)7-18(26)27/h2-6,8-9,11,15,21H,7,10H2,1H3,(H,22,28)(H,23,25)(H,26,27)/t15-/m0/s1",WJYVXARRCUTRBW-HNNXBMFYSA-N,274,(3S)-3-[(6-{[3-(ethanesulfonyl)benzene]sulfonamidomethyl}pyridin-3-yl)formamido]-4-oxobutanoic acid::(S)-3-({6-[(3-Acetylsulfamoyl-benzenesulfonylamino)-methyl]pyridine-3-carbonyl}amino)-4-oxo-butyric AcidTrifluoroacetate::Inhibitor 55::Pyridine Scaffold 55,Caspase-3,Homo sapiens,
317,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2cccc(c2)-c2nnn[nH]2)nc1)C=O,"InChI=1S/C18H17N7O6S/c26-10-14(7-16(27)28)21-18(29)12-4-5-13(19-8-12)9-20-32(30,31)15-3-1-2-11(6-15)17-22-24-25-23-17/h1-6,8,10,14,20H,7,9H2,(H,21,29)(H,27,28)(H,22,23,24,25)/t14-/m0/s1",DWMVUTWXNPMAGJ-AWEZNQCLSA-N,275,"(3S)-4-oxo-3-[(6-{[3-(1H-1,2,3,4-tetrazol-5-yl)benzene]sulfonamidomethyl}pyridin-3-yl)formamido]butanoic acid::(S)-4-Oxo-3-[(6-{[3-(1H-tetrazol-5-yl)benzenesulfonylamino]methyl}pyridine-3-carbonyl)amino]butyric Acid Trifluoroacetate::Inhibitor 56::Pyridine Scaffold 56",Caspase-3,Homo sapiens,
318,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2cccc(c2)-c2nc(=O)o[nH]2)nc1)C=O,"InChI=1S/C19H17N5O8S/c25-10-14(7-16(26)27)22-18(28)12-4-5-13(20-8-12)9-21-33(30,31)15-3-1-2-11(6-15)17-23-19(29)32-24-17/h1-6,8,10,14,21H,7,9H2,(H,22,28)(H,26,27)(H,23,24,29)/t14-/m0/s1",IOBPWVWEMXSDBY-AWEZNQCLSA-N,276,"(3S)-4-oxo-3-[(6-{[3-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)benzene]sulfonamidomethyl}pyridin-3-yl)formamido]butanoic acid::(S)-4-Oxo-3-[(6-{[3-(5-oxo-4,5-dihydro[1,2,4]oxadiazol-3-yl)benzenesulfonylamino]methyl}pyridine-3-carbonyl)amino]butyric Acid Trifluoroacetate::Inhibitor 57::Pyridine Scaffold 57",Caspase-3,Homo sapiens,
319,CSCC(=O)[C@H](CC(O)=O)NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1,"InChI=1S/C20H21N3O9S2/c1-33-10-17(25)15(7-18(26)27)23-19(28)11-2-3-12(21-8-11)9-22-34(31,32)13-4-5-16(24)14(6-13)20(29)30/h2-6,8,15,22,24H,7,9-10H2,1H3,(H,23,28)(H,26,27)(H,29,30)/t15-/m0/s1",QAQDHNYHJFERKX-HNNXBMFYSA-N,277,(S)-5-{[5-(1-Carboxymethyl-3-methylsulfanyl-2-oxo-propylcarbamoyl)pyridin-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-(methylsulfanyl)-3-oxobutan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 58::Pyridine Scaffold 58,Caspase-3,Homo sapiens,
320,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H24ClN3O9S2/c27-20-4-2-1-3-16(20)13-40-14-23(32)21(10-24(33)34)30-25(35)15-5-6-17(28-11-15)12-29-41(38,39)18-7-8-22(31)19(9-18)26(36)37/h1-9,11,21,29,31H,10,12-14H2,(H,30,35)(H,33,34)(H,36,37)/t21-/m0/s1",AYQUXMOMSNPZEF-NRFANRHFSA-N,222,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyridin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Pyridine Scaffold 59,Caspase-3,Homo sapiens,
321,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)c1ncc(o1)-c1c(Cl)cccc1Cl,"InChI=1S/C27H20Cl2N4O10S/c28-17-2-1-3-18(29)23(17)21-12-31-26(43-21)24(37)19(9-22(35)36)33-25(38)13-4-5-14(30-10-13)11-32-44(41,42)15-6-7-20(34)16(8-15)27(39)40/h1-8,10,12,19,32,34H,9,11H2,(H,33,38)(H,35,36)(H,39,40)/t19-/m0/s1",VANHQTOUHVZHHF-IBGZPJMESA-N,278,"5-{[(5-{[(2S)-3-carboxy-1-[5-(2,6-dichlorophenyl)-1,3-oxazol-2-yl]-1-oxopropan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 60::N-{1-[5-(2,6-Dichloro-phenyl)oxazole-2-carbonyl]-propyl}-6-[(4-hydroxy-3-methyl-benzenesulfonylamino)-methyl]nicotinamide::Pyridine Scaffold 60",Caspase-3,Homo sapiens,
322,COc1cccc2nc(oc12)C(=O)[C@H](CC(O)=O)NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1,"InChI=1S/C26H22N4O11S/c1-40-20-4-2-3-17-23(20)41-25(30-17)22(34)18(10-21(32)33)29-24(35)13-5-6-14(27-11-13)12-28-42(38,39)15-7-8-19(31)16(9-15)26(36)37/h2-9,11,18,28,31H,10,12H2,1H3,(H,29,35)(H,32,33)(H,36,37)/t18-/m0/s1",SIRDBTDSADKLJV-SFHVURJKSA-N,279,"5-{[(5-{[(2S)-3-carboxy-1-(7-methoxy-1,3-benzoxazol-2-yl)-1-oxopropan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::6-[(4-Hydroxy-3-methyl-benzenesulfonylamino)methyl]-N-[1-(7-methoxy-benzooxazole-2-carbonyl)propyl]nicotinamide::Inhibitor 61::Pyridine Scaffold 61",Caspase-3,Homo sapiens,
323,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C=O,"InChI=1S/C17H16N4O9S/c22-8-10(3-15(24)25)21-16(26)9-5-18-14(19-6-9)7-20-31(29,30)11-1-2-13(23)12(4-11)17(27)28/h1-2,4-6,8,10,20,23H,3,7H2,(H,21,26)(H,24,25)(H,27,28)/t10-/m0/s1",USLNDGYXFRVAEJ-JTQLQIEISA-N,280,(S)-5-{[5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-pyrimidin-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pyrimidin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 62a::Inhibitor 62a,Caspase-3,Homo sapiens,
324,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cc1)C=O,"InChI=1S/C19H18N2O9S/c22-10-13(7-17(24)25)21-18(26)12-3-1-11(2-4-12)9-20-31(29,30)14-5-6-16(23)15(8-14)19(27)28/h1-6,8,10,13,20,23H,7,9H2,(H,21,26)(H,24,25)(H,27,28)/t13-/m0/s1",FMTZTJFXNZOBIQ-ZDUSSCGKSA-N,220,5-{[(4-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}phenyl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 3,Caspase-2,Homo sapiens,
325,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C=O,"InChI=1S/C18H17N3O9S/c22-9-12(5-16(24)25)21-17(26)10-1-2-11(19-7-10)8-20-31(29,30)13-3-4-15(23)14(6-13)18(27)28/h1-4,6-7,9,12,20,23H,5,8H2,(H,21,26)(H,24,25)(H,27,28)/t12-/m0/s1",BZEURKGKCWHMON-LBPRGKRZSA-N,221,5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 4::Pyridine Scaffold 4,Caspase-2,Homo sapiens,
326,CN(Cc1ccc(s1)C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl)Cc1ccc(O)c(c1)C(O)=O,"InChI=1S/C27H27ClN2O7S2/c1-30(12-16-6-8-22(31)19(10-16)27(36)37)13-18-7-9-24(39-18)26(35)29-21(11-25(33)34)23(32)15-38-14-17-4-2-3-5-20(17)28/h2-10,21,31H,11-15H2,1H3,(H,29,35)(H,33,34)(H,36,37)/t21-/m0/s1",FIEQQFOHZKVJLV-NRFANRHFSA-N,219,5-({[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl](methyl)amino}methyl)-2-hydroxybenzoic acid::Inhibitor 47c::Thiophene Scaffold 47c,Caspase-2,Homo sapiens,
327,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H24ClN3O9S2/c27-20-4-2-1-3-16(20)13-40-14-23(32)21(10-24(33)34)30-25(35)15-5-6-17(28-11-15)12-29-41(38,39)18-7-8-22(31)19(9-18)26(36)37/h1-9,11,21,29,31H,10,12-14H2,(H,30,35)(H,33,34)(H,36,37)/t21-/m0/s1",AYQUXMOMSNPZEF-NRFANRHFSA-N,222,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyridin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyridin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Pyridine Scaffold 59,Caspase-2,Homo sapiens,
328,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)nc1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN4O9S2/c26-18-4-2-1-3-14(18)12-40-13-21(32)19(8-23(33)34)30-24(35)15-9-27-22(28-10-15)11-29-41(38,39)16-5-6-20(31)17(7-16)25(36)37/h1-7,9-10,19,29,31H,8,11-13H2,(H,30,35)(H,33,34)(H,36,37)/t19-/m0/s1",NAJZBQCCBCKDIT-IBGZPJMESA-N,223,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]pyrimidin-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}pyrimidin-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 62b::Inhibitor 62b,Caspase-2,Homo sapiens,
329,OC(=O)C[C@H](NC(=O)c1cnc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C24H22ClN3O9S3/c25-16-4-2-1-3-13(16)11-38-12-19(30)17(8-22(31)32)28-23(33)20-9-26-21(39-20)10-27-40(36,37)14-5-6-18(29)15(7-14)24(34)35/h1-7,9,17,27,29H,8,10-12H2,(H,28,33)(H,31,32)(H,34,35)/t17-/m0/s1",VCWYKJKQZUPTQP-KRWDZBQOSA-N,224,"(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiazol-2-hydroxy-benzoic Acidylmethyl}sulfamoyl)-2-::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-1,3-thiazol-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 64b::Inhibitor 64b",Caspase-2,Homo sapiens,
330,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C=O,"InChI=1S/C17H16N2O9S2/c20-8-9(5-15(22)23)19-16(24)14-4-1-10(29-14)7-18-30(27,28)11-2-3-13(21)12(6-11)17(25)26/h1-4,6,8-9,18,21H,5,7H2,(H,19,24)(H,22,23)(H,25,26)/t9-/m0/s1",VUJHWZDCLPHWMO-VIFPVBQESA-N,225,(S)-5-5-(1-Carboxymethyl-2-oxo-ethylcarbamoyl)-thiophen-2-ylmethyl]sulfamoyl}-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66a::Thiophene Scaffold 66a,Caspase-2,Homo sapiens,
331,OC(=O)C[C@H](NC(=O)c1ccc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)s1)C(=O)CSCc1ccccc1Cl,"InChI=1S/C25H23ClN2O9S3/c26-18-4-2-1-3-14(18)12-38-13-21(30)19(10-23(31)32)28-24(33)22-8-5-15(39-22)11-27-40(36,37)16-6-7-20(29)17(9-16)25(34)35/h1-9,19,27,29H,10-13H2,(H,28,33)(H,31,32)(H,34,35)/t19-/m0/s1",ZOVHWLRITDMPBF-IBGZPJMESA-N,226,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]thiophen-2-ylmethyl}sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Inhibitor 66b::Thiophene Scaffold 66b,Caspase-2,Homo sapiens,
332,Cc1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)sc1C(=O)N[C@@H](CC(O)=O)C(=O)CSCc1ccccc1Cl,"InChI=1S/C26H25ClN2O9S3/c1-14-8-16(11-28-41(37,38)17-6-7-21(30)18(9-17)26(35)36)40-24(14)25(34)29-20(10-23(32)33)22(31)13-39-12-15-4-2-3-5-19(15)27/h2-9,20,28,30H,10-13H2,1H3,(H,29,34)(H,32,33)(H,35,36)/t20-/m0/s1",PZMBYHSWPUMKMR-FQEVSTJZSA-N,227,(S)-5-({5-[1-Carboxymethyl-3-(2-chloro-benzylsulfanyl)-2-oxo-propylcarbamoyl]-4-methyl-thiophen-2-ylmethyl}-sulfamoyl)-2-hydroxy-benzoic Acid::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}-4-methylthiophen-2-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 69b::Inhibitor 69b,Caspase-2,Homo sapiens,
333,CCCN1CCN(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CCS(=O)(=O)[C@@H]2C(C)C)[C@@H](C1)C(=O)NC(C)(C)C,"InChI=1S/C30H50N4O6S/c1-7-14-33-15-16-34(24(19-33)28(36)32-30(4,5)6)20-25(35)23(18-22-11-9-8-10-12-22)31-29(37)40-26-13-17-41(38,39)27(26)21(2)3/h8-12,21,23-27,35H,7,13-20H2,1-6H3,(H,31,37)(H,32,36)/t23-,24-,25+,26+,27+/m0/s1",KIUZLKJJOFIWAW-OFOQQJIRSA-N,290,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-propylpiperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 1",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 13.7
334,CCCCCCCCN1CCN(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CCS(=O)(=O)[C@@H]2C(C)C)[C@@H](C1)C(=O)NC(C)(C)C,"InChI=1S/C35H60N4O6S/c1-7-8-9-10-11-15-19-38-20-21-39(29(24-38)33(41)37-35(4,5)6)25-30(40)28(23-27-16-13-12-14-17-27)36-34(42)45-31-18-22-46(43,44)32(31)26(2)3/h12-14,16-17,26,28-32,40H,7-11,15,18-25H2,1-6H3,(H,36,42)(H,37,41)/t28-,29-,30+,31+,32+/m0/s1",ODUDZQZUKNNLMD-PCYHVKPNSA-N,291,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-octylpiperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 8.4
335,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C(C)C,"InChI=1S/C30H50N4O6S/c1-20(2)27-26(13-16-41(27,38)39)40-29(37)31-23(17-22-11-9-8-10-12-22)25(35)19-34-15-14-33(21(3)4)18-24(34)28(36)32-30(5,6)7/h8-12,20-21,23-27,35H,13-19H2,1-7H3,(H,31,37)(H,32,36)/t23-,24-,25+,26+,27+/m0/s1",OBYKBHXLZYEYIL-OFOQQJIRSA-N,292,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-(propan-2-yl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 3",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 57
336,CCC(CC)N1CCN(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CCS(=O)(=O)[C@@H]2C(C)C)[C@@H](C1)C(=O)NC(C)(C)C,"InChI=1S/C32H54N4O6S/c1-8-24(9-2)35-16-17-36(26(20-35)30(38)34-32(5,6)7)21-27(37)25(19-23-13-11-10-12-14-23)33-31(39)42-28-15-18-43(40,41)29(28)22(3)4/h10-14,22,24-29,37H,8-9,15-21H2,1-7H3,(H,33,39)(H,34,38)/t25-,26-,27+,28+,29+/m0/s1",NHMIHQZMBYIQSR-MUPNWXRXSA-N,293,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-(pentan-3-yl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 4",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 98.6
337,CC(C)CN1CCN(C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@@H]2CCS(=O)(=O)[C@@H]2C(C)C)[C@@H](C1)C(=O)NC(C)(C)C,"InChI=1S/C31H52N4O6S/c1-21(2)18-34-14-15-35(25(19-34)29(37)33-31(5,6)7)20-26(36)24(17-23-11-9-8-10-12-23)32-30(38)41-27-13-16-42(39,40)28(27)22(3)4/h8-12,21-22,24-28,36H,13-20H2,1-7H3,(H,32,38)(H,33,37)/t24-,25-,26+,27+,28+/m0/s1",MKOFHUCSPZPDFD-UZSVIBPSSA-N,294,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-(2-methylpropyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 5",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 27.1
338,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(CC(C)(C)C)C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H54N4O6S/c1-22(2)28-27(14-17-43(28,40)41)42-30(39)33-24(18-23-12-10-9-11-13-23)26(37)20-36-16-15-35(21-31(3,4)5)19-25(36)29(38)34-32(6,7)8/h9-13,22,24-28,37H,14-21H2,1-8H3,(H,33,39)(H,34,38)/t24-,25-,26+,27+,28+/m0/s1",QLRILQAKWMNACH-UZSVIBPSSA-N,295,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-(2,2-dimethylpropyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 6",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 48
339,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CCCCCC1,"InChI=1S/C34H56N4O6S/c1-24(2)31-30(17-20-45(31,42)43)44-33(41)35-27(21-25-13-9-8-10-14-25)29(39)23-38-19-18-37(26-15-11-6-7-12-16-26)22-28(38)32(40)36-34(3,4)5/h8-10,13-14,24,26-31,39H,6-7,11-12,15-23H2,1-5H3,(H,35,41)(H,36,40)/t27-,28-,29+,30+,31+/m0/s1",QFEKPGPVGJUOKF-OXMBMXHISA-N,296,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-cycloheptylpiperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 7",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 91.4
340,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CCCCC1,"InChI=1S/C33H54N4O6S/c1-23(2)30-29(16-19-44(30,41)42)43-32(40)34-26(20-24-12-8-6-9-13-24)28(38)22-37-18-17-36(25-14-10-7-11-15-25)21-27(37)31(39)35-33(3,4)5/h6,8-9,12-13,23,25-30,38H,7,10-11,14-22H2,1-5H3,(H,34,40)(H,35,39)/t26-,27-,28+,29+,30+/m0/s1",ORYDIKCVEIVVEP-ATAZIPLOSA-N,297,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-cyclohexylpiperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 8",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 75.3
341,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CCCC1,"InChI=1S/C32H52N4O6S/c1-22(2)29-28(15-18-43(29,40)41)42-31(39)33-25(19-23-11-7-6-8-12-23)27(37)21-36-17-16-35(24-13-9-10-14-24)20-26(36)30(38)34-32(3,4)5/h6-8,11-12,22,24-29,37H,9-10,13-21H2,1-5H3,(H,33,39)(H,34,38)/t25-,26-,27+,28+,29+/m0/s1",LETUUQQGDRSIEO-MUPNWXRXSA-N,298,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-cyclopentylpiperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 9",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 50.3
342,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CCC1,"InChI=1S/C31H50N4O6S/c1-21(2)28-27(14-17-42(28,39)40)41-30(38)32-24(18-22-10-7-6-8-11-22)26(36)20-35-16-15-34(23-12-9-13-23)19-25(35)29(37)33-31(3,4)5/h6-8,10-11,21,23-28,36H,9,12-20H2,1-5H3,(H,32,38)(H,33,37)/t24-,25-,26+,27+,28+/m0/s1",WHDODXPIRGKCQX-UZSVIBPSSA-N,299,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-cyclobutylpiperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 22.5
343,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CCCCC1,"InChI=1S/C33H54N4O6S/c1-23(2)30-29(16-19-44(30,41)42)43-32(40)34-26(20-24-12-8-6-9-13-24)28(38)22-37-18-17-36(25-14-10-7-11-15-25)21-27(37)31(39)35-33(3,4)5/h6,8-9,12-13,23,25-30,38H,7,10-11,14-22H2,1-5H3,(H,34,40)(H,35,39)/t26-,27-,28+,29+,30+/m0/s1",ORYDIKCVEIVVEP-ATAZIPLOSA-N,297,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-cyclohexylpiperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 8",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 13.4
344,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CCCC1,"InChI=1S/C32H52N4O6S/c1-22(2)29-28(15-18-43(29,40)41)42-31(39)33-25(19-23-11-7-6-8-12-23)27(37)21-36-17-16-35(24-13-9-10-14-24)20-26(36)30(38)34-32(3,4)5/h6-8,11-12,22,24-29,37H,9-10,13-21H2,1-5H3,(H,33,39)(H,34,38)/t25-,26-,27+,28+,29+/m0/s1",LETUUQQGDRSIEO-MUPNWXRXSA-N,298,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-cyclopentylpiperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 9",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 18.5
345,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CCC1,"InChI=1S/C31H50N4O6S/c1-21(2)28-27(14-17-42(28,39)40)41-30(38)32-24(18-22-10-7-6-8-11-22)26(36)20-35-16-15-34(23-12-9-13-23)19-25(35)29(37)33-31(3,4)5/h6-8,10-11,21,23-28,36H,9,12-20H2,1-5H3,(H,32,38)(H,33,37)/t24-,25-,26+,27+,28+/m0/s1",WHDODXPIRGKCQX-UZSVIBPSSA-N,299,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-cyclobutylpiperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 17.3
346,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CC1,"InChI=1S/C30H48N4O6S/c1-20(2)27-26(13-16-41(27,38)39)40-29(37)31-23(17-21-9-7-6-8-10-21)25(35)19-34-15-14-33(22-11-12-22)18-24(34)28(36)32-30(3,4)5/h6-10,20,22-27,35H,11-19H2,1-5H3,(H,31,37)(H,32,36)/t23-,24-,25+,26+,27+/m0/s1",XWFVMFCPRNQHFS-OFOQQJIRSA-N,300,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-cyclopropylpiperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 11",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.8
347,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CCOCC1,"InChI=1S/C32H52N4O7S/c1-22(2)29-28(13-18-44(29,40)41)43-31(39)33-25(19-23-9-7-6-8-10-23)27(37)21-36-15-14-35(24-11-16-42-17-12-24)20-26(36)30(38)34-32(3,4)5/h6-10,22,24-29,37H,11-21H2,1-5H3,(H,33,39)(H,34,38)/t25-,26-,27+,28+,29+/m0/s1",CDPHXFOTSPZQDA-MUPNWXRXSA-N,301,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-(oxan-4-yl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 12",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 34.6
348,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CCSCC1,"InChI=1S/C32H52N4O6S2/c1-22(2)29-28(13-18-44(29,40)41)42-31(39)33-25(19-23-9-7-6-8-10-23)27(37)21-36-15-14-35(24-11-16-43-17-12-24)20-26(36)30(38)34-32(3,4)5/h6-10,22,24-29,37H,11-21H2,1-5H3,(H,33,39)(H,34,38)/t25-,26-,27+,28+,29+/m0/s1",MKHHRMQNGQGAQQ-MUPNWXRXSA-N,302,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-(thian-4-yl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 238
349,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CCSC1,"InChI=1S/C31H50N4O6S2/c1-21(2)28-27(12-16-43(28,39)40)41-30(38)32-24(17-22-9-7-6-8-10-22)26(36)19-35-14-13-34(23-11-15-42-20-23)18-25(35)29(37)33-31(3,4)5/h6-10,21,23-28,36H,11-20H2,1-5H3,(H,32,38)(H,33,37)/t23?,24-,25-,26+,27+,28+/m0/s1",WXZWZEOFGKINDU-KBSKDMDSSA-N,303,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-(thiolan-3-yl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 14",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 8.3
350,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1Cc2ccccc2C1,"InChI=1S/C36H52N4O6S/c1-24(2)33-32(15-18-47(33,44)45)46-35(43)37-29(19-25-11-7-6-8-12-25)31(41)23-40-17-16-39(22-30(40)34(42)38-36(3,4)5)28-20-26-13-9-10-14-27(26)21-28/h6-14,24,28-33,41H,15-23H2,1-5H3,(H,37,43)(H,38,42)/t29-,30-,31+,32+,33+/m0/s1",OZFWFWGNTOMSOK-WWPLQOFTSA-N,304,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-(2,3-dihydro-1H-inden-2-yl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 15",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 5.3
351,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CCN(C[C@H]1C(=O)NC(C)(C)C)C1CC(C1)c1ccccc1,"InChI=1S/C37H54N4O6S/c1-25(2)34-33(16-19-48(34,45)46)47-36(44)38-30(20-26-12-8-6-9-13-26)32(42)24-41-18-17-40(23-31(41)35(43)39-37(3,4)5)29-21-28(22-29)27-14-10-7-11-15-27/h6-15,25,28-34,42H,16-24H2,1-5H3,(H,38,44)(H,39,43)/t28?,29?,30-,31-,32+,33+,34+/m0/s1",CZFIMHWLICRIED-AAYATXMLSA-N,305,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(2S)-2-(tert-butylcarbamoyl)-4-(3-phenylcyclobutyl)piperazin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::1-(2OHPr)-4-Substit-piperazine, thienyl carbamate deriv. 16",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.8
352,C[C@@H]1OCC[C@@H]1OC(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C28H43N3O5S2/c1-18-24(10-12-35-18)36-27(34)29-21(17-38-20-8-6-5-7-9-20)23(32)16-31-15-19-11-13-37-25(19)14-22(31)26(33)30-28(2,3)4/h5-9,18-19,21-25,32H,10-17H2,1-4H3,(H,29,34)(H,30,33)/t18-,19+,21-,22?,23+,24-,25-/m0/s1",UYIDPTWMZFMUKR-STKMKRHHSA-N,306,"(2S,3S)-2-methyloxolan-3-yl N-[(2R,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-(phenylsulfanyl)butan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 1::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.28
353,C[C@H]1OCC[C@H]1OC(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C28H43N3O5S2/c1-18-24(10-12-35-18)36-27(34)29-21(17-38-20-8-6-5-7-9-20)23(32)16-31-15-19-11-13-37-25(19)14-22(31)26(33)30-28(2,3)4/h5-9,18-19,21-25,32H,10-17H2,1-4H3,(H,29,34)(H,30,33)/t18-,19-,21+,22?,23-,24-,25+/m1/s1",UYIDPTWMZFMUKR-GKYYWXSGSA-N,307,"(2R,3R)-2-methyloxolan-3-yl N-[(2R,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-(phenylsulfanyl)butan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 2::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.0
354,CC(C)(C)NC(=O)C1C[C@@H]2SCC[C@@H]2CN1C[C@@H](O)[C@H](CSc1ccccc1)NC(=O)O[C@H]1CCS(=O)(=O)C1,"InChI=1S/C27H41N3O6S3/c1-27(2,3)29-25(32)22-13-24-18(9-11-37-24)14-30(22)15-23(31)21(16-38-20-7-5-4-6-8-20)28-26(33)36-19-10-12-39(34,35)17-19/h4-8,18-19,21-24,31H,9-17H2,1-3H3,(H,28,33)(H,29,32)/t18-,19+,21+,22?,23-,24+/m1/s1",DMVZKUWZKVVEEN-URXFVSRTSA-N,308,"(3S)-1,1-dioxo--thiolan-3-yl N-[(2R,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-(phenylsulfanyl)butan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 3::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.7
355,CC(C)(C)NC(=O)C1C[C@@H]2SCC[C@@H]2CN1C[C@@H](O)[C@H](CSc1ccccc1)NC(=O)O[C@@H]1CCS(=O)(=O)C1,"InChI=1S/C27H41N3O6S3/c1-27(2,3)29-25(32)22-13-24-18(9-11-37-24)14-30(22)15-23(31)21(16-38-20-7-5-4-6-8-20)28-26(33)36-19-10-12-39(34,35)17-19/h4-8,18-19,21-24,31H,9-17H2,1-3H3,(H,28,33)(H,29,32)/t18-,19-,21+,22?,23-,24+/m1/s1",DMVZKUWZKVVEEN-QKTFIHILSA-N,309,"(3R)-1,1-dioxo--thiolan-3-yl N-[(2R,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-(phenylsulfanyl)butan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 4::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.0
356,C[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S/c1-20-27(14-15-40(20,37)38)39-29(36)31-24(16-21-10-6-5-7-11-21)26(34)19-33-18-23-13-9-8-12-22(23)17-25(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22+,23-,24+,25?,26-,27-/m1/s1",ZWBLHWHBSYSDFK-ISZKJJAPSA-N,310,"(2R,3R)-2-methyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 8::Thienopyridine thienyl urethane deriv. 5::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 10.0
357,C[C@@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C28H43N3O6S3/c1-18-24(11-13-40(18,35)36)37-27(34)29-21(17-39-20-8-6-5-7-9-20)23(32)16-31-15-19-10-12-38-25(19)14-22(31)26(33)30-28(2,3)4/h5-9,18-19,21-25,32H,10-17H2,1-4H3,(H,29,34)(H,30,33)/t18-,19-,21+,22?,23-,24+,25+/m1/s1",SSAWLODCPROYGG-UMGKMRNCSA-N,311,"(2R,3S)-2-methyl-1,1-dioxo--thiolan-3-yl N-[(2R,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-(phenylsulfanyl)butan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 6::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 5.2
358,C[C@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C28H43N3O6S3/c1-18-24(11-13-40(18,35)36)37-27(34)29-21(17-39-20-8-6-5-7-9-20)23(32)16-31-15-19-10-12-38-25(19)14-22(31)26(33)30-28(2,3)4/h5-9,18-19,21-25,32H,10-17H2,1-4H3,(H,29,34)(H,30,33)/t18-,19+,21-,22?,23+,24+,25-/m0/s1",SSAWLODCPROYGG-INDMFVBASA-N,312,"(2S,3R)-2-methyl-1,1-dioxo--thiolan-3-yl N-[(2R,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-(phenylsulfanyl)butan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 7::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.4
359,C[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C28H43N3O6S3/c1-18-24(11-13-40(18,35)36)37-27(34)29-21(17-39-20-8-6-5-7-9-20)23(32)16-31-15-19-10-12-38-25(19)14-22(31)26(33)30-28(2,3)4/h5-9,18-19,21-25,32H,10-17H2,1-4H3,(H,29,34)(H,30,33)/t18-,19+,21-,22?,23+,24-,25-/m0/s1",SSAWLODCPROYGG-STKMKRHHSA-N,313,"(2S,3S)-2-methyl-1,1-dioxo--thiolan-3-yl N-[(2R,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-(phenylsulfanyl)butan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 8::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.4
360,C[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C28H43N3O6S3/c1-18-24(11-13-40(18,35)36)37-27(34)29-21(17-39-20-8-6-5-7-9-20)23(32)16-31-15-19-10-12-38-25(19)14-22(31)26(33)30-28(2,3)4/h5-9,18-19,21-25,32H,10-17H2,1-4H3,(H,29,34)(H,30,33)/t18-,19-,21+,22?,23-,24-,25+/m1/s1",SSAWLODCPROYGG-GKYYWXSGSA-N,314,"(2R,3R)-2-methyl-1,1-dioxo--thiolan-3-yl N-[(2R,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-(phenylsulfanyl)butan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 9::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.75
361,CC(C)[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C32H51N3O6S/c1-21(2)29-28(15-16-42(29,39)40)41-31(38)33-25(17-22-11-7-6-8-12-22)27(36)20-35-19-24-14-10-9-13-23(24)18-26(35)30(37)34-32(3,4)5/h6-8,11-12,21,23-29,36H,9-10,13-20H2,1-5H3,(H,33,38)(H,34,37)/t23-,24+,25-,26?,27+,28-,29-/m0/s1",DYRQCFKJNPXYSL-LMUQLAANSA-N,315,"(2S,3S)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 11::Thienopyridine thienyl urethane deriv. 10::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 8.1
362,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C32H51N3O6S/c1-21(2)29-28(15-16-42(29,39)40)41-31(38)33-25(17-22-11-7-6-8-12-22)27(36)20-35-19-24-14-10-9-13-23(24)18-26(35)30(37)34-32(3,4)5/h6-8,11-12,21,23-29,36H,9-10,13-20H2,1-5H3,(H,33,38)(H,34,37)/t23-,24+,25-,26?,27+,28+,29+/m0/s1",DYRQCFKJNPXYSL-JDANZANYSA-N,316,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 12::Thienopyridine thienyl urethane deriv. 11::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.3
363,CC(C)[C@@H]1SCC[C@@H]1OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O4S2/c1-19(2)27-25(12-14-39-27)37-29(36)31-22(15-20-9-7-6-8-10-20)24(34)18-33-17-21-11-13-38-26(21)16-23(33)28(35)32-30(3,4)5/h6-10,19,21-27,34H,11-18H2,1-5H3,(H,31,36)(H,32,35)/t21-,22+,23?,24-,25+,26+,27+/m1/s1",QLFYYBGXVAYDRB-QLPLKHFUSA-N,317,"(2S,3S)-2-(propan-2-yl)thiolan-3-yl N-[(2S,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 12::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.6
364,CC(C)[C@H]1SCC[C@H]1OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O4S2/c1-19(2)27-25(12-14-39-27)37-29(36)31-22(15-20-9-7-6-8-10-20)24(34)18-33-17-21-11-13-38-26(21)16-23(33)28(35)32-30(3,4)5/h6-10,19,21-27,34H,11-18H2,1-5H3,(H,31,36)(H,32,35)/t21-,22+,23?,24-,25-,26+,27-/m1/s1",QLFYYBGXVAYDRB-WUHYLDPHSA-N,318,"(2R,3R)-2-(propan-2-yl)thiolan-3-yl N-[(2S,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 13::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.26
365,CC(C)[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S2/c1-19(2)27-25(12-14-41(27,37)38)39-29(36)31-22(15-20-9-7-6-8-10-20)24(34)18-33-17-21-11-13-40-26(21)16-23(33)28(35)32-30(3,4)5/h6-10,19,21-27,34H,11-18H2,1-5H3,(H,31,36)(H,32,35)/t21-,22+,23?,24-,25+,26+,27+/m1/s1",NYGTUPVXRQEYFU-QLPLKHFUSA-N,319,"(2S,3S)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 14::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.6
366,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S2/c1-19(2)27-25(12-14-41(27,37)38)39-29(36)31-22(15-20-9-7-6-8-10-20)24(34)18-33-17-21-11-13-40-26(21)16-23(33)28(35)32-30(3,4)5/h6-10,19,21-27,34H,11-18H2,1-5H3,(H,31,36)(H,32,35)/t21-,22+,23?,24-,25-,26+,27-/m1/s1",NYGTUPVXRQEYFU-WUHYLDPHSA-N,320,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 15::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.3
367,CC(C)[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S3/c1-19(2)27-25(12-14-42(27,37)38)39-29(36)31-22(18-41-21-9-7-6-8-10-21)24(34)17-33-16-20-11-13-40-26(20)15-23(33)28(35)32-30(3,4)5/h6-10,19-20,22-27,34H,11-18H2,1-5H3,(H,31,36)(H,32,35)/t20-,22+,23?,24-,25+,26+,27+/m1/s1",ZYXJGWBYPOHODT-KAFGCEBJSA-N,321,"(2S,3S)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2R,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-(phenylsulfanyl)butan-2-yl]carbamate::Thienopyridine thienyl urethane deriv. 16::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.95
368,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S3/c1-19(2)27-25(12-14-42(27,37)38)39-29(36)31-22(18-41-21-9-7-6-8-10-21)24(34)17-33-16-20-11-13-40-26(20)15-23(33)28(35)32-30(3,4)5/h6-10,19-20,22-27,34H,11-18H2,1-5H3,(H,31,36)(H,32,35)/t20-,22+,23?,24-,25-,26+,27-/m1/s1",ZYXJGWBYPOHODT-IIEFZGSLSA-N,322,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2R,3R)-4-[(3aR,7aS)-6-(tert-butylcarbamoyl)-octahydrothieno[3,2-c]pyridin-5-yl]-3-hydroxy-1-(phenylsulfanyl)butan-2-yl]carbamate::LY326188::Thienopyridine thienyl urethane deriv. 17::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.42
369,CN1[C@H](COc2ccccc2)[C@H](O)[C@@H](O)[C@@H](COc2ccccc2)N(C)S1(=O)=O,"InChI=1S/C20H26N2O6S/c1-21-17(13-27-15-9-5-3-6-10-15)19(23)20(24)18(22(2)29(21,25)26)14-28-16-11-7-4-8-12-16/h3-12,17-20,23-24H,13-14H2,1-2H3/t17-,18-,19+,20+/m1/s1",QLCXYAHOWGNDHH-ZRNYENFQSA-N,323,"(3R,4S,5S,6R)-2,7-Bismethyl-3,6-bis(phenoxymethyl)-4,5-dihydroxy-1,2,7-thiadiazepine 1,1-Dioxide::(3R,4S,5S,6R)-4,5-dihydroxy-2,7-dimethyl-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepane-1,1-dione::Cyclic Sulfamide deriv. 1",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
370,CNC(=O)CN1[C@H](COc2ccccc2)[C@H](O)[C@@H](O)[C@@H](COc2ccccc2)N(CC(=O)NC)S1(=O)=O,"InChI=1S/C24H32N4O8S/c1-25-21(29)13-27-19(15-35-17-9-5-3-6-10-17)23(31)24(32)20(16-36-18-11-7-4-8-12-18)28(37(27,33)34)14-22(30)26-2/h3-12,19-20,23-24,31-32H,13-16H2,1-2H3,(H,25,29)(H,26,30)/t19-,20-,23+,24+/m1/s1",XMBUPTFPXOMFLK-CHOVIJNXSA-N,324,"(3R,4S,5S,6R)-2,7-Bis[(N-methylcarbamoyl)methyl]-3,6-bis(phenoxymethyl)-4,5-dihydroxy-1,2,7-thiadiazepine 1,1-Dioxide::2-[(3R,4S,5S,6R)-4,5-dihydroxy-7-[(methylcarbamoyl)methyl]-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]-N-methylacetamide::Cyclic Sulfamide deriv. 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
371,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(CC(=O)Nc2nccs2)S(=O)(=O)N(CC(=O)Nc2nccs2)[C@@H]1COc1ccccc1,"InChI=1S/C28H30N6O8S3/c35-23(31-27-29-11-13-43-27)15-33-21(17-41-19-7-3-1-4-8-19)25(37)26(38)22(18-42-20-9-5-2-6-10-20)34(45(33,39)40)16-24(36)32-28-30-12-14-44-28/h1-14,21-22,25-26,37-38H,15-18H2,(H,29,31,35)(H,30,32,36)/t21-,22-,25+,26+/m1/s1",FEESVQMWSQCTLV-PWGHIRGTSA-N,325,"(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-4,5-dihydroxy-2,7-bis[(N-2-thiazolylcarbamoyl)methyl]-1,2,7-thiadiazepine 1,1-Dioxide::2-[(3R,4S,5S,6R)-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-7-[(1,3-thiazol-2-ylcarbamoyl)methyl]-1,2,7-thiadiazepan-2-yl]-N-(1,3-thiazol-2-yl)acetamide::CHEMBL356225::Cyclic Sulfamide deriv. 3",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
372,CNC(=O)c1cccc(CN2[C@H](COc3ccccc3)[C@H](O)[C@@H](O)[C@@H](COc3ccccc3)N(Cc3cccc(c3)C(=O)NC)S2(=O)=O)c1,"InChI=1S/C36H40N4O8S/c1-37-35(43)27-13-9-11-25(19-27)21-39-31(23-47-29-15-5-3-6-16-29)33(41)34(42)32(24-48-30-17-7-4-8-18-30)40(49(39,45)46)22-26-12-10-14-28(20-26)36(44)38-2/h3-20,31-34,41-42H,21-24H2,1-2H3,(H,37,43)(H,38,44)/t31-,32-,33+,34+/m1/s1",JXCRNYYHOBWABD-WZJLIZBTSA-N,326,"(3R,4S,5S,6R)-2,7-Bis[3-(N-methylcarbamoyl)benzyl]-3,6-bis(phenoxymethyl)-4,5-dihydroxy-1,2,7-thiadiazepine 1,1-Dioxide::3-{[(3R,4S,5S,6R)-4,5-dihydroxy-7-{[3-(methylcarbamoyl)phenyl]methyl}-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl}-N-methylbenzamide::CHEMBL436262::Cyclic Sulfamide deriv. 4",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
373,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc2cccc(I)c2)S(=O)(=O)N(Cc2cccc(I)c2)[C@@H]1COc1ccccc1,"InChI=1S/C32H32I2N2O6S/c33-25-11-7-9-23(17-25)19-35-29(21-41-27-13-3-1-4-14-27)31(37)32(38)30(22-42-28-15-5-2-6-16-28)36(43(35,39)40)20-24-10-8-12-26(34)18-24/h1-18,29-32,37-38H,19-22H2/t29-,30-,31+,32+/m1/s1",UZQKURFZWNWDNX-ZRTHHSRSSA-N,327,"(3R,4S,5S,6R)-2,7-Bis[3-Iodobenzyl]-3,6-bis(phenoxymethyl)-4,5-dihydroxy-1,2,7-thiadiazepine 1,1-Dioxide::(3R,4S,5S,6R)-4,5-dihydroxy-2,7-bis[(3-iodophenyl)methyl]-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepane-1,1-dione::CHEMBL439636::Cyclic Sulfamide deriv. 5",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
374,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc2cccc(c2)-c2cccs2)S(=O)(=O)N(Cc2cccc(c2)-c2cccs2)[C@@H]1COc1ccccc1,"InChI=1S/C40H38N2O6S3/c43-39-35(27-47-33-15-3-1-4-16-33)41(25-29-11-7-13-31(23-29)37-19-9-21-49-37)51(45,46)42(36(40(39)44)28-48-34-17-5-2-6-18-34)26-30-12-8-14-32(24-30)38-20-10-22-50-38/h1-24,35-36,39-40,43-44H,25-28H2/t35-,36-,39+,40+/m1/s1",BFCBBDDJOYSCOW-JFDQHVTASA-N,328,"(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-2,7-bis[3-(2-thienyl)benzyl]-4,5-dihydroxy-1,2,7-thiadiazepine 1,1-Dioxide::(3R,4S,5S,6R)-4,5-dihydroxy-3,6-bis(phenoxymethyl)-2,7-bis({[3-(thiophen-2-yl)phenyl]methyl})-1,2,7-thiadiazepane-1,1-dione::Cyclic Sulfamide deriv. 6",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
375,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc2ccc(cc2)-c2cccs2)S(=O)(=O)N(Cc2ccc(cc2)-c2cccs2)[C@@H]1COc1ccccc1,"InChI=1S/C40H38N2O6S3/c43-39-35(27-47-33-9-3-1-4-10-33)41(25-29-15-19-31(20-16-29)37-13-7-23-49-37)51(45,46)42(36(40(39)44)28-48-34-11-5-2-6-12-34)26-30-17-21-32(22-18-30)38-14-8-24-50-38/h1-24,35-36,39-40,43-44H,25-28H2/t35-,36-,39+,40+/m1/s1",UMDCQGGNNGRKRN-JFDQHVTASA-N,329,"(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-2,7-bis[4-(2-thienyl)benzyl]-4,5-dihydroxy-1,2,7-thiadiazepine 1,1-Dioxide::(3R,4S,5S,6R)-4,5-dihydroxy-3,6-bis(phenoxymethyl)-2,7-bis({[4-(thiophen-2-yl)phenyl]methyl})-1,2,7-thiadiazepane-1,1-dione::CHEMBL345997::Cyclic Sulfamide deriv. 7",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
376,CN1[C@H](COc2ccccc2)[C@H](O)[C@@H](O)[C@@H](COc2ccccc2)N(Cc2ccccc2)S1(=O)=O,"InChI=1S/C26H30N2O6S/c1-27-23(18-33-21-13-7-3-8-14-21)25(29)26(30)24(19-34-22-15-9-4-10-16-22)28(35(27,31)32)17-20-11-5-2-6-12-20/h2-16,23-26,29-30H,17-19H2,1H3/t23-,24-,25+,26+/m1/s1",JGESUXRXNORBLL-XPGKHFPBSA-N,330,"(3R,4S,5S,6R)-2-benzyl-4,5-dihydroxy-7-methyl-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepane-1,1-dione::(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-4,5-dihydroxy-7-methyl-2-benzyl-1,2,7-thiadiazepine 1,1-Dioxide::Cyclic Sulfamide deriv. 8",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
377,CNC(=O)CN1[C@H](COc2ccccc2)[C@H](O)[C@@H](O)[C@@H](COc2ccccc2)N(Cc2ccccc2)S1(=O)=O,"InChI=1S/C28H33N3O7S/c1-29-26(32)18-31-25(20-38-23-15-9-4-10-16-23)28(34)27(33)24(19-37-22-13-7-3-8-14-22)30(39(31,35)36)17-21-11-5-2-6-12-21/h2-16,24-25,27-28,33-34H,17-20H2,1H3,(H,29,32)/t24-,25-,27+,28+/m1/s1",ISFJKIAUJZLAIF-CZJMETBBSA-N,331,"(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-4,5-dihydroxy-2-[(N-methylcarbamoyl)methyl]-7-benzyl-1,2,7-thiadiazepine 1,1-Dioxide::2-[(3R,4S,5S,6R)-7-benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]-N-methylacetamide::Cyclic Sulfamide deriv. 9",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
378,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc2ccccc2)S(=O)(=O)N(CC(=O)Nc2nccs2)[C@@H]1COc1ccccc1,"InChI=1S/C30H32N4O7S2/c35-27(32-30-31-16-17-42-30)19-34-26(21-41-24-14-8-3-9-15-24)29(37)28(36)25(20-40-23-12-6-2-7-13-23)33(43(34,38)39)18-22-10-4-1-5-11-22/h1-17,25-26,28-29,36-37H,18-21H2,(H,31,32,35)/t25-,26-,28+,29+/m1/s1",FXKDNYVQGLYSRE-KFADFNFCSA-N,332,"(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-4,5-dihydroxy-7-benzyl-2-[(N-2-thiazolylcarbamoyl)methyl]-1,2,7-thiadiazepine 1,1-Dioxide::2-[(3R,4S,5S,6R)-7-benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]-N-(1,3-thiazol-2-yl)acetamide::Cyclic Sulfamide deriv. 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
379,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc2ccc(cc2)-c2cccs2)S(=O)(=O)N(Cc2ccccc2)[C@@H]1COc1ccccc1,"InChI=1S/C36H36N2O6S2/c39-35-32(25-43-30-13-6-2-7-14-30)37(23-27-11-4-1-5-12-27)46(41,42)38(33(36(35)40)26-44-31-15-8-3-9-16-31)24-28-18-20-29(21-19-28)34-17-10-22-45-34/h1-22,32-33,35-36,39-40H,23-26H2/t32-,33-,35+,36+/m1/s1",SQYQMSXWYITDJM-IHIHPJAWSA-N,333,"(3R,4S,5S,6R)-2-benzyl-4,5-dihydroxy-3,6-bis(phenoxymethyl)-7-{[4-(thiophen-2-yl)phenyl]methyl}-1,2,7-thiadiazepane-1,1-dione::(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-4,5-dihydroxy-7-benzyl-2-[4-(2-thienyl)benzyl]-1,2,7-thiadiazepine 1,1-Dioxide::Cyclic Sulfamide deriv. 11",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
380,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc2cccc(c2)-c2cccs2)S(=O)(=O)N(Cc2ccccc2)[C@@H]1COc1ccccc1,"InChI=1S/C36H36N2O6S2/c39-35-32(25-43-30-16-6-2-7-17-30)37(23-27-12-4-1-5-13-27)46(41,42)38(33(36(35)40)26-44-31-18-8-3-9-19-31)24-28-14-10-15-29(22-28)34-20-11-21-45-34/h1-22,32-33,35-36,39-40H,23-26H2/t32-,33-,35+,36+/m1/s1",BZHUTTKEDGUJII-IHIHPJAWSA-N,334,"(3R,4S,5S,6R)-2-benzyl-4,5-dihydroxy-3,6-bis(phenoxymethyl)-7-{[3-(thiophen-2-yl)phenyl]methyl}-1,2,7-thiadiazepane-1,1-dione::(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-4,5-O-isopropylidene-7-benzyl-2-[3-(2-thienyl)benzyl]-1,2,7-thiadiazepine 1,1-Dioxide::Cyclic Sulfamide deriv. 12",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
381,CNC(=O)c1cccc(CN2[C@H](COc3ccccc3)[C@H](O)[C@@H](O)[C@@H](COc3ccccc3)N(Cc3ccccc3)S2(=O)=O)c1,"InChI=1S/C34H37N3O7S/c1-35-34(40)27-15-11-14-26(20-27)22-37-31(24-44-29-18-9-4-10-19-29)33(39)32(38)30(23-43-28-16-7-3-8-17-28)36(45(37,41)42)21-25-12-5-2-6-13-25/h2-20,30-33,38-39H,21-24H2,1H3,(H,35,40)/t30-,31-,32+,33+/m1/s1",CGBDAHCDSVOMCF-FYZVQMPESA-N,335,"(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-4,5-dihydroxy-2-[3-(N-methylcarbamoyl)benzyl]-7-benzyl-1,2,7-thiadiazepine 1,1-Dioxide::3-{[(3R,4S,5S,6R)-7-benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl}-N-methylbenzamide::CHEMBL357057::Cyclic Sulfamide deriv. 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
382,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc2cccc(I)c2)S(=O)(=O)N(CC(=O)Nc2nccs2)[C@@H]1COc1ccccc1,"InChI=1S/C30H31IN4O7S2/c31-22-9-7-8-21(16-22)17-34-25(19-41-23-10-3-1-4-11-23)28(37)29(38)26(20-42-24-12-5-2-6-13-24)35(44(34,39)40)18-27(36)33-30-32-14-15-43-30/h1-16,25-26,28-29,37-38H,17-20H2,(H,32,33,36)/t25-,26-,28+,29+/m1/s1",KVNMMQYWUYFLTJ-KFADFNFCSA-N,336,"(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-4,5-dihydroxy-7-(3-iodobenzyl)-2-[(N-2-thiazolylcarbamoyl)methyl]-1,2,7-thiadiazepine 1,1-Dioxide::2-[(3R,4S,5S,6R)-4,5-dihydroxy-7-[(3-iodophenyl)methyl]-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]-N-(1,3-thiazol-2-yl)acetamide::Cyclic Sulfamide deriv. 14",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
383,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc2cccc(c2)-c2cccs2)S(=O)(=O)N(CC(=O)Nc2nccs2)[C@@H]1COc1ccccc1,"InChI=1S/C34H34N4O7S3/c39-31(36-34-35-16-18-47-34)21-38-29(23-45-27-13-5-2-6-14-27)33(41)32(40)28(22-44-26-11-3-1-4-12-26)37(48(38,42)43)20-24-9-7-10-25(19-24)30-15-8-17-46-30/h1-19,28-29,32-33,40-41H,20-23H2,(H,35,36,39)/t28-,29-,32+,33+/m1/s1",XNITVQGILMAHID-KMYPOQQFSA-N,337,"(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-4,5-dihydroxy-2-[(N-2-thiazolylcarbamoyl)methyl]-7-[3-(2-thienyl)benzyl]-1,2,7-thiadiazepine 1,1-Dioxide::2-[(3R,4S,5S,6R)-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-7-{[3-(thiophen-2-yl)phenyl]methyl}-1,2,7-thiadiazepan-2-yl]-N-(1,3-thiazol-2-yl)acetamide::Cyclic Sulfamide deriv. 15",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
384,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc2ccc(cc2)-c2cccs2)S(=O)(=O)N(CC(=O)Nc2nccs2)[C@@H]1COc1ccccc1,"InChI=1S/C34H34N4O7S3/c39-31(36-34-35-17-19-47-34)21-38-29(23-45-27-10-5-2-6-11-27)33(41)32(40)28(22-44-26-8-3-1-4-9-26)37(48(38,42)43)20-24-13-15-25(16-14-24)30-12-7-18-46-30/h1-19,28-29,32-33,40-41H,20-23H2,(H,35,36,39)/t28-,29-,32+,33+/m1/s1",VJIXURHCUSPWQO-KMYPOQQFSA-N,338,"(3R,4S,5S,6R)-3,6-Bis(benzyl)-4,5-dihydroxy-2-[(N-2-thiazolylcarbamoyl)methyl]-7-[4-(2-thienyl)benzyl]-1,2,7-thiadiazepine 1,1-Dioxide::2-[(3R,4S,5S,6R)-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-7-{[4-(thiophen-2-yl)phenyl]methyl}-1,2,7-thiadiazepan-2-yl]-N-(1,3-thiazol-2-yl)acetamide::Cyclic Sulfamide deriv. 16",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
385,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc2cccc(c2)-c2cccs2)S(=O)(=O)N(Cc2ccc(cc2)-c2cccs2)[C@@H]1COc1ccccc1,"InChI=1S/C40H38N2O6S3/c43-39-35(27-47-33-12-3-1-4-13-33)41(25-29-18-20-31(21-19-29)37-16-8-22-49-37)51(45,46)42(36(40(39)44)28-48-34-14-5-2-6-15-34)26-30-10-7-11-32(24-30)38-17-9-23-50-38/h1-24,35-36,39-40,43-44H,25-28H2/t35-,36-,39+,40+/m1/s1",BLJAEJBFZWHGMO-JFDQHVTASA-N,339,"(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-4,5-dihydroxy-2-[3-(2-thienyl)benzyl]-7-[4-(2-thienyl)benzyl]-1,2,7-thiadiazepine 1,1-Dioxide::(3R,4S,5S,6R)-4,5-dihydroxy-3,6-bis(phenoxymethyl)-7-{[3-(thiophen-2-yl)phenyl]methyl}-2-{[4-(thiophen-2-yl)phenyl]methyl}-1,2,7-thiadiazepane-1,1-dione::Cyclic Sulfamide deriv. 17",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
386,COC(O)c1ccc(CN2[C@H](COc3ccccc3)[C@H](O)[C@@H](O)[C@@H](COc3ccccc3)N(Cc3ccc(CO)cc3)S2(=O)=O)cc1,"InChI=1S/C35H40N2O9S/c1-44-35(41)28-18-16-26(17-19-28)21-37-32(24-46-30-10-6-3-7-11-30)34(40)33(39)31(23-45-29-8-4-2-5-9-29)36(47(37,42)43)20-25-12-14-27(22-38)15-13-25/h2-19,31-35,38-41H,20-24H2,1H3/t31-,32-,33+,34+,35?/m1/s1",XLJNZONSWKENRP-DLCPRKGNSA-N,340,"(3R,4S,5S,6R)-3,6-Bis(phenoxymethyl)-4,5-dihydroxy-7-[4-(hydroxymethyl)benzyl]-2-[4-(methoxycarbonyl)benzyl]-1,2,7-thiadiazepine-1,1-Dioxide::(3R,4S,5S,6R)-4,5-dihydroxy-2-({4-[hydroxy(methoxy)methyl]phenyl}methyl)-7-{[4-(hydroxymethyl)phenyl]methyl}-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepane-1,1-dione::Cyclic Sulfamide deriv. 18",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
387,O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc2ccccc2)S(=O)(=O)N(Cc2ccccc2)[C@@H]1COc1ccccc1,"InChI=1S/C32H34N2O6S/c35-31-29(23-39-27-17-9-3-10-18-27)33(21-25-13-5-1-6-14-25)41(37,38)34(22-26-15-7-2-8-16-26)30(32(31)36)24-40-28-19-11-4-12-20-28/h1-20,29-32,35-36H,21-24H2/t29-,30-,31+,32+/m1/s1",CAGHBXQSDLNCES-ZRTHHSRSSA-N,1163,"(3R,4S,5S,6R)-2,7-Dibenzyl-3,6-bis(phenoxymethyl)-4,5-dihydroxy-1,2,7-thiadiazepan 1,1-Dioxide::(3R,4S,5S,6R)-2,7-dibenzyl-4,5-dihydroxy-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepane-1,1-dione::CHEMBL130998::Cyclic Sulfamide 4::Cyclic Sulfamide deriv. 19",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
388,CC(N=O)c1cccc(CN2[C@H](COc3ccccc3)[C@H](O)[C@@H](O)[C@@H](COc3ccccc3)N(Cc3cccc(c3)C(C)N=O)S2(=O)=O)c1,"InChI=1S/C36H40N4O8S/c1-25(37-43)29-13-9-11-27(19-29)21-39-33(23-47-31-15-5-3-6-16-31)35(41)36(42)34(24-48-32-17-7-4-8-18-32)40(49(39,45)46)22-28-12-10-14-30(20-28)26(2)38-44/h3-20,25-26,33-36,41-42H,21-24H2,1-2H3/t25?,26?,33-,34-,35+,36+/m1/s1",SXGGEMRFBQBUFK-OHHGTCQSSA-N,342,"(3R,4S,5S,6R)-4,5-dihydroxy-2,7-bis({3-[(1E)-1-(hydroxyimino)ethyl]phenyl}methyl)-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepane-1,1-dione::CHEMBL150626::Cyclic Sulfamide deriv. 20",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
389,CC(=O)c1cccc(CN2[C@H](COc3ccccc3)[C@H](O)[C@@H](O)[C@@H](COc3ccccc3)N(Cc3cccc(c3)C(C)=O)S2(=O)=O)c1,"InChI=1S/C36H38N2O8S/c1-25(39)29-13-9-11-27(19-29)21-37-33(23-45-31-15-5-3-6-16-31)35(41)36(42)34(24-46-32-17-7-4-8-18-32)38(47(37,43)44)22-28-12-10-14-30(20-28)26(2)40/h3-20,33-36,41-42H,21-24H2,1-2H3/t33-,34-,35+,36+/m1/s1",SSKLZXDOGDJZRC-NWJWHWDBSA-N,343,"(3R,4S,5S,6R)-2,7-bis[(3-acetylphenyl)methyl]-4,5-dihydroxy-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepane-1,1-dione::CHEMBL340986::Cyclic Sulfamide deriv. 21",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
390,OCCc1cccc(CN2[C@H](COc3ccccc3)[C@H](O)[C@@H](O)[C@@H](COc3ccccc3)N(Cc3cccc(CCO)c3)S2(=O)=O)c1,"InChI=1S/C36H42N2O8S/c39-19-17-27-9-7-11-29(21-27)23-37-33(25-45-31-13-3-1-4-14-31)35(41)36(42)34(26-46-32-15-5-2-6-16-32)38(47(37,43)44)24-30-12-8-10-28(22-30)18-20-40/h1-16,21-22,33-36,39-42H,17-20,23-26H2/t33-,34-,35+,36+/m1/s1",HOSLSXONLCDFQY-NWJWHWDBSA-N,344,"(3R,4S,5S,6R)-4,5-dihydroxy-2,7-bis({[3-(2-hydroxyethyl)phenyl]methyl})-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepane-1,1-dione::CHEMBL337872::Cyclic Sulfamide deriv. 22",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
391,COC(Cc1cccc(CN2[C@H](COc3ccccc3)[C@H](O)[C@@H](O)[C@@H](COc3ccccc3)N(Cc3cccc(CC(OC)OC)c3)S2(=O)=O)c1)OC,"InChI=1S/C40H50N2O10S/c1-47-37(48-2)23-29-13-11-15-31(21-29)25-41-35(27-51-33-17-7-5-8-18-33)39(43)40(44)36(28-52-34-19-9-6-10-20-34)42(53(41,45)46)26-32-16-12-14-30(22-32)24-38(49-3)50-4/h5-22,35-40,43-44H,23-28H2,1-4H3/t35-,36-,39+,40+/m1/s1",OPGMBBOOHWIFIQ-JFDQHVTASA-N,345,"(3R,4S,5S,6R)-2,7-bis({[3-(2,2-dimethoxyethyl)phenyl]methyl})-4,5-dihydroxy-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepane-1,1-dione::CHEMBL130426::Cyclic Sulfamide deriv. 23",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
392,OCc1ccc(CN2[C@H](COc3ccccc3)[C@H](O)[C@@H](O)[C@@H](COc3ccccc3)N(Cc3ccc(CO)cc3)S2(=O)=O)cc1,"InChI=1S/C34H38N2O8S/c37-21-27-15-11-25(12-16-27)19-35-31(23-43-29-7-3-1-4-8-29)33(39)34(40)32(24-44-30-9-5-2-6-10-30)36(45(35,41)42)20-26-13-17-28(22-38)18-14-26/h1-18,31-34,37-40H,19-24H2/t31-,32-,33+,34+/m1/s1",AWUYZKRFZVNVEM-WZJLIZBTSA-N,346,"(3R,4S,5S,6R)-4,5-dihydroxy-2,7-bis({[4-(hydroxymethyl)phenyl]methyl})-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepane-1,1-dione::CHEMBL340616::Cyclic Sulfamide deriv. 24",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
393,COC(=O)c1ccc(CN2[C@H](COc3ccccc3)[C@H](O)[C@@H](O)[C@@H](COc3ccccc3)N(Cc3ccc(cc3)C(=O)OC)S2(=O)=O)cc1,"InChI=1S/C36H38N2O10S/c1-45-35(41)27-17-13-25(14-18-27)21-37-31(23-47-29-9-5-3-6-10-29)33(39)34(40)32(24-48-30-11-7-4-8-12-30)38(49(37,43)44)22-26-15-19-28(20-16-26)36(42)46-2/h3-20,31-34,39-40H,21-24H2,1-2H3/t31-,32-,33+,34+/m1/s1",JBZIZENFALHCSQ-WZJLIZBTSA-N,347,CHEMBL133573::Cyclic Sulfamide deriv. 25,Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
394,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccccc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H46N4O8/c1-19(2)23(29(39)33-5)35-31(41)27(43-17-21-13-9-7-10-14-21)25(37)26(38)28(44-18-22-15-11-8-12-16-22)32(42)36-24(20(3)4)30(40)34-6/h7-16,19-20,23-28,37-38H,17-18H2,1-6H3,(H,33,39)(H,34,40)(H,35,41)(H,36,42)/t23-,24-,25+,26+,27+,28+/m0/s1",QHMBKCCJSCSGHG-BQXGFVACSA-N,348,"(2R,3R,4R,5R)-2,5-bis(benzyloxy)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 1::C2-Symmetric Inhibitor 2::C2-symmetric compound 5::CHEMBL105459::Diol-Based HIV-1 protease inhibitor 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
395,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccccc1F)[C@H](O)[C@@H](O)[C@@H](OCc1ccccc1F)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H44F2N4O8/c1-17(2)23(29(41)35-5)37-31(43)27(45-15-19-11-7-9-13-21(19)33)25(39)26(40)28(46-16-20-12-8-10-14-22(20)34)32(44)38-24(18(3)4)30(42)36-6/h7-14,17-18,23-28,39-40H,15-16H2,1-6H3,(H,35,41)(H,36,42)(H,37,43)(H,38,44)/t23-,24-,25+,26+,27+,28+/m0/s1",VQMZYQKMPARVIQ-BQXGFVACSA-N,349,"(2R,3R,4R,5R)-2,5-bis[(2-fluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 2::N1,N6-Bis-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis-(2-fluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
396,CNC(=O)[C@@H](NC(=O)[C@H](OCc1cccc(F)c1)[C@H](O)[C@@H](O)[C@@H](OCc1cccc(F)c1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H44F2N4O8/c1-17(2)23(29(41)35-5)37-31(43)27(45-15-19-9-7-11-21(33)13-19)25(39)26(40)28(46-16-20-10-8-12-22(34)14-20)32(44)38-24(18(3)4)30(42)36-6/h7-14,17-18,23-28,39-40H,15-16H2,1-6H3,(H,35,41)(H,36,42)(H,37,43)(H,38,44)/t23-,24-,25+,26+,27+,28+/m0/s1",WQFIXFLIBHKDSR-BQXGFVACSA-N,350,"(2R,3R,4R,5R)-2,5-bis[(3-fluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 3::N1,N6-Bis-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis-(3-fluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
397,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(F)cc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(F)cc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H44F2N4O8/c1-17(2)23(29(41)35-5)37-31(43)27(45-15-19-7-11-21(33)12-8-19)25(39)26(40)28(46-16-20-9-13-22(34)14-10-20)32(44)38-24(18(3)4)30(42)36-6/h7-14,17-18,23-28,39-40H,15-16H2,1-6H3,(H,35,41)(H,36,42)(H,37,43)(H,38,44)/t23-,24-,25+,26+,27+,28+/m0/s1",RRHNFHNXWMHGQP-BQXGFVACSA-N,351,"(2R,3R,4R,5R)-2,5-bis[(4-fluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 4::N1,N6-Bis-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis-(4-fluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
398,CNC(=O)[C@@H](NC(=O)[C@H](OCc1cccc(F)c1F)[C@H](O)[C@@H](O)[C@@H](OCc1cccc(F)c1F)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H42F4N4O8/c1-15(2)23(29(43)37-5)39-31(45)27(47-13-17-9-7-11-19(33)21(17)35)25(41)26(42)28(32(46)40-24(16(3)4)30(44)38-6)48-14-18-10-8-12-20(34)22(18)36/h7-12,15-16,23-28,41-42H,13-14H2,1-6H3,(H,37,43)(H,38,44)(H,39,45)(H,40,46)/t23-,24-,25+,26+,27+,28+/m0/s1",YLEGWYXZMZBAFY-BQXGFVACSA-N,352,"(2R,3R,4R,5R)-2,5-bis[(2,3-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 5::N1,N6-Bis-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis-(2,3-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
399,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(F)cc1F)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(F)cc1F)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H42F4N4O8/c1-15(2)23(29(43)37-5)39-31(45)27(47-13-17-7-9-19(33)11-21(17)35)25(41)26(42)28(32(46)40-24(16(3)4)30(44)38-6)48-14-18-8-10-20(34)12-22(18)36/h7-12,15-16,23-28,41-42H,13-14H2,1-6H3,(H,37,43)(H,38,44)(H,39,45)(H,40,46)/t23-,24-,25+,26+,27+,28+/m0/s1",QZBGFQPYINAGJE-BQXGFVACSA-N,353,"(2R,3R,4R,5R)-2,5-bis[(2,4-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 6::N1,N6-Bis-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis-(2,4-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
400,CNC(=O)[C@@H](NC(=O)[C@H](OCc1cc(F)ccc1F)[C@H](O)[C@@H](O)[C@@H](OCc1cc(F)ccc1F)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H42F4N4O8/c1-15(2)23(29(43)37-5)39-31(45)27(47-13-17-11-19(33)7-9-21(17)35)25(41)26(42)28(32(46)40-24(16(3)4)30(44)38-6)48-14-18-12-20(34)8-10-22(18)36/h7-12,15-16,23-28,41-42H,13-14H2,1-6H3,(H,37,43)(H,38,44)(H,39,45)(H,40,46)/t23-,24-,25+,26+,27+,28+/m0/s1",JCRRNSCPFUQUFN-BQXGFVACSA-N,354,"(2R,3R,4R,5R)-2,5-bis[(2,5-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 7::N1,N6-Bis-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis-(2,5-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
401,CNC(=O)[C@@H](NC(=O)[C@H](OCc1c(F)cccc1F)[C@H](O)[C@@H](O)[C@@H](OCc1c(F)cccc1F)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H42F4N4O8/c1-15(2)23(29(43)37-5)39-31(45)27(47-13-17-19(33)9-7-10-20(17)34)25(41)26(42)28(32(46)40-24(16(3)4)30(44)38-6)48-14-18-21(35)11-8-12-22(18)36/h7-12,15-16,23-28,41-42H,13-14H2,1-6H3,(H,37,43)(H,38,44)(H,39,45)(H,40,46)/t23-,24-,25+,26+,27+,28+/m0/s1",SPTXJZHACPMACC-BQXGFVACSA-N,355,"(2R,3R,4R,5R)-2,5-bis[(2,6-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 8::N1,N6-Bis-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis-(2,6-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
402,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(F)c(F)c1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(F)c(F)c1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H42F4N4O8/c1-15(2)23(29(43)37-5)39-31(45)27(47-13-17-7-9-19(33)21(35)11-17)25(41)26(42)28(32(46)40-24(16(3)4)30(44)38-6)48-14-18-8-10-20(34)22(36)12-18/h7-12,15-16,23-28,41-42H,13-14H2,1-6H3,(H,37,43)(H,38,44)(H,39,45)(H,40,46)/t23-,24-,25+,26+,27+,28+/m0/s1",QIZKEGQOQMEFPD-BQXGFVACSA-N,356,"(2R,3R,4R,5R)-2,5-bis[(3,4-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 9::N1,N6-Bis-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis-(3,4-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
403,CNC(=O)[C@@H](NC(=O)[C@H](OCc1cc(F)cc(F)c1)[C@H](O)[C@@H](O)[C@@H](OCc1cc(F)cc(F)c1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H42F4N4O8/c1-15(2)23(29(43)37-5)39-31(45)27(47-13-17-7-19(33)11-20(34)8-17)25(41)26(42)28(32(46)40-24(16(3)4)30(44)38-6)48-14-18-9-21(35)12-22(36)10-18/h7-12,15-16,23-28,41-42H,13-14H2,1-6H3,(H,37,43)(H,38,44)(H,39,45)(H,40,46)/t23-,24-,25+,26+,27+,28+/m0/s1",KDYPVPWYOGIVQF-BQXGFVACSA-N,357,"(2R,3R,4R,5R)-2,5-bis[(3,5-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 10::N1,N6-Bis-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis-(3,5-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
404,O[C@H]([C@@H](O)[C@@H](OCc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](OCc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H40N2O8/c41-29-19-25-15-7-9-17-27(25)31(29)39-37(45)35(47-21-23-11-3-1-4-12-23)33(43)34(44)36(48-22-24-13-5-2-6-14-24)38(46)40-32-28-18-10-8-16-26(28)20-30(32)42/h1-18,29-36,41-44H,19-22H2,(H,39,45)(H,40,46)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",UOHMQWQGAJAUGT-JQFCFGFHSA-N,358,"(2R,3R,4R,5R)-2,5-bis(benzyloxy)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::1-Valine Methylamide deriv. 11::C2-symmetric compound 8::Diol-Based HIV-1 protease inhibitor 1::symmetric/asymmetric inhibitor 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
405,O[C@H]([C@@H](O)[C@@H](OCc1ccccc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](OCc1ccccc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H38F2N2O8/c39-27-15-7-3-11-23(27)19-49-35(37(47)41-31-25-13-5-1-9-21(25)17-29(31)43)33(45)34(46)36(50-20-24-12-4-8-16-28(24)40)38(48)42-32-26-14-6-2-10-22(26)18-30(32)44/h1-16,29-36,43-46H,17-20H2,(H,41,47)(H,42,48)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",LYHLPPXMBKMSSZ-JQFCFGFHSA-N,359,"(2R,3R,4R,5R)-2,5-bis[(2-fluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::1-Valine Methylamide deriv. 12::N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(2-fluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
406,O[C@H]([C@@H](O)[C@@H](OCc1cccc(F)c1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](OCc1cccc(F)c1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H38F2N2O8/c39-25-11-5-7-21(15-25)19-49-35(37(47)41-31-27-13-3-1-9-23(27)17-29(31)43)33(45)34(46)36(50-20-22-8-6-12-26(40)16-22)38(48)42-32-28-14-4-2-10-24(28)18-30(32)44/h1-16,29-36,43-46H,17-20H2,(H,41,47)(H,42,48)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",FSNSRNCFARXZOP-JQFCFGFHSA-N,360,"(2R,3R,4R,5R)-2,5-bis[(3-fluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::1-Valine Methylamide deriv. 13::N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(3-fluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
407,O[C@H]([C@@H](O)[C@@H](OCc1ccc(F)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](OCc1ccc(F)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H38F2N2O8/c39-25-13-9-21(10-14-25)19-49-35(37(47)41-31-27-7-3-1-5-23(27)17-29(31)43)33(45)34(46)36(50-20-22-11-15-26(40)16-12-22)38(48)42-32-28-8-4-2-6-24(28)18-30(32)44/h1-16,29-36,43-46H,17-20H2,(H,41,47)(H,42,48)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",PVAYDHDASDVWCK-JQFCFGFHSA-N,361,"(2R,3R,4R,5R)-2,5-bis[(4-fluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::1-Valine Methylamide deriv. 14::N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(4-fluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
408,O[C@H]([C@@H](O)[C@@H](OCc1cccc(F)c1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](OCc1cccc(F)c1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H36F4N2O8/c39-25-13-5-9-21(29(25)41)17-51-35(37(49)43-31-23-11-3-1-7-19(23)15-27(31)45)33(47)34(48)36(52-18-22-10-6-14-26(40)30(22)42)38(50)44-32-24-12-4-2-8-20(24)16-28(32)46/h1-14,27-28,31-36,45-48H,15-18H2,(H,43,49)(H,44,50)/t27-,28-,31+,32+,33-,34-,35-,36-/m1/s1",FJIRQAXCBOCEQN-QHNIKEGDSA-N,362,"(2R,3R,4R,5R)-2,5-bis[(2,3-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::1-Valine Methylamide deriv. 15::N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(2,3-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
409,O[C@H]([C@@H](O)[C@@H](OCc1ccc(F)cc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](OCc1ccc(F)cc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H36F4N2O8/c39-23-11-9-21(27(41)15-23)17-51-35(37(49)43-31-25-7-3-1-5-19(25)13-29(31)45)33(47)34(48)36(52-18-22-10-12-24(40)16-28(22)42)38(50)44-32-26-8-4-2-6-20(26)14-30(32)46/h1-12,15-16,29-36,45-48H,13-14,17-18H2,(H,43,49)(H,44,50)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",YVNITSOLRPDTNX-JQFCFGFHSA-N,363,"(2R,3R,4R,5R)-2,5-bis[(2,4-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::1-Valine Methylamide deriv. 16::N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(2,4-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
410,O[C@H]([C@@H](O)[C@@H](OCc1cc(F)ccc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](OCc1cc(F)ccc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H36F4N2O8/c39-23-9-11-27(41)21(13-23)17-51-35(37(49)43-31-25-7-3-1-5-19(25)15-29(31)45)33(47)34(48)36(52-18-22-14-24(40)10-12-28(22)42)38(50)44-32-26-8-4-2-6-20(26)16-30(32)46/h1-14,29-36,45-48H,15-18H2,(H,43,49)(H,44,50)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",MHRYDJWKKUNWJY-JQFCFGFHSA-N,364,"(2R,3R,4R,5R)-2,5-bis[(2,5-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::1-Valine Methylamide deriv. 17::N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(2,5-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
411,O[C@H]([C@@H](O)[C@@H](OCc1c(F)cccc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](OCc1c(F)cccc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H36F4N2O8/c39-25-11-5-12-26(40)23(25)17-51-35(37(49)43-31-21-9-3-1-7-19(21)15-29(31)45)33(47)34(48)36(52-18-24-27(41)13-6-14-28(24)42)38(50)44-32-22-10-4-2-8-20(22)16-30(32)46/h1-14,29-36,45-48H,15-18H2,(H,43,49)(H,44,50)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",YHWGARGFNUGEHK-JQFCFGFHSA-N,365,"(2R,3R,4R,5R)-2,5-bis[(2,6-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::1-Valine Methylamide deriv. 18::N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(2,6-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
412,O[C@H]([C@@H](O)[C@@H](OCc1ccc(F)c(F)c1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](OCc1ccc(F)c(F)c1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H36F4N2O8/c39-25-11-9-19(13-27(25)41)17-51-35(37(49)43-31-23-7-3-1-5-21(23)15-29(31)45)33(47)34(48)36(52-18-20-10-12-26(40)28(42)14-20)38(50)44-32-24-8-4-2-6-22(24)16-30(32)46/h1-14,29-36,45-48H,15-18H2,(H,43,49)(H,44,50)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",LQOYTFWXDYWAEL-JQFCFGFHSA-N,366,"(2R,3R,4R,5R)-2,5-bis[(3,4-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::1-Valine Methylamide deriv. 19::N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(3,4-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
413,O[C@H]([C@@H](O)[C@@H](OCc1cc(F)cc(F)c1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](OCc1cc(F)cc(F)c1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H36F4N2O8/c39-23-9-19(10-24(40)15-23)17-51-35(37(49)43-31-27-7-3-1-5-21(27)13-29(31)45)33(47)34(48)36(52-18-20-11-25(41)16-26(42)12-20)38(50)44-32-28-8-4-2-6-22(28)14-30(32)46/h1-12,15-16,29-36,45-48H,13-14,17-18H2,(H,43,49)(H,44,50)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",JAPYKPCIFHRZGF-JQFCFGFHSA-N,367,"(2R,3R,4R,5R)-2,5-bis[(3,5-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::1-Valine Methylamide deriv. 20::N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(3,5-difluorobenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
414,CC(C)(C)NC(=O)C1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1,"InChI=1S/C29H45N3O5/c1-29(2,3)31-27(34)25-16-21-11-7-8-12-22(21)17-32(25)18-26(33)24(15-20-9-5-4-6-10-20)30-28(35)37-23-13-14-36-19-23/h4-6,9-10,21-26,33H,7-8,11-19H2,1-3H3,(H,30,35)(H,31,34)/t21-,22+,23-,24-,25?,26+/m0/s1",RWJPHGJNZTXMGR-XCXWGBNBSA-N,368,"(3S)-oxolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 1",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 160
415,CC(C)(C)NC(=O)C1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCS(=O)(=O)C1,"InChI=1S/C29H45N3O6S/c1-29(2,3)31-27(34)25-16-21-11-7-8-12-22(21)17-32(25)18-26(33)24(15-20-9-5-4-6-10-20)30-28(35)38-23-13-14-39(36,37)19-23/h4-6,9-10,21-26,33H,7-8,11-19H2,1-3H3,(H,30,35)(H,31,34)/t21-,22+,23-,24-,25?,26+/m0/s1",UPYUBPUDWRHOBW-XCXWGBNBSA-N,369,"(3S)-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 75
416,CC(C)(C)NC(=O)C1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CCS(=O)(=O)C1,"InChI=1S/C29H45N3O6S/c1-29(2,3)31-27(34)25-16-21-11-7-8-12-22(21)17-32(25)18-26(33)24(15-20-9-5-4-6-10-20)30-28(35)38-23-13-14-39(36,37)19-23/h4-6,9-10,21-26,33H,7-8,11-19H2,1-3H3,(H,30,35)(H,31,34)/t21-,22+,23+,24-,25?,26+/m0/s1",UPYUBPUDWRHOBW-DKQAMVAGSA-N,370,"(3R)-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 3",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 140
417,CC(C)(C)NC(=O)C1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OCCS(C)(=O)=O,"InChI=1S/C28H45N3O6S/c1-28(2,3)30-26(33)24-17-21-12-8-9-13-22(21)18-31(24)19-25(32)23(16-20-10-6-5-7-11-20)29-27(34)37-14-15-38(4,35)36/h5-7,10-11,21-25,32H,8-9,12-19H2,1-4H3,(H,29,34)(H,30,33)/t21-,22+,23-,24?,25+/m0/s1",XWDWUINGEMTUCN-UETCWDDOSA-N,371,"2-methanesulfonylethyl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 4",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1030
418,C[C@@H]1OCC[C@@H]1OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O5/c1-20-27(14-15-37-20)38-29(36)31-24(16-21-10-6-5-7-11-21)26(34)19-33-18-23-13-9-8-12-22(23)17-25(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22-,23+,24-,25?,26+,27-/m0/s1",WZRBCRPZAJNYRP-QPXXPZPASA-N,372,"(2S,3S)-2-methyloxolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 5",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 52.4
419,C[C@H]1OCC[C@H]1OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O5/c1-20-27(14-15-37-20)38-29(36)31-24(16-21-10-6-5-7-11-21)26(34)19-33-18-23-13-9-8-12-22(23)17-25(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22+,23-,24+,25?,26-,27-/m1/s1",WZRBCRPZAJNYRP-ISZKJJAPSA-N,373,"(2R,3R)-2-methyloxolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 6",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 169
420,C[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S/c1-20-27(14-15-40(20,37)38)39-29(36)31-24(16-21-10-6-5-7-11-21)26(34)19-33-18-23-13-9-8-12-22(23)17-25(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22-,23+,24-,25?,26+,27-/m0/s1",ZWBLHWHBSYSDFK-QPXXPZPASA-N,374,"(2S,3S)-2-methyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 7",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 11.4
421,C[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S/c1-20-27(14-15-40(20,37)38)39-29(36)31-24(16-21-10-6-5-7-11-21)26(34)19-33-18-23-13-9-8-12-22(23)17-25(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22+,23-,24+,25?,26-,27-/m1/s1",ZWBLHWHBSYSDFK-ISZKJJAPSA-N,310,"(2R,3R)-2-methyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 8::Thienopyridine thienyl urethane deriv. 5::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 22.3
422,CC[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C31H49N3O6S/c1-5-28-27(15-16-41(28,38)39)40-30(37)32-24(17-21-11-7-6-8-12-21)26(35)20-34-19-23-14-10-9-13-22(23)18-25(34)29(36)33-31(2,3)4/h6-8,11-12,22-28,35H,5,9-10,13-20H2,1-4H3,(H,32,37)(H,33,36)/t22-,23+,24-,25?,26+,27-,28-/m0/s1",DQMCOXURPZMVFV-OJTHUCJASA-N,376,"(2S,3S)-2-ethyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 9",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 5.4
423,CC[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C31H49N3O6S/c1-5-28-27(15-16-41(28,38)39)40-30(37)32-24(17-21-11-7-6-8-12-21)26(35)20-34-19-23-14-10-9-13-22(23)18-25(34)29(36)33-31(2,3)4/h6-8,11-12,22-28,35H,5,9-10,13-20H2,1-4H3,(H,32,37)(H,33,36)/t22-,23+,24-,25?,26+,27+,28+/m0/s1",DQMCOXURPZMVFV-SCNOPYMHSA-N,377,"(2R,3R)-2-ethyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 13.1
424,CC(C)[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C32H51N3O6S/c1-21(2)29-28(15-16-42(29,39)40)41-31(38)33-25(17-22-11-7-6-8-12-22)27(36)20-35-19-24-14-10-9-13-23(24)18-26(35)30(37)34-32(3,4)5/h6-8,11-12,21,23-29,36H,9-10,13-20H2,1-5H3,(H,33,38)(H,34,37)/t23-,24+,25-,26?,27+,28-,29-/m0/s1",DYRQCFKJNPXYSL-LMUQLAANSA-N,315,"(2S,3S)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 11::Thienopyridine thienyl urethane deriv. 10::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 11.0
425,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C32H51N3O6S/c1-21(2)29-28(15-16-42(29,39)40)41-31(38)33-25(17-22-11-7-6-8-12-22)27(36)20-35-19-24-14-10-9-13-23(24)18-26(35)30(37)34-32(3,4)5/h6-8,11-12,21,23-29,36H,9-10,13-20H2,1-5H3,(H,33,38)(H,34,37)/t23-,24+,25-,26?,27+,28+,29+/m0/s1",DYRQCFKJNPXYSL-JDANZANYSA-N,316,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 12::Thienopyridine thienyl urethane deriv. 11::hydroxyethylamine isostere::hydroxyethylene isostere",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.0
426,CC(C)C[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C33H53N3O6S/c1-22(2)17-30-29(15-16-43(30,40)41)42-32(39)34-26(18-23-11-7-6-8-12-23)28(37)21-36-20-25-14-10-9-13-24(25)19-27(36)31(38)35-33(3,4)5/h6-8,11-12,22,24-30,37H,9-10,13-21H2,1-5H3,(H,34,39)(H,35,38)/t24-,25+,26-,27?,28+,29-,30-/m0/s1",OTYAZVZPQIOMFF-PWCBBPMJSA-N,380,"(2S,3S)-2-(2-methylpropyl)-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 12
427,CC(C)C[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2CC1C(=O)NC(C)(C)C,"InChI=1S/C33H53N3O6S/c1-22(2)17-30-29(15-16-43(30,40)41)42-32(39)34-26(18-23-11-7-6-8-12-23)28(37)21-36-20-25-14-10-9-13-24(25)19-27(36)31(38)35-33(3,4)5/h6-8,11-12,22,24-30,37H,9-10,13-21H2,1-5H3,(H,34,39)(H,35,38)/t24-,25+,26-,27?,28+,29+,30+/m0/s1",OTYAZVZPQIOMFF-KURZSNSCSA-N,381,"(2R,3R)-2-(2-methylpropyl)-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Sulfone Deriv. 14",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 30
428,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C33H40N2O5/c1-33(2,3)40-32(39)34-27(19-23-14-8-5-9-15-23)28(36)21-25(18-22-12-6-4-7-13-22)31(38)35-30-26-17-11-10-16-24(26)20-29(30)37/h4-17,25,27-30,36-37H,18-21H2,1-3H3,(H,34,39)(H,35,38)/t25-,27+,28+,29-,30+/m1/s1",ZJBUCZFZQXPYFC-JOFXVPDFSA-N,1030,"CHEMBL296115::L-685,434::Urethane deriv. 1::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.3
429,O[C@@H](C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1,"InChI=1S/C33H38N2O6/c36-29(28(18-23-11-5-2-6-12-23)34-33(39)41-26-15-16-40-21-26)20-25(17-22-9-3-1-4-10-22)32(38)35-31-27-14-8-7-13-24(27)19-30(31)37/h1-14,25-26,28-31,36-37H,15-21H2,(H,34,39)(H,35,38)/t25-,26+,28+,29+,30-,31+/m1/s1",PKJPLBXKJRGYRL-NKGNNZHESA-N,383,"(3S)-oxolan-3-yl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate::Urethane deriv. 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,<0.03
430,O[C@@H](C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CCOC1,"InChI=1S/C33H38N2O6/c36-29(28(18-23-11-5-2-6-12-23)34-33(39)41-26-15-16-40-21-26)20-25(17-22-9-3-1-4-10-22)32(38)35-31-27-14-8-7-13-24(27)19-30(31)37/h1-14,25-26,28-31,36-37H,15-21H2,(H,34,39)(H,35,38)/t25-,26-,28+,29+,30-,31+/m1/s1",PKJPLBXKJRGYRL-NKBYLQHSSA-N,384,"(3R)-oxolan-3-yl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate::Urethane deriv. 3",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.03
431,O[C@@H](C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@H](Cc1ccccc1)NC(=O)OC1CCCC1,"InChI=1S/C34H40N2O5/c37-30(29(20-24-13-5-2-6-14-24)35-34(40)41-27-16-8-9-17-27)22-26(19-23-11-3-1-4-12-23)33(39)36-32-28-18-10-7-15-25(28)21-31(32)38/h1-7,10-15,18,26-27,29-32,37-38H,8-9,16-17,19-22H2,(H,35,40)(H,36,39)/t26-,29+,30+,31-,32+/m1/s1",UMNROTOYYWSPDV-KHQGQIEXSA-N,385,"Urethane deriv. 4::cyclopentyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.33
432,O[C@@H](C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCCOC1,"InChI=1S/C34H40N2O6/c37-30(29(19-24-12-5-2-6-13-24)35-34(40)42-27-15-9-17-41-22-27)21-26(18-23-10-3-1-4-11-23)33(39)36-32-28-16-8-7-14-25(28)20-31(32)38/h1-8,10-14,16,26-27,29-32,37-38H,9,15,17-22H2,(H,35,40)(H,36,39)/t26-,27+,29+,30+,31-,32+/m1/s1",WHEAOWNCXPCPCE-QWELAOBGSA-N,386,"(3S)-oxan-3-yl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate::Urethane deriv. 5",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,<0.03
433,O[C@@H](C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CCCOC1,"InChI=1S/C34H40N2O6/c37-30(29(19-24-12-5-2-6-13-24)35-34(40)42-27-15-9-17-41-22-27)21-26(18-23-10-3-1-4-11-23)33(39)36-32-28-16-8-7-14-25(28)20-31(32)38/h1-8,10-14,16,26-27,29-32,37-38H,9,15,17-22H2,(H,35,40)(H,36,39)/t26-,27-,29+,30+,31-,32+/m1/s1",WHEAOWNCXPCPCE-LOOYLFGLSA-N,387,"(3R)-oxan-3-yl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate::Urethane deriv. 6",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,<0.03
434,O[C@@H](C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@H](Cc1ccccc1)NC(=O)OC1CCOCC1,"InChI=1S/C34H40N2O6/c37-30(29(20-24-11-5-2-6-12-24)35-34(40)42-27-15-17-41-18-16-27)22-26(19-23-9-3-1-4-10-23)33(39)36-32-28-14-8-7-13-25(28)21-31(32)38/h1-14,26-27,29-32,37-38H,15-22H2,(H,35,40)(H,36,39)/t26-,29+,30+,31-,32+/m1/s1",PFYXADIWLAQFKJ-KHQGQIEXSA-N,388,"Urethane deriv. 7::oxan-4-yl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.22
435,CC(C)(C)NC(=O)C1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C,"InChI=1S/C29H47N3O4/c1-28(2,3)31-26(34)24-17-21-14-10-11-15-22(21)18-32(24)19-25(33)23(16-20-12-8-7-9-13-20)30-27(35)36-29(4,5)6/h7-9,12-13,21-25,33H,10-11,14-19H2,1-6H3,(H,30,35)(H,31,34)/t21-,22+,23-,24?,25+/m0/s1",LYMBPRXTWAXSBF-UETCWDDOSA-N,389,"Urethane deriv. 8::tert-butyl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>3000
436,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,"InChI=1S/C28H39N3O7S/c1-3-19(2)16-31(39(34,35)22-11-9-21(29)10-12-22)17-25(32)24(15-20-7-5-4-6-8-20)30-28(33)38-26-18-37-27-23(26)13-14-36-27/h4-12,19,23-27,32H,3,13-18,29H2,1-2H3,(H,30,33)/t19-,23-,24-,25+,26-,27+/m0/s1",NKLRQHQHYBFPSD-DRMLODCJSA-N,112654,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-((S)-2-methylbutyl)phenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate (10a)","Gag-Pol polyprotein [484-582,Q491K,I494L,I497V,V499I,E519D,I534V,R541K,D544E,Q553K,A555V,L573M]",Human immunodeficiency virus,
437,CC(C)(C)NC(=O)C1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CCOC1,"InChI=1S/C29H45N3O5/c1-29(2,3)31-27(34)25-16-21-11-7-8-12-22(21)17-32(25)18-26(33)24(15-20-9-5-4-6-10-20)30-28(35)37-23-13-14-36-19-23/h4-6,9-10,21-26,33H,7-8,11-19H2,1-3H3,(H,30,35)(H,31,34)/t21-,22+,23+,24-,25?,26+/m0/s1",RWJPHGJNZTXMGR-DKQAMVAGSA-N,391,"(3R)-oxolan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Urethane deriv. 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 694
438,CC(C)(C)NC(=O)C1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1COCC=C1,"InChI=1S/C30H45N3O5/c1-30(2,3)32-28(35)26-17-22-12-7-8-13-23(22)18-33(26)19-27(34)25(16-21-10-5-4-6-11-21)31-29(36)38-24-14-9-15-37-20-24/h4-6,9-11,14,22-27,34H,7-8,12-13,15-20H2,1-3H3,(H,31,36)(H,32,35)/t22-,23+,24-,25-,26?,27+/m0/s1",LYPBPTICLJCIAA-YAAGLGSPSA-N,392,"(3S)-3,6-dihydro-2H-pyran-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Urethane deriv. 11",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 314
439,CC(C)(C)NC(=O)C1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1COCC=C1,"InChI=1S/C30H45N3O5/c1-30(2,3)32-28(35)26-17-22-12-7-8-13-23(22)18-33(26)19-27(34)25(16-21-10-5-4-6-11-21)31-29(36)38-24-14-9-15-37-20-24/h4-6,9-11,14,22-27,34H,7-8,12-13,15-20H2,1-3H3,(H,31,36)(H,32,35)/t22-,23+,24+,25-,26?,27+/m0/s1",LYPBPTICLJCIAA-QAFQPKEQSA-N,393,"(3R)-3,6-dihydro-2H-pyran-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Urethane deriv. 12",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 48.9
440,CC(C)(C)NC(=O)C1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCCOC1,"InChI=1S/C30H47N3O5/c1-30(2,3)32-28(35)26-17-22-12-7-8-13-23(22)18-33(26)19-27(34)25(16-21-10-5-4-6-11-21)31-29(36)38-24-14-9-15-37-20-24/h4-6,10-11,22-27,34H,7-9,12-20H2,1-3H3,(H,31,36)(H,32,35)/t22-,23+,24-,25-,26?,27+/m0/s1",FNTQXASNMYZUHY-YAAGLGSPSA-N,394,"(3S)-oxan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Urethane deriv. 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 392
441,CC(C)(C)NC(=O)C1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CCCOC1,"InChI=1S/C30H47N3O5/c1-30(2,3)32-28(35)26-17-22-12-7-8-13-23(22)18-33(26)19-27(34)25(16-21-10-5-4-6-11-21)31-29(36)38-24-14-9-15-37-20-24/h4-6,10-11,22-27,34H,7-9,12-20H2,1-3H3,(H,31,36)(H,32,35)/t22-,23+,24+,25-,26?,27+/m0/s1",FNTQXASNMYZUHY-QAFQPKEQSA-N,395,"(3R)-oxan-3-yl N-[(2S,3R)-4-[(4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Urethane deriv. 14",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 308
442,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C27H35NO4S/c1-16(2)27(12-11-18-7-9-19(29)10-8-18)15-22(30)24(25(31)32-27)33-23-13-17(3)21(28)14-20(23)26(4,5)6/h7-10,13-14,16,24,29H,11-12,15,28H2,1-6H3",HPYCGBSIYDCTOZ-UHFFFAOYSA-N,396,"3-[(4-amino-2-tert-butyl-5-methylphenyl)sulfanyl]-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-(propan-2-yl)-5,6-dihydro-2H-pyran-2-one::CHEMBL38268::Dihydropyran-2-one deriv. 1",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.7
443,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(C)(=O)=O)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C28H37NO6S2/c1-17(2)28(13-12-19-8-10-20(30)11-9-19)16-23(31)25(26(32)35-28)36-24-14-18(3)22(29-37(7,33)34)15-21(24)27(4,5)6/h8-11,14-15,17,25,29-30H,12-13,16H2,1-7H3",LKQLSTRUEQYVIV-UHFFFAOYSA-N,397,"CHEMBL352964::Dihydropyran-2-one deriv. 2::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]methanesulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.0
444,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccccc3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C33H39NO6S2/c1-21(2)33(17-16-23-12-14-24(35)15-13-23)20-28(36)30(31(37)40-33)41-29-18-22(3)27(19-26(29)32(4,5)6)34-42(38,39)25-10-8-7-9-11-25/h7-15,18-19,21,30,34-35H,16-17,20H2,1-6H3",OPLZOZKKMATPRR-UHFFFAOYSA-N,398,"CHEMBL287361::Dihydropyran-2-one deriv. 3::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]benzenesulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.8
445,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(F)cc3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C33H38FNO6S2/c1-20(2)33(16-15-22-7-11-24(36)12-8-22)19-28(37)30(31(38)41-33)42-29-17-21(3)27(18-26(29)32(4,5)6)35-43(39,40)25-13-9-23(34)10-14-25/h7-14,17-18,20,30,35-36H,15-16,19H2,1-6H3",UTHFVHRXENTJKM-UHFFFAOYSA-N,399,"CHEMBL171720::Dihydropyran-2-one deriv. 4::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-4-fluorobenzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.1
446,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(Cl)cc3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C33H38ClNO6S2/c1-20(2)33(16-15-22-7-11-24(36)12-8-22)19-28(37)30(31(38)41-33)42-29-17-21(3)27(18-26(29)32(4,5)6)35-43(39,40)25-13-9-23(34)10-14-25/h7-14,17-18,20,30,35-36H,15-16,19H2,1-6H3",PZFDGOGGHGSOLD-UHFFFAOYSA-N,400,"CHEMBL169543::Dihydropyran-2-one deriv. 5::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-4-chlorobenzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 5.3
447,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(cc3)C(F)(F)F)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C34H38F3NO6S2/c1-20(2)33(16-15-22-7-11-24(39)12-8-22)19-28(40)30(31(41)44-33)45-29-17-21(3)27(18-26(29)32(4,5)6)38-46(42,43)25-13-9-23(10-14-25)34(35,36)37/h7-14,17-18,20,30,38-39H,15-16,19H2,1-6H3",UVKPIMAIGAGEPD-UHFFFAOYSA-N,401,"CHEMBL171873::Dihydropyran-2-one deriv. 6::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-4-(trifluoromethyl)benzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 18.3
448,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3cccc(c3)C#N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C34H38N2O6S2/c1-21(2)34(15-14-23-10-12-25(37)13-11-23)19-29(38)31(32(39)42-34)43-30-16-22(3)28(18-27(30)33(4,5)6)36-44(40,41)26-9-7-8-24(17-26)20-35/h7-13,16-18,21,31,36-37H,14-15,19H2,1-6H3",NHBRWSXIRJAJCD-UHFFFAOYSA-N,402,"CHEMBL354027::Dihydropyran-2-one deriv. 7::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-3-cyanobenzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
449,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(cc3)C#N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C34H38N2O6S2/c1-21(2)34(16-15-23-7-11-25(37)12-8-23)19-29(38)31(32(39)42-34)43-30-17-22(3)28(18-27(30)33(4,5)6)36-44(40,41)26-13-9-24(20-35)10-14-26/h7-14,17-18,21,31,36-37H,15-16,19H2,1-6H3",MPBRLEOTRZKRTK-UHFFFAOYSA-N,403,"CHEMBL169391::Dihydropyran-2-one deriv. 8::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-4-cyanobenzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.2
450,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3cccs3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C31H37NO6S3/c1-19(2)31(14-13-21-9-11-22(33)12-10-21)18-25(34)28(29(35)38-31)40-26-16-20(3)24(17-23(26)30(4,5)6)32-41(36,37)27-8-7-15-39-27/h7-12,15-17,19,28,32-33H,13-14,18H2,1-6H3",QAILBMJRZRYBHL-UHFFFAOYSA-N,404,"CHEMBL354803::Dihydropyran-2-one deriv. 9::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]thiophene-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 8.7
451,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccccn3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C32H38N2O6S2/c1-20(2)32(15-14-22-10-12-23(35)13-11-22)19-26(36)29(30(37)40-32)41-27-17-21(3)25(18-24(27)31(4,5)6)34-42(38,39)28-9-7-8-16-33-28/h7-13,16-18,20,29,34-35H,14-15,19H2,1-6H3",MVGRNBSHAITXKQ-UHFFFAOYSA-N,405,"CHEMBL169714::Dihydropyran-2-one deriv. 10::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]pyridine-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.6
452,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3cccnc3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C32H38N2O6S2/c1-20(2)32(14-13-22-9-11-23(35)12-10-22)18-27(36)29(30(37)40-32)41-28-16-21(3)26(17-25(28)31(4,5)6)34-42(38,39)24-8-7-15-33-19-24/h7-12,15-17,19-20,29,34-35H,13-14,18H2,1-6H3",WRVZUEWXYSNGFU-UHFFFAOYSA-N,406,"CHEMBL354867::Dihydropyran-2-one deriv. 11::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]pyridine-3-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.6
453,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C33H37F3N2O6S2/c1-19(2)32(14-13-21-7-10-23(39)11-8-21)17-26(40)29(30(41)44-32)45-27-15-20(3)25(16-24(27)31(4,5)6)38-46(42,43)28-12-9-22(18-37-28)33(34,35)36/h7-12,15-16,18-19,29,38-39H,13-14,17H2,1-6H3",FRTFPCUYPFXAEP-UHFFFAOYSA-N,407,"Dihydropyran-2-one deriv. 12::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
454,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1N)C(C)(C)C,"InChI=1S/C25H31NO4S/c1-15-12-21(18(13-19(15)26)24(2,3)4)31-22-20(28)14-25(5,30-23(22)29)11-10-16-6-8-17(27)9-7-16/h6-9,12-13,22,27H,10-11,14,26H2,1-5H3",GIQNBXFSCSHTJB-UHFFFAOYSA-N,408,"3-[(4-amino-2-tert-butyl-5-methylphenyl)sulfanyl]-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-5,6-dihydro-2H-pyran-2-one::CHEMBL37755::Dihydropyran-2-one deriv. 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 13.0
455,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1NS(C)(=O)=O)C(C)(C)C,"InChI=1S/C26H33NO6S2/c1-16-13-22(19(25(2,3)4)14-20(16)27-35(6,31)32)34-23-21(29)15-26(5,33-24(23)30)12-11-17-7-9-18(28)10-8-17/h7-10,13-14,23,27-28H,11-12,15H2,1-6H3",NTVLLLJJTUOVIM-UHFFFAOYSA-N,409,"CHEMBL354173::Dihydropyran-2-one deriv. 14::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]methanesulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 9.7
456,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1NS(=O)(=O)c1ccccc1)C(C)(C)C,"InChI=1S/C31H35NO6S2/c1-20-17-27(24(30(2,3)4)18-25(20)32-40(36,37)23-9-7-6-8-10-23)39-28-26(34)19-31(5,38-29(28)35)16-15-21-11-13-22(33)14-12-21/h6-14,17-18,28,32-33H,15-16,19H2,1-5H3",ORVSXGUIFCRJPY-UHFFFAOYSA-N,410,"CHEMBL168270::Dihydropyran-2-one deriv. 15::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]benzenesulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.5
457,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1NS(=O)(=O)c1ccc(F)cc1)C(C)(C)C,"InChI=1S/C31H34FNO6S2/c1-19-16-27(24(30(2,3)4)17-25(19)33-41(37,38)23-12-8-21(32)9-13-23)40-28-26(35)18-31(5,39-29(28)36)15-14-20-6-10-22(34)11-7-20/h6-13,16-17,28,33-34H,14-15,18H2,1-5H3",KYJXMAVQBIBNSM-UHFFFAOYSA-N,411,"CHEMBL170117::Dihydropyran-2-one deriv. 16::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-4-fluorobenzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.7
458,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1NS(=O)(=O)c1ccc(Cl)cc1)C(C)(C)C,"InChI=1S/C31H34ClNO6S2/c1-19-16-27(24(30(2,3)4)17-25(19)33-41(37,38)23-12-8-21(32)9-13-23)40-28-26(35)18-31(5,39-29(28)36)15-14-20-6-10-22(34)11-7-20/h6-13,16-17,28,33-34H,14-15,18H2,1-5H3",FAPTVEMQFPJREA-UHFFFAOYSA-N,412,"CHEMBL354616::Dihydropyran-2-one deriv. 17::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-4-chlorobenzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.5
459,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1NS(=O)(=O)c1ccc(cc1)C(F)(F)F)C(C)(C)C,"InChI=1S/C32H34F3NO6S2/c1-19-16-27(43-28-26(38)18-31(5,42-29(28)39)15-14-20-6-10-22(37)11-7-20)24(30(2,3)4)17-25(19)36-44(40,41)23-12-8-21(9-13-23)32(33,34)35/h6-13,16-17,28,36-37H,14-15,18H2,1-5H3",NAHRPNHOMFIECG-UHFFFAOYSA-N,413,"CHEMBL263268::Dihydropyran-2-one deriv. 18::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-4-(trifluoromethyl)benzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 12.3
460,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1NS(=O)(=O)c1ccc(cc1)C#N)C(C)(C)C,"InChI=1S/C32H34N2O6S2/c1-20-16-28(25(31(2,3)4)17-26(20)34-42(38,39)24-12-8-22(19-33)9-13-24)41-29-27(36)18-32(5,40-30(29)37)15-14-21-6-10-23(35)11-7-21/h6-13,16-17,29,34-35H,14-15,18H2,1-5H3",HQUDBBBWSWCJRS-UHFFFAOYSA-N,414,"CHEMBL168369::Dihydropyran-2-one deriv. 19::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-4-cyanobenzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.1
461,CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1cc(c(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)cc1C)C(C)(C)C,"InChI=1S/C33H38N2O7S2/c1-20-17-29(43-30-28(38)19-33(6,42-31(30)39)16-15-22-7-11-24(37)12-8-22)26(32(3,4)5)18-27(20)35-44(40,41)25-13-9-23(10-14-25)34-21(2)36/h7-14,17-18,30,35,37H,15-16,19H2,1-6H3,(H,34,36)",GGDHDGAZQSBJMN-UHFFFAOYSA-N,415,"Dihydropyran-2-one deriv. 20::N-(4-{[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]sulfamoyl}phenyl)acetamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
462,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1NS(=O)(=O)c1cccc(c1)-c1cccs1)C(C)(C)C,"InChI=1S/C35H37NO6S3/c1-22-18-31(44-32-29(38)21-35(5,42-33(32)39)16-15-23-11-13-25(37)14-12-23)27(34(2,3)4)20-28(22)36-45(40,41)26-9-6-8-24(19-26)30-10-7-17-43-30/h6-14,17-20,32,36-37H,15-16,21H2,1-5H3",JRNBLPBFNFDMSA-UHFFFAOYSA-N,416,"Dihydropyran-2-one deriv. 21::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-3-(thiophen-2-yl)benzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 6.3
463,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1NS(=O)(=O)c1nccn1C)C(C)(C)C,"InChI=1S/C29H35N3O6S2/c1-18-15-24(21(28(2,3)4)16-22(18)31-40(36,37)27-30-13-14-32(27)6)39-25-23(34)17-29(5,38-26(25)35)12-11-19-7-9-20(33)10-8-19/h7-10,13-16,25,31,33H,11-12,17H2,1-6H3",CODNKLCWFNHVHB-UHFFFAOYSA-N,417,"Dihydropyran-2-one deriv. 22::N-[5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]-1-methyl-1H-imidazole-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.9
464,Cc1cc(SC2C(=O)CC(CCc3ccc(O)cc3)(OC2=O)C2CC2)c(cc1NS(=O)(=O)c1ccccc1)C(C)(C)C,"InChI=1S/C33H37NO6S2/c1-21-18-29(26(32(2,3)4)19-27(21)34-42(38,39)25-8-6-5-7-9-25)41-30-28(36)20-33(23-12-13-23,40-31(30)37)17-16-22-10-14-24(35)15-11-22/h5-11,14-15,18-19,23,30,34-35H,12-13,16-17,20H2,1-4H3",MIUOGBGVBODJGV-UHFFFAOYSA-N,418,"CHEMBL168269::Dihydropyran-2-one deriv. 23::N-[5-tert-butyl-4-({6-cyclopropyl-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]benzenesulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.6
465,Cc1cc(SC2C(=O)CC(CCc3ccc(O)cc3)(OC2=O)C2CCCC2)c(cc1NS(=O)(=O)c1ccccc1)C(C)(C)C,"InChI=1S/C35H41NO6S2/c1-23-20-31(28(34(2,3)4)21-29(23)36-44(40,41)27-12-6-5-7-13-27)43-32-30(38)22-35(42-33(32)39,25-10-8-9-11-25)19-18-24-14-16-26(37)17-15-24/h5-7,12-17,20-21,25,32,36-37H,8-11,18-19,22H2,1-4H3",FMKHKPTUTHWRFS-UHFFFAOYSA-N,419,"CHEMBL169278::Dihydropyran-2-one deriv. 24::N-[5-tert-butyl-4-({6-cyclopentyl-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl]benzenesulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 8.6
466,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C27H35NO3S/c1-17(2)27(13-12-19-10-8-7-9-11-19)16-22(29)24(25(30)31-27)32-23-14-18(3)21(28)15-20(23)26(4,5)6/h7-11,14-15,17,24H,12-13,16,28H2,1-6H3",TVJVEEFOSYUFLV-UHFFFAOYSA-N,420,"3-[(4-amino-2-tert-butyl-5-methylphenyl)sulfanyl]-4-hydroxy-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-2-one::CHEMBL288033::Dihydropyran-2-one deriv. 25",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.6
467,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(C)(=O)=O)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C28H37NO5S2/c1-18(2)28(14-13-20-11-9-8-10-12-20)17-23(30)25(26(31)34-28)35-24-15-19(3)22(29-36(7,32)33)16-21(24)27(4,5)6/h8-12,15-16,18,25,29H,13-14,17H2,1-7H3",SUWZEBHPOHCUJK-UHFFFAOYSA-N,421,"CHEMBL169849::Dihydropyran-2-one deriv. 26::N-(5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)methanesulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
468,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(cc3)C(F)(F)F)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C34H38F3NO5S2/c1-21(2)33(17-16-23-10-8-7-9-11-23)20-28(39)30(31(40)43-33)44-29-18-22(3)27(19-26(29)32(4,5)6)38-45(41,42)25-14-12-24(13-15-25)34(35,36)37/h7-15,18-19,21,30,38H,16-17,20H2,1-6H3",BKEQKOQDMKMYFD-UHFFFAOYSA-N,422,"CHEMBL263026::Dihydropyran-2-one deriv. 27::N-(5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)-4-(trifluoromethyl)benzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
469,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3cccc(c3)C#N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C34H38N2O5S2/c1-22(2)34(16-15-24-11-8-7-9-12-24)20-29(37)31(32(38)41-34)42-30-17-23(3)28(19-27(30)33(4,5)6)36-43(39,40)26-14-10-13-25(18-26)21-35/h7-14,17-19,22,31,36H,15-16,20H2,1-6H3",UIXCYALOKLEACH-UHFFFAOYSA-N,423,"CHEMBL263028::Dihydropyran-2-one deriv. 28::N-(5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)-3-cyanobenzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
470,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(cc3)C#N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C34H38N2O5S2/c1-22(2)34(17-16-24-10-8-7-9-11-24)20-29(37)31(32(38)41-34)42-30-18-23(3)28(19-27(30)33(4,5)6)36-43(39,40)26-14-12-25(21-35)13-15-26/h7-15,18-19,22,31,36H,16-17,20H2,1-6H3",IBLLFFDTKYKCIH-UHFFFAOYSA-N,424,"Dihydropyran-2-one deriv. 29::N-(5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)-4-cyanobenzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 9.1
471,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3cccs3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C31H37NO5S3/c1-20(2)31(15-14-22-11-8-7-9-12-22)19-25(33)28(29(34)37-31)39-26-17-21(3)24(18-23(26)30(4,5)6)32-40(35,36)27-13-10-16-38-27/h7-13,16-18,20,28,32H,14-15,19H2,1-6H3",UPHFTAYWVMXIIQ-UHFFFAOYSA-N,425,"CHEMBL351155::Dihydropyran-2-one deriv. 30::N-(5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)thiophene-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.6
472,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccccn3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C32H38N2O5S2/c1-21(2)32(16-15-23-12-8-7-9-13-23)20-26(35)29(30(36)39-32)40-27-18-22(3)25(19-24(27)31(4,5)6)34-41(37,38)28-14-10-11-17-33-28/h7-14,17-19,21,29,34H,15-16,20H2,1-6H3",NEXLNTJXJOMJQI-UHFFFAOYSA-N,426,"CHEMBL169381::Dihydropyran-2-one deriv. 31::N-(5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)pyridine-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.0
473,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3cccnc3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C32H38N2O5S2/c1-21(2)32(15-14-23-11-8-7-9-12-23)19-27(35)29(30(36)39-32)40-28-17-22(3)26(18-25(28)31(4,5)6)34-41(37,38)24-13-10-16-33-20-24/h7-13,16-18,20-21,29,34H,14-15,19H2,1-6H3",SFVPVFTZWFMYEH-UHFFFAOYSA-N,427,"CHEMBL353086::Dihydropyran-2-one deriv. 32::N-(5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)pyridine-3-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.5
474,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3nccn3C)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C31H39N3O5S2/c1-20(2)31(14-13-22-11-9-8-10-12-22)19-25(35)27(28(36)39-31)40-26-17-21(3)24(18-23(26)30(4,5)6)33-41(37,38)29-32-15-16-34(29)7/h8-12,15-18,20,27,33H,13-14,19H2,1-7H3",MZZAMNSGOMITLV-UHFFFAOYSA-N,428,"Dihydropyran-2-one deriv. 33::N-(5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)-1-methyl-1H-imidazole-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.9
475,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C33H37F3N2O5S2/c1-20(2)32(15-14-22-10-8-7-9-11-22)18-26(39)29(30(40)43-32)44-27-16-21(3)25(17-24(27)31(4,5)6)38-45(41,42)28-13-12-23(19-37-28)33(34,35)36/h7-13,16-17,19-20,29,38H,14-15,18H2,1-6H3",PYUKXYYRMDJVBH-UHFFFAOYSA-N,429,"Dihydropyran-2-one deriv. 34::N-(5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
476,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(O)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C27H34O5S/c1-16(2)27(12-11-18-7-9-19(28)10-8-18)15-22(30)24(25(31)32-27)33-23-13-17(3)21(29)14-20(23)26(4,5)6/h7-10,13-14,16,24,28-29H,11-12,15H2,1-6H3",UZJWFTBGWDPLSE-UHFFFAOYSA-N,430,"3-[(2-tert-butyl-4-hydroxy-5-methylphenyl)sulfanyl]-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-(propan-2-yl)-5,6-dihydro-2H-pyran-2-one::Dihydropyran-2-one deriv. 35::PD 178390 Analog 23",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
477,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(C)(=O)=O)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C28H36O7S2/c1-17(2)28(13-12-19-8-10-20(29)11-9-19)16-22(30)25(26(31)34-28)36-24-14-18(3)23(35-37(7,32)33)15-21(24)27(4,5)6/h8-11,14-15,17,25,29H,12-13,16H2,1-7H3",SRXOPQHLBAIVTA-UHFFFAOYSA-N,431,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl methanesulfonate::Dihydropyran-2-one deriv. 36",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.2
478,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3ccccc3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C33H38O7S2/c1-21(2)33(17-16-23-12-14-24(34)15-13-23)20-27(35)30(31(36)39-33)41-29-18-22(3)28(19-26(29)32(4,5)6)40-42(37,38)25-10-8-7-9-11-25/h7-15,18-19,21,30,34H,16-17,20H2,1-6H3",VEUDSQHJLWZUQH-UHFFFAOYSA-N,432,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl benzenesulfonate::CHEMBL353812::Dihydropyran-2-one deriv. 37",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 10.4
479,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3ccc(F)cc3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C33H37FO7S2/c1-20(2)33(16-15-22-7-11-24(35)12-8-22)19-27(36)30(31(37)40-33)42-29-17-21(3)28(18-26(29)32(4,5)6)41-43(38,39)25-13-9-23(34)10-14-25/h7-14,17-18,20,30,35H,15-16,19H2,1-6H3",GCVGZJAIFZSWHH-UHFFFAOYSA-N,433,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl 4-fluorobenzene-1-sulfonate::CHEMBL354216::Dihydropyran-2-one deriv. 38",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 9.6
480,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3ccc(cc3)C#N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C34H37NO7S2/c1-21(2)34(16-15-23-7-11-25(36)12-8-23)19-28(37)31(32(38)41-34)43-30-17-22(3)29(18-27(30)33(4,5)6)42-44(39,40)26-13-9-24(20-35)10-14-26/h7-14,17-18,21,31,36H,15-16,19H2,1-6H3",ATEUHFXRLAHXQF-UHFFFAOYSA-N,434,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl 4-cyanobenzene-1-sulfonate::CHEMBL168839::Dihydropyran-2-one deriv. 39",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.5
481,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3cccs3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C31H36O7S3/c1-19(2)31(14-13-21-9-11-22(32)12-10-21)18-24(33)28(29(34)37-31)40-26-16-20(3)25(17-23(26)30(4,5)6)38-41(35,36)27-8-7-15-39-27/h7-12,15-17,19,28,32H,13-14,18H2,1-6H3",DKYFRKTYCLSWTP-UHFFFAOYSA-N,435,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl thiophene-2-sulfonate::CHEMBL169142::Dihydropyran-2-one deriv. 40",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 21.8
482,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3nccn3C)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C31H38N2O7S2/c1-19(2)31(13-12-21-8-10-22(34)11-9-21)18-24(35)27(28(36)39-31)41-26-16-20(3)25(17-23(26)30(4,5)6)40-42(37,38)29-32-14-15-33(29)7/h8-11,14-17,19,27,34H,12-13,18H2,1-7H3",RMNOPDORPUDRHZ-UHFFFAOYSA-N,436,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl 1-methyl-1H-imidazole-2-sulfonate::Dihydropyran-2-one deriv. 41",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.4
483,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3ccccn3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C32H37NO7S2/c1-20(2)32(15-14-22-10-12-23(34)13-11-22)19-25(35)29(30(36)39-32)41-27-17-21(3)26(18-24(27)31(4,5)6)40-42(37,38)28-9-7-8-16-33-28/h7-13,16-18,20,29,34H,14-15,19H2,1-6H3",DQTXNRJBCUCBBK-UHFFFAOYSA-N,437,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl pyridine-2-sulfonate::CHEMBL169535::Dihydropyran-2-one deriv. 42",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 5.0
484,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3cccnc3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C32H37NO7S2/c1-20(2)32(14-13-22-9-11-23(34)12-10-22)18-26(35)29(30(36)39-32)41-28-16-21(3)27(17-25(28)31(4,5)6)40-42(37,38)24-8-7-15-33-19-24/h7-12,15-17,19-20,29,34H,13-14,18H2,1-6H3",UZWWPHAMYGSIDQ-UHFFFAOYSA-N,438,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl pyridine-3-sulfonate::CHEMBL171786::Dihydropyran-2-one deriv. 43",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.5
485,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1OS(=O)(=O)c1ccccc1)C(C)(C)C,"InChI=1S/C31H34O7S2/c1-20-17-27(24(30(2,3)4)18-26(20)38-40(35,36)23-9-7-6-8-10-23)39-28-25(33)19-31(5,37-29(28)34)16-15-21-11-13-22(32)14-12-21/h6-14,17-18,28,32H,15-16,19H2,1-5H3",JZVQUOURBNNNNS-UHFFFAOYSA-N,439,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl benzenesulfonate::CHEMBL172622::Dihydropyran-2-one deriv. 44",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 9.8
486,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1OS(=O)(=O)c1ccc(F)cc1)C(C)(C)C,"InChI=1S/C31H33FO7S2/c1-19-16-27(24(30(2,3)4)17-26(19)39-41(36,37)23-12-8-21(32)9-13-23)40-28-25(34)18-31(5,38-29(28)35)15-14-20-6-10-22(33)11-7-20/h6-13,16-17,28,33H,14-15,18H2,1-5H3",HPBWDVGROMRPLF-UHFFFAOYSA-N,440,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl 4-fluorobenzene-1-sulfonate::CHEMBL168384::Dihydropyran-2-one deriv. 45",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 16.9
487,Cc1cc(SC2C(=O)CC(C)(CCc3ccc(O)cc3)OC2=O)c(cc1OS(=O)(=O)c1nccn1C)C(C)(C)C,"InChI=1S/C29H34N2O7S2/c1-18-15-24(21(28(2,3)4)16-23(18)38-40(35,36)27-30-13-14-31(27)6)39-25-22(33)17-29(5,37-26(25)34)12-11-19-7-9-20(32)10-8-19/h7-10,13-16,25,32H,11-12,17H2,1-6H3",XTVVMXWFFSPMKY-UHFFFAOYSA-N,441,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-methyl-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl 1-methyl-1H-imidazole-2-sulfonate::Dihydropyran-2-one deriv. 46",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.0
488,Cc1cc(SC2C(=O)CC(CCc3ccc(O)cc3)(OC2=O)C2CCCCC2)c(cc1OS(=O)(=O)c1ccccc1)C(C)(C)C,"InChI=1S/C36H42O7S2/c1-24-21-32(29(35(2,3)4)22-31(24)43-45(40,41)28-13-9-6-10-14-28)44-33-30(38)23-36(42-34(33)39,26-11-7-5-8-12-26)20-19-25-15-17-27(37)18-16-25/h6,9-10,13-18,21-22,26,33,37H,5,7-8,11-12,19-20,23H2,1-4H3",UORQTGNEQQOGFW-UHFFFAOYSA-N,442,"5-tert-butyl-4-({6-cyclohexyl-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl benzenesulfonate::CHEMBL355438::Dihydropyran-2-one deriv. 47",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 130
489,Cc1cc(SC2C(=O)CC(CCc3ccc(O)cc3)(OC2=O)C2CCCCC2)c(cc1OS(=O)(=O)c1ccc(cc1)C#N)C(C)(C)C,"InChI=1S/C37H41NO7S2/c1-24-20-33(30(36(2,3)4)21-32(24)45-47(42,43)29-16-12-26(23-38)13-17-29)46-34-31(40)22-37(44-35(34)41,27-8-6-5-7-9-27)19-18-25-10-14-28(39)15-11-25/h10-17,20-21,27,34,39H,5-9,18-19,22H2,1-4H3",RVAFNRVDJDDZPG-UHFFFAOYSA-N,443,"5-tert-butyl-4-({6-cyclohexyl-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl 4-cyanobenzene-1-sulfonate::CHEMBL171404::Dihydropyran-2-one deriv. 48",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 21.0
490,Cc1cc(SC2C(=O)CC(CCc3ccc(O)cc3)(OC2=O)C2CCCCC2)c(cc1OS(=O)(=O)c1ccc(F)cc1)C(C)(C)C,"InChI=1S/C36H41FO7S2/c1-23-20-32(29(35(2,3)4)21-31(23)44-46(41,42)28-16-12-26(37)13-17-28)45-33-30(39)22-36(43-34(33)40,25-8-6-5-7-9-25)19-18-24-10-14-27(38)15-11-24/h10-17,20-21,25,33,38H,5-9,18-19,22H2,1-4H3",YMYGUYHTYDDKEH-UHFFFAOYSA-N,444,"5-tert-butyl-4-({6-cyclohexyl-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl 4-fluorobenzene-1-sulfonate::CHEMBL355735::Dihydropyran-2-one deriv. 49",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 29.0
491,Cc1cc(SC2C(=O)CC(CCc3ccc(O)cc3)(OC2=O)C2CCCCC2)c(cc1OS(=O)(=O)c1nccn1C)C(C)(C)C,"InChI=1S/C34H42N2O7S2/c1-22-19-29(26(33(2,3)4)20-28(22)43-45(40,41)32-35-17-18-36(32)5)44-30-27(38)21-34(42-31(30)39,24-9-7-6-8-10-24)16-15-23-11-13-25(37)14-12-23/h11-14,17-20,24,30,37H,6-10,15-16,21H2,1-5H3",CYJOOPVNQHHGKQ-UHFFFAOYSA-N,445,"5-tert-butyl-4-({6-cyclohexyl-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl 1-methyl-1H-imidazole-2-sulfonate::Dihydropyran-2-one deriv. 50",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 8.0
492,CCCC1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3nccn3C)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C31H38N2O7S2/c1-7-13-31(14-12-21-8-10-22(34)11-9-21)19-24(35)27(28(36)39-31)41-26-17-20(2)25(18-23(26)30(3,4)5)40-42(37,38)29-32-15-16-33(29)6/h8-11,15-18,27,34H,7,12-14,19H2,1-6H3",UWSPSACTIXQLMR-UHFFFAOYSA-N,446,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-propyl-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl 1-methyl-1H-imidazole-2-sulfonate::Dihydropyran-2-one deriv. 51",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.2
493,CC(C)CC1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3nccn3C)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C32H40N2O7S2/c1-20(2)18-32(13-12-22-8-10-23(35)11-9-22)19-25(36)28(29(37)40-32)42-27-16-21(3)26(17-24(27)31(4,5)6)41-43(38,39)30-33-14-15-34(30)7/h8-11,14-17,20,28,35H,12-13,18-19H2,1-7H3",PUIYNYGJGRBLOL-UHFFFAOYSA-N,447,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-(2-methylpropyl)-2-oxo-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl 1-methyl-1H-imidazole-2-sulfonate::Dihydropyran-2-one deriv. 52",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.6
494,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(O)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C27H34O4S/c1-17(2)27(13-12-19-10-8-7-9-11-19)16-22(29)24(25(30)31-27)32-23-14-18(3)21(28)15-20(23)26(4,5)6/h7-11,14-15,17,24,28H,12-13,16H2,1-6H3",DLUCVYRCGBRSMO-UHFFFAOYSA-N,448,"3-[(2-tert-butyl-4-hydroxy-5-methylphenyl)sulfanyl]-4-hydroxy-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-2-one::CHEMBL171729::Dihydropyran-2-one deriv. 53::PD 178390 Analog 40",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
495,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3nccn3C)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C31H38N2O6S2/c1-20(2)31(14-13-22-11-9-8-10-12-22)19-24(34)27(28(35)38-31)40-26-17-21(3)25(18-23(26)30(4,5)6)39-41(36,37)29-32-15-16-33(29)7/h8-12,15-18,20,27H,13-14,19H2,1-7H3",PEEGPVPTIVTDOG-UHFFFAOYSA-N,449,"5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl 1-methyl-1H-imidazole-2-sulfonate::Dihydropyran-2-one deriv. 54",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.0
496,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3ccccn3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C32H37NO6S2/c1-21(2)32(16-15-23-12-8-7-9-13-23)20-25(34)29(30(35)38-32)40-27-18-22(3)26(19-24(27)31(4,5)6)39-41(36,37)28-14-10-11-17-33-28/h7-14,17-19,21,29H,15-16,20H2,1-6H3",DXVFCUQURWMVPI-UHFFFAOYSA-N,450,"5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl pyridine-2-sulfonate::CHEMBL354615::Dihydropyran-2-one deriv. 55",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 6.7
497,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3cccnc3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C32H37NO6S2/c1-21(2)32(15-14-23-11-8-7-9-12-23)19-26(34)29(30(35)38-32)40-28-17-22(3)27(18-25(28)31(4,5)6)39-41(36,37)24-13-10-16-33-20-24/h7-13,16-18,20-21,29H,14-15,19H2,1-6H3",BKDCANWPAHIFHA-UHFFFAOYSA-N,451,"5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl pyridine-3-sulfonate::CHEMBL354499::Dihydropyran-2-one deriv. 56",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 14.0
498,CC(C)C1(CCc2ccc(N)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3ccc(cc3)C#N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C34H38N2O6S2/c1-21(2)34(16-15-23-7-11-25(36)12-8-23)19-28(37)31(32(38)41-34)43-30-17-22(3)29(18-27(30)33(4,5)6)42-44(39,40)26-13-9-24(20-35)10-14-26/h7-14,17-18,21,31H,15-16,19,36H2,1-6H3",AWGVBIKPFNPQGZ-UHFFFAOYSA-N,452,"4-({6-[2-(4-aminophenyl)ethyl]-4-hydroxy-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-5-tert-butyl-2-methylphenyl 4-cyanobenzene-1-sulfonate::CHEMBL168525::Dihydropyran-2-one deriv. 57",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.3
499,CC(C)C1(CCc2ccc(N)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3cccc(c3)-c3cccnc3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C38H42N2O6S2/c1-24(2)38(17-16-26-12-14-29(39)15-13-26)22-32(41)35(36(42)45-38)47-34-19-25(3)33(21-31(34)37(4,5)6)46-48(43,44)30-11-7-9-27(20-30)28-10-8-18-40-23-28/h7-15,18-21,23-24,35H,16-17,22,39H2,1-6H3",XQFMWPJXJNDDSL-UHFFFAOYSA-N,453,"4-({6-[2-(4-aminophenyl)ethyl]-4-hydroxy-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-5-tert-butyl-2-methylphenyl 3-(pyridin-3-yl)benzene-1-sulfonate::Dihydropyran-2-one deriv. 58",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.1
500,CC(C)C1(CCc2ccc(N)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3nccn3C)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C31H39N3O6S2/c1-19(2)31(13-12-21-8-10-22(32)11-9-21)18-24(35)27(28(36)39-31)41-26-16-20(3)25(17-23(26)30(4,5)6)40-42(37,38)29-33-14-15-34(29)7/h8-11,14-17,19,27H,12-13,18,32H2,1-7H3",KJZQGMLNRPHVPN-UHFFFAOYSA-N,454,"4-({6-[2-(4-aminophenyl)ethyl]-4-hydroxy-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-5-tert-butyl-2-methylphenyl 1-methyl-1H-imidazole-2-sulfonate::Dihydropyran-2-one deriv. 59",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.2
501,CC(C)C1(CCc2ccc(N)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3ccccc3-c3cccs3)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C37H41NO6S3/c1-23(2)37(18-17-25-13-15-26(38)16-14-25)22-29(39)34(35(40)43-37)46-32-20-24(3)30(21-28(32)36(4,5)6)44-47(41,42)33-12-8-7-10-27(33)31-11-9-19-45-31/h7-16,19-21,23,34H,17-18,22,38H2,1-6H3",FLYZCMGUPHRDDW-UHFFFAOYSA-N,455,"4-({6-[2-(4-aminophenyl)ethyl]-4-hydroxy-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-5-tert-butyl-2-methylphenyl 2-(thiophen-2-yl)benzene-1-sulfonate::Dihydropyran-2-one deriv. 60",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 18.5
502,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)N(C)C)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C29H40N2O6S2/c1-18(2)29(14-13-20-9-11-21(32)12-10-20)17-24(33)26(27(34)37-29)38-25-15-19(3)23(16-22(25)28(4,5)6)30-39(35,36)31(7)8/h9-12,15-16,18,26,30,32H,13-14,17H2,1-8H3",XMKQPNRTUYFWGW-UHFFFAOYSA-N,456,"3-({2-tert-butyl-4-[(dimethylsulfamoyl)amino]-5-methylphenyl}sulfanyl)-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-(propan-2-yl)-5,6-dihydro-2H-pyran-2-one::CHEMBL354783::Dihydropyran-2-one deriv. 61",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.6
503,CCNS(=O)(=O)Nc1cc(c(SC2C(=O)CC(CCc3ccc(O)cc3)(OC2=O)C(C)C)cc1C)C(C)(C)C,"InChI=1S/C29H40N2O6S2/c1-8-30-39(35,36)31-23-16-22(28(5,6)7)25(15-19(23)4)38-26-24(33)17-29(18(2)3,37-27(26)34)14-13-20-9-11-21(32)12-10-20/h9-12,15-16,18,26,30-32H,8,13-14,17H2,1-7H3",SUVOBBUZDNAUIG-UHFFFAOYSA-N,457,"3-({2-tert-butyl-4-[(ethylsulfamoyl)amino]-5-methylphenyl}sulfanyl)-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-(propan-2-yl)-5,6-dihydro-2H-pyran-2-one::CHEMBL172271::Dihydropyran-2-one deriv. 62",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.7
504,CCNS(=O)(=O)Nc1cc(c(SC2C(=O)CC(CCc3ccccc3)(OC2=O)C(C)C)cc1C)C(C)(C)C,"InChI=1S/C29H40N2O5S2/c1-8-30-38(34,35)31-23-17-22(28(5,6)7)25(16-20(23)4)37-26-24(32)18-29(19(2)3,36-27(26)33)15-14-21-12-10-9-11-13-21/h9-13,16-17,19,26,30-31H,8,14-15,18H2,1-7H3",QZXHJRVMNULICR-UHFFFAOYSA-N,458,"3-({2-tert-butyl-4-[(ethylsulfamoyl)amino]-5-methylphenyl}sulfanyl)-4-hydroxy-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-2-one::CHEMBL169074::Dihydropyran-2-one deriv. 63",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.3
505,CC(C)C1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)N(C)C)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C29H39NO7S2/c1-18(2)29(14-13-20-9-11-21(31)12-10-20)17-23(32)26(27(33)36-29)38-25-15-19(3)24(16-22(25)28(4,5)6)37-39(34,35)30(7)8/h9-12,15-16,18,26,31H,13-14,17H2,1-8H3",COPIJZAPYYSMBJ-UHFFFAOYSA-N,459,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl N,N-dimethylsulfamate::6-Alkyl-5,6-Dihydropyran-2-one 22::CHEMBL312293::Dihydropyran-2-one deriv. 64",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.4
506,CCNS(=O)(=O)Oc1cc(c(SC2C(=O)CC(CCc3ccc(O)cc3)(OC2=O)C(C)C)cc1C)C(C)(C)C,"InChI=1S/C29H39NO7S2/c1-8-30-39(34,35)37-24-16-22(28(5,6)7)25(15-19(24)4)38-26-23(32)17-29(18(2)3,36-27(26)33)14-13-20-9-11-21(31)12-10-20/h9-12,15-16,18,26,30-31H,8,13-14,17H2,1-7H3",HSNRJUAETVIRHN-UHFFFAOYSA-N,460,"5-tert-butyl-4-({4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-2-methylphenyl N-ethylsulfamate::6-Alkyl-5,6-Dihydropyran-2-one 20::CHEMBL70986::Dihydropyran-2-one deriv. 65",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.9
507,CC(C)C1(CCc2ccc(N)cc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)N(C)C)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C29H40N2O6S2/c1-18(2)29(14-13-20-9-11-21(30)12-10-20)17-23(32)26(27(33)36-29)38-25-15-19(3)24(16-22(25)28(4,5)6)37-39(34,35)31(7)8/h9-12,15-16,18,26H,13-14,17,30H2,1-8H3",QHTFYXMAYRTEOY-UHFFFAOYSA-N,461,"4-({6-[2-(4-aminophenyl)ethyl]-4-hydroxy-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-5-tert-butyl-2-methylphenyl N,N-dimethylsulfamate::6-Alkyl-5,6-Dihydropyran-2-one 30::CHEMBL306421::Dihydropyran-2-one deriv. 66",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.9
508,CCNS(=O)(=O)Oc1cc(c(SC2C(=O)CC(CCc3ccc(N)cc3)(OC2=O)C(C)C)cc1C)C(C)(C)C,"InChI=1S/C29H40N2O6S2/c1-8-31-39(34,35)37-24-16-22(28(5,6)7)25(15-19(24)4)38-26-23(32)17-29(18(2)3,36-27(26)33)14-13-20-9-11-21(30)12-10-20/h9-12,15-16,18,26,31H,8,13-14,17,30H2,1-7H3",GGNHFKBTBQMCPR-UHFFFAOYSA-N,462,"4-({6-[2-(4-aminophenyl)ethyl]-4-hydroxy-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl}sulfanyl)-5-tert-butyl-2-methylphenyl N-ethylsulfamate::6-Alkyl-5,6-Dihydropyran-2-one 29::CHEMBL305204::Dihydropyran-2-one deriv. 67",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.3
509,CCNS(=O)(=O)Oc1cc(c(SC2C(=O)CC(CCc3ccccc3)(OC2=O)C(C)C)cc1C)C(C)(C)C,"InChI=1S/C29H39NO6S2/c1-8-30-38(33,34)36-24-17-22(28(5,6)7)25(16-20(24)4)37-26-23(31)18-29(19(2)3,35-27(26)32)15-14-21-12-10-9-11-13-21/h9-13,16-17,19,26,30H,8,14-15,18H2,1-7H3",IEYXIHIOKLKWDH-UHFFFAOYSA-N,463,"5-tert-butyl-4-{[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl N-ethylsulfamate::6-Alkyl-5,6-Dihydropyran-2-one 32::CHEMBL67867::Dihydropyran-2-one deriv. 68",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 8.9
510,CC(C)C1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(OS(=O)(=O)c3ccc(cc3)C#N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C34H37NO6S2/c1-22(2)34(17-16-24-10-8-7-9-11-24)20-28(36)31(32(37)40-34)42-30-18-23(3)29(19-27(30)33(4,5)6)41-43(38,39)26-14-12-25(21-35)13-15-26/h7-15,18-19,22,31H,16-17,20H2,1-6H3",OLQNWFNXXQSOOA-UHFFFAOYSA-N,464,"5-tert-butyl-4-{[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl 4-cyanobenzene-1-sulfonate::CHEMBL354504::Dihydropyran-2-one deriv. 69",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
511,CC(C)[C@]1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C27H35NO4S/c1-16(2)27(12-11-18-7-9-19(29)10-8-18)15-22(30)24(25(31)32-27)33-23-13-17(3)21(28)14-20(23)26(4,5)6/h7-10,13-14,16,24,29H,11-12,15,28H2,1-6H3/t24?,27-/m0/s1",HPYCGBSIYDCTOZ-WKDCXCOVSA-N,465,"(6S)-3-[(4-amino-2-tert-butyl-5-methylphenyl)sulfanyl]-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-(propan-2-yl)-5,6-dihydro-2H-pyran-2-one::CHEMBL2114404::Dihydropyran-2-one deriv. 70",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
512,CC(C)[C@@]1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C27H35NO4S/c1-16(2)27(12-11-18-7-9-19(29)10-8-18)15-22(30)24(25(31)32-27)33-23-13-17(3)21(28)14-20(23)26(4,5)6/h7-10,13-14,16,24,29H,11-12,15,28H2,1-6H3/t24?,27-/m1/s1",HPYCGBSIYDCTOZ-LFHRXCRSSA-N,466,"(6R)-3-[(4-amino-2-tert-butyl-5-methylphenyl)sulfanyl]-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-(propan-2-yl)-5,6-dihydro-2H-pyran-2-one::Dihydropyran-2-one deriv. 71",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
513,CC(C)[C@]1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C33H37F3N2O6S2/c1-19(2)32(14-13-21-7-10-23(39)11-8-21)17-26(40)29(30(41)44-32)45-27-15-20(3)25(16-24(27)31(4,5)6)38-46(42,43)28-12-9-22(18-37-28)33(34,35)36/h7-12,15-16,18-19,29,38-39H,13-14,17H2,1-6H3/t29?,32-/m0/s1",FRTFPCUYPFXAEP-VQSVVBPOSA-N,467,"(S)-N-(5-tert-Butyl-4-{4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-6-isopropyl-2-oxo-5,6-dihydro-2H-pyran-3-ylsulfanyl}-2-methylphenyl)-2-(5-trifluoromethyl)pyridinesulfonamide::CHEMBL2110203::Dihydropyran-2-one deriv. 72::N-(5-tert-butyl-4-{[(6S)-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
514,CC(C)[C@@]1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C33H37F3N2O6S2/c1-19(2)32(14-13-21-7-10-23(39)11-8-21)17-26(40)29(30(41)44-32)45-27-15-20(3)25(16-24(27)31(4,5)6)38-46(42,43)28-12-9-22(18-37-28)33(34,35)36/h7-12,15-16,18-19,29,38-39H,13-14,17H2,1-6H3/t29?,32-/m1/s1",FRTFPCUYPFXAEP-CUPMVOCTSA-N,468,"Dihydropyran-2-one deriv. 73::N-(5-tert-butyl-4-{[(6R)-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
515,CC(C)[C@]1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(cc3)C#N)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C34H38N2O5S2/c1-22(2)34(17-16-24-10-8-7-9-11-24)20-29(37)31(32(38)41-34)42-30-18-23(3)28(19-27(30)33(4,5)6)36-43(39,40)26-14-12-25(21-35)13-15-26/h7-15,18-19,22,31,36H,16-17,20H2,1-6H3/t31?,34-/m0/s1",IBLLFFDTKYKCIH-AEHIRBQFSA-N,469,"CHEMBL2110206::Dihydropyran-2-one deriv. 74::N-(5-tert-butyl-4-{[(6S)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)-4-cyanobenzene-1-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
516,CC(C)[C@]1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C33H37F3N2O5S2/c1-20(2)32(15-14-22-10-8-7-9-11-22)18-26(39)29(30(40)43-32)44-27-16-21(3)25(17-24(27)31(4,5)6)38-45(41,42)28-13-12-23(19-37-28)33(34,35)36/h7-13,16-17,19-20,29,38H,14-15,18H2,1-6H3/t29?,32-/m0/s1",PYUKXYYRMDJVBH-VQSVVBPOSA-N,470,"CHEMBL2110205::Dihydropyran-2-one deriv. 75::N-(5-tert-butyl-4-{[(6S)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
517,CC(C)[C@@]1(CCc2ccccc2)CC(=O)C(Sc2cc(C)c(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C33H37F3N2O5S2/c1-20(2)32(15-14-22-10-8-7-9-11-22)18-26(39)29(30(40)43-32)44-27-16-21(3)25(17-24(27)31(4,5)6)38-45(41,42)28-13-12-23(19-37-28)33(34,35)36/h7-13,16-17,19-20,29,38H,14-15,18H2,1-6H3/t29?,32-/m1/s1",PYUKXYYRMDJVBH-CUPMVOCTSA-N,471,"Dihydropyran-2-one deriv. 76::N-(5-tert-butyl-4-{[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
518,CC(C)[C@]1(CCc2ccc(O)cc2)CC(=O)C(Sc2cc(C)c(OS(C)(=O)=O)cc2C(C)(C)C)C(=O)O1,"InChI=1S/C28H36O7S2/c1-17(2)28(13-12-19-8-10-20(29)11-9-19)16-22(30)25(26(31)34-28)36-24-14-18(3)23(35-37(7,32)33)15-21(24)27(4,5)6/h8-11,14-15,17,25,29H,12-13,16H2,1-7H3/t25?,28-/m0/s1",SRXOPQHLBAIVTA-NMXAJACMSA-N,472,"5-tert-butyl-4-{[(6S)-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-2-oxo-6-(propan-2-yl)-5,6-dihydro-2H-pyran-3-yl]sulfanyl}-2-methylphenyl methanesulfonate::CHEMBL2110204::Dihydropyran-2-one deriv. 77",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
519,CNC(=O)N(C)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1,"InChI=1S/C25H33N5O6/c1-27-24(34)30(2)15-21(31)19(13-17-9-5-3-6-10-17)28-23(33)20(14-22(26)32)29-25(35)36-16-18-11-7-4-8-12-18/h3-12,19-21,31H,13-16H2,1-2H3,(H2,26,32)(H,27,34)(H,28,33)(H,29,35)/t19-,20-,21+/m0/s1",ZMVQTFDECGHPLO-PCCBWWKXSA-N,473,"(Hydroxyethyl)urea Isostere deriv. 1::benzyl N-[(1S)-2-carbamoyl-1-{[(2S,3R)-3-hydroxy-4-[methyl(methylcarbamoyl)amino]-1-phenylbutan-2-yl]carbamoyl}ethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>10000
520,CCCCNC(=O)N(C)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1,"InChI=1S/C28H39N5O6/c1-3-4-15-30-27(37)33(2)18-24(34)22(16-20-11-7-5-8-12-20)31-26(36)23(17-25(29)35)32-28(38)39-19-21-13-9-6-10-14-21/h5-14,22-24,34H,3-4,15-19H2,1-2H3,(H2,29,35)(H,30,37)(H,31,36)(H,32,38)/t22-,23-,24+/m0/s1",GLRNYQUCFLGJNB-KMDXXIMOSA-N,474,"(Hydroxyethyl)urea Isostere deriv. 2::benzyl N-[(1S)-1-{[(2S,3R)-4-[(butylcarbamoyl)(methyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>10000
521,CNC(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1,"InChI=1S/C28H39N5O6/c1-19(2)16-33(27(37)30-3)17-24(34)22(14-20-10-6-4-7-11-20)31-26(36)23(15-25(29)35)32-28(38)39-18-21-12-8-5-9-13-21/h4-13,19,22-24,34H,14-18H2,1-3H3,(H2,29,35)(H,30,37)(H,31,36)(H,32,38)/t22-,23-,24+/m0/s1",KGHZDRBKSVQHQS-KMDXXIMOSA-N,475,"(Hydroxyethyl)urea Isostere deriv. 3::benzyl N-[(1S)-2-carbamoyl-1-{[(2S,3R)-3-hydroxy-4-[(methylcarbamoyl)(2-methylpropyl)amino]-1-phenylbutan-2-yl]carbamoyl}ethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1500
522,CCCCNC(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1,"InChI=1S/C31H45N5O6/c1-4-5-16-33-30(40)36(19-22(2)3)20-27(37)25(17-23-12-8-6-9-13-23)34-29(39)26(18-28(32)38)35-31(41)42-21-24-14-10-7-11-15-24/h6-15,22,25-27,37H,4-5,16-21H2,1-3H3,(H2,32,38)(H,33,40)(H,34,39)(H,35,41)/t25-,26-,27+/m0/s1",XNLZVXPTFMKQCK-GMQQYTKMSA-N,476,"(Hydroxyethyl)urea Isostere deriv. 4::benzyl N-[(1S)-1-{[(2S,3R)-4-[(butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 940
523,CCCCNC(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,"InChI=1S/C33H44N6O5/c1-4-5-17-35-33(44)39(20-22(2)3)21-29(40)27(18-23-11-7-6-8-12-23)37-32(43)28(19-30(34)41)38-31(42)26-16-15-24-13-9-10-14-25(24)36-26/h6-16,22,27-29,40H,4-5,17-21H2,1-3H3,(H2,34,41)(H,35,44)(H,37,43)(H,38,42)/t27-,28-,29+/m0/s1",CVKKUZMEEKVVIR-YTCPBCGMSA-N,477,"(2S)-N-[(2S,3R)-4-[(butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::(Hydroxyethyl)urea Isostere deriv. 5",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 126
524,CCCNC(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1,"InChI=1S/C30H43N5O6/c1-4-15-32-29(39)35(18-21(2)3)19-26(36)24(16-22-11-7-5-8-12-22)33-28(38)25(17-27(31)37)34-30(40)41-20-23-13-9-6-10-14-23/h5-14,21,24-26,36H,4,15-20H2,1-3H3,(H2,31,37)(H,32,39)(H,33,38)(H,34,40)/t24-,25-,26+/m0/s1",XWEQBHNRDFTICX-KKUQBAQOSA-N,478,"(Hydroxyethyl)urea Isostere deriv. 6::benzyl N-[(1S)-2-carbamoyl-1-{[(2S,3R)-3-hydroxy-4-[(2-methylpropyl)(propylcarbamoyl)amino]-1-phenylbutan-2-yl]carbamoyl}ethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 518
525,CCNC(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1,"InChI=1S/C29H41N5O6/c1-4-31-28(38)34(17-20(2)3)18-25(35)23(15-21-11-7-5-8-12-21)32-27(37)24(16-26(30)36)33-29(39)40-19-22-13-9-6-10-14-22/h5-14,20,23-25,35H,4,15-19H2,1-3H3,(H2,30,36)(H,31,38)(H,32,37)(H,33,39)/t23-,24-,25+/m0/s1",CJCIXXWUTZAVFY-CCDWMCETSA-N,479,"(Hydroxyethyl)urea Isostere deriv. 7::benzyl N-[(1S)-2-carbamoyl-1-{[(2S,3R)-4-[(ethylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}ethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 330
526,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1)C(=O)NC(C)C,"InChI=1S/C30H43N5O6/c1-20(2)17-35(29(39)32-21(3)4)18-26(36)24(15-22-11-7-5-8-12-22)33-28(38)25(16-27(31)37)34-30(40)41-19-23-13-9-6-10-14-23/h5-14,20-21,24-26,36H,15-19H2,1-4H3,(H2,31,37)(H,32,39)(H,33,38)(H,34,40)/t24-,25-,26+/m0/s1",JYCRZVGDFQMBST-KKUQBAQOSA-N,480,"(Hydroxyethyl)urea Isostere deriv. 8::benzyl N-[(1S)-2-carbamoyl-1-{[(2S,3R)-3-hydroxy-4-[(2-methylpropyl)(propan-2-ylcarbamoyl)amino]-1-phenylbutan-2-yl]carbamoyl}ethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 260
527,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1)C(=O)NC(C)(C)C,"InChI=1S/C31H45N5O6/c1-21(2)18-36(29(40)35-31(3,4)5)19-26(37)24(16-22-12-8-6-9-13-22)33-28(39)25(17-27(32)38)34-30(41)42-20-23-14-10-7-11-15-23/h6-15,21,24-26,37H,16-20H2,1-5H3,(H2,32,38)(H,33,39)(H,34,41)(H,35,40)/t24-,25-,26+/m0/s1",RLEOZZSYFKNBQU-KKUQBAQOSA-N,481,"(Hydroxyethyl)urea Isostere deriv. 9::benzyl N-[(1S)-1-{[(2S,3R)-4-[(tert-butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 35
528,CC(C)CN(C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1)C(=O)NC(C)(C)C,"InChI=1S/C31H45N5O6/c1-21(2)18-36(29(40)35-31(3,4)5)19-26(37)24(16-22-12-8-6-9-13-22)33-28(39)25(17-27(32)38)34-30(41)42-20-23-14-10-7-11-15-23/h6-15,21,24-26,37H,16-20H2,1-5H3,(H2,32,38)(H,33,39)(H,34,41)(H,35,40)/t24-,25-,26-/m0/s1",RLEOZZSYFKNBQU-GSDHBNRESA-N,482,"(Hydroxyethyl)urea Isostere deriv. 10::benzyl N-[(1S)-1-{[(2S,3S)-4-[(tert-butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 54000
529,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)C(=O)NC(C)(C)C,"InChI=1S/C33H44N6O5/c1-21(2)19-39(32(44)38-33(3,4)5)20-28(40)26(17-22-11-7-6-8-12-22)36-31(43)27(18-29(34)41)37-30(42)25-16-15-23-13-9-10-14-24(23)35-25/h6-16,21,26-28,40H,17-20H2,1-5H3,(H2,34,41)(H,36,43)(H,37,42)(H,38,44)/t26-,27-,28+/m0/s1",ZILOOGIOHVCEKS-HZFUHODCSA-N,483,"(2S)-N-[(2S,3R)-4-[(tert-butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::(Hydroxyethyl)urea Isostere deriv. 11",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 6
530,CC(C)CN(C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)C(=O)NC(C)(C)C,"InChI=1S/C33H44N6O5/c1-21(2)19-39(32(44)38-33(3,4)5)20-28(40)26(17-22-11-7-6-8-12-22)36-31(43)27(18-29(34)41)37-30(42)25-16-15-23-13-9-10-14-24(23)35-25/h6-16,21,26-28,40H,17-20H2,1-5H3,(H2,34,41)(H,36,43)(H,37,42)(H,38,44)/t26-,27-,28-/m0/s1",ZILOOGIOHVCEKS-KCHLEUMXSA-N,484,"(2S)-N-[(2S,3S)-4-[(tert-butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::(Hydroxyethyl)urea Isostere deriv. 12",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 10000
531,CC(C)CCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1)C(=O)NC(C)(C)C,"InChI=1S/C32H47N5O6/c1-22(2)16-17-37(30(41)36-32(3,4)5)20-27(38)25(18-23-12-8-6-9-13-23)34-29(40)26(19-28(33)39)35-31(42)43-21-24-14-10-7-11-15-24/h6-15,22,25-27,38H,16-21H2,1-5H3,(H2,33,39)(H,34,40)(H,35,42)(H,36,41)/t25-,26-,27+/m0/s1",KDWKDCOYYOJJPC-GMQQYTKMSA-N,485,"(Hydroxyethyl)urea Isostere deriv. 13::benzyl N-[(1S)-1-{[(2S,3R)-4-[(tert-butylcarbamoyl)(3-methylbutyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 13
532,CC(C)CCN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)C(=O)NC(C)(C)C,"InChI=1S/C34H46N6O5/c1-22(2)17-18-40(33(45)39-34(3,4)5)21-29(41)27(19-23-11-7-6-8-12-23)37-32(44)28(20-30(35)42)38-31(43)26-16-15-24-13-9-10-14-25(24)36-26/h6-16,22,27-29,41H,17-21H2,1-5H3,(H2,35,42)(H,37,44)(H,38,43)(H,39,45)/t27-,28-,29+/m0/s1",OOOXXPKYELPWCH-YTCPBCGMSA-N,486,"(2S)-N-[(2S,3R)-4-[(tert-butylcarbamoyl)(3-methylbutyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::(Hydroxyethyl)urea Isostere deriv. 14",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3
533,CC(C)(C)NC(=O)N(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1)CC1CCCCC1,"InChI=1S/C34H49N5O6/c1-34(2,3)38-32(43)39(21-25-15-9-5-10-16-25)22-29(40)27(19-24-13-7-4-8-14-24)36-31(42)28(20-30(35)41)37-33(44)45-23-26-17-11-6-12-18-26/h4,6-8,11-14,17-18,25,27-29,40H,5,9-10,15-16,19-23H2,1-3H3,(H2,35,41)(H,36,42)(H,37,44)(H,38,43)/t27-,28-,29+/m0/s1",IJBPAVCQGVFAKL-YTCPBCGMSA-N,487,"(Hydroxyethyl)urea Isostere deriv. 15::benzyl N-[(1S)-1-{[(2S,3R)-4-[(tert-butylcarbamoyl)(cyclohexylmethyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 29
534,CC(C)(C)NC(=O)N(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)CC1CCCCC1,"InChI=1S/C36H48N6O5/c1-36(2,3)41-35(47)42(22-25-14-8-5-9-15-25)23-31(43)29(20-24-12-6-4-7-13-24)39-34(46)30(21-32(37)44)40-33(45)28-19-18-26-16-10-11-17-27(26)38-28/h4,6-7,10-13,16-19,25,29-31,43H,5,8-9,14-15,20-23H2,1-3H3,(H2,37,44)(H,39,46)(H,40,45)(H,41,47)/t29-,30-,31+/m0/s1",LDOHVDYPFKGCAF-RWSKJCERSA-N,488,"(2S)-N-[(2S,3R)-4-[(tert-butylcarbamoyl)(cyclohexylmethyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::(Hydroxyethyl)urea Isostere deriv. 16",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 5
535,CC(C)(C)NC(=O)N(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1)Cc1ccccc1,"InChI=1S/C34H43N5O6/c1-34(2,3)38-32(43)39(21-25-15-9-5-10-16-25)22-29(40)27(19-24-13-7-4-8-14-24)36-31(42)28(20-30(35)41)37-33(44)45-23-26-17-11-6-12-18-26/h4-18,27-29,40H,19-23H2,1-3H3,(H2,35,41)(H,36,42)(H,37,44)(H,38,43)/t27-,28-,29+/m0/s1",ZCYWJXRPVCVWED-YTCPBCGMSA-N,489,"(Hydroxyethyl)urea Isostere deriv. 17::benzyl N-[(1S)-1-{[(2S,3R)-4-[benzyl(tert-butylcarbamoyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 19
536,CC(C)(C)NC(=O)N(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)Cc1ccccc1,"InChI=1S/C36H42N6O5/c1-36(2,3)41-35(47)42(22-25-14-8-5-9-15-25)23-31(43)29(20-24-12-6-4-7-13-24)39-34(46)30(21-32(37)44)40-33(45)28-19-18-26-16-10-11-17-27(26)38-28/h4-19,29-31,43H,20-23H2,1-3H3,(H2,37,44)(H,39,46)(H,40,45)(H,41,47)/t29-,30-,31+/m0/s1",DEBMANAPOANQRD-RWSKJCERSA-N,490,"(2S)-N-[(2S,3R)-4-[benzyl(tert-butylcarbamoyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::(Hydroxyethyl)urea Isostere deriv. 18",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3
537,C[C@@H](N(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1)C(=O)NC(C)(C)C)c1ccccc1,"InChI=1S/C35H45N5O6/c1-24(27-18-12-7-13-19-27)40(33(44)39-35(2,3)4)22-30(41)28(20-25-14-8-5-9-15-25)37-32(43)29(21-31(36)42)38-34(45)46-23-26-16-10-6-11-17-26/h5-19,24,28-30,41H,20-23H2,1-4H3,(H2,36,42)(H,37,43)(H,38,45)(H,39,44)/t24-,28+,29+,30-/m1/s1",JWZDCFNILWOTAP-QVDUQQMDSA-N,491,"(Hydroxyethyl)urea Isostere deriv. 19::benzyl N-[(1S)-1-{[(2S,3R)-4-[(tert-butylcarbamoyl)[(1R)-1-phenylethyl]amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 6500
538,C[C@H](N(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1)C(=O)NC(C)(C)C)c1ccccc1,"InChI=1S/C35H45N5O6/c1-24(27-18-12-7-13-19-27)40(33(44)39-35(2,3)4)22-30(41)28(20-25-14-8-5-9-15-25)37-32(43)29(21-31(36)42)38-34(45)46-23-26-16-10-6-11-17-26/h5-19,24,28-30,41H,20-23H2,1-4H3,(H2,36,42)(H,37,43)(H,38,45)(H,39,44)/t24-,28-,29-,30+/m0/s1",JWZDCFNILWOTAP-DNEFNOKRSA-N,492,"(Hydroxyethyl)urea Isostere deriv. 20::benzyl N-[(1S)-1-{[(2S,3R)-4-[(tert-butylcarbamoyl)[(1S)-1-phenylethyl]amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 5100
539,CC(C)(C)NC(=O)N(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1)Cc1ccncc1,"InChI=1S/C33H42N6O6/c1-33(2,3)38-31(43)39(20-24-14-16-35-17-15-24)21-28(40)26(18-23-10-6-4-7-11-23)36-30(42)27(19-29(34)41)37-32(44)45-22-25-12-8-5-9-13-25/h4-17,26-28,40H,18-22H2,1-3H3,(H2,34,41)(H,36,42)(H,37,44)(H,38,43)/t26-,27-,28+/m0/s1",YKTNGJFMMFMSNS-HZFUHODCSA-N,493,"(Hydroxyethyl)urea Isostere deriv. 21::benzyl N-[(1S)-1-{[(2S,3R)-4-[(tert-butylcarbamoyl)(pyridin-4-ylmethyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 105
540,CC(C)(C)NC(=O)N(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)Cc1ccncc1,"InChI=1S/C35H41N7O5/c1-35(2,3)41-34(47)42(21-24-15-17-37-18-16-24)22-30(43)28(19-23-9-5-4-6-10-23)39-33(46)29(20-31(36)44)40-32(45)27-14-13-25-11-7-8-12-26(25)38-27/h4-18,28-30,43H,19-22H2,1-3H3,(H2,36,44)(H,39,46)(H,40,45)(H,41,47)/t28-,29-,30+/m0/s1",IQYYZQHLJFWTTR-OIFRRMEBSA-N,494,"(2S)-N-[(2S,3R)-4-[(tert-butylcarbamoyl)(pyridin-4-ylmethyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::(Hydroxyethyl)urea Isostere deriv. 22",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 19
541,CNC(=O)N(C)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1,"InChI=1S/C25H33N5O6/c1-27-24(34)30(2)15-21(31)19(13-17-9-5-3-6-10-17)28-23(33)20(14-22(26)32)29-25(35)36-16-18-11-7-4-8-12-18/h3-12,19-21,31H,13-16H2,1-2H3,(H2,26,32)(H,27,34)(H,28,33)(H,29,35)/t19-,20-,21-/m0/s1",ZMVQTFDECGHPLO-ACRUOGEOSA-N,495,"(Hydroxyethyl)urea Isostere deriv. 23::benzyl N-[(1S)-2-carbamoyl-1-{[(2S,3S)-3-hydroxy-4-[methyl(methylcarbamoyl)amino]-1-phenylbutan-2-yl]carbamoyl}ethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>10000
542,CCCCNC(=O)N(C)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1,"InChI=1S/C28H39N5O6/c1-3-4-15-30-27(37)33(2)18-24(34)22(16-20-11-7-5-8-12-20)31-26(36)23(17-25(29)35)32-28(38)39-19-21-13-9-6-10-14-21/h5-14,22-24,34H,3-4,15-19H2,1-2H3,(H2,29,35)(H,30,37)(H,31,36)(H,32,38)/t22-,23-,24-/m0/s1",GLRNYQUCFLGJNB-HJOGWXRNSA-N,496,"(Hydroxyethyl)urea Isostere deriv. 24::benzyl N-[(1S)-1-{[(2S,3S)-4-[(butylcarbamoyl)(methyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>10000
543,CNC(=O)N(CC(C)C)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1,"InChI=1S/C28H39N5O6/c1-19(2)16-33(27(37)30-3)17-24(34)22(14-20-10-6-4-7-11-20)31-26(36)23(15-25(29)35)32-28(38)39-18-21-12-8-5-9-13-21/h4-13,19,22-24,34H,14-18H2,1-3H3,(H2,29,35)(H,30,37)(H,31,36)(H,32,38)/t22-,23-,24-/m0/s1",KGHZDRBKSVQHQS-HJOGWXRNSA-N,497,"(Hydroxyethyl)urea Isostere deriv. 25::benzyl N-[(1S)-2-carbamoyl-1-{[(2S,3S)-3-hydroxy-4-[(methylcarbamoyl)(2-methylpropyl)amino]-1-phenylbutan-2-yl]carbamoyl}ethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>10000
544,CCCCNC(=O)N(CC(C)C)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1,"InChI=1S/C31H45N5O6/c1-4-5-16-33-30(40)36(19-22(2)3)20-27(37)25(17-23-12-8-6-9-13-23)34-29(39)26(18-28(32)38)35-31(41)42-21-24-14-10-7-11-15-24/h6-15,22,25-27,37H,4-5,16-21H2,1-3H3,(H2,32,38)(H,33,40)(H,34,39)(H,35,41)/t25-,26-,27-/m0/s1",XNLZVXPTFMKQCK-QKDODKLFSA-N,498,"(Hydroxyethyl)urea Isostere deriv. 26::benzyl N-[(1S)-1-{[(2S,3S)-4-[(butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamoyl}-2-carbamoylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>10000
545,CCCCCCc1cc2C(O)C(C(c3ccccc3)c3c(O)c4cc(CCCCCC)c(O)cc4oc3=O)C(=O)Oc2cc1O,"InChI=1S/C37H42O8/c1-3-5-7-10-16-23-18-25-29(20-27(23)38)44-36(42)32(34(25)40)31(22-14-12-9-13-15-22)33-35(41)26-19-24(17-11-8-6-4-2)28(39)21-30(26)45-37(33)43/h9,12-15,18-21,31-32,34,38-41H,3-8,10-11,16-17H2,1-2H3",FAXOZEJBGOLTAY-UHFFFAOYSA-N,499,"6-hexyl-3-[(6-hexyl-4,7-dihydroxy-2-oxo-3,4-dihydro-2H-1-benzopyran-3-yl)(phenyl)methyl]-4,7-dihydroxy-2H-chromen-2-one::CHEMBL64802::Cancer Chemotherapy National Service Center (CCNSC) compound 32180::NSC 32180",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 320
546,OC1C(Sc2c(O)c3ccccc3oc2=O)C(=O)Oc2ccccc12,"InChI=1S/C18H12O6S/c19-13-9-5-1-3-7-11(9)23-17(21)15(13)25-16-14(20)10-6-2-4-8-12(10)24-18(16)22/h1-8,13,15,19-20H",IDHBHFXFHJPAMQ-UHFFFAOYSA-N,500,"4-hydroxy-3-[(4-hydroxy-2-oxo-3,4-dihydro-2H-1-benzopyran-3-yl)sulfanyl]-2H-chromen-2-one::CHEMBL303093::Cancer Chemotherapy National Service Center (CCNSC) compound 41234::NSC 41234",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 21000 
547,C[C@]12C[C@H](O)[C@@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O,"InChI=1S/C25H34O8/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30/h11,16-18,22,27,32H,3-10,12-13H2,1-2H3,(H,29,30)/t16-,17+,18-,22-,23-,24-,25-/m0/s1",VWQWXZAWFPZJDA-ODCPPJKJSA-N,501,"4-{2-[(1R,2R,10S,11R,14S,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl]-2-oxoethoxy}-4-oxobutanoic acid::Cancer Chemotherapy National Service Center (CCNSC) compound 7576::NSC 7576",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 27000
548,Oc1c(O)c2ccccc2c(O)c1C(=C1C(=O)C(=O)c2ccccc2C1=O)c1ccc(cc1)C(C1C(=O)C(=O)c2ccccc2C1=O)C1C(=O)C(=O)c2ccccc2C1=O,"InChI=1S/C48H26O12/c49-37-23-9-1-5-13-27(23)41(53)45(57)33(37)31(34-38(50)24-10-2-6-14-28(24)42(54)46(34)58)21-17-19-22(20-18-21)32(35-39(51)25-11-3-7-15-29(25)43(55)47(35)59)36-40(52)26-12-4-8-16-30(26)44(56)48(36)60/h1-20,31,33-34,51,55,59H",UPELKACGIHBTIT-UHFFFAOYSA-N,502,"2-({4-[bis(3-hydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)methyl]phenyl}(3-hydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)methyl)-3-hydroxy-1,4-dihydronaphthalene-1,4-dione::CHEMBL66033::Cancer Chemotherapy National Service Center (CCNSC) compound 117027::NSC 117027",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 750
549,Oc1cccc2oc(=O)c(Cc3ccccc3)c(O)c12,"InChI=1S/C16H12O4/c17-12-7-4-8-13-14(12)15(18)11(16(19)20-13)9-10-5-2-1-3-6-10/h1-8,17-18H,9H2",SLSNVVVTKCREAW-UHFFFAOYSA-N,503,"3-benzyl-4,5-dihydroxy-2H-chromen-2-one::CHEMBL64588::Cancer Chemotherapy National Service Center (CCNSC) compound 251156::NSC 251156",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 6000
550,CC(=O)NC(Cc1ccsc1)(C(O)=O)C(O)=O,"InChI=1S/C10H11NO5S/c1-6(12)11-10(8(13)14,9(15)16)4-7-2-3-17-5-7/h2-3,5H,4H2,1H3,(H,11,12)(H,13,14)(H,15,16)",GMQAWKVCWPWFMI-UHFFFAOYSA-N,504,2-acetamido-2-(thiophen-3-ylmethyl)propanedioic acid::Cancer Chemotherapy National Service Center (CCNSC) compound 109412::NSC 109412,Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 23000
551,Oc1c(C(c2ccc3OCOc3c2)c2c(O)c3ccccc3oc2=O)c(=O)oc2ccccc12,"InChI=1S/C26H16O8/c27-23-14-5-1-3-7-16(14)33-25(29)21(23)20(13-9-10-18-19(11-13)32-12-31-18)22-24(28)15-6-2-4-8-17(15)34-26(22)30/h1-11,20,27-28H,12H2",RRHGSCFLDXVUNI-UHFFFAOYSA-N,505,"3-[2H-1,3-benzodioxol-5-yl(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-4-hydroxy-2H-chromen-2-one::CHEMBL64213::Cancer Chemotherapy National Service Center (CCNSC) compound 373937::NSC 373937",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 30000
552,Oc1c(C(c2ccc(cc2)C(c2c(O)c3ccccc3oc2=O)c2c(O)c3ccccc3oc2=O)c2c(O)c3ccccc3oc2=O)c(=O)oc2ccccc12,"InChI=1S/C44H26O12/c45-37-23-9-1-5-13-27(23)53-41(49)33(37)31(34-38(46)24-10-2-6-14-28(24)54-42(34)50)21-17-19-22(20-18-21)32(35-39(47)25-11-3-7-15-29(25)55-43(35)51)36-40(48)26-12-4-8-16-30(26)56-44(36)52/h1-20,31-32,45-48H",BXKKDJUEVYKLOT-UHFFFAOYSA-N,506,3-({4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]phenyl}(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl)-4-hydroxy-2H-chromen-2-one::CHEMBL293914::Cancer Chemotherapy National Service Center (CCNSC) compound 158393::NSC 158393,Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1700
553,CC1CCC2(O)C(O)C(CCC2(C)C1C)OC(C)=O,"InChI=1S/C15H26O4/c1-9-5-8-15(18)13(17)12(19-11(3)16)6-7-14(15,4)10(9)2/h9-10,12-13,17-18H,5-8H2,1-4H3",XWXOSWUWTVUNIG-UHFFFAOYSA-N,507,"1,8a-dihydroxy-4a,5,6-trimethyl-decahydronaphthalen-2-yl acetate::Cancer Chemotherapy National Service Center (CCNSC) compound 112500::NSC 112500",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 16000
554,Oc1c(O)c2ccccc2c(O)c1C(=C1C(=O)C(=O)c2ccccc2C1=O)c1ccc(Cl)cc1Cl,"InChI=1S/C27H14Cl2O6/c28-12-9-10-17(18(29)11-12)19(20-22(30)13-5-1-3-7-15(13)24(32)26(20)34)21-23(31)14-6-2-4-8-16(14)25(33)27(21)35/h1-11,30,32,34H",GTKAWFLUACSQAN-UHFFFAOYSA-N,508,"2-[(2,4-dichlorophenyl)(3-hydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)methyl]-3-hydroxy-1,4-dihydronaphthalene-1,4-dione::CHEMBL291663::Cancer Chemotherapy National Service Center (CCNSC) compound 117272::NSC 117272",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 24000
555,OCCN(C(C(O)c1ccccc1)c1ccccc1)C(=O)Oc1ccccc1,"InChI=1S/C23H23NO4/c25-17-16-24(23(27)28-20-14-8-3-9-15-20)21(18-10-4-1-5-11-18)22(26)19-12-6-2-7-13-19/h1-15,21-22,25-26H,16-17H2",SZCAVXACQFEDQN-UHFFFAOYSA-N,509,"Cancer Chemotherapy National Service Center (CCNSC) compound 40328::NSC 40328::phenyl N-(2-hydroxy-1,2-diphenylethyl)-N-(2-hydroxyethyl)carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 32000
556,OC1(C2N=CC=CC2C2=C(C(=O)c3ccccc3C2=O)C1(O)S(O)(=O)=O)S(O)(=O)=O,"InChI=1S/C17H13NO10S2/c19-13-8-4-1-2-5-9(8)14(20)12-11(13)10-6-3-7-18-15(10)17(22,30(26,27)28)16(12,21)29(23,24)25/h1-7,10,15,21-22H,(H,23,24,25)(H,26,27,28)",ZCPINFBBTBQKOP-UHFFFAOYSA-N,510,"11,12-dihydroxy-5,10-dioxo-4a,5,10,11,12,12a-hexahydro-1-azatetraphene-11,12-disulfonic acid::Cancer Chemotherapy National Service Center (CCNSC) compound 9152::NSC 9152",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2000
557,CC(C)CC(NC(=O)OCc1ccccc1)(C(O)=O)C(O)=O,"InChI=1S/C15H19NO6/c1-10(2)8-15(12(17)18,13(19)20)16-14(21)22-9-11-6-4-3-5-7-11/h3-7,10H,8-9H2,1-2H3,(H,16,21)(H,17,18)(H,19,20)",TYMFSJMODYALDQ-UHFFFAOYSA-N,511,2-{[(benzyloxy)carbonyl]amino}-2-(2-methylpropyl)propanedioic acid::Cancer Chemotherapy National Service Center (CCNSC) compound 20143::NSC 20143,Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 17000
558,CCCC(=O)C1C(=O)C(Cc2c(O)c(C)c(O)c(C(=O)CCC)c2O)C(=O)C(C)(C)C1=O,"InChI=1S/C24H30O8/c1-6-8-14(25)16-19(28)11(3)18(27)12(20(16)29)10-13-21(30)17(15(26)9-7-2)23(32)24(4,5)22(13)31/h13,17,27-29H,6-10H2,1-5H3",CPYIAGRDDAUWHX-UHFFFAOYSA-N,512,"2-butanoyl-6-[(3-butanoyl-2,4,6-trihydroxy-5-methylphenyl)methyl]-3,5-dihydroxy-4,4-dimethylcyclohexa-2,5-dien-1-one::Cancer Chemotherapy National Service Center (CCNSC) compound 115497::NSC 115497",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 26000
559,CC1(C)CC[C@@]2(CC[C@@]3(C)C(=CC[C@H]4[C@@]5(C)C[C@H](O)[C@H](O)[C@@](C)([C@H]5CC[C@@]34C)C(O)=O)[C@@H]2C1)C(O)=O,"InChI=1S/C30H46O6/c1-25(2)11-13-30(24(35)36)14-12-27(4)17(18(30)15-25)7-8-20-26(3)16-19(31)22(32)29(6,23(33)34)21(26)9-10-28(20,27)5/h7,18-22,31-32H,8-16H2,1-6H3,(H,33,34)(H,35,36)/t18-,19-,20-,21-,22-,26+,27-,28+,29+,30-/m0/s1",IDGXIXSKISLYAC-DKTLNTJISA-N,513,"(2S,3R,4R,4aS,6aR,6bR,8aS,12aS,14aS,14bR)-2,3-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicene-4,8a-dicarboxylic acid::Cancer Chemotherapy National Service Center (CCNSC) compound 382025::NSC 382025",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 35000
560,Oc1c(-c2ccccc2)c(=O)oc2c(cccc12)-c1ccccc1,"InChI=1S/C21H14O3/c22-19-17-13-7-12-16(14-8-3-1-4-9-14)20(17)24-21(23)18(19)15-10-5-2-6-11-15/h1-13,22H",KHZAWTVDPWVVBY-UHFFFAOYSA-N,514,"4-hydroxy-3,8-diphenyl-2H-chromen-2-one::Cancer Chemotherapy National Service Center (CCNSC) compound 251150::NSC 251150",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 13000
561,Oc1c(-c2ccccc2)c(=O)oc2ccccc12,"InChI=1S/C15H10O3/c16-14-11-8-4-5-9-12(11)18-15(17)13(14)10-6-2-1-3-7-10/h1-9,16H",CBHMYFPBBDCWSY-UHFFFAOYSA-N,515,4-hydroxy-3-phenyl-2H-chromen-2-one::Cancer Chemotherapy National Service Center (CCNSC) compound 251152::NSC 251152,Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 42000
562,CC(C)c1cccc(C(C)C)c1NC(=O)C(=O)CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,"InChI=1S/C33H33NO6/c1-19(2)23-14-10-15-24(20(3)4)30(23)34-32(38)27(36)18-22(35)17-26(21-11-6-5-7-12-21)29-31(37)25-13-8-9-16-28(25)40-33(29)39/h5-16,19-20,26,37H,17-18H2,1-4H3,(H,34,38)",DJDZPJCHQJIERW-UHFFFAOYSA-N,516,"CHEMBL62658::N-[2,6-bis(propan-2-yl)phenyl]-6-(4-hydroxy-2-oxo-2H-chromen-3-yl)-2,4-dioxo-6-phenylhexanamide::NSC 647086",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 31000
563,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1,"InChI=1S/C28H43N3O5/c1-28(2,3)30-26(33)24-15-20-10-7-11-21(20)16-31(24)17-25(32)23(14-19-8-5-4-6-9-19)29-27(34)36-22-12-13-35-18-22/h4-6,8-9,20-25,32H,7,10-18H2,1-3H3,(H,29,34)(H,30,33)/t20-,21+,22-,23-,24-,25+/m0/s1",GIJVOAULRYJRGU-HLXSIYPQSA-N,521,"(3S)-oxolan-3-yl N-[(2S,3R)-4-[(3S,4aS,7aS)-3-(tert-butylcarbamoyl)-octahydro-1H-cyclopenta[c]pyridin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::N-tert-Butyloctahydro-2-[2(R)-hydroxy-4-phenyl-[[[3(S)-tetrahydrofuranyloxy]carbonyl]amino]butyl]-(3S,4aS,7aS)-1H-pyrindene-3-carboxamide::Sulfone deriv. 15",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 61
564,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCSC1,"InChI=1S/C29H45N3O4S/c1-29(2,3)31-27(34)25-16-21-11-7-8-12-22(21)17-32(25)18-26(33)24(15-20-9-5-4-6-10-20)30-28(35)36-23-13-14-37-19-23/h4-6,9-10,21-26,33H,7-8,11-19H2,1-3H3,(H,30,35)(H,31,34)/t21-,22+,23-,24-,25-,26+/m0/s1",SFUSYMKBUIQBHK-FBQZJRKBSA-N,522,"(3S)-thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 16",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 132
565,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CCSC1,"InChI=1S/C29H45N3O4S/c1-29(2,3)31-27(34)25-16-21-11-7-8-12-22(21)17-32(25)18-26(33)24(15-20-9-5-4-6-10-20)30-28(35)36-23-13-14-37-19-23/h4-6,9-10,21-26,33H,7-8,11-19H2,1-3H3,(H,30,35)(H,31,34)/t21-,22+,23+,24-,25-,26+/m0/s1",SFUSYMKBUIQBHK-GKLJYDMOSA-N,523,"(3R)-thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 17",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 220
566,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCS(=O)(=O)C1,"InChI=1S/C28H43N3O6S/c1-28(2,3)30-26(33)24-15-20-10-7-11-21(20)16-31(24)17-25(32)23(14-19-8-5-4-6-9-19)29-27(34)37-22-12-13-38(35,36)18-22/h4-6,8-9,20-25,32H,7,10-18H2,1-3H3,(H,29,34)(H,30,33)/t20-,21+,22-,23-,24-,25+/m0/s1",MHLNARDQQWONOV-HLXSIYPQSA-N,524,"(3S)-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,7aS)-3-(tert-butylcarbamoyl)-octahydro-1H-cyclopenta[c]pyridin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 18",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 11.3
567,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCCS(=O)(=O)C1,"InChI=1S/C30H47N3O6S/c1-30(2,3)32-28(35)26-17-22-12-7-8-13-23(22)18-33(26)19-27(34)25(16-21-10-5-4-6-11-21)31-29(36)39-24-14-9-15-40(37,38)20-24/h4-6,10-11,22-27,34H,7-9,12-20H2,1-3H3,(H,31,36)(H,32,35)/t22-,23+,24-,25-,26-,27+/m0/s1",WKVRBPOPJCYCGY-HBEKHWMPSA-N,525,"(3S)-1,1-dioxo--thian-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 19",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1745
568,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CCCS(=O)(=O)C1,"InChI=1S/C30H47N3O6S/c1-30(2,3)32-28(35)26-17-22-12-7-8-13-23(22)18-33(26)19-27(34)25(16-21-10-5-4-6-11-21)31-29(36)39-24-14-9-15-40(37,38)20-24/h4-6,10-11,22-27,34H,7-9,12-20H2,1-3H3,(H,31,36)(H,32,35)/t22-,23+,24+,25-,26-,27+/m0/s1",WKVRBPOPJCYCGY-YECVLQETSA-N,526,"(3R)-1,1-dioxo--thian-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 20",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2068
569,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OC1CS(=O)(=O)C1,"InChI=1S/C28H43N3O6S/c1-28(2,3)30-26(33)24-14-20-11-7-8-12-21(20)15-31(24)16-25(32)23(13-19-9-5-4-6-10-19)29-27(34)37-22-17-38(35,36)18-22/h4-6,9-10,20-25,32H,7-8,11-18H2,1-3H3,(H,29,34)(H,30,33)/t20-,21+,23-,24-,25+/m0/s1",YDXWVSNLNBSYOF-PZNJWVMQSA-N,527,"1,1-dioxo--thietan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 21",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 104
570,C[C@@H]1OCC[C@@H]1OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O5/c1-20-27(14-15-37-20)38-29(36)31-24(16-21-10-6-5-7-11-21)26(34)19-33-18-23-13-9-8-12-22(23)17-25(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22-,23+,24-,25-,26+,27-/m0/s1",WZRBCRPZAJNYRP-MOTZDZOKSA-N,528,"(2S,3S)-2-methyloxolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 22",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 52.4
571,C[C@H]1OCC[C@H]1OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O5/c1-20-27(14-15-37-20)38-29(36)31-24(16-21-10-6-5-7-11-21)26(34)19-33-18-23-13-9-8-12-22(23)17-25(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22+,23-,24+,25+,26-,27-/m1/s1",WZRBCRPZAJNYRP-XUJNKOSYSA-N,529,"(2R,3R)-2-methyloxolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 23",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 169
572,C[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S/c1-20-27(14-15-40(20,37)38)39-29(36)31-24(16-21-10-6-5-7-11-21)26(34)19-33-18-23-13-9-8-12-22(23)17-25(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22-,23+,24-,25-,26+,27-/m0/s1",ZWBLHWHBSYSDFK-MOTZDZOKSA-N,530,"(2S,3S)-2-methyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::N- tert-butyldecahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[[[2 (S)-methyl-( 3 S)- l , l -dioxotetrahydrothiophene-3 -yl]-oxy]carbonyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide::Sulfone deriv. 24",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 11.4
573,C[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C29H45N3O6S/c1-19-26(13-14-39(19,36)37)38-28(35)30-23(15-20-9-6-5-7-10-20)25(33)18-32-17-22-12-8-11-21(22)16-24(32)27(34)31-29(2,3)4/h5-7,9-10,19,21-26,33H,8,11-18H2,1-4H3,(H,30,35)(H,31,34)/t19-,21-,22+,23-,24-,25+,26-/m0/s1",CHZGNAXNHGNYFW-ASMLMKMTSA-N,531,"(2S,3S)-2-methyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,7aS)-3-(tert-butylcarbamoyl)-octahydro-1H-cyclopenta[c]pyridin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 25",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 12.6
574,C[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S/c1-20-27(14-15-40(20,37)38)39-29(36)31-24(16-21-10-6-5-7-11-21)26(34)19-33-18-23-13-9-8-12-22(23)17-25(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22+,23-,24+,25+,26-,27-/m1/s1",ZWBLHWHBSYSDFK-XUJNKOSYSA-N,532,"(2R,3R)-2-methyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::N- tert-butyldecahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[[[4 (S)-methyl-( 3 R)- l , l -dioxotetrahydrothiophene-3 -yl]-oxy]carbonyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide::Sulfone deriv. 26",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 22.3
575,C[C@H]1CS(=O)(=O)C[C@H]1OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S/c1-20-18-40(37,38)19-27(20)39-29(36)31-24(14-21-10-6-5-7-11-21)26(34)17-33-16-23-13-9-8-12-22(23)15-25(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22-,23+,24-,25-,26+,27+/m0/s1",JGNJWIIHVZPCLO-ITASEOMLSA-N,533,"(3S,4R)-4-methyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 27",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 70
576,C[C@@H]1CS(=O)(=O)C[C@@H]1OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S/c1-20-18-40(37,38)19-27(20)39-29(36)31-24(14-21-10-6-5-7-11-21)26(34)17-33-16-23-13-9-8-12-22(23)15-25(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22+,23-,24+,25+,26-,27+/m1/s1",JGNJWIIHVZPCLO-JPNSLTJHSA-N,534,"(3R,4S)-4-methyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::N- tert-Butyldecahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[[[4 (S)-methyl-(3 R)- l ,l -dioxotetrahydrothiophene-3 -yl]-oxy]carbonyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide::Sulfone deriv. 28",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 216
577,C[C@@H]1C[C@@H](CS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S/c1-20-14-24(19-40(20,37)38)39-29(36)31-25(15-21-10-6-5-7-11-21)27(34)18-33-17-23-13-9-8-12-22(23)16-26(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22+,23-,24+,25+,26+,27-/m1/s1",VZLVYEBEUCOLCO-HKQCOZBKSA-N,535,"(3S,5R)-5-methyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::N- tert-Butyldecahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[[[5 (R)-methyl-3 (S)-l ,l -dioxotetrahydrothiophene-3 -yl]-oxy]carbonyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide::Sulfone deriv. 29",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 82
578,C[C@H]1C[C@H](CS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C30H47N3O6S/c1-20-14-24(19-40(20,37)38)39-29(36)31-25(15-21-10-6-5-7-11-21)27(34)18-33-17-23-13-9-8-12-22(23)16-26(33)28(35)32-30(2,3)4/h5-7,10-11,20,22-27,34H,8-9,12-19H2,1-4H3,(H,31,36)(H,32,35)/t20-,22-,23+,24+,25-,26-,27+/m0/s1",VZLVYEBEUCOLCO-WOVHLGJYSA-N,536,"(3R,5S)-5-methyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::N-tert-Butyldecahydro-2-[2(R)-hydroxy-4-pheny1-3(S)-[[[[5 (S)-methyl-(3 R)-l ,l -dioxotetrahydrothiophene-3 -yl]-oxy]carbonyl]amino]butyl]-(4aS,8a5)-isoquinoline-3(S)-carboxamide::Sulfone deriv. 30",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1600
579,CCC[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H51N3O6S/c1-5-11-29-28(16-17-42(29,39)40)41-31(38)33-25(18-22-12-7-6-8-13-22)27(36)21-35-20-24-15-10-9-14-23(24)19-26(35)30(37)34-32(2,3)4/h6-8,12-13,23-29,36H,5,9-11,14-21H2,1-4H3,(H,33,38)(H,34,37)/t23-,24+,25-,26-,27+,28-,29-/m0/s1",RHMWHSCIEZRMHZ-QXWHLYFESA-N,537,"(2S,3S)-1,1-dioxo-2-propyl--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 31",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 6.2
580,CCC[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H51N3O6S/c1-5-11-29-28(16-17-42(29,39)40)41-31(38)33-25(18-22-12-7-6-8-13-22)27(36)21-35-20-24-15-10-9-14-23(24)19-26(35)30(37)34-32(2,3)4/h6-8,12-13,23-29,36H,5,9-11,14-21H2,1-4H3,(H,33,38)(H,34,37)/t23-,24+,25-,26-,27+,28+,29+/m0/s1",RHMWHSCIEZRMHZ-XHTFZTLQSA-N,538,"(2R,3R)-1,1-dioxo-2-propyl--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::Sulfone deriv. 32",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 20.1
581,CC(C)[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C31H49N3O6S/c1-20(2)28-27(14-15-41(28,38)39)40-30(37)32-24(16-21-10-7-6-8-11-21)26(35)19-34-18-23-13-9-12-22(23)17-25(34)29(36)33-31(3,4)5/h6-8,10-11,20,22-28,35H,9,12-19H2,1-5H3,(H,32,37)(H,33,36)/t22-,23+,24-,25-,26+,27+,28+/m0/s1",MTBIKTXGJMGCBP-XTXCQKKVSA-N,539,"(2R,3R)-1,1-dioxo-2-(propan-2-yl)--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,7aS)-3-(tert-butylcarbamoyl)-octahydro-1H-cyclopenta[c]pyridin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::sulfone deriv. 33",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3
582,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCS(=O)(=O)[C@H]1C1CCCC1,"InChI=1S/C34H53N3O6S/c1-34(2,3)36-32(39)28-20-25-15-9-10-16-26(25)21-37(28)22-29(38)27(19-23-11-5-4-6-12-23)35-33(40)43-30-17-18-44(41,42)31(30)24-13-7-8-14-24/h4-6,11-12,24-31,38H,7-10,13-22H2,1-3H3,(H,35,40)(H,36,39)/t25-,26+,27-,28-,29+,30-,31-/m0/s1",SCVGALCLJNKWJI-MXKPVQFSSA-N,540,"(2S,3S)-2-cyclopentyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::sulfone deriv. 34",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 6.2
583,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CCS(=O)(=O)[C@@H]1C1CCCC1,"InChI=1S/C34H53N3O6S/c1-34(2,3)36-32(39)28-20-25-15-9-10-16-26(25)21-37(28)22-29(38)27(19-23-11-5-4-6-12-23)35-33(40)43-30-17-18-44(41,42)31(30)24-13-7-8-14-24/h4-6,11-12,24-31,38H,7-10,13-22H2,1-3H3,(H,35,40)(H,36,39)/t25-,26+,27-,28-,29+,30+,31+/m0/s1",SCVGALCLJNKWJI-VKKKTGERSA-N,541,"(2R,3R)-2-cyclopentyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::sulfone deriv. 35",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 22.6
584,CCCC[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H53N3O6S/c1-5-6-16-30-29(17-18-43(30,40)41)42-32(39)34-26(19-23-12-8-7-9-13-23)28(37)22-36-21-25-15-11-10-14-24(25)20-27(36)31(38)35-33(2,3)4/h7-9,12-13,24-30,37H,5-6,10-11,14-22H2,1-4H3,(H,34,39)(H,35,38)/t24-,25+,26-,27-,28+,29-,30-/m0/s1",NTNXTIVVNYYALB-OWCZDTJQSA-N,542,"(2S,3S)-2-butyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::sulfone deriv. 36",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 14.9
585,CCCC[C@@H]1[C@@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H53N3O6S/c1-5-6-16-30-29(17-18-43(30,40)41)42-32(39)34-26(19-23-12-8-7-9-13-23)28(37)22-36-21-25-15-11-10-14-24(25)20-27(36)31(38)35-33(2,3)4/h7-9,12-13,24-30,37H,5-6,10-11,14-22H2,1-4H3,(H,34,39)(H,35,38)/t24-,25+,26-,27-,28+,29+,30+/m0/s1",NTNXTIVVNYYALB-KZKRDFPPSA-N,543,"(2R,3R)-2-butyl-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog::sulfone deriv. 37",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 45.8
586,CCCC1(CCc2ccccc2)CC(=O)C(C(CC)c2cccc(NS(=O)(=O)c3ccccc3)c2)C(=O)O1,"InChI=1S/C31H35NO5S/c1-3-19-31(20-18-23-12-7-5-8-13-23)22-28(33)29(30(34)37-31)27(4-2)24-14-11-15-25(21-24)32-38(35,36)26-16-9-6-10-17-26/h5-17,21,27,29,32H,3-4,18-20,22H2,1-2H3",VYQDDDRBWRKECZ-UHFFFAOYSA-N,544,"N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)benzenesulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 1",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
587,CCCC1(CCc2ccccc2)CC(=O)C(C(CC)c2cccc(NS(=O)(=O)c3ccc(cc3)C#N)c2)C(=O)O1,"InChI=1S/C32H34N2O5S/c1-3-18-32(19-17-23-9-6-5-7-10-23)21-29(35)30(31(36)39-32)28(4-2)25-11-8-12-26(20-25)34-40(37,38)27-15-13-24(22-33)14-16-27/h5-16,20,28,30,34H,3-4,17-19,21H2,1-2H3",BQKCUXNGMWFRMA-UHFFFAOYSA-N,545,"4-cyano-N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)benzene-1-sulfonamide::CHEMBL21281::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
588,CCCC1(CCc2ccccc2)CC(=O)C(C(CC)c2cccc(NS(=O)(=O)c3ccc(F)cc3)c2)C(=O)O1,"InChI=1S/C31H34FNO5S/c1-3-18-31(19-17-22-9-6-5-7-10-22)21-28(34)29(30(35)38-31)27(4-2)23-11-8-12-25(20-23)33-39(36,37)26-15-13-24(32)14-16-26/h5-16,20,27,29,33H,3-4,17-19,21H2,1-2H3",ZJGCSFBIEQRWHM-UHFFFAOYSA-N,546,"4-fluoro-N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)benzene-1-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 3",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
589,CCCC1(CCc2ccccc2)CC(=O)C(C(CC)c2cccc(NS(=O)(=O)c3cccc4cccnc34)c2)C(=O)O1,"InChI=1S/C34H36N2O5S/c1-3-19-34(20-18-24-11-6-5-7-12-24)23-29(37)31(33(38)41-34)28(4-2)26-14-8-16-27(22-26)36-42(39,40)30-17-9-13-25-15-10-21-35-32(25)30/h5-17,21-22,28,31,36H,3-4,18-20,23H2,1-2H3",PXEMUSOJMFGOOU-UHFFFAOYSA-N,547,"CHEMBL20846::N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)quinoline-8-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 4",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
590,CCCC1(CCc2ccccc2)CC(=O)C(C(CC)c2cccc(NS(=O)(=O)c3cn(C)cn3)c2)C(=O)O1,"InChI=1S/C29H35N3O5S/c1-4-15-29(16-14-21-10-7-6-8-11-21)18-25(33)27(28(34)37-29)24(5-2)22-12-9-13-23(17-22)31-38(35,36)26-19-32(3)20-30-26/h6-13,17,19-20,24,27,31H,4-5,14-16,18H2,1-3H3",XWOYUJQEURHLCR-UHFFFAOYSA-N,548,"CHEMBL21188::N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-1-methyl-1H-imidazole-4-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 5",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
591,CCC[C@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3cn(C)cn3)c2)C(=O)O1,"InChI=1S/C29H35N3O5S/c1-4-15-29(16-14-21-10-7-6-8-11-21)18-25(33)27(28(34)37-29)24(5-2)22-12-9-13-23(17-22)31-38(35,36)26-19-32(3)20-30-26/h6-13,17,19-20,24,27,31H,4-5,14-16,18H2,1-3H3/t24-,27?,29+/m1/s1",XWOYUJQEURHLCR-AVSUOYITSA-N,549,"N-{3-[(1R)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-1-methyl-1H-imidazole-4-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 6",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
592,CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3cn(C)cn3)c2)C(=O)O1,"InChI=1S/C29H35N3O5S/c1-4-15-29(16-14-21-10-7-6-8-11-21)18-25(33)27(28(34)37-29)24(5-2)22-12-9-13-23(17-22)31-38(35,36)26-19-32(3)20-30-26/h6-13,17,19-20,24,27,31H,4-5,14-16,18H2,1-3H3/t24-,27?,29-/m1/s1",XWOYUJQEURHLCR-ZBSLUPEWSA-N,550,"N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-1-methyl-1H-imidazole-4-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 7",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
593,CCC[C@]1(CCc2ccccc2)CC(=O)C([C@@H](CC)c2cccc(NS(=O)(=O)c3cn(C)cn3)c2)C(=O)O1,"InChI=1S/C29H35N3O5S/c1-4-15-29(16-14-21-10-7-6-8-11-21)18-25(33)27(28(34)37-29)24(5-2)22-12-9-13-23(17-22)31-38(35,36)26-19-32(3)20-30-26/h6-13,17,19-20,24,27,31H,4-5,14-16,18H2,1-3H3/t24-,27?,29-/m0/s1",XWOYUJQEURHLCR-IDWGMCNCSA-N,551,"N-{3-[(1S)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-1-methyl-1H-imidazole-4-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 8",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
594,CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@@H](CC)c2cccc(NS(=O)(=O)c3cn(C)cn3)c2)C(=O)O1,"InChI=1S/C29H35N3O5S/c1-4-15-29(16-14-21-10-7-6-8-11-21)18-25(33)27(28(34)37-29)24(5-2)22-12-9-13-23(17-22)31-38(35,36)26-19-32(3)20-30-26/h6-13,17,19-20,24,27,31H,4-5,14-16,18H2,1-3H3/t24-,27?,29+/m0/s1",XWOYUJQEURHLCR-FVMJCILESA-N,552,"N-{3-[(1S)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-1-methyl-1H-imidazole-4-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 9",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
595,CCC[C@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C#N)c2)C(=O)O1,"InChI=1S/C31H33N3O5S/c1-3-16-31(17-15-22-9-6-5-7-10-22)19-27(35)29(30(36)39-31)26(4-2)24-11-8-12-25(18-24)34-40(37,38)28-14-13-23(20-32)21-33-28/h5-14,18,21,26,29,34H,3-4,15-17,19H2,1-2H3/t26-,29?,31+/m1/s1",CNXLIJOZVTZRJJ-IRIRSIKVSA-N,553,"5-cyano-N-{3-[(1R)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}pyridine-2-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
596,CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C#N)c2)C(=O)O1,"InChI=1S/C31H33N3O5S/c1-3-16-31(17-15-22-9-6-5-7-10-22)19-27(35)29(30(36)39-31)26(4-2)24-11-8-12-25(18-24)34-40(37,38)28-14-13-23(20-32)21-33-28/h5-14,18,21,26,29,34H,3-4,15-17,19H2,1-2H3/t26-,29?,31-/m1/s1",CNXLIJOZVTZRJJ-AOJKPLOISA-N,554,"5-cyano-N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}pyridine-2-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 11",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
597,CCC[C@]1(CCc2ccccc2)CC(=O)C([C@@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C#N)c2)C(=O)O1,"InChI=1S/C31H33N3O5S/c1-3-16-31(17-15-22-9-6-5-7-10-22)19-27(35)29(30(36)39-31)26(4-2)24-11-8-12-25(18-24)34-40(37,38)28-14-13-23(20-32)21-33-28/h5-14,18,21,26,29,34H,3-4,15-17,19H2,1-2H3/t26-,29?,31-/m0/s1",CNXLIJOZVTZRJJ-MMHUAGGKSA-N,555,"5-cyano-N-{3-[(1S)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}pyridine-2-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 12",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
598,CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C#N)c2)C(=O)O1,"InChI=1S/C31H33N3O5S/c1-3-16-31(17-15-22-9-6-5-7-10-22)19-27(35)29(30(36)39-31)26(4-2)24-11-8-12-25(18-24)34-40(37,38)28-14-13-23(20-32)21-33-28/h5-14,18,21,26,29,34H,3-4,15-17,19H2,1-2H3/t26-,29?,31+/m0/s1",CNXLIJOZVTZRJJ-LGZOALLCSA-N,556,"5-cyano-N-{3-[(1S)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}pyridine-2-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
599,CCC[C@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1,"InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,28,36H,3-4,15-17,19H2,1-2H3/t25-,28?,30+/m1/s1",MYXACKZCYFKMTE-DJHFWHLDSA-N,557,"N-{3-[(1R)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 14",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
600,CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1,"InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,28,36H,3-4,15-17,19H2,1-2H3/t25-,28?,30-/m1/s1",MYXACKZCYFKMTE-JETRDCLMSA-N,558,"N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide::PNU-140690::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir::U-140690",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
601,CCC[C@]1(CCc2ccccc2)CC(=O)C([C@@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1,"InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,28,36H,3-4,15-17,19H2,1-2H3/t25-,28?,30-/m0/s1",MYXACKZCYFKMTE-NFUCCUETSA-N,559,"N-{3-[(1S)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 16",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
602,CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1,"InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,28,36H,3-4,15-17,19H2,1-2H3/t25-,28?,30+/m0/s1",MYXACKZCYFKMTE-XVTNRJGNSA-N,560,"N-{3-[(1S)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide::Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones::Tipranavir analog 17",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
603,COC[C@@H]1SCC[C@@H]1OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C31H49N3O5S/c1-31(2,3)33-29(36)25-17-22-12-8-9-13-23(22)18-34(25)19-26(35)24(16-21-10-6-5-7-11-21)32-30(37)39-27-14-15-40-28(27)20-38-4/h5-7,10-11,22-28,35H,8-9,12-20H2,1-4H3,(H,32,37)(H,33,36)/t22-,23+,24-,25-,26+,27-,28-/m0/s1",TVASCYDFQDRAJE-PMJXQHFJSA-N,561,"(2S,3S)-2-(methoxymethyl)thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog. 1",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 19.7
604,COC[C@H]1[C@H](CCS1(=O)=O)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C31H49N3O7S/c1-31(2,3)33-29(36)25-17-22-12-8-9-13-23(22)18-34(25)19-26(35)24(16-21-10-6-5-7-11-21)32-30(37)41-27-14-15-42(38,39)28(27)20-40-4/h5-7,10-11,22-28,35H,8-9,12-20H2,1-4H3,(H,32,37)(H,33,36)/t22-,23+,24-,25-,26+,27-,28-/m0/s1",GOUHZFOYJFSEKP-PMJXQHFJSA-N,562,"(2S,3S)-2-(methoxymethyl)-1,1-dioxo--thiolan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog. 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 23.8
605,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12,"InChI=1S/C31H47N3O6/c1-31(2,3)33-28(36)25-16-21-11-7-8-12-22(21)17-34(25)18-26(35)24(15-20-9-5-4-6-10-20)32-30(37)40-27-19-39-29-23(27)13-14-38-29/h4-6,9-10,21-27,29,35H,7-8,11-19H2,1-3H3,(H,32,37)(H,33,36)/t21-,22+,23-,24-,25-,26+,27-,29+/m0/s1",LQBLSQUSWJJCSP-UZIBIQIJSA-N,563,"(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (1S,2R)-1-benzyl-3-[(3S,4aS,8aS)-3-[(tert-butylamino)carbonyl]octahydroisoquinolin-2(1H)-yl]-2-hydroxypropylcarbamate::(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::CHEMBL315403::Isoquinoline furanyl urethane analog. 3::urethane analog 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.8
606,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CO[C@@H]2OCC[C@H]12,"InChI=1S/C31H47N3O6/c1-31(2,3)33-28(36)25-16-21-11-7-8-12-22(21)17-34(25)18-26(35)24(15-20-9-5-4-6-10-20)32-30(37)40-27-19-39-29-23(27)13-14-38-29/h4-6,9-10,21-27,29,35H,7-8,11-19H2,1-3H3,(H,32,37)(H,33,36)/t21-,22+,23+,24-,25-,26+,27+,29-/m0/s1",LQBLSQUSWJJCSP-XRTFMURDSA-N,564,"(3S,3aR,6aS)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::(3S,4aS,8aS,2 R,3 S,3 S,3 aR,6 aS)-N-tert-Butyl-2-[2 -hydroxy-4 -phenyl-3 -[[[(3 -hexahydrofuro[2,3-b]furanyl)oxy]carbonyl]amino]butyl]decahydroisoquinoline-3-carboxamide::CHEMBL83768::Isoquinoline furanyl urethane analog. 4",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 6.4
607,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCCC[C@@H]12,"InChI=1S/C32H49N3O6/c1-32(2,3)34-29(37)26-17-22-12-7-8-13-23(22)18-35(26)19-27(36)25(16-21-10-5-4-6-11-21)33-31(38)41-28-20-40-30-24(28)14-9-15-39-30/h4-6,10-11,22-28,30,36H,7-9,12-20H2,1-3H3,(H,33,38)(H,34,37)/t22-,23+,24-,25-,26-,27+,28-,30+/m0/s1",GGSRUTDSWCRZNI-DBMFPBDGSA-N,565,"(3R,3aS,7aR)-hexahydro-2H-furo[2,3-b]pyran-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::(3S,4aS,8aS,2 R,3 S,3 R,3 aS,7 aR)-N-tert-Butyl-2-[2 -hydroxy-4 -phenyl-3 -[[[(3 -hexahydro-4 H-furo[2,3-b]pyranyl)oxy]carbonyl]amino]butyl]decahydroisoquinoline-3-carboxamide::Isoquinoline furanyl urethane analog. 5",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.2
608,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CO[C@@H]2OCCC[C@H]12,"InChI=1S/C32H49N3O6/c1-32(2,3)34-29(37)26-17-22-12-7-8-13-23(22)18-35(26)19-27(36)25(16-21-10-5-4-6-11-21)33-31(38)41-28-20-40-30-24(28)14-9-15-39-30/h4-6,10-11,22-28,30,36H,7-9,12-20H2,1-3H3,(H,33,38)(H,34,37)/t22-,23+,24+,25-,26-,27+,28+,30-/m0/s1",GGSRUTDSWCRZNI-NBDAMYGJSA-N,566,"(3S,3aR,7aS)-hexahydro-2H-furo[2,3-b]pyran-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::(3S,4aS,8aS,2 R,3 S,3 S,3 aR,7 aS)-N-tert-Butyl-2-[2 -hydroxy-4 -phenyl-3 -[[[(3 -hexahydro-4 H-furo[2,3-b]pyranyl)oxy]carbonyl]amino]butyl]decahydroisoquinoline-3-carboxamide::Isoquinoline furanyl urethane analog. 6",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.2
609,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2CCC[C@@H]12,"InChI=1S/C32H49N3O5/c1-32(2,3)34-30(37)26-17-22-12-7-8-13-23(22)18-35(26)19-27(36)25(16-21-10-5-4-6-11-21)33-31(38)40-29-20-39-28-15-9-14-24(28)29/h4-6,10-11,22-29,36H,7-9,12-20H2,1-3H3,(H,33,38)(H,34,37)/t22-,23+,24+,25-,26-,27+,28-,29-/m0/s1",LUICRMGYHPZLQE-XUSCARPCSA-N,567,"(3R,3aR,6aS)-hexahydro-2H-cyclopenta[b]furan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::(3S,4aS,8aS,2 R,3 S,4 R,3 aR,6 aS)-N-tert-Butyl-2-[2 -hydroxy-4 -phenyl-3 -[[[(3 -hexahydro-2H-cyclopenta[b]-furanyl)oxy]carbonyl]amino]butyl]decahydroiso-quinoline-3-carboxamide::Isoquinoline furanyl urethane analog. 7",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 190
610,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CC[C@H]2OCC[C@@H]12,"InChI=1S/C32H49N3O5/c1-32(2,3)34-30(37)26-18-22-11-7-8-12-23(22)19-35(26)20-27(36)25(17-21-9-5-4-6-10-21)33-31(38)40-29-14-13-28-24(29)15-16-39-28/h4-6,9-10,22-29,36H,7-8,11-20H2,1-3H3,(H,33,38)(H,34,37)/t22-,23+,24+,25-,26-,27+,28+,29-/m0/s1",BXHKUQJOWIKKIH-LNDVOCBLSA-N,568,"(3S,4aS,8aS,2 R,3 S,3 aS,4 S,6 aR)-N-tert-Butyl-2-[2 -hydroxy-4 -phenyl-3 -[[[(4 -hexahydro-2H-cyclopenta[b]-furanyl)oxy]carbonyl]amino]butyl]decahydroiso-quinoline-3-carboxamide::(3aR,4S,6aR)-hexahydro-2H-cyclopenta[b]furan-4-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog. 8",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 17
611,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@]12CCO[C@H]1OCC2,"InChI=1S/C31H47N3O6/c1-30(2,3)33-27(36)25-18-22-11-7-8-12-23(22)19-34(25)20-26(35)24(17-21-9-5-4-6-10-21)32-29(37)40-31-13-15-38-28(31)39-16-14-31/h4-6,9-10,22-26,28,35H,7-8,11-20H2,1-3H3,(H,32,37)(H,33,36)/t22-,23+,24-,25-,26+,28-,31-/m0/s1",ACUPOAMDZYDNCK-JYBCPWHASA-N,569,"(3S,4aS,8aS,2 R,3 S)-N-tert-Butyl-2-[2 -hydroxy-4 -phenyl-3 -[[[(3a -hexahydrofuro[2,3-b]furanyl)oxy]carbonyl]-amino]butyl]decahydroisoquinoline-3-carboxamide::Isoquinoline furanyl urethane analog. 9::hexahydrofuro[2,3-b]furan-3a-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 410
612,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2COC[C@@H]12,"InChI=1S/C31H47N3O6/c1-31(2,3)33-29(36)25-14-21-11-7-8-12-22(21)15-34(25)16-26(35)24(13-20-9-5-4-6-10-20)32-30(37)40-28-19-39-27-18-38-17-23(27)28/h4-6,9-10,21-28,35H,7-8,11-19H2,1-3H3,(H,32,37)(H,33,36)/t21-,22+,23+,24-,25-,26+,27-,28-/m0/s1",FKIFLFSCPVYJLA-WWHGPYDISA-N,570,"(3R,3aR,6aR)-hexahydrofuro[2,3-c]furan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog. 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1700
613,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CO[C@@H]2CCO[C@H]12,"InChI=1S/C31H47N3O6/c1-31(2,3)33-29(36)24-16-21-11-7-8-12-22(21)17-34(24)18-25(35)23(15-20-9-5-4-6-10-20)32-30(37)40-27-19-39-26-13-14-38-28(26)27/h4-6,9-10,21-28,35H,7-8,11-19H2,1-3H3,(H,32,37)(H,33,36)/t21-,22+,23-,24-,25+,26+,27+,28-/m0/s1",UADOOGITMYZIDM-QHVVJTBISA-N,571,"(3R,3aS,6aR)-hexahydrofuro[3,2-b]furan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog. 11",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>3000
614,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@@]2(C)OCC[C@@H]12,"InChI=1S/C32H49N3O6/c1-31(2,3)34-29(37)26-17-22-12-8-9-13-23(22)18-35(26)19-27(36)25(16-21-10-6-5-7-11-21)33-30(38)41-28-20-40-32(4)24(28)14-15-39-32/h5-7,10-11,22-28,36H,8-9,12-20H2,1-4H3,(H,33,38)(H,34,37)/t22-,23+,24-,25-,26-,27+,28-,32+/m0/s1",ZLEDGBHPLZJCAM-WWBVHEESSA-N,572,"(3R,3aS,6aR)-6a-methyl-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Isoquinoline furanyl urethane analog. 12",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 18.1
615,C[C@@H]1C[C@H]2[C@H](CO[C@H]2O1)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H49N3O6/c1-20-14-24-28(19-39-30(24)40-20)41-31(38)33-25(15-21-10-6-5-7-11-21)27(36)18-35-17-23-13-9-8-12-22(23)16-26(35)29(37)34-32(2,3)4/h5-7,10-11,20,22-28,30,36H,8-9,12-19H2,1-4H3,(H,33,38)(H,34,37)/t20-,22+,23-,24+,25+,26+,27-,28+,30+/m1/s1",GULNVBULBGZNHI-OFBJBTPISA-N,573,"(3R,3aS,5R,6aS)-5-methyl-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::(3S,4aS,8aS,2 R,3 S,3 R,3 aS,5 R,6 aR)-N-tert-Butyl-2-[2 -hydroxy-4 -phenyl-3 -[[[(5 -methyl-3 -hexahydrofuro-[2,3-b]furanyl)oxy]carbonyl]amino]butyl]decahydroiso-quinoline-3-carboxamide::Isoquinoline furanyl urethane analog. 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.1
616,C[C@H]1C[C@H]2[C@H](CO[C@H]2O1)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H49N3O6/c1-20-14-24-28(19-39-30(24)40-20)41-31(38)33-25(15-21-10-6-5-7-11-21)27(36)18-35-17-23-13-9-8-12-22(23)16-26(35)29(37)34-32(2,3)4/h5-7,10-11,20,22-28,30,36H,8-9,12-19H2,1-4H3,(H,33,38)(H,34,37)/t20-,22-,23+,24-,25-,26-,27+,28-,30-/m0/s1",GULNVBULBGZNHI-YQGWVJSMSA-N,574,"(3R,3aS,5S,6aS)-5-methyl-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::(3S,4aS,8aS,2 R,3 S,3 R,3 aS,5 S,6 aR)-N-tert-Butyl-2-[2 -hydroxy-4 -phenyl-3 -[[[(5 -methyl-3 -hexahydrofuro-[2,3-b]furanyl)oxy]carbonyl]amino]butyl]decahydroiso-quinoline-3-carboxamide::Isoquinoline furanyl urethane analog. 14",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 27.1
617,O[C@H]([C@@H](O)[C@@H](OCc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](OCc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H40N2O8/c41-29-19-25-15-7-9-17-27(25)31(29)39-37(45)35(47-21-23-11-3-1-4-12-23)33(43)34(44)36(48-22-24-13-5-2-6-14-24)38(46)40-32-28-18-10-8-16-26(28)20-30(32)42/h1-18,29-36,41-44H,19-22H2,(H,39,45)(H,40,46)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",UOHMQWQGAJAUGT-JQFCFGFHSA-N,358,"(2R,3R,4R,5R)-2,5-bis(benzyloxy)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::1-Valine Methylamide deriv. 11::C2-symmetric compound 8::Diol-Based HIV-1 protease inhibitor 1::symmetric/asymmetric inhibitor 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
618,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccccc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H46N4O8/c1-19(2)23(29(39)33-5)35-31(41)27(43-17-21-13-9-7-10-14-21)25(37)26(38)28(44-18-22-15-11-8-12-16-22)32(42)36-24(20(3)4)30(40)34-6/h7-16,19-20,23-28,37-38H,17-18H2,1-6H3,(H,33,39)(H,34,40)(H,35,41)(H,36,42)/t23-,24-,25+,26+,27+,28+/m0/s1",QHMBKCCJSCSGHG-BQXGFVACSA-N,348,"(2R,3R,4R,5R)-2,5-bis(benzyloxy)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 1::C2-Symmetric Inhibitor 2::C2-symmetric compound 5::CHEMBL105459::Diol-Based HIV-1 protease inhibitor 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
619,O[C@@H]([C@@H](O)[C@@H](CCc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](CCc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C40H44N2O6/c43-33-23-27-15-7-9-17-29(27)35(33)41-39(47)31(21-19-25-11-3-1-4-12-25)37(45)38(46)32(22-20-26-13-5-2-6-14-26)40(48)42-36-30-18-10-8-16-28(30)24-34(36)44/h1-18,31-38,43-46H,19-24H2,(H,41,47)(H,42,48)/t31-,32-,33-,34-,35+,36+,37-,38+/m1/s1",GQKBYZPVKVXMJL-RUUZJYLSSA-N,584,"(2R,3R,4S,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide::Diol-Based HIV-1 protease inhibitor 3::N1,N6 -Bis[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4S,5R)-3,4-dihydroxy-2,5-bis(2-phenylethyl)hexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
620,O[C@@H]([C@H](O)[C@@H](CCc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](CCc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C40H44N2O6/c43-33-23-27-15-7-9-17-29(27)35(33)41-39(47)31(21-19-25-11-3-1-4-12-25)37(45)38(46)32(22-20-26-13-5-2-6-14-26)40(48)42-36-30-18-10-8-16-28(30)24-34(36)44/h1-18,31-38,43-46H,19-24H2,(H,41,47)(H,42,48)/t31-,32-,33-,34-,35+,36+,37-,38-/m1/s1",GQKBYZPVKVXMJL-LAFNQVRVSA-N,585,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide::Diol-Based HIV-1 protease inhibitor 4::N1,N6 -Bis[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-3,4-dihydroxy-2,5-bis(2-phenylethyl)hexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
621,CNC(=O)[C@@H](NC(=O)[C@H](CCc1ccccc1)[C@@H](O)[C@@H](O)[C@@H](CCc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C34H50N4O6/c1-21(2)27(33(43)35-5)37-31(41)25(19-17-23-13-9-7-10-14-23)29(39)30(40)26(20-18-24-15-11-8-12-16-24)32(42)38-28(22(3)4)34(44)36-6/h7-16,21-22,25-30,39-40H,17-20H2,1-6H3,(H,35,43)(H,36,44)(H,37,41)(H,38,42)/t25-,26-,27+,28+,29-,30+/m1/s1",GHXMNIYXDTYJRJ-FBLDLFPLSA-N,586,"(2R,3R,4S,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis(2-phenylethyl)hexanediamide::Diol-Based HIV-1 protease inhibitor 5::N ,N6 -Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4S,5R)-3,4-dihydroxy-2,5-bis(2-phenylethyl)hexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
622,CNC(=O)[C@@H](NC(=O)[C@H](CCc1ccccc1)[C@@H](O)[C@H](O)[C@@H](CCc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C34H50N4O6/c1-21(2)27(33(43)35-5)37-31(41)25(19-17-23-13-9-7-10-14-23)29(39)30(40)26(20-18-24-15-11-8-12-16-24)32(42)38-28(22(3)4)34(44)36-6/h7-16,21-22,25-30,39-40H,17-20H2,1-6H3,(H,35,43)(H,36,44)(H,37,41)(H,38,42)/t25-,26-,27+,28+,29-,30-/m1/s1",GHXMNIYXDTYJRJ-RTJSNJMCSA-N,587,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis(2-phenylethyl)hexanediamide::Diol-Based HIV-1 protease inhibitor 6::N1,N 6 -Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-3,4-dihydroxy-2,5-bis(2-phenylethyl)hexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
623,COC(=O)[C@@H](NC(=O)Cc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)Cc2ccccc2)C(=O)OC)C(C)(C)S1,"InChI=1S/C36H48N6O8S2/c1-35(2)27(41-31(51-35)25(33(47)49-5)39-23(43)19-21-13-9-7-10-14-21)29(45)37-17-18-38-30(46)28-36(3,4)52-32(42-28)26(34(48)50-6)40-24(44)20-22-15-11-8-12-16-22/h7-16,25-28,31-32,41-42H,17-20H2,1-6H3,(H,37,45)(H,38,46)(H,39,43)(H,40,44)/t25-,26-,27-,28-,31+,32+/m0/s1",CMJNUODSZAGDEG-WBASAELKSA-N,588,"CHEMBL104525::[ 2R-[ 2a(R*),4B ] ]-4,4 -[ 1,2-Ethanediylbis[ aminocarbonyl ] ]-bis[ 5,5-dimethyl-a-[ (phenylacetyl)amino]-2-thiazolidineacetic acid, methyl ester]::methyl (2R)-2-[(2R,4S)-4-[(2-{[(2R,4S)-2-[(1R)-2-methoxy-2-oxo-1-(1-phenylacetamido)ethyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)carbamoyl]-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-(1-phenylacetamido)acetate::penicillin Et(NH)2 Sym dimer::penicillin deriv. 1",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 60
624,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(N)=O)[C@H](NC(=O)Cc1ccccc1)C(N)=O,"InChI=1S/C34H46N8O6S2/c1-33(2)25(41-31(49-33)23(27(35)45)39-21(43)17-19-11-7-5-8-12-19)29(47)37-15-16-38-30(48)26-34(3,4)50-32(42-26)24(28(36)46)40-22(44)18-20-13-9-6-10-14-20/h5-14,23-26,31-32,41-42H,15-18H2,1-4H3,(H2,35,45)(H2,36,46)(H,37,47)(H,38,48)(H,39,43)(H,40,44)/t23-,24-,25+,26+,31-,32-/m1/s1",IDHURSFRXZMVBL-QTDZXXNUSA-N,589,"(2R,4S)-2-[(R)-carbamoyl(1-phenylacetamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-carbamoyl(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::CHEMBL105695::penicillin Et(NH)2 Sym dimer::penicillin deriv. 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.0
625,CCNC(=O)[C@@H](NC(=O)Cc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)Cc2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C38H54N8O6S2/c1-7-39-31(49)27(43-25(47)21-23-15-11-9-12-16-23)35-45-29(37(3,4)53-35)33(51)41-19-20-42-34(52)30-38(5,6)54-36(46-30)28(32(50)40-8-2)44-26(48)22-24-17-13-10-14-18-24/h9-18,27-30,35-36,45-46H,7-8,19-22H2,1-6H3,(H,39,49)(H,40,50)(H,41,51)(H,42,52)(H,43,47)(H,44,48)/t27-,28-,29+,30+,35-,36-/m1/s1",YPQFZEWXZJFGOG-HTCODBRUSA-N,590,"(2R,4S)-2-[(R)-(ethylcarbamoyl)(1-phenylacetamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::CHEMBL105851::[2R-[2a(R*),4B]]-4,4 -[ 1,2-Ethanediylbis[ aminocarbonyl]]-bis[N-ethyl-5,5-dimethyl-a-[ (phenylacetyl)amino]-2-thiazolidineacetamide]::penicillin Et(NH)2 Sym dimmer::penicillin deriv. 3",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.8
626,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C48H58N8O6S2/c1-47(2)39(55-45(63-47)37(41(59)51-29-33-21-13-7-14-22-33)53-35(57)27-31-17-9-5-10-18-31)43(61)49-25-26-50-44(62)40-48(3,4)64-46(56-40)38(42(60)52-30-34-23-15-8-16-24-34)54-36(58)28-32-19-11-6-12-20-32/h5-24,37-40,45-46,55-56H,25-30H2,1-4H3,(H,49,61)(H,50,62)(H,51,59)(H,52,60)(H,53,57)(H,54,58)/t37-,38-,39+,40+,45-,46-/m1/s1",RSEVSRUJHNNIBW-UWLABFHASA-N,591,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::CHEMBL102664::penicillin deriv. 4",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.9
627,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)OCc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)OCc1ccccc1,"InChI=1S/C48H56N6O8S2/c1-47(2)39(53-43(63-47)37(45(59)61-29-33-21-13-7-14-22-33)51-35(55)27-31-17-9-5-10-18-31)41(57)49-25-26-50-42(58)40-48(3,4)64-44(54-40)38(46(60)62-30-34-23-15-8-16-24-34)52-36(56)28-32-19-11-6-12-20-32/h5-24,37-40,43-44,53-54H,25-30H2,1-4H3,(H,49,57)(H,50,58)(H,51,55)(H,52,56)/t37-,38-,39-,40-,43+,44+/m0/s1",IKUFDUQKHKVTGZ-HGQKMWNXSA-N,592,"Penicillin Et(NH)2 Sym dimer ::benzyl (2R)-2-[(2R,4S)-4-[(2-{[(2R,4S)-2-[(1R)-2-(benzyloxy)-2-oxo-1-(1-phenylacetamido)ethyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)carbamoyl]-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-(1-phenylacetamido)acetate::penicillin deriv. 5",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 75
628,CN(C)C(=O)[C@@H](NC(=O)Cc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)Cc2ccccc2)C(=O)N(C)C)C(C)(C)S1,"InChI=1S/C38H54N8O6S2/c1-37(2)29(43-33(53-37)27(35(51)45(5)6)41-25(47)21-23-15-11-9-12-16-23)31(49)39-19-20-40-32(50)30-38(3,4)54-34(44-30)28(36(52)46(7)8)42-26(48)22-24-17-13-10-14-18-24/h9-18,27-30,33-34,43-44H,19-22H2,1-8H3,(H,39,49)(H,40,50)(H,41,47)(H,42,48)/t27-,28-,29-,30-,33+,34+/m0/s1",ONTDUWVAEQZOGD-VPKQJOIYSA-N,593,"(2R,4S)-2-[(R)-(dimethylcarbamoyl)(1-phenylacetamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-(dimethylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 6",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 5.2
629,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCC(F)(F)F)[C@H](NC(=O)Cc1ccccc1)C(=O)NCC(F)(F)F,"InChI=1S/C38H48F6N8O6S2/c1-35(2)27(51-33(59-35)25(29(55)47-19-37(39,40)41)49-23(53)17-21-11-7-5-8-12-21)31(57)45-15-16-46-32(58)28-36(3,4)60-34(52-28)26(30(56)48-20-38(42,43)44)50-24(54)18-22-13-9-6-10-14-22/h5-14,25-28,33-34,51-52H,15-20H2,1-4H3,(H,45,57)(H,46,58)(H,47,55)(H,48,56)(H,49,53)(H,50,54)/t25-,26-,27+,28+,33-,34-/m1/s1",SRJPSKNGOVFEQC-FXDWKFNTSA-N,594,"(2R,4S)-N-(2-{[(2R,4S)-5,5-dimethyl-2-[(R)-(1-phenylacetamido)[(2,2,2-trifluoroethyl)carbamoyl]methyl]-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-2-[(R)-(1-phenylacetamido)[(2,2,2-trifluoroethyl)carbamoyl]methyl]-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 7",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.4
630,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)N1CCCCC1)[C@H](NC(=O)Cc1ccccc1)C(=O)N1CCCCC1,"InChI=1S/C44H62N8O6S2/c1-43(2)35(49-39(59-43)33(41(57)51-23-13-7-14-24-51)47-31(53)27-29-17-9-5-10-18-29)37(55)45-21-22-46-38(56)36-44(3,4)60-40(50-36)34(42(58)52-25-15-8-16-26-52)48-32(54)28-30-19-11-6-12-20-30/h5-6,9-12,17-20,33-36,39-40,49-50H,7-8,13-16,21-28H2,1-4H3,(H,45,55)(H,46,56)(H,47,53)(H,48,54)/t33-,34-,35-,36-,39+,40+/m0/s1",MOCWEQREIHGFDD-WYQIBVNASA-N,595,"(2R,4S)-N-(2-{[(2R,4S)-5,5-dimethyl-2-[(1R)-2-oxo-1-(1-phenylacetamido)-2-(piperidin-1-yl)ethyl]-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-2-[(1R)-2-oxo-1-(1-phenylacetamido)-2-(piperidin-1-yl)ethyl]-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 8",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 6.9
631,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCC1CCCCC1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCC1CCCCC1,"InChI=1S/C48H70N8O6S2/c1-47(2)39(55-45(63-47)37(41(59)51-29-33-21-13-7-14-22-33)53-35(57)27-31-17-9-5-10-18-31)43(61)49-25-26-50-44(62)40-48(3,4)64-46(56-40)38(42(60)52-30-34-23-15-8-16-24-34)54-36(58)28-32-19-11-6-12-20-32/h5-6,9-12,17-20,33-34,37-40,45-46,55-56H,7-8,13-16,21-30H2,1-4H3,(H,49,61)(H,50,62)(H,51,59)(H,52,60)(H,53,57)(H,54,58)/t37-,38-,39+,40+,45-,46-/m1/s1",ITOFMHXYOAGPKK-UWLABFHASA-N,596,"(2R,4S)-2-[(R)-[(cyclohexylmethyl)carbamoyl](1-phenylacetamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-[(cyclohexylmethyl)carbamoyl](1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 9",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 40
632,CN(Cc1ccccc1)C(=O)[C@@H](NC(=O)Cc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)Cc2ccccc2)C(=O)N(C)Cc2ccccc2)C(C)(C)S1,"InChI=1S/C50H62N8O6S2/c1-49(2)41(55-45(65-49)39(53-37(59)29-33-19-11-7-12-20-33)47(63)57(5)31-35-23-15-9-16-24-35)43(61)51-27-28-52-44(62)42-50(3,4)66-46(56-42)40(54-38(60)30-34-21-13-8-14-22-34)48(64)58(6)32-36-25-17-10-18-26-36/h7-26,39-42,45-46,55-56H,27-32H2,1-6H3,(H,51,61)(H,52,62)(H,53,59)(H,54,60)/t39-,40-,41-,42-,45+,46+/m0/s1",ATVGQDPVWYFCCA-RQBKSZSXSA-N,597,"(2R,4S)-2-[(R)-[benzyl(methyl)carbamoyl](1-phenylacetamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-[benzyl(methyl)carbamoyl](1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 820
633,CN(C)c1ccc(CNC(=O)[C@@H](NC(=O)Cc2ccccc2)[C@@H]2N[C@@H](C(=O)NCCNC(=O)[C@@H]3N[C@H](SC3(C)C)[C@H](NC(=O)Cc3ccccc3)C(=O)NCc3ccc(cc3)N(C)C)C(C)(C)S2)cc1,"InChI=1S/C52H68N10O6S2/c1-51(2)43(59-49(69-51)41(57-39(63)29-33-15-11-9-12-16-33)45(65)55-31-35-19-23-37(24-20-35)61(5)6)47(67)53-27-28-54-48(68)44-52(3,4)70-50(60-44)42(58-40(64)30-34-17-13-10-14-18-34)46(66)56-32-36-21-25-38(26-22-36)62(7)8/h9-26,41-44,49-50,59-60H,27-32H2,1-8H3,(H,53,67)(H,54,68)(H,55,65)(H,56,66)(H,57,63)(H,58,64)/t41-,42-,43+,44+,49-,50-/m1/s1",PCAHLYVLNWSQMR-GLLSFVIGSA-N,598,"(2R,4S)-2-[(R)-({[4-(dimethylamino)phenyl]methyl}carbamoyl)(1-phenylacetamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-({[4-(dimethylamino)phenyl]methyl}carbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 11",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 47
634,CC(C)(C)OC(=O)CNC(=O)[C@@H](NC(=O)Cc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)Cc2ccccc2)C(=O)NCC(=O)OC(C)(C)C)C(C)(C)S1,"InChI=1S/C46H66N8O10S2/c1-43(2,3)63-31(57)25-49-37(59)33(51-29(55)23-27-17-13-11-14-18-27)41-53-35(45(7,8)65-41)39(61)47-21-22-48-40(62)36-46(9,10)66-42(54-36)34(38(60)50-26-32(58)64-44(4,5)6)52-30(56)24-28-19-15-12-16-20-28/h11-20,33-36,41-42,53-54H,21-26H2,1-10H3,(H,47,61)(H,48,62)(H,49,59)(H,50,60)(H,51,55)(H,52,56)/t33-,34-,35+,36+,41-,42-/m1/s1",VMKIRLPDTOOXPM-VWMDCUNYSA-N,599,"Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 12::tert-butyl 2-[(2R)-2-[(2R,4S)-4-[(2-{[(2R,4S)-2-[(R)-{[2-(tert-butoxy)-2-oxoethyl]carbamoyl}(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)carbamoyl]-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-(1-phenylacetamido)acetamido]acetate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 21
635,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCC(O)=O)[C@H](NC(=O)Cc1ccccc1)C(=O)NCC(O)=O,"InChI=1S/C38H50N8O10S2/c1-37(2)29(45-35(57-37)27(31(53)41-19-25(49)50)43-23(47)17-21-11-7-5-8-12-21)33(55)39-15-16-40-34(56)30-38(3,4)58-36(46-30)28(32(54)42-20-26(51)52)44-24(48)18-22-13-9-6-10-14-22/h5-14,27-30,35-36,45-46H,15-20H2,1-4H3,(H,39,55)(H,40,56)(H,41,53)(H,42,54)(H,43,47)(H,44,48)(H,49,50)(H,51,52)/t27-,28-,29+,30+,35-,36-/m1/s1",XHDOJHIGYFGOND-HTCODBRUSA-N,600,"2-[(2R)-2-[(2R,4S)-4-[(2-{[(2R,4S)-2-[(R)-[(carboxymethyl)carbamoyl](1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)carbamoyl]-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-(1-phenylacetamido)acetamido]acetic acid::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 39
636,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccn1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccn1,"InChI=1S/C46H56N10O6S2/c1-45(2)37(55-43(63-45)35(39(59)51-27-31-19-11-13-21-47-31)53-33(57)25-29-15-7-5-8-16-29)41(61)49-23-24-50-42(62)38-46(3,4)64-44(56-38)36(40(60)52-28-32-20-12-14-22-48-32)54-34(58)26-30-17-9-6-10-18-30/h5-22,35-38,43-44,55-56H,23-28H2,1-4H3,(H,49,61)(H,50,62)(H,51,59)(H,52,60)(H,53,57)(H,54,58)/t35-,36-,37+,38+,43-,44-/m1/s1",ISGIGDDPEZVQPE-ZDHSOWNUSA-N,601,"(2R,4S)-N-(2-{[(2R,4S)-5,5-dimethyl-2-[(R)-(1-phenylacetamido)[(pyridin-2-ylmethyl)carbamoyl]methyl]-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-2-[(R)-(1-phenylacetamido)[(pyridin-2-ylmethyl)carbamoyl]methyl]-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer::penicillin deriv. 14",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 11
637,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCCO)[C@H](NC(=O)Cc1ccccc1)C(=O)NCCO,"InChI=1S/C38H54N8O8S2/c1-37(2)29(45-35(55-37)27(31(51)41-17-19-47)43-25(49)21-23-11-7-5-8-12-23)33(53)39-15-16-40-34(54)30-38(3,4)56-36(46-30)28(32(52)42-18-20-48)44-26(50)22-24-13-9-6-10-14-24/h5-14,27-30,35-36,45-48H,15-22H2,1-4H3,(H,39,53)(H,40,54)(H,41,51)(H,42,52)(H,43,49)(H,44,50)/t27-,28-,29+,30+,35-,36-/m1/s1",BFFIPVLTEGEZDJ-HTCODBRUSA-N,602,"(2R,4S)-2-[(R)-[(2-hydroxyethyl)carbamoyl](1-phenylacetamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-[(2-hydroxyethyl)carbamoyl](1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer::penicillin deriv. 15",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 40
638,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)N(CCO)CCO)[C@H](NC(=O)Cc1ccccc1)C(=O)N(CCO)CCO,"InChI=1S/C42H62N8O10S2/c1-41(2)33(47-37(61-41)31(39(59)49(17-21-51)18-22-52)45-29(55)25-27-11-7-5-8-12-27)35(57)43-15-16-44-36(58)34-42(3,4)62-38(48-34)32(40(60)50(19-23-53)20-24-54)46-30(56)26-28-13-9-6-10-14-28/h5-14,31-34,37-38,47-48,51-54H,15-26H2,1-4H3,(H,43,57)(H,44,58)(H,45,55)(H,46,56)/t31-,32-,33-,34-,37+,38+/m0/s1",XHWZVIVIZRMCEG-YGOPLRPISA-N,603,"(2R,4S)-2-[(R)-[bis(2-hydroxyethyl)carbamoyl](1-phenylacetamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-[bis(2-hydroxyethyl)carbamoyl](1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer::penicillin deriv. 16",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 840
639,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@@H](CO)NC(=O)Cc1ccccc1)[C@@H](CO)NC(=O)Cc1ccccc1,"InChI=1S/C34H48N6O6S2/c1-33(2)27(39-31(47-33)23(19-41)37-25(43)17-21-11-7-5-8-12-21)29(45)35-15-16-36-30(46)28-34(3,4)48-32(40-28)24(20-42)38-26(44)18-22-13-9-6-10-14-22/h5-14,23-24,27-28,31-32,39-42H,15-20H2,1-4H3,(H,35,45)(H,36,46)(H,37,43)(H,38,44)/t23-,24-,27+,28+,31-,32-/m1/s1",ZJWOSCDRPXZBJU-AWAUJLNSSA-N,604,"(2R,4S)-2-[(1R)-2-hydroxy-1-(1-phenylacetamido)ethyl]-N-(2-{[(2R,4S)-2-[(1R)-2-hydroxy-1-(1-phenylacetamido)ethyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer::[ 2R[ 2a(R*),4B]]-N,N -[ l,2-Ethanediyl]bis[ 2-[2-hydroxyl-[ (phenylacetyl)amino]ethyl]-5,5-dimethyl-4-thiazolidinecarboxamide]::penicillin deriv. 17",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 140
640,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@@H](COC(=O)c1ccccc1)NC(=O)Cc1ccccc1)[C@@H](COC(=O)c1ccccc1)NC(=O)Cc1ccccc1,"InChI=1S/C48H56N6O8S2/c1-47(2)39(53-43(63-47)35(29-61-45(59)33-21-13-7-14-22-33)51-37(55)27-31-17-9-5-10-18-31)41(57)49-25-26-50-42(58)40-48(3,4)64-44(54-40)36(30-62-46(60)34-23-15-8-16-24-34)52-38(56)28-32-19-11-6-12-20-32/h5-24,35-36,39-40,43-44,53-54H,25-30H2,1-4H3,(H,49,57)(H,50,58)(H,51,55)(H,52,56)/t35-,36-,39+,40+,43-,44-/m1/s1",KPWCKNINNOIZFO-ZQYMVMDPSA-N,605,"(2R)-2-[(2R,4S)-4-[(2-{[(2R,4S)-2-[(1R)-2-(benzoyloxy)-1-(1-phenylacetamido)ethyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)carbamoyl]-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-(1-phenylacetamido)ethyl benzoate::Penicillin Et(NH)2 Sym dimer ::[2R[2a(R*),4B]]-N,N -[ l,2-Ethanediyl]bis[2-(benzoyloxy)-5,5-dimethyl-1-[ [ (phenylacetyl)amino]ethyl]-4-thiazolidinecarbolamide]::penicillin deriv. 18",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 70
641,CC1(C)S[C@H](CNC(=O)Cc2ccccc2)N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@@H](CNC(=O)Cc2ccccc2)SC1(C)C,"InChI=1S/C32H44N6O4S2/c1-31(2)27(37-25(43-31)19-35-23(39)17-21-11-7-5-8-12-21)29(41)33-15-16-34-30(42)28-32(3,4)44-26(38-28)20-36-24(40)18-22-13-9-6-10-14-22/h5-14,25-28,37-38H,15-20H2,1-4H3,(H,33,41)(H,34,42)(H,35,39)(H,36,40)/t25-,26-,27+,28+/m1/s1",WEWOEWMQDXTZHN-VIJSPRBVSA-N,606,"(2R,4S)-N-(2-{[(2R,4S)-5,5-dimethyl-2-[(1-phenylacetamido)methyl]-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-2-[(1-phenylacetamido)methyl]-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::[2R-trans]-N,N -[1,2-ethanediyl]bis[5,5-dimethyl-2-[[(phenylacetyl)amino]methyl]-4-thiazolidinecarboxamide]::penicillin deriv. 19",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 7800
642,CCNC(=O)[C@@H](NC(=O)Cc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@@H](CNC(=O)Cc3ccccc3)SC2(C)C)C(C)(C)S1,"InChI=1S/C35H49N7O5S2/c1-6-36-30(45)27(40-25(44)20-23-15-11-8-12-16-23)33-42-29(35(4,5)49-33)32(47)38-18-17-37-31(46)28-34(2,3)48-26(41-28)21-39-24(43)19-22-13-9-7-10-14-22/h7-16,26-29,33,41-42H,6,17-21H2,1-5H3,(H,36,45)(H,37,46)(H,38,47)(H,39,43)(H,40,44)/t26-,27-,28+,29+,33-/m1/s1",NRHQSCBNXQVHDR-HPLNQGHOSA-N,607,"(2R,4S)-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-2-[(1-phenylacetamido)methyl]-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::[2R-[ 2a( R*),4B]2 R-[ 2 B,4 a]]-N-Et hyl-5,5-dimethyl-4-[[[2-[[[5,5-dimethyl-2-[[ (phenylacetyl)amino]methyl]-4-thiazolidinyl]carbonyl]amino]ethyl]amino]carbonyl]-::a-[(phenylaceyl)amino]-2-thiazolidineacetamide::penicillin deriv. 20",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 35
643,CCNC(=O)[C@@H](NC(=O)Cc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2NCSC2(C)C)C(C)(C)S1,"InChI=1S/C26H40N6O4S2/c1-6-27-21(34)18(31-17(33)14-16-10-8-7-9-11-16)24-32-20(26(4,5)38-24)23(36)29-13-12-28-22(35)19-25(2,3)37-15-30-19/h7-11,18-20,24,30,32H,6,12-15H2,1-5H3,(H,27,34)(H,28,35)(H,29,36)(H,31,33)/t18-,19+,20+,24-/m1/s1",APXHKVJRHHJRLS-KCOOYEKVSA-N,608,"(4S)-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::[2R-[2a(R*),4B(S*)]-N-Ethyl-5,5-dimethyl-4-[[[2-[[(5,5-dimethyl-4-thiazolidinyl)carbonyl]amino]ethyl]amino-carbonyl-a-[(phenylacetyl)amino]-2-thiazolidineacetamide::penicillin deriv. 21",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 8800
644,CCNC(=O)[C@@H](NC(=O)Cc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)Cc2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C38H54N8O6S2/c1-7-39-31(49)27(43-25(47)21-23-15-11-9-12-16-23)35-45-29(37(3,4)53-35)33(51)41-19-20-42-34(52)30-38(5,6)54-36(46-30)28(32(50)40-8-2)44-26(48)22-24-17-13-10-14-18-24/h9-18,27-30,35-36,45-46H,7-8,19-22H2,1-6H3,(H,39,49)(H,40,50)(H,41,51)(H,42,52)(H,43,47)(H,44,48)/t27-,28-,29+,30+,35-,36-/m1/s1",YPQFZEWXZJFGOG-HTCODBRUSA-N,50407005,CHEMBL2021323::CHEMBL2021324::penicillin deriv. 22::penicillin deriv. 23,Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1300
645,CCNC(=O)[C@@H](NC(=O)Cc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)Cc2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C38H54N8O6S2/c1-7-39-31(49)27(43-25(47)21-23-15-11-9-12-16-23)35-45-29(37(3,4)53-35)33(51)41-19-20-42-34(52)30-38(5,6)54-36(46-30)28(32(50)40-8-2)44-26(48)22-24-17-13-10-14-18-24/h9-18,27-30,35-36,45-46H,7-8,19-22H2,1-6H3,(H,39,49)(H,40,50)(H,41,51)(H,42,52)(H,43,47)(H,44,48)/t27-,28-,29+,30+,35-,36-/m1/s1",YPQFZEWXZJFGOG-HTCODBRUSA-N,50407005,CHEMBL2021323::CHEMBL2021324::penicillin deriv. 22::penicillin deriv. 23,Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1300
646,CCNC(=O)[C@@H](N)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](N)C(=O)NCC)C(C)(C)S1,"InChI=1S/C22H42N8O4S2/c1-7-25-15(31)11(23)19-29-13(21(3,4)35-19)17(33)27-9-10-28-18(34)14-22(5,6)36-20(30-14)12(24)16(32)26-8-2/h11-14,19-20,29-30H,7-10,23-24H2,1-6H3,(H,25,31)(H,26,32)(H,27,33)(H,28,34)/t11-,12-,13+,14+,19-,20-/m1/s1",WVZKRTWBAZGGHV-YCUPPDIOSA-N,611,"(2R,4S)-2-[(R)-amino(ethylcarbamoyl)methyl]-N-(2-{[(2R,4S)-2-[(R)-amino(ethylcarbamoyl)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::[2R-[2a(R*),4B]]-4,4 -[1,2-Ethanediylbis[aminocarbonyl]]-bis[a-amino-5,5-dimethyl-N-(phenylmethyl)-2-thiazolidineacetamide]::penicillin deriv. 24",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 120000
647,CCNC(=O)[C@@H](NC(=O)c1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)c2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C36H50N8O6S2/c1-7-37-29(47)23(41-27(45)21-15-11-9-12-16-21)33-43-25(35(3,4)51-33)31(49)39-19-20-40-32(50)26-36(5,6)52-34(44-26)24(30(48)38-8-2)42-28(46)22-17-13-10-14-18-22/h9-18,23-26,33-34,43-44H,7-8,19-20H2,1-6H3,(H,37,47)(H,38,48)(H,39,49)(H,40,50)(H,41,45)(H,42,46)/t23-,24-,25+,26+,33-,34-/m1/s1",MXNDJZKEFYGXNY-BNFGRBGVSA-N,612,"(2R,4S)-2-[(R)-(ethylcarbamoyl)(phenylformamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)(phenylformamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 25",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 390
648,CCNC(=O)[C@@H](NC(=O)CCc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)CCc2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C40H58N8O6S2/c1-7-41-33(51)29(45-27(49)21-19-25-15-11-9-12-16-25)37-47-31(39(3,4)55-37)35(53)43-23-24-44-36(54)32-40(5,6)56-38(48-32)30(34(52)42-8-2)46-28(50)22-20-26-17-13-10-14-18-26/h9-18,29-32,37-38,47-48H,7-8,19-24H2,1-6H3,(H,41,51)(H,42,52)(H,43,53)(H,44,54)(H,45,49)(H,46,50)/t29-,30-,31+,32+,37-,38-/m1/s1",OSVARXBLQYUJJF-GDWNOHHZSA-N,613,"(2R,4S)-2-[(R)-(ethylcarbamoyl)(3-phenylpropanamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)(3-phenylpropanamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 26",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.4
649,CCNC(=O)[C@@H](NC(=O)Cc1ccc2ccccc2c1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)Cc2ccc3ccccc3c2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C46H58N8O6S2/c1-7-47-39(57)35(51-33(55)25-27-17-19-29-13-9-11-15-31(29)23-27)43-53-37(45(3,4)61-43)41(59)49-21-22-50-42(60)38-46(5,6)62-44(54-38)36(40(58)48-8-2)52-34(56)26-28-18-20-30-14-10-12-16-32(30)24-28/h9-20,23-24,35-38,43-44,53-54H,7-8,21-22,25-26H2,1-6H3,(H,47,57)(H,48,58)(H,49,59)(H,50,60)(H,51,55)(H,52,56)/t35-,36-,37+,38+,43-,44-/m1/s1",VDXLUWKNQATZLB-ZDHSOWNUSA-N,614,"(2R,4S)-2-[(R)-(ethylcarbamoyl)[1-(naphthalen-2-yl)acetamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)[1-(naphthalen-2-yl)acetamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 27",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 820
650,CCNC(=O)[C@@H](NC(=O)Cc1ccccn1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)Cc2ccccn2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C36H52N10O6S2/c1-7-37-29(49)25(43-23(47)19-21-13-9-11-15-39-21)33-45-27(35(3,4)53-33)31(51)41-17-18-42-32(52)28-36(5,6)54-34(46-28)26(30(50)38-8-2)44-24(48)20-22-14-10-12-16-40-22/h9-16,25-28,33-34,45-46H,7-8,17-20H2,1-6H3,(H,37,49)(H,38,50)(H,41,51)(H,42,52)(H,43,47)(H,44,48)/t25-,26-,27+,28+,33-,34-/m1/s1",PYVYPFLWULRSGG-FXDWKFNTSA-N,615,"(2R,4S)-2-[(R)-(ethylcarbamoyl)[1-(pyridin-2-yl)acetamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)[1-(pyridin-2-yl)acetamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 28",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 19
651,CCNC(=O)[C@@H](NC(=O)Cc1cccs1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)Cc2cccs2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C34H50N8O6S4/c1-7-35-27(45)23(39-21(43)17-19-11-9-15-49-19)31-41-25(33(3,4)51-31)29(47)37-13-14-38-30(48)26-34(5,6)52-32(42-26)24(28(46)36-8-2)40-22(44)18-20-12-10-16-50-20/h9-12,15-16,23-26,31-32,41-42H,7-8,13-14,17-18H2,1-6H3,(H,35,45)(H,36,46)(H,37,47)(H,38,48)(H,39,43)(H,40,44)/t23-,24-,25+,26+,31-,32-/m1/s1",CUBGMDXVITWRSB-QTDZXXNUSA-N,616,"(2R,4S)-2-[(R)-(ethylcarbamoyl)[1-(thiophen-2-yl)acetamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)[1-(thiophen-2-yl)acetamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::[2R-[2a(R*),4B]]-4,4 -[1,2-Ethanediyl] bis[aminocarbonyl]-bis[N-ethyl-5,5-dimethyl-a-[(2-thienylacetyl)amino]-2-thiazolidineacetamide]i::penicillin deriv. 29",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 15
652,CCNC(=O)[C@@H](NS(=O)(=O)Cc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NS(=O)(=O)Cc2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C36H54N8O8S4/c1-7-37-29(45)25(43-55(49,50)21-23-15-11-9-12-16-23)33-41-27(35(3,4)53-33)31(47)39-19-20-40-32(48)28-36(5,6)54-34(42-28)26(30(46)38-8-2)44-56(51,52)22-24-17-13-10-14-18-24/h9-18,25-28,33-34,41-44H,7-8,19-22H2,1-6H3,(H,37,45)(H,38,46)(H,39,47)(H,40,48)/t25-,26-,27+,28+,33-,34-/m1/s1",JSHJDJSZOFESCN-FXDWKFNTSA-N,617,"(2R,4S)-2-[(R)-(ethylcarbamoyl)(phenylmethane)sulfonamidomethyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)(phenylmethane)sulfonamidomethyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 30",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 58
653,CCNC(=O)[C@@H](NC(=O)Cc1ccc(O)cc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)Cc2ccc(O)cc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C38H54N8O8S2/c1-7-39-31(51)27(43-25(49)19-21-9-13-23(47)14-10-21)35-45-29(37(3,4)55-35)33(53)41-17-18-42-34(54)30-38(5,6)56-36(46-30)28(32(52)40-8-2)44-26(50)20-22-11-15-24(48)16-12-22/h9-16,27-30,35-36,45-48H,7-8,17-20H2,1-6H3,(H,39,51)(H,40,52)(H,41,53)(H,42,54)(H,43,49)(H,44,50)/t27-,28-,29+,30+,35-,36-/m1/s1",RAUZNXCOGCDWDG-HTCODBRUSA-N,618,"(2R,4S)-2-[(R)-(ethylcarbamoyl)[1-(4-hydroxyphenyl)acetamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)[1-(4-hydroxyphenyl)acetamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer::penicillin deriv. 31",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>12000
654,CCNC(=O)[C@@H](NC(=O)CC(C)C)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)CC(C)C)C(=O)NCC)C(C)(C)S1,"InChI=1S/C32H58N8O6S2/c1-11-33-25(43)21(37-19(41)15-17(3)4)29-39-23(31(7,8)47-29)27(45)35-13-14-36-28(46)24-32(9,10)48-30(40-24)22(26(44)34-12-2)38-20(42)16-18(5)6/h17-18,21-24,29-30,39-40H,11-16H2,1-10H3,(H,33,43)(H,34,44)(H,35,45)(H,36,46)(H,37,41)(H,38,42)/t21-,22-,23+,24+,29-,30-/m1/s1",DXBMQQLBQTVBBQ-DNVGPVBHSA-N,619,"(2R,4S)-2-[(R)-(ethylcarbamoyl)(3-methylbutanamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)(3-methylbutanamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::penicillin Et(NH)2 Sym dimer::penicillin deriv. 32",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 8.7
655,CCNC(=O)[C@@H](NC(=O)c1c(C)onc1-c1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)c2c(C)onc2-c2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C44H56N10O8S2/c1-9-45-37(57)31(49-35(55)27-23(3)61-53-29(27)25-17-13-11-14-18-25)41-51-33(43(5,6)63-41)39(59)47-21-22-48-40(60)34-44(7,8)64-42(52-34)32(38(58)46-10-2)50-36(56)28-24(4)62-54-30(28)26-19-15-12-16-20-26/h11-20,31-34,41-42,51-52H,9-10,21-22H2,1-8H3,(H,45,57)(H,46,58)(H,47,59)(H,48,60)(H,49,55)(H,50,56)/t31-,32-,33+,34+,41-,42-/m1/s1",HKLUQPHPQBDWEO-SZODPJFOSA-N,620,"Penicillin Et(NH)2 Sym dimer ::[2R-[ 2a(R*),4B]]-4,4 -[1,2-Ethanediylbis[aminocarbonyl]]-bis[N-ethyl-5,5-dimethyl-a-[ [ (5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-2-thiazolidineacetamide]::penicillin deriv. 33",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 5.4
656,CCNC(=O)[C@@H](NC(=O)c1ccccc1-c1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)c2ccccc2-c2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C48H58N8O6S2/c1-7-49-41(59)35(53-39(57)33-25-17-15-23-31(33)29-19-11-9-12-20-29)45-55-37(47(3,4)63-45)43(61)51-27-28-52-44(62)38-48(5,6)64-46(56-38)36(42(60)50-8-2)54-40(58)34-26-18-16-24-32(34)30-21-13-10-14-22-30/h9-26,35-38,45-46,55-56H,7-8,27-28H2,1-6H3,(H,49,59)(H,50,60)(H,51,61)(H,52,62)(H,53,57)(H,54,58)/t35-,36-,37+,38+,45-,46-/m1/s1",IHQOLDBRNQEINO-PEPUJIJLSA-N,621,"(2R,4S)-2-[(R)-(ethylcarbamoyl)[(2-phenylphenyl)formamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)[(2-phenylphenyl)formamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 34",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 9.9
657,CCNC(=O)[C@@H](NC(=O)c1ccccc1Cc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)c2ccccc2Cc2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C50H62N8O6S2/c1-7-51-43(61)37(55-41(59)35-25-17-15-23-33(35)29-31-19-11-9-12-20-31)47-57-39(49(3,4)65-47)45(63)53-27-28-54-46(64)40-50(5,6)66-48(58-40)38(44(62)52-8-2)56-42(60)36-26-18-16-24-34(36)30-32-21-13-10-14-22-32/h9-26,37-40,47-48,57-58H,7-8,27-30H2,1-6H3,(H,51,61)(H,52,62)(H,53,63)(H,54,64)(H,55,59)(H,56,60)/t37-,38-,39+,40+,47-,48-/m1/s1",XWGIKPIIQBFYGG-UOTBZOLVSA-N,622,"(2R,4S)-2-[(R)-[(2-benzylphenyl)formamido](ethylcarbamoyl)methyl]-N-(2-{[(2R,4S)-2-[(R)-[(2-benzylphenyl)formamido](ethylcarbamoyl)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 35",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 72
658,CCNC(=O)[C@@H](NC(=O)c1ccccc1Oc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)c2ccccc2Oc2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C48H58N8O8S2/c1-7-49-41(59)35(53-39(57)31-23-15-17-25-33(31)63-29-19-11-9-12-20-29)45-55-37(47(3,4)65-45)43(61)51-27-28-52-44(62)38-48(5,6)66-46(56-38)36(42(60)50-8-2)54-40(58)32-24-16-18-26-34(32)64-30-21-13-10-14-22-30/h9-26,35-38,45-46,55-56H,7-8,27-28H2,1-6H3,(H,49,59)(H,50,60)(H,51,61)(H,52,62)(H,53,57)(H,54,58)/t35-,36-,37+,38+,45-,46-/m1/s1",GJUACQHGCKQUSS-PEPUJIJLSA-N,623,"(2R,4S)-2-[(R)-(ethylcarbamoyl)[(2-phenoxyphenyl)formamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)[(2-phenoxyphenyl)formamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 36",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 160
659,CCNC(=O)[C@@H](NC(=O)c1ccccc1Nc1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)c2ccccc2Nc2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C48H60N10O6S2/c1-7-49-41(61)35(55-39(59)31-23-15-17-25-33(31)53-29-19-11-9-12-20-29)45-57-37(47(3,4)65-45)43(63)51-27-28-52-44(64)38-48(5,6)66-46(58-38)36(42(62)50-8-2)56-40(60)32-24-16-18-26-34(32)54-30-21-13-10-14-22-30/h9-26,35-38,45-46,53-54,57-58H,7-8,27-28H2,1-6H3,(H,49,61)(H,50,62)(H,51,63)(H,52,64)(H,55,59)(H,56,60)/t35-,36-,37+,38+,45-,46-/m1/s1",MOGAQQGCGJDNAL-PEPUJIJLSA-N,624,"(2R,4S)-2-[(R)-(ethylcarbamoyl)({[2-(phenylamino)phenyl]formamido})methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)({[2-(phenylamino)phenyl]formamido})methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 37",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4800
660,CCNC(=O)[C@@H](NC(=O)\C=C/c1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)\C=C/c2ccccc2)C(=O)NCC)C(C)(C)S1,"InChI=1S/C40H54N8O6S2/c1-7-41-33(51)29(45-27(49)21-19-25-15-11-9-12-16-25)37-47-31(39(3,4)55-37)35(53)43-23-24-44-36(54)32-40(5,6)56-38(48-32)30(34(52)42-8-2)46-28(50)22-20-26-17-13-10-14-18-26/h9-22,29-32,37-38,47-48H,7-8,23-24H2,1-6H3,(H,41,51)(H,42,52)(H,43,53)(H,44,54)(H,45,49)(H,46,50)/b21-19-,22-20-/t29-,30-,31+,32+,37-,38-/m1/s1",PHRPVVBORYLBTD-QOXXXAJFSA-N,625,"(2R,4S)-2-[(R)-(ethylcarbamoyl)[(2Z)-3-phenylprop-2-enamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-(ethylcarbamoyl)[(2Z)-3-phenylprop-2-enamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer::penicillin deriv. 38",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.9
661,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccn1)C(=O)NCc1ccccc1)[C@H](NC(=O)Cc1ccccn1)C(=O)NCc1ccccc1,"InChI=1S/C46H56N10O6S2/c1-45(2)37(55-43(63-45)35(39(59)51-27-29-15-7-5-8-16-29)53-33(57)25-31-19-11-13-21-47-31)41(61)49-23-24-50-42(62)38-46(3,4)64-44(56-38)36(40(60)52-28-30-17-9-6-10-18-30)54-34(58)26-32-20-12-14-22-48-32/h5-22,35-38,43-44,55-56H,23-28H2,1-4H3,(H,49,61)(H,50,62)(H,51,59)(H,52,60)(H,53,57)(H,54,58)/t35-,36-,37+,38+,43-,44-/m1/s1",GJFDHKMKAAWPPS-ZDHSOWNUSA-N,626,"(2R,4S)-2-[(R)-(benzylcarbamoyl)[1-(pyridin-2-yl)acetamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)[1-(pyridin-2-yl)acetamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 39",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.55
662,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccn1)C(=O)NCc1ccc(Cl)cc1)[C@H](NC(=O)Cc1ccccn1)C(=O)NCc1ccc(Cl)cc1,"InChI=1S/C46H54Cl2N10O6S2/c1-45(2)37(57-43(65-45)35(55-33(59)23-31-9-5-7-19-49-31)39(61)53-25-27-11-15-29(47)16-12-27)41(63)51-21-22-52-42(64)38-46(3,4)66-44(58-38)36(56-34(60)24-32-10-6-8-20-50-32)40(62)54-26-28-13-17-30(48)18-14-28/h5-20,35-38,43-44,57-58H,21-26H2,1-4H3,(H,51,63)(H,52,64)(H,53,61)(H,54,62)(H,55,59)(H,56,60)/t35-,36-,37+,38+,43-,44-/m1/s1",YFQXDMQSJQFILP-ZDHSOWNUSA-N,627,"(2R,4S)-2-[(R)-{[(4-chlorophenyl)methyl]carbamoyl}[1-(pyridin-2-yl)acetamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-{[(4-chlorophenyl)methyl]carbamoyl}[1-(pyridin-2-yl)acetamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::penicillin Et(NH)2 Sym dimer::penicillin deriv. 40",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 7.5
663,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccn1)C(=O)NCc1ccc(Cl)cc1Cl)[C@H](NC(=O)Cc1ccccn1)C(=O)NCc1ccc(Cl)cc1Cl,"InChI=1S/C46H52Cl4N10O6S2/c1-45(2)37(59-43(67-45)35(57-33(61)21-29-9-5-7-15-51-29)39(63)55-23-25-11-13-27(47)19-31(25)49)41(65)53-17-18-54-42(66)38-46(3,4)68-44(60-38)36(58-34(62)22-30-10-6-8-16-52-30)40(64)56-24-26-12-14-28(48)20-32(26)50/h5-16,19-20,35-38,43-44,59-60H,17-18,21-24H2,1-4H3,(H,53,65)(H,54,66)(H,55,63)(H,56,64)(H,57,61)(H,58,62)/t35-,36-,37+,38+,43-,44-/m1/s1",UFCZJNJTAXXEEG-ZDHSOWNUSA-N,628,"(2R,4S)-2-[(R)-{[(2,4-dichlorophenyl)methyl]carbamoyl}[1-(pyridin-2-yl)acetamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-{[(2,4-dichlorophenyl)methyl]carbamoyl}[1-(pyridin-2-yl)acetamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 41",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 14
664,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)c1ccccc1-c1ccccc1)C(=O)NCc1ccccc1)[C@H](NC(=O)c1ccccc1-c1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C58H62N8O6S2/c1-57(2)47(65-55(73-57)45(51(69)61-35-37-21-9-5-10-22-37)63-49(67)43-31-19-17-29-41(43)39-25-13-7-14-26-39)53(71)59-33-34-60-54(72)48-58(3,4)74-56(66-48)46(52(70)62-36-38-23-11-6-12-24-38)64-50(68)44-32-20-18-30-42(44)40-27-15-8-16-28-40/h5-32,45-48,55-56,65-66H,33-36H2,1-4H3,(H,59,71)(H,60,72)(H,61,69)(H,62,70)(H,63,67)(H,64,68)/t45-,46-,47+,48+,55-,56-/m1/s1",ZOQHQYKHUNCUNU-MMKQIJOCSA-N,629,"(2R,4S)-2-[(R)-(benzylcarbamoyl)[(2-phenylphenyl)formamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)[(2-phenylphenyl)formamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::[2R-[ 2a(R*),4B]]-4,4 -[1,2-Ethanediylbis[aminocarbonyl]]-bis[5,5-dimethyl-a-[[[(1,1 -biphenyl)-2-yl]carbonyl]amino]-N-(phenylmethyl)-2-thiazolidineacetamide]::penicillin deriv. 42",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 7.5
665,CN(C)c1ccc(CNC(=O)[C@@H](NC(=O)c2ccccc2-c2ccccc2)[C@@H]2N[C@@H](C(=O)NCCNC(=O)[C@@H]3N[C@H](SC3(C)C)[C@H](NC(=O)c3ccccc3-c3ccccc3)C(=O)NCc3ccc(cc3)N(C)C)C(C)(C)S2)cc1,"InChI=1S/C62H72N10O6S2/c1-61(2)51(69-59(79-61)49(55(75)65-37-39-27-31-43(32-28-39)71(5)6)67-53(73)47-25-17-15-23-45(47)41-19-11-9-12-20-41)57(77)63-35-36-64-58(78)52-62(3,4)80-60(70-52)50(56(76)66-38-40-29-33-44(34-30-40)72(7)8)68-54(74)48-26-18-16-24-46(48)42-21-13-10-14-22-42/h9-34,49-52,59-60,69-70H,35-38H2,1-8H3,(H,63,77)(H,64,78)(H,65,75)(H,66,76)(H,67,73)(H,68,74)/t49-,50-,51+,52+,59-,60-/m1/s1",KCAIPQHHQNOLSV-SYQKYBDCSA-N,630,"(2R,4S)-2-[(R)-({[4-(dimethylamino)phenyl]methyl}carbamoyl)[(2-phenylphenyl)formamido]methyl]-N-(2-{[(2R,4S)-2-[(R)-({[4-(dimethylamino)phenyl]methyl}carbamoyl)[(2-phenylphenyl)formamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 43",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.23
666,CC(C)(C)OC(=O)CNC(=O)[C@@H](NC(=O)c1ccccc1-c1ccccc1)[C@@H]1N[C@@H](C(=O)NCCNC(=O)[C@@H]2N[C@H](SC2(C)C)[C@H](NC(=O)c2ccccc2-c2ccccc2)C(=O)NCC(=O)OC(C)(C)C)C(C)(C)S1,"InChI=1S/C56H70N8O10S2/c1-53(2,3)73-39(65)31-59-47(69)41(61-45(67)37-27-19-17-25-35(37)33-21-13-11-14-22-33)51-63-43(55(7,8)75-51)49(71)57-29-30-58-50(72)44-56(9,10)76-52(64-44)42(48(70)60-32-40(66)74-54(4,5)6)62-46(68)38-28-20-18-26-36(38)34-23-15-12-16-24-34/h11-28,41-44,51-52,63-64H,29-32H2,1-10H3,(H,57,71)(H,58,72)(H,59,69)(H,60,70)(H,61,67)(H,62,68)/t41-,42-,43+,44+,51-,52-/m1/s1",FJCFRXMLYMDVAR-FFWFDUBJSA-N,631,"Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 44::tert-butyl 2-[(2R)-2-[(2R,4S)-4-[(2-{[(2R,4S)-2-[(R)-{[2-(tert-butoxy)-2-oxoethyl]carbamoyl}[(2-phenylphenyl)formamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)carbamoyl]-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylphenyl)formamido]acetamido]acetate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.1
667,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)c1ccccc1-c1ccccc1)C(=O)NCC(O)=O)[C@H](NC(=O)c1ccccc1-c1ccccc1)C(=O)NCC(O)=O,"InChI=1S/C48H54N8O10S2/c1-47(2)37(55-45(67-47)35(41(63)51-25-33(57)58)53-39(61)31-21-13-11-19-29(31)27-15-7-5-8-16-27)43(65)49-23-24-50-44(66)38-48(3,4)68-46(56-38)36(42(64)52-26-34(59)60)54-40(62)32-22-14-12-20-30(32)28-17-9-6-10-18-28/h5-22,35-38,45-46,55-56H,23-26H2,1-4H3,(H,49,65)(H,50,66)(H,51,63)(H,52,64)(H,53,61)(H,54,62)(H,57,58)(H,59,60)/t35-,36-,37+,38+,45-,46-/m1/s1",JQBRNXDUXTYTKY-PEPUJIJLSA-N,632,"2-[(2R)-2-[(2R,4S)-4-[(2-{[(2R,4S)-2-[(R)-[(carboxymethyl)carbamoyl][(2-phenylphenyl)formamido]methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)carbamoyl]-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-[(2-phenylphenyl)formamido]acetamido]acetic acid::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 45",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 39
668,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(OC)cc1,"InChI=1S/C29H40N2O8S/c1-4-20(2)17-31(40(34,35)23-12-10-22(36-3)11-13-23)18-26(32)25(16-21-8-6-5-7-9-21)30-29(33)39-27-19-38-28-24(27)14-15-37-28/h5-13,20,24-28,32H,4,14-19H2,1-3H3,(H,30,33)/t20-,24-,25-,26+,27-,28+/m0/s1",CXUFZTSMYKDYRK-QKULBLGOSA-N,112655,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-3-hydroxy-4-(4-methoxy-N-((S)-2-methylbutyl)phenylsulfonamido)-1-phenylbutan-2-yl)carbamate (10b)","Gag-Pol polyprotein [484-582,Q491K,I494L,I497V,V499I,E519D,I534V,R541K,D544E,Q553K,A555V,L573M]",Human immunodeficiency virus,
669,CC1(C)S[C@@H](N[C@H]1C(=O)NCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C48H58N8O6S2/c1-47(2)39(55-45(63-47)37(41(59)51-29-33-21-13-7-14-22-33)53-35(57)27-31-17-9-5-10-18-31)43(61)49-25-26-50-44(62)40-48(3,4)64-46(56-40)38(42(60)52-30-34-23-15-8-16-24-34)54-36(58)28-32-19-11-6-12-20-32/h5-24,37-40,45-46,55-56H,25-30H2,1-4H3,(H,49,61)(H,50,62)(H,51,59)(H,52,60)(H,53,57)(H,54,58)/t37-,38-,39+,40+,45-,46-/m1/s1",RSEVSRUJHNNIBW-UWLABFHASA-N,591,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-(2-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}ethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::CHEMBL102664::penicillin deriv. 4",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.9
670,CC1(C)S[C@@H](N[C@H]1C(=O)NCCCNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C49H60N8O6S2/c1-48(2)40(56-46(64-48)38(42(60)52-30-34-22-13-7-14-23-34)54-36(58)28-32-18-9-5-10-19-32)44(62)50-26-17-27-51-45(63)41-49(3,4)65-47(57-41)39(43(61)53-31-35-24-15-8-16-25-35)55-37(59)29-33-20-11-6-12-21-33/h5-16,18-25,38-41,46-47,56-57H,17,26-31H2,1-4H3,(H,50,62)(H,51,63)(H,52,60)(H,53,61)(H,54,58)(H,55,59)/t38-,39-,40+,41+,46-,47-/m1/s1",XMIJDZJXXSLMTK-WATWFJIKSA-N,635,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-(3-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}propyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::CHEMBL318844::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 48",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 540
671,CC1(C)S[C@@H](N[C@H]1C(=O)NCC(O)CNC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C49H60N8O7S2/c1-48(2)40(56-46(65-48)38(42(61)50-27-33-21-13-7-14-22-33)54-36(59)25-31-17-9-5-10-18-31)44(63)52-29-35(58)30-53-45(64)41-49(3,4)66-47(57-41)39(43(62)51-28-34-23-15-8-16-24-34)55-37(60)26-32-19-11-6-12-20-32/h5-24,35,38-41,46-47,56-58H,25-30H2,1-4H3,(H,50,61)(H,51,62)(H,52,63)(H,53,64)(H,54,59)(H,55,60)/t38-,39-,40+,41+,46-,47-/m1/s1",GXCDCTCRXPBCGV-WATWFJIKSA-N,636,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-(3-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-2-hydroxypropyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::CHEMBL317882::Penicillin Et(NH)2 Sym dimer ::penicillin deriv. 49",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 5
672,CC1(C)S[C@@H](N[C@H]1C(N)=O)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C23H28N4O3S/c1-23(2)19(20(24)29)27-22(31-23)18(21(30)25-14-16-11-7-4-8-12-16)26-17(28)13-15-9-5-3-6-10-15/h3-12,18-19,22,27H,13-14H2,1-2H3,(H2,24,29)(H,25,30)(H,26,28)/t18-,19+,22-/m1/s1",FHJRDQOWYRRIAG-XQBPLPMBSA-N,637,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::[2R-[2a(R*),4B]]-4-Carbamoyl-5,5-dimethyl-a-[(phenylacetyl)amino]-N-(phenylmethyl)-2-thiazolidineacetamide::penicillin deriv. 50",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>230000
673,CC1(C)S[C@@H](N[C@H]1C(=O)NCCO)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C25H32N4O4S/c1-25(2)21(23(33)26-13-14-30)29-24(34-25)20(22(32)27-16-18-11-7-4-8-12-18)28-19(31)15-17-9-5-3-6-10-17/h3-12,20-21,24,29-30H,13-16H2,1-2H3,(H,26,33)(H,27,32)(H,28,31)/t20-,21+,24-/m1/s1",VBUYWJMBLILCOH-ZFGGDYGUSA-N,638,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-(2-hydroxyethyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::penicillin deriv. 51",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 180000
674,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](CO)Cc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C32H38N4O4S/c1-32(2)28(30(40)34-25(21-37)18-22-12-6-3-7-13-22)36-31(41-32)27(29(39)33-20-24-16-10-5-11-17-24)35-26(38)19-23-14-8-4-9-15-23/h3-17,25,27-28,31,36-37H,18-21H2,1-2H3,(H,33,39)(H,34,40)(H,35,38)/t25-,27+,28-,31+/m0/s1",USQYZVYUUXQZHL-CRNZTWHPSA-N,639,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::penicillin deriv. 52",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>170000
675,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@@H](CO)Cc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C32H38N4O4S/c1-32(2)28(30(40)34-25(21-37)18-22-12-6-3-7-13-22)36-31(41-32)27(29(39)33-20-24-16-10-5-11-17-24)35-26(38)19-23-14-8-4-9-15-23/h3-17,25,27-28,31,36-37H,18-21H2,1-2H3,(H,33,39)(H,34,40)(H,35,38)/t25-,27-,28+,31-/m1/s1",USQYZVYUUXQZHL-IIHCQYLKSA-N,640,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-[(2R)-1-hydroxy-3-phenylpropan-2-yl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::[2R-[2a(R*),4B(R)]]-5,5-Dimethyl-a-[(phenylacety1)amino]-N-(phenylmethyl)-4-[[[1-(2-phenyl-1-( hydroxymethyl))ethyl]amino]carbonyl]-2-thiazolidineacetamide::penicillin deriv. 53",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 150
676,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](CO)CCc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C33H40N4O4S/c1-33(2)29(31(41)35-26(22-38)19-18-23-12-6-3-7-13-23)37-32(42-33)28(30(40)34-21-25-16-10-5-11-17-25)36-27(39)20-24-14-8-4-9-15-24/h3-17,26,28-29,32,37-38H,18-22H2,1-2H3,(H,34,40)(H,35,41)(H,36,39)/t26-,28+,29-,32+/m0/s1",XYMBMWROXCSVHN-MDBSOONOSA-N,641,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-[(2S)-1-hydroxy-4-phenylbutan-2-yl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::penicillin deriv. 54",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 26000
677,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@@H](CO)CCc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C33H40N4O4S/c1-33(2)29(31(41)35-26(22-38)19-18-23-12-6-3-7-13-23)37-32(42-33)28(30(40)34-21-25-16-10-5-11-17-25)36-27(39)20-24-14-8-4-9-15-24/h3-17,26,28-29,32,37-38H,18-22H2,1-2H3,(H,34,40)(H,35,41)(H,36,39)/t26-,28-,29+,32-/m1/s1",XYMBMWROXCSVHN-NFFKMHHLSA-N,642,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-[(2R)-1-hydroxy-4-phenylbutan-2-yl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::penicillin deriv. 55",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 25000
678,CC(C)C[C@H](CO)NC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C29H40N4O4S/c1-19(2)15-22(18-34)31-27(37)25-29(3,4)38-28(33-25)24(26(36)30-17-21-13-9-6-10-14-21)32-23(35)16-20-11-7-5-8-12-20/h5-14,19,22,24-25,28,33-34H,15-18H2,1-4H3,(H,30,36)(H,31,37)(H,32,35)/t22-,24-,25+,28-/m1/s1",QXFCNTMNRXZPSF-KEHCTXMOSA-N,643,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-[(2R)-1-hydroxy-4-methylpentan-2-yl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::penicillin deriv. 56",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>4600
679,CC(C)[C@H](CO)NC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C28H38N4O4S/c1-18(2)21(17-33)30-26(36)24-28(3,4)37-27(32-24)23(25(35)29-16-20-13-9-6-10-14-20)31-22(34)15-19-11-7-5-8-12-19/h5-14,18,21,23-24,27,32-33H,15-17H2,1-4H3,(H,29,35)(H,30,36)(H,31,34)/t21-,23+,24-,27+/m0/s1",VKKGVLUDMWPWOL-WCJVPVSSSA-N,644,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-[(2R)-1-hydroxy-3-methylbutan-2-yl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::penicillin deriv. 57",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>4700
680,CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(CO)cc1,"InChI=1S/C29H40N2O8S/c1-3-20(2)16-31(40(35,36)23-11-9-22(18-32)10-12-23)17-26(33)25(15-21-7-5-4-6-8-21)30-29(34)39-27-19-38-28-24(27)13-14-37-28/h4-12,20,24-28,32-33H,3,13-19H2,1-2H3,(H,30,34)/t20-,24-,25-,26+,27-,28+/m0/s1",ALWBGUNCNDFMFE-QKULBLGOSA-N,112656,"(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-3-hydroxy-4-(4-(hydroxymethyl)-N-((S)-2-methylbutyl)phenylsulfonamido)-1-phenylbutan-2-yl)carbamate (10c)","Gag-Pol polyprotein [484-582,Q491K,I494L,I497V,V499I,E519D,I534V,R541K,D544E,Q553K,A555V,L573M]",Human immunodeficiency virus,
681,CCCCC(CO)NC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C29H40N4O4S/c1-4-5-16-22(19-34)31-27(37)25-29(2,3)38-28(33-25)24(26(36)30-18-21-14-10-7-11-15-21)32-23(35)17-20-12-8-6-9-13-20/h6-15,22,24-25,28,33-34H,4-5,16-19H2,1-3H3,(H,30,36)(H,31,37)(H,32,35)/t22?,24-,25+,28-/m1/s1",JRGKTJWRQVHKOO-OQWLWMRCSA-N,646,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-(1-hydroxyhexan-2-yl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::penicillin deriv. 59",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 250
682,CCC(C)C(CO)NC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C29H40N4O4S/c1-5-19(2)22(18-34)31-27(37)25-29(3,4)38-28(33-25)24(26(36)30-17-21-14-10-7-11-15-21)32-23(35)16-20-12-8-6-9-13-20/h6-15,19,22,24-25,28,33-34H,5,16-18H2,1-4H3,(H,30,36)(H,31,37)(H,32,35)/t19?,22?,24-,25+,28-/m1/s1",BCZIGYZPCOHKSH-QLWOFVCWSA-N,647,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-(1-hydroxy-3-methylpentan-2-yl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::penicillin deriv. 60",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>540
683,C[C@H](CO)NC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C26H34N4O4S/c1-17(16-31)28-24(34)22-26(2,3)35-25(30-22)21(23(33)27-15-19-12-8-5-9-13-19)29-20(32)14-18-10-6-4-7-11-18/h4-13,17,21-22,25,30-31H,14-16H2,1-3H3,(H,27,33)(H,28,34)(H,29,32)/t17-,21-,22+,25-/m1/s1",SSQONQKUEJFTBA-SQTZCGGWSA-N,648,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-N-[(2R)-1-hydroxypropan-2-yl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::penicillin deriv. 61",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>20000
684,C[C@@H](Cc1ccccc1)NC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C32H38N4O3S/c1-22(19-23-13-7-4-8-14-23)34-30(39)28-32(2,3)40-31(36-28)27(29(38)33-21-25-17-11-6-12-18-25)35-26(37)20-24-15-9-5-10-16-24/h4-18,22,27-28,31,36H,19-21H2,1-3H3,(H,33,38)(H,34,39)(H,35,37)/t22-,27+,28-,31+/m0/s1",QTNAAUNGPVSOQG-UTRCQKEQSA-N,649,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-N-[(2S)-1-phenylpropan-2-yl]-1,3-thiazolidine-4-carboxamide::penicillin deriv. 62",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>180000
685,C[C@H](Cc1ccccc1)NC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C32H38N4O3S/c1-22(19-23-13-7-4-8-14-23)34-30(39)28-32(2,3)40-31(36-28)27(29(38)33-21-25-17-11-6-12-18-25)35-26(37)20-24-15-9-5-10-16-24/h4-18,22,27-28,31,36H,19-21H2,1-3H3,(H,33,38)(H,34,39)(H,35,37)/t22-,27-,28+,31-/m1/s1",QTNAAUNGPVSOQG-JZJGJFRJSA-N,650,"(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-N-[(2R)-1-phenylpropan-2-yl]-1,3-thiazolidine-4-carboxamide::penicillin deriv. 63",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>180000
686,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](Cc1ccccc1)[C@@H](O)CC(N)=O)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C34H41N5O5S/c1-34(2)30(32(44)37-25(26(40)20-27(35)41)18-22-12-6-3-7-13-22)39-33(45-34)29(31(43)36-21-24-16-10-5-11-17-24)38-28(42)19-23-14-8-4-9-15-23/h3-17,25-26,29-30,33,39-40H,18-21H2,1-2H3,(H2,35,41)(H,36,43)(H,37,44)(H,38,42)/t25-,26+,29-,30+,33-/m1/s1",KMGABVMIQPZZHU-YQGVTGCHSA-N,651,"(3S,4R)-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-5-phenylpentanamide::penicillin deriv. 64",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1900
687,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](Cc1ccccc1)[C@H](O)CC(N)=O)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C34H41N5O5S/c1-34(2)30(32(44)37-25(26(40)20-27(35)41)18-22-12-6-3-7-13-22)39-33(45-34)29(31(43)36-21-24-16-10-5-11-17-24)38-28(42)19-23-14-8-4-9-15-23/h3-17,25-26,29-30,33,39-40H,18-21H2,1-2H3,(H2,35,41)(H,36,43)(H,37,44)(H,38,42)/t25-,26-,29-,30+,33-/m1/s1",KMGABVMIQPZZHU-MOYXPMDPSA-N,652,"(3R,4R)-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-5-phenylpentanamide::penicillin deriv. 65",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 82
688,CC(C)CNC(=O)C[C@H](O)[C@@H](Cc1ccccc1)NC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C38H49N5O5S/c1-25(2)23-39-31(45)22-30(44)29(20-26-14-8-5-9-15-26)41-36(48)34-38(3,4)49-37(43-34)33(35(47)40-24-28-18-12-7-13-19-28)42-32(46)21-27-16-10-6-11-17-27/h5-19,25,29-30,33-34,37,43-44H,20-24H2,1-4H3,(H,39,45)(H,40,47)(H,41,48)(H,42,46)/t29-,30+,33-,34+,37-/m1/s1",VASWCZNNYHXDLS-DQKWKFQLSA-N,653,"(3S,4R)-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-N-(2-methylpropyl)-5-phenylpentanamide::penicillin deriv. 66",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2800
689,CC(C)CNC(=O)C[C@@H](O)[C@@H](Cc1ccccc1)NC(=O)[C@@H]1N[C@H](SC1(C)C)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C38H49N5O5S/c1-25(2)23-39-31(45)22-30(44)29(20-26-14-8-5-9-15-26)41-36(48)34-38(3,4)49-37(43-34)33(35(47)40-24-28-18-12-7-13-19-28)42-32(46)21-27-16-10-6-11-17-27/h5-19,25,29-30,33-34,37,43-44H,20-24H2,1-4H3,(H,39,45)(H,40,47)(H,41,48)(H,42,46)/t29-,30-,33-,34+,37-/m1/s1",VASWCZNNYHXDLS-RKSPLQEMSA-N,654,"(3R,4R)-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-N-(2-methylpropyl)-5-phenylpentanamide::[2R-[2a(R*),4B(R*,R*)]]-5,5-Dimethyl-a-[(phenylacetyl)-amino]-N (phenylmet hy1)-4-[[[1-[ 2-hydroxy-4-[1-(2-methylpropyl)amino]]-4-oxo-1-(phenylmethyl)butyl]amino]carbonyl]-2-thiazolidineacetamide::penicillin deriv. 67",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 69
690,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](Cc1ccccc1)[C@@H](O)CC(=O)NCc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C41H47N5O5S/c1-41(2)37(39(51)44-32(23-28-15-7-3-8-16-28)33(47)25-34(48)42-26-30-19-11-5-12-20-30)46-40(52-41)36(38(50)43-27-31-21-13-6-14-22-31)45-35(49)24-29-17-9-4-10-18-29/h3-22,32-33,36-37,40,46-47H,23-27H2,1-2H3,(H,42,48)(H,43,50)(H,44,51)(H,45,49)/t32-,33+,36-,37+,40-/m1/s1",RNBNABRBLMLESP-DPWMVYLFSA-N,655,"(3S,4R)-N-benzyl-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-5-phenylpentanamide::penicillin deriv. 68",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2900
691,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](Cc1ccccc1)[C@H](O)CC(=O)NCc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C41H47N5O5S/c1-41(2)37(39(51)44-32(23-28-15-7-3-8-16-28)33(47)25-34(48)42-26-30-19-11-5-12-20-30)46-40(52-41)36(38(50)43-27-31-21-13-6-14-22-31)45-35(49)24-29-17-9-4-10-18-29/h3-22,32-33,36-37,40,46-47H,23-27H2,1-2H3,(H,42,48)(H,43,50)(H,44,51)(H,45,49)/t32-,33-,36-,37+,40-/m1/s1",RNBNABRBLMLESP-AVVHONGESA-N,656,"(3R,4R)-N-benzyl-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-5-phenylpentanamide::penicillin deriv. 69",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4.6
692,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](Cc1ccccc1)[C@@H](O)CC(=O)Nc1nc2ccccc2[nH]1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C41H45N7O5S/c1-41(2)36(48-39(54-41)35(37(52)42-25-28-18-10-5-11-19-28)46-33(50)23-27-16-8-4-9-17-27)38(53)43-31(22-26-14-6-3-7-15-26)32(49)24-34(51)47-40-44-29-20-12-13-21-30(29)45-40/h3-21,31-32,35-36,39,48-49H,22-25H2,1-2H3,(H,42,52)(H,43,53)(H,46,50)(H2,44,45,47,51)/t31-,32+,35-,36+,39-/m1/s1",BGTODZAMNVMTGT-JNNWWUKYSA-N,657,"(3S,4R)-N-(1H-1,3-benzodiazol-2-yl)-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-5-phenylpentanamide::penicillin deriv. 70",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>3800
693,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](Cc1ccccc1)[C@H](O)CC(=O)Nc1nc2ccccc2[nH]1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C41H45N7O5S/c1-41(2)36(48-39(54-41)35(37(52)42-25-28-18-10-5-11-19-28)46-33(50)23-27-16-8-4-9-17-27)38(53)43-31(22-26-14-6-3-7-15-26)32(49)24-34(51)47-40-44-29-20-12-13-21-30(29)45-40/h3-21,31-32,35-36,39,48-49H,22-25H2,1-2H3,(H,42,52)(H,43,53)(H,46,50)(H2,44,45,47,51)/t31-,32-,35-,36+,39-/m1/s1",BGTODZAMNVMTGT-NKMQKLKPSA-N,658,"(3R,4R)-N-(1H-1,3-benzodiazol-2-yl)-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-5-phenylpentanamide::penicillin deriv. 71",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 3.8
694,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](Cc1ccccc1)[C@H](O)CC(=O)N[C@@H](CO)c1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C42H49N5O6S/c1-42(2)38(47-41(54-42)37(39(52)43-26-30-19-11-5-12-20-30)46-35(50)24-29-17-9-4-10-18-29)40(53)45-32(23-28-15-7-3-8-16-28)34(49)25-36(51)44-33(27-48)31-21-13-6-14-22-31/h3-22,32-34,37-38,41,47-49H,23-27H2,1-2H3,(H,43,52)(H,44,51)(H,45,53)(H,46,50)/t32-,33+,34-,37-,38+,41-/m1/s1",QPKRELCYQDFLQW-IIWFEVDGSA-N,659,"(3R,4R)-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-N-[(1R)-2-hydroxy-1-phenylethyl]-5-phenylpentanamide::penicillin deriv. 72",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 190
695,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](Cc1ccccc1)[C@H](O)CC(=O)N[C@H](CO)c1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C42H49N5O6S/c1-42(2)38(47-41(54-42)37(39(52)43-26-30-19-11-5-12-20-30)46-35(50)24-29-17-9-4-10-18-29)40(53)45-32(23-28-15-7-3-8-16-28)34(49)25-36(51)44-33(27-48)31-21-13-6-14-22-31/h3-22,32-34,37-38,41,47-49H,23-27H2,1-2H3,(H,43,52)(H,44,51)(H,45,53)(H,46,50)/t32-,33-,34-,37-,38+,41-/m1/s1",QPKRELCYQDFLQW-QZXPXDSVSA-N,660,"(3R,4R)-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-N-[(1S)-2-hydroxy-1-phenylethyl]-5-phenylpentanamide::penicillin deriv. 73",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 170
696,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](Cc1ccccc1)[C@H](O)CC(=O)N[C@@H](CO)Cc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C43H51N5O6S/c1-43(2)39(48-42(55-43)38(40(53)44-27-32-21-13-6-14-22-32)47-36(51)25-31-19-11-5-12-20-31)41(54)46-34(24-30-17-9-4-10-18-30)35(50)26-37(52)45-33(28-49)23-29-15-7-3-8-16-29/h3-22,33-35,38-39,42,48-50H,23-28H2,1-2H3,(H,44,53)(H,45,52)(H,46,54)(H,47,51)/t33-,34-,35-,38-,39+,42-/m1/s1",KFGIHCFGDLBYGM-IQZCXPHWSA-N,661,"(3R,4R)-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-N-[(2R)-1-hydroxy-3-phenylpropan-2-yl]-5-phenylpentanamide::penicillin deriv. 74",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 170
697,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](Cc1ccccc1)[C@H](O)CC(=O)N[C@H](CO)Cc1ccccc1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C43H51N5O6S/c1-43(2)39(48-42(55-43)38(40(53)44-27-32-21-13-6-14-22-32)47-36(51)25-31-19-11-5-12-20-31)41(54)46-34(24-30-17-9-4-10-18-30)35(50)26-37(52)45-33(28-49)23-29-15-7-3-8-16-29/h3-22,33-35,38-39,42,48-50H,23-28H2,1-2H3,(H,44,53)(H,45,52)(H,46,54)(H,47,51)/t33-,34+,35+,38+,39-,42+/m0/s1",KFGIHCFGDLBYGM-JIWIJYQHSA-N,662,"(3R,4R)-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-5-phenylpentanamide::penicillin deriv. 75",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 220
698,CC1(C)S[C@@H](N[C@H]1C(=O)N[C@H](Cc1ccccc1)[C@H](O)CC(=O)NCCc1ncc[nH]1)[C@H](NC(=O)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C39H47N7O5S/c1-39(2)35(37(51)44-29(22-26-12-6-3-7-13-26)30(47)24-32(48)42-19-18-31-40-20-21-41-31)46-38(52-39)34(36(50)43-25-28-16-10-5-11-17-28)45-33(49)23-27-14-8-4-9-15-27/h3-17,20-21,29-30,34-35,38,46-47H,18-19,22-25H2,1-2H3,(H,40,41)(H,42,48)(H,43,50)(H,44,51)(H,45,49)/t29-,30-,34-,35+,38-/m1/s1",XCSQTRCCSZFEKV-CAHXSHAFSA-N,663,"(3R,4R)-4-{[(2R,4S)-2-[(R)-(benzylcarbamoyl)(1-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidin-4-yl]formamido}-3-hydroxy-N-[2-(1H-imidazol-2-yl)ethyl]-5-phenylpentanamide::penicillin deriv. 76",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 300
699,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C,"InChI=1S/C30H45N3O6/c1-29(2,3)38-27(36)32-23(17-21-13-9-7-10-14-21)25(34)19-31-20-26(35)24(18-22-15-11-8-12-16-22)33-28(37)39-30(4,5)6/h7-16,23-26,31,34-35H,17-20H2,1-6H3,(H,32,36)(H,33,37)/t23-,24-,25+,26+/m0/s1",KKRYDPVDJYCEER-QEGGNFSNSA-N,914,"Aminodiol deriv. 9a::BMS-186318 analog 1::[(S,R)-3-[[(R,S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-phenylbutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 125
700,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccncc1)NC(=O)OC(C)(C)C,"InChI=1S/C29H44N4O6/c1-28(2,3)38-26(36)32-22(16-20-10-8-7-9-11-20)24(34)18-31-19-25(35)23(17-21-12-14-30-15-13-21)33-27(37)39-29(4,5)6/h7-15,22-25,31,34-35H,16-19H2,1-6H3,(H,32,36)(H,33,37)/t22-,23-,24+,25+/m0/s1",HFYNRTHTPCWYOT-CXSMSNRLSA-N,665,"BMS-186318 analog 2::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-phenylbutyl]amino]-2-hydroxy-1-(4-pyridinylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-(pyridin-4-yl)butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 400
701,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc2ncccc2c1)NC(=O)OC(C)(C)C,"InChI=1S/C33H46N4O6/c1-32(2,3)42-30(40)36-26(18-22-11-8-7-9-12-22)28(38)20-34-21-29(39)27(37-31(41)43-33(4,5)6)19-23-14-15-25-24(17-23)13-10-16-35-25/h7-17,26-29,34,38-39H,18-21H2,1-6H3,(H,36,40)(H,37,41)/t26-,27-,28+,29+/m0/s1",SCFUZBGSNDDHBF-QUAHOIDUSA-N,666,"BMS-186318 analog 3::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-phenylbutyl]amino]-2-hydroxy-1-(6-quinolinylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-(quinolin-6-yl)butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 130
702,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(O)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C30H45N3O7/c1-29(2,3)39-27(37)32-23(16-20-10-8-7-9-11-20)25(35)18-31-19-26(36)24(33-28(38)40-30(4,5)6)17-21-12-14-22(34)15-13-21/h7-15,23-26,31,34-36H,16-19H2,1-6H3,(H,32,37)(H,33,38)/t23-,24-,25+,26+/m0/s1",QVGOLNUEBCOLGS-QEGGNFSNSA-N,918,"(1S-(1R*,2S*(2S,3R*)))-[3-[[3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-(4-hydroxyphenyl)butyl]amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::Aminodiol deriv. 15b::BMS-186318 analog 4::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-(4-hydroxyphenyl)butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 100
703,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1cccc(O)c1)NC(=O)OC(C)(C)C,"InChI=1S/C30H45N3O7/c1-29(2,3)39-27(37)32-23(16-20-11-8-7-9-12-20)25(35)18-31-19-26(36)24(33-28(38)40-30(4,5)6)17-21-13-10-14-22(34)15-21/h7-15,23-26,31,34-36H,16-19H2,1-6H3,(H,32,37)(H,33,38)/t23-,24-,25+,26+/m0/s1",KOHJMQXAUBCBFT-QEGGNFSNSA-N,668,"BMS-186318 analog 5::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-(3-hydroxyphenyl)butyl]-amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-(3-hydroxyphenyl)butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 200
704,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccccc1O)NC(=O)OC(C)(C)C,"InChI=1S/C30H45N3O7/c1-29(2,3)39-27(37)32-22(16-20-12-8-7-9-13-20)25(35)18-31-19-26(36)23(33-28(38)40-30(4,5)6)17-21-14-10-11-15-24(21)34/h7-15,22-23,25-26,31,34-36H,16-19H2,1-6H3,(H,32,37)(H,33,38)/t22-,23-,25+,26+/m0/s1",WAQDMMDIFOJGCP-IHBRBHLJSA-N,669,"BMS-186318 analog 6::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-(2-hydroxyphenyl)butyl]amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-(2-hydroxyphenyl)butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 300
705,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCCn2ccnc2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C35H51N5O7/c1-34(2,3)46-32(43)38-28(20-25-10-8-7-9-11-25)30(41)22-37-23-31(42)29(39-33(44)47-35(4,5)6)21-26-12-14-27(15-13-26)45-19-18-40-17-16-36-24-40/h7-17,24,28-31,37,41-42H,18-23H2,1-6H3,(H,38,43)(H,39,44)/t28-,29-,30+,31+/m0/s1",MMKHYVMEYOSGDI-SYQUUIDJSA-N,670,"BMS-186318 analog 7::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-[4-[2-(1H-imidazol-1-yl)ethoxy]phenyl]butyl]amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Es::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[2-(1H-imidazol-1-yl)ethoxy]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 90
706,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCCc2ccccn2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C37H52N4O7/c1-36(2,3)47-34(44)40-30(22-26-12-8-7-9-13-26)32(42)24-38-25-33(43)31(41-35(45)48-37(4,5)6)23-27-15-17-29(18-16-27)46-21-19-28-14-10-11-20-39-28/h7-18,20,30-33,38,42-43H,19,21-25H2,1-6H3,(H,40,44)(H,41,45)/t30-,31-,32+,33+/m0/s1",XGSPSWMOULVMMN-UYEZAFAQSA-N,671,"BMS-186318 analog 8::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-(4-[2-(2-pyridinyl)ethoxy]phenyl]butyl]amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[2-(pyridin-2-yl)ethoxy]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 50
707,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCCOc2cccnc2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C37H52N4O8/c1-36(2,3)48-34(44)40-30(21-26-11-8-7-9-12-26)32(42)24-39-25-33(43)31(41-35(45)49-37(4,5)6)22-27-14-16-28(17-15-27)46-19-20-47-29-13-10-18-38-23-29/h7-18,23,30-33,39,42-43H,19-22,24-25H2,1-6H3,(H,40,44)(H,41,45)/t30-,31-,32+,33+/m0/s1",OFSZIOSVMKUCOI-UYEZAFAQSA-N,672,"(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::BMS-186318 analog 9::[1S-[1R*,2S*(2S*, 3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-[4-[2-(3-pyridinyloxy)ethoxy]phenyl]butyl]amino]-2-hydroxy-1-::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[2-(pyridin-3-yloxy)ethoxy]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 60
708,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCC(O)c2cccnc2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C37H52N4O8/c1-36(2,3)48-34(45)40-29(19-25-11-8-7-9-12-25)31(42)22-39-23-32(43)30(41-35(46)49-37(4,5)6)20-26-14-16-28(17-15-26)47-24-33(44)27-13-10-18-38-21-27/h7-18,21,29-33,39,42-44H,19-20,22-24H2,1-6H3,(H,40,45)(H,41,46)/t29-,30-,31+,32+,33?/m0/s1",XBPZCWQSUUUWSF-LUPTZNFISA-N,673,"(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::BMS-186318 analog 10::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-[4-[2-hydroxy-2-(3-pyridinyl)ethoxy]phenyl]butyl]amino]-2-hydroxy-1-::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[2-hydroxy-2-(pyridin-3-yl)ethoxy]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 110
709,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCCO)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C32H49N3O8/c1-31(2,3)42-29(39)34-25(18-22-10-8-7-9-11-22)27(37)20-33-21-28(38)26(35-30(40)43-32(4,5)6)19-23-12-14-24(15-13-23)41-17-16-36/h7-15,25-28,33,36-38H,16-21H2,1-6H3,(H,34,39)(H,35,40)/t25-,26-,27+,28+/m0/s1",IAXLWGCXGGUUOU-YVHASNINSA-N,674,"BMS-186318 analog 11::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-[4-(2-hydroxyethoxy)phenyl]butyl]amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-[4-(2-hydroxyethoxy)phenyl]butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 64
710,COCCOc1ccc(C[C@H](NC(=O)OC(C)(C)C)[C@H](O)CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)cc1,"InChI=1S/C33H51N3O8/c1-32(2,3)43-30(39)35-26(19-23-11-9-8-10-12-23)28(37)21-34-22-29(38)27(36-31(40)44-33(4,5)6)20-24-13-15-25(16-14-24)42-18-17-41-7/h8-16,26-29,34,37-38H,17-22H2,1-7H3,(H,35,39)(H,36,40)/t26-,27-,28+,29+/m0/s1",OQICOQSTWCHGKT-QUAHOIDUSA-N,675,"BMS-186318 analog 12::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-[4-(2-methoxyethoxy)phenyl]butyl]amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-[4-(2-methoxyethoxy)phenyl]butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 72
711,CC(O)COc1ccc(C[C@H](NC(=O)OC(C)(C)C)[C@H](O)CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)cc1,"InChI=1S/C33H51N3O8/c1-22(37)21-42-25-15-13-24(14-16-25)18-27(36-31(41)44-33(5,6)7)29(39)20-34-19-28(38)26(17-23-11-9-8-10-12-23)35-30(40)43-32(2,3)4/h8-16,22,26-29,34,37-39H,17-21H2,1-7H3,(H,35,40)(H,36,41)/t22?,26-,27-,28+,29+/m0/s1",SPEPPPKXFJRIFN-PNJHWDESSA-N,676,"BMS-186318 analog 13::[1S-[1R*, 2S*(2S*, 3R*)]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-[4-(2-hydroxypropoxy)phenyl]butyl]amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-[4-(2-hydroxypropoxy)phenyl]butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 49
712,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCC(C)(C)O)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C34H53N3O8/c1-32(2,3)44-30(40)36-26(18-23-12-10-9-11-13-23)28(38)20-35-21-29(39)27(37-31(41)45-33(4,5)6)19-24-14-16-25(17-15-24)43-22-34(7,8)42/h9-17,26-29,35,38-39,42H,18-22H2,1-8H3,(H,36,40)(H,37,41)/t26-,27-,28+,29+/m0/s1",IWDXCNVEWVCNBM-QUAHOIDUSA-N,677,"(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::BMS-186318 analog 14::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-[4-(2-hydroxy-2-methylpropoxy)phenyl]butyl]amino]-2-hydroxy-1-::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-[4-(2-hydroxy-2-methylpropoxy)phenyl]butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 120
713,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCCC(O)=O)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C33H49N3O9/c1-32(2,3)44-30(41)35-25(18-22-10-8-7-9-11-22)27(37)20-34-21-28(38)26(36-31(42)45-33(4,5)6)19-23-12-14-24(15-13-23)43-17-16-29(39)40/h7-15,25-28,34,37-38H,16-21H2,1-6H3,(H,35,41)(H,36,42)(H,39,40)/t25-,26-,27+,28+/m0/s1",PJSBMULNVPRXJP-YVHASNINSA-N,678,"3-{4-[(2S,3R)-2-{[(tert-butoxy)carbonyl]amino}-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-phenylbutyl]amino}-3-hydroxybutyl]phenoxy}propanoic acid::BMS-186318 analog 15::[1S-[1R*,2S*(2S*,3R*)]]-[4-[4-(Carboxymethoxy)phenyl]-3-[[3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-1-(phenylmethyl)propyl)carbamic Acid, 1,1-Dimethylethyl Ester",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 150
714,CN(C)C(=O)OCCOc1ccc(C[C@H](NC(=O)OC(C)(C)C)[C@H](O)CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)cc1,"InChI=1S/C35H54N4O9/c1-34(2,3)47-31(42)37-27(20-24-12-10-9-11-13-24)29(40)22-36-23-30(41)28(38-32(43)48-35(4,5)6)21-25-14-16-26(17-15-25)45-18-19-46-33(44)39(7)8/h9-17,27-30,36,40-41H,18-23H2,1-8H3,(H,37,42)(H,38,43)/t27-,28-,29+,30+/m0/s1",HGZGSIWZDXBMDK-VZNYXHRGSA-N,679,"BMS-186318 analog 16::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[4-[4-[2-[[(Dimethylamino)-carbonyl]oxy]ethoxy]phenyl]-3-[[(1,1-dimethylethoxy)-carbonyl]amino]-2-hydroxybutyl]amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-4-(4-{2-[(dimethylcarbamoyl)oxy]ethoxy}phenyl)-2-hydroxybutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 40
715,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCCN2CCOC2=O)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C35H52N4O9/c1-34(2,3)47-31(42)37-27(20-24-10-8-7-9-11-24)29(40)22-36-23-30(41)28(38-32(43)48-35(4,5)6)21-25-12-14-26(15-13-25)45-18-16-39-17-19-46-33(39)44/h7-15,27-30,36,40-41H,16-23H2,1-6H3,(H,37,42)(H,38,43)/t27-,28-,29+,30+/m0/s1",SGPZLDNIZDMEIK-VZNYXHRGSA-N,680,"(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethylethyl Ester::BMS-186318 analog 17::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-[4-[2-(2-oxo-3-oxazolidinyl)-ethoxy]phenyl]butyl]amino]-2-hydroxy-1-::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 40
716,CN1CCN(CCOc2ccc(C[C@H](NC(=O)OC(C)(C)C)[C@H](O)CNC[C@@H](O)[C@H](Cc3ccccc3)NC(=O)OC(C)(C)C)cc2)C1=O,"InChI=1S/C36H55N5O8/c1-35(2,3)48-32(44)38-28(21-25-11-9-8-10-12-25)30(42)23-37-24-31(43)29(39-33(45)49-36(4,5)6)22-26-13-15-27(16-14-26)47-20-19-41-18-17-40(7)34(41)46/h8-16,28-31,37,42-43H,17-24H2,1-7H3,(H,38,44)(H,39,45)/t28-,29-,30+,31+/m0/s1",KQBXKNMHEJHPCA-SYQUUIDJSA-N,681,"BMS-186318 analog 18::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-[4-[2-(3-methyl-2-oxo-1-imidazolidinyl)ethoxy]phenyl]butyl]amino]-2-::hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[2-(3-methyl-2-oxoimidazolidin-1-yl)ethoxy]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 60
717,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCC(=O)N2CCOCC2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C36H54N4O9/c1-35(2,3)48-33(44)38-28(20-25-10-8-7-9-11-25)30(41)22-37-23-31(42)29(39-34(45)49-36(4,5)6)21-26-12-14-27(15-13-26)47-24-32(43)40-16-18-46-19-17-40/h7-15,28-31,37,41-42H,16-24H2,1-6H3,(H,38,44)(H,39,45)/t28-,29-,30+,31+/m0/s1",OQHZMGOXOOOFEE-SYQUUIDJSA-N,682,"BMS-186318 analog 19::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-[4-[2-(4-morpholinyl)-2-oxoethoxyphenyl]butyl]amino]-2-::hydroxy-1-(phenylmethyl)]propyl]carbamic Acid, 1,1-Dimethylethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[2-(morpholin-4-yl)-2-oxoethoxy]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 100
718,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(CCC(=O)N2CCOCC2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C37H56N4O8/c1-36(2,3)48-34(45)39-29(22-27-10-8-7-9-11-27)31(42)24-38-25-32(43)30(40-35(46)49-37(4,5)6)23-28-14-12-26(13-15-28)16-17-33(44)41-18-20-47-21-19-41/h7-15,29-32,38,42-43H,16-25H2,1-6H3,(H,39,45)(H,40,46)/t29-,30-,31+,32+/m0/s1",SGSVELRCCSUWEU-GASGPIRDSA-N,683,"BMS-186318 analog 20::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoamino]-2-hydroxy-4-[4-[3-(4-morpholinyl)-3-oxopropyl]xy)-carbonyl]phenyl]butyl]amino]-2-::hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethy Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[3-(morpholin-4-yl)-3-oxopropyl]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 85
719,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCCN2CCOCC2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C36H56N4O8/c1-35(2,3)47-33(43)38-29(22-26-10-8-7-9-11-26)31(41)24-37-25-32(42)30(39-34(44)48-36(4,5)6)23-27-12-14-28(15-13-27)46-21-18-40-16-19-45-20-17-40/h7-15,29-32,37,41-42H,16-25H2,1-6H3,(H,38,43)(H,39,44)/t29-,30-,31+,32+/m0/s1",RCFQGEMHANXIRS-GASGPIRDSA-N,684,"(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::BMS-186318 analog 21::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-[4-[2-(4-morpholinyl)ethoxy]-phenyl]butyl]amino]-2-hydroxy-1-::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[2-(morpholin-4-yl)ethoxy]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 100
720,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCC(=O)N2CCCCC2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C37H56N4O8/c1-36(2,3)48-34(45)39-29(21-26-13-9-7-10-14-26)31(42)23-38-24-32(43)30(40-35(46)49-37(4,5)6)22-27-15-17-28(18-16-27)47-25-33(44)41-19-11-8-12-20-41/h7,9-10,13-18,29-32,38,42-43H,8,11-12,19-25H2,1-6H3,(H,39,45)(H,40,46)/t29-,30-,31+,32+/m0/s1",CKXAPPBTNSDDKV-GASGPIRDSA-N,685,"BMS-186318 analog 22::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,1-Dimethylethoxy)-carbonyl]amino]-2-hydroxy-4-[4-(2-piperidinylethoxy)-phenyl]butyl]amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[2-oxo-2-(piperidin-1-yl)ethoxy]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 90
721,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(COC(=O)N2CCOCC2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C36H54N4O9/c1-35(2,3)48-32(43)38-28(20-25-10-8-7-9-11-25)30(41)22-37-23-31(42)29(39-33(44)49-36(4,5)6)21-26-12-14-27(15-13-26)24-47-34(45)40-16-18-46-19-17-40/h7-15,28-31,37,41-42H,16-24H2,1-6H3,(H,38,43)(H,39,44)/t28-,29-,30+,31+/m0/s1",DDHUVWKEFAMGRB-SYQUUIDJSA-N,686,"BMS-186318 analog 23::[1S-[1R*,2S*(2S*,3R*)]]-[3-[[3-[[(1,10-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-[4-[[(4-morpholinyl-carbonyl)oxy]methyl]phenyl]butyl]amino]-2-::hydroxy-1-(phenylmethyl)propyl]carbamic Acid, 1,1-Dimethylethyl Ester",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 30
722,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCc2ccccc2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C37H51N3O7/c1-36(2,3)46-34(43)39-30(21-26-13-9-7-10-14-26)32(41)23-38-24-33(42)31(40-35(44)47-37(4,5)6)22-27-17-19-29(20-18-27)45-25-28-15-11-8-12-16-28/h7-20,30-33,38,41-42H,21-25H2,1-6H3,(H,39,43)(H,40,44)/t30-,31-,32+,33+/m0/s1",VERMKZUVUYNLHI-UYEZAFAQSA-N,687,"BMS-186318 analog 24::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-4-[4-(benzyloxy)phenyl]-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxybutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 300
723,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1cccc(OCc2ccccc2)c1)NC(=O)OC(C)(C)C,"InChI=1S/C37H51N3O7/c1-36(2,3)46-34(43)39-30(21-26-14-9-7-10-15-26)32(41)23-38-24-33(42)31(40-35(44)47-37(4,5)6)22-28-18-13-19-29(20-28)45-25-27-16-11-8-12-17-27/h7-20,30-33,38,41-42H,21-25H2,1-6H3,(H,39,43)(H,40,44)/t30-,31-,32+,33+/m0/s1",DSQIWNUFPPHLBD-UYEZAFAQSA-N,688,"BMS-186318 analog 25::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-4-[3-(benzyloxy)phenyl]-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxybutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 140
724,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCCCc2nc3ccccc3o2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C40H54N4O8/c1-39(2,3)51-37(47)43-31(23-27-13-8-7-9-14-27)33(45)25-41-26-34(46)32(44-38(48)52-40(4,5)6)24-28-18-20-29(21-19-28)49-22-12-17-36-42-30-15-10-11-16-35(30)50-36/h7-11,13-16,18-21,31-34,41,45-46H,12,17,22-26H2,1-6H3,(H,43,47)(H,44,48)/t31-,32-,33+,34+/m0/s1",SYMCBBYJOYFSNB-PSWJWLENSA-N,689,"BMS-186318 analog 26::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-4-{4-[3-(1,3-benzoxazol-2-yl)propoxy]phenyl}-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxybutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 280
725,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCc2nc3ccccc3o2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C38H50N4O8/c1-37(2,3)49-35(45)41-29(20-25-12-8-7-9-13-25)31(43)22-39-23-32(44)30(42-36(46)50-38(4,5)6)21-26-16-18-27(19-17-26)47-24-34-40-28-14-10-11-15-33(28)48-34/h7-19,29-32,39,43-44H,20-24H2,1-6H3,(H,41,45)(H,42,46)/t29-,30-,31+,32+/m0/s1",WNDVEZVRDLTINH-GASGPIRDSA-N,690,"BMS-186318 analog 27::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-4-[4-(1,3-benzoxazol-2-ylmethoxy)phenyl]-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxybutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 320
726,COCCCCOc1ccc(C[C@H](NC(=O)OC(C)(C)C)[C@H](O)CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)cc1,"InChI=1S/C35H55N3O8/c1-34(2,3)45-32(41)37-28(21-25-13-9-8-10-14-25)30(39)23-36-24-31(40)29(38-33(42)46-35(4,5)6)22-26-15-17-27(18-16-26)44-20-12-11-19-43-7/h8-10,13-18,28-31,36,39-40H,11-12,19-24H2,1-7H3,(H,37,41)(H,38,42)/t28-,29-,30+,31+/m0/s1",VVYUNBWXGPXGBU-SYQUUIDJSA-N,691,"BMS-186318 analog 28::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-[4-(4-methoxybutoxy)phenyl]butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 50
727,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCCCN2CCOCC2)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C37H58N4O8/c1-36(2,3)48-34(44)39-30(23-27-11-8-7-9-12-27)32(42)25-38-26-33(43)31(40-35(45)49-37(4,5)6)24-28-13-15-29(16-14-28)47-20-10-17-41-18-21-46-22-19-41/h7-9,11-16,30-33,38,42-43H,10,17-26H2,1-6H3,(H,39,44)(H,40,45)/t30-,31-,32+,33+/m0/s1",GVGIURATDJMDNM-UYEZAFAQSA-N,692,"BMS-186318 analog 29::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[3-(morpholin-4-yl)propoxy]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 86
728,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccc(OCCCN2CCOCC2=O)cc1)NC(=O)OC(C)(C)C,"InChI=1S/C37H56N4O9/c1-36(2,3)49-34(45)39-29(21-26-11-8-7-9-12-26)31(42)23-38-24-32(43)30(40-35(46)50-37(4,5)6)22-27-13-15-28(16-14-27)48-19-10-17-41-18-20-47-25-33(41)44/h7-9,11-16,29-32,38,42-43H,10,17-25H2,1-6H3,(H,39,45)(H,40,46)/t29-,30-,31+,32+/m0/s1",SJLKQIOVIJCRQA-GASGPIRDSA-N,693,"BMS-186318 analog 30::tert-butyl N-[(2S,3R)-4-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-{4-[3-(3-oxomorpholin-4-yl)propoxy]phenyl}butyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 80
729,O[C@H]([C@@H](O)[C@@H](Sc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](Sc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H36N2O6S2/c39-27-19-21-11-7-9-17-25(21)29(27)37-35(43)33(45-23-13-3-1-4-14-23)31(41)32(42)34(46-24-15-5-2-6-16-24)36(44)38-30-26-18-10-8-12-22(26)20-28(30)40/h1-18,27-34,39-42H,19-20H2,(H,37,43)(H,38,44)/t27-,28-,29+,30+,31-,32-,33-,34-/m1/s1",CHPRWKVRTHNVDK-IABCWADSSA-N,694,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(phenylsulfanyl)hexanediamide::Diol-Based HIV-1 protease inhibitor 7::N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-3,4-dihydroxy-2,5-di(phenylsulfanyl)hexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
730,O[C@H]([C@@H](O)[C@@H](SCc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](SCc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H40N2O6S2/c41-29-19-25-15-7-9-17-27(25)31(29)39-37(45)35(47-21-23-11-3-1-4-12-23)33(43)34(44)36(48-22-24-13-5-2-6-14-24)38(46)40-32-28-18-10-8-16-26(28)20-30(32)42/h1-18,29-36,41-44H,19-22H2,(H,39,45)(H,40,46)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",AQSPQRYYUJKXGM-JQFCFGFHSA-N,695,"(2R,3R,4R,5R)-2,5-bis(benzylsulfanyl)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::Diol-Based HIV-1 protease inhibitor 8::N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-2,5-di(benzylsulfanyl)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
731,O[C@H]([C@@H](O)[C@@H](Sc1ccccc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](Sc1ccccc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H34F2N2O6S2/c37-23-13-5-7-15-27(23)47-33(35(45)39-29-21-11-3-1-9-19(21)17-25(29)41)31(43)32(44)34(48-28-16-8-6-14-24(28)38)36(46)40-30-22-12-4-2-10-20(22)18-26(30)42/h1-16,25-26,29-34,41-44H,17-18H2,(H,39,45)(H,40,46)/t25-,26-,29+,30+,31-,32-,33-,34-/m1/s1",SATUMOZSOUYLEG-ONYODVSHSA-N,696,"(2R,3R,4R,5R)-2,5-bis[(2-fluorophenyl)sulfanyl]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::Diol-Based HIV-1 protease inhibitor 9::N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-2,5-di(2-fluorophenylsulfanyl)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
732,O[C@H]([C@@H](O)[C@@H](SCc1ccccc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](SCc1ccccc1F)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C38H38F2N2O6S2/c39-27-15-7-3-11-23(27)19-49-35(37(47)41-31-25-13-5-1-9-21(25)17-29(31)43)33(45)34(46)36(50-20-24-12-4-8-16-28(24)40)38(48)42-32-26-14-6-2-10-22(26)18-30(32)44/h1-16,29-36,43-46H,17-20H2,(H,41,47)(H,42,48)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1",LPMHPYHJEHDWEG-JQFCFGFHSA-N,697,"(2R,3R,4R,5R)-2,5-bis({[(2-fluorophenyl)methyl]sulfanyl})-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide::Diol-Based HIV-1 protease inhibitor 10::N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-2,5-di(2-fluorobenzylsulfanyl)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
733,O[C@H]([C@@H](O)[C@@H](Sc1ccccn1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](Sc1ccccn1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C34H34N4O6S2/c39-23-17-19-9-1-3-11-21(19)27(23)37-33(43)31(45-25-13-5-7-15-35-25)29(41)30(42)32(46-26-14-6-8-16-36-26)34(44)38-28-22-12-4-2-10-20(22)18-24(28)40/h1-16,23-24,27-32,39-42H,17-18H2,(H,37,43)(H,38,44)/t23-,24-,27+,28+,29-,30-,31-,32-/m1/s1",QUECFITXFQWJRW-AYQNXNKXSA-N,698,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(pyridin-2-ylsulfanyl)hexanediamide::Diol-Based HIV-1 protease inhibitor 11::N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-3,4-dihydroxy-2,5-di(2-pyridylsulfanyl)hexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
734,O[C@H]([C@@H](O)[C@@H](SCC=C)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](SCC=C)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C30H36N2O6S2/c1-3-13-39-27(29(37)31-23-19-11-7-5-9-17(19)15-21(23)33)25(35)26(36)28(40-14-4-2)30(38)32-24-20-12-8-6-10-18(20)16-22(24)34/h3-12,21-28,33-36H,1-2,13-16H2,(H,31,37)(H,32,38)/t21-,22-,23+,24+,25-,26-,27-,28-/m1/s1",KCNUMUHYFUJGAS-YNMRTIPJSA-N,699,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(prop-2-en-1-ylsulfanyl)hexanediamide::Diol-Based HIV-1 protease inhibitor 12::N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-2,5-di(allylsulfanyl)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
735,O[C@H]([C@@H](O)[C@@H](Sc1cccs1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)[C@@H](Sc1cccs1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C32H32N2O6S4/c35-21-15-17-7-1-3-9-19(17)25(21)33-31(39)29(43-23-11-5-13-41-23)27(37)28(38)30(44-24-12-6-14-42-24)32(40)34-26-20-10-4-2-8-18(20)16-22(26)36/h1-14,21-22,25-30,35-38H,15-16H2,(H,33,39)(H,34,40)/t21-,22-,25+,26+,27-,28-,29-,30-/m1/s1",FTARTHFTPFFKDG-NTZBCTBQSA-N,700,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(thiophen-2-ylsulfanyl)hexanediamide::Diol-Based HIV-1 protease inhibitor 13::N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-3,4-dihydroxy-2,5-di(thiophen-3-ylsulfanyl)hexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
736,CNC(=O)[C@@H](NC(=O)[C@H](Sc1ccccc1)[C@H](O)[C@@H](O)[C@@H](Sc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C30H42N4O6S2/c1-17(2)21(27(37)31-5)33-29(39)25(41-19-13-9-7-10-14-19)23(35)24(36)26(42-20-15-11-8-12-16-20)30(40)34-22(18(3)4)28(38)32-6/h7-18,21-26,35-36H,1-6H3,(H,31,37)(H,32,38)(H,33,39)(H,34,40)/t21-,22-,23+,24+,25+,26+/m0/s1",FXXCOXGHNXZQPW-XOGRSFEHSA-N,701,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis(phenylsulfanyl)hexanediamide::Diol-Based HIV-1 protease inhibitor 14::N1,N6-Di-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-3,4-dihydroxy-2,5-di(phenylsulfanyl)hexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
737,CNC(=O)[C@@H](NC(=O)[C@H](Sc1ccccc1F)[C@H](O)[C@@H](O)[C@@H](Sc1ccccc1F)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C30H40F2N4O6S2/c1-15(2)21(27(39)33-5)35-29(41)25(43-19-13-9-7-11-17(19)31)23(37)24(38)26(44-20-14-10-8-12-18(20)32)30(42)36-22(16(3)4)28(40)34-6/h7-16,21-26,37-38H,1-6H3,(H,33,39)(H,34,40)(H,35,41)(H,36,42)/t21-,22-,23+,24+,25+,26+/m0/s1",RRSJFIZKJZRETD-XOGRSFEHSA-N,702,"(2R,3R,4R,5R)-2,5-bis[(2-fluorophenyl)sulfanyl]-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::Diol-Based HIV-1 protease inhibitor 15::N1,N6-Di-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-di(2-fluorophenylsulfanyl)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
738,CNC(=O)[C@@H](NC(=O)[C@H](Sc1cccs1)[C@H](O)[C@@H](O)[C@@H](Sc1cccs1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C26H38N4O6S4/c1-13(2)17(23(33)27-5)29-25(35)21(39-15-9-7-11-37-15)19(31)20(32)22(40-16-10-8-12-38-16)26(36)30-18(14(3)4)24(34)28-6/h7-14,17-22,31-32H,1-6H3,(H,27,33)(H,28,34)(H,29,35)(H,30,36)/t17-,18-,19+,20+,21+,22+/m0/s1",LGQICAULOIAVMN-IUVRRTPNSA-N,703,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis(thiophen-2-ylsulfanyl)hexanediamide::Diol-Based HIV-1 protease inhibitor 16::N1,N6-Di-[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-3,4-dihydroxy-2,5-di(thiophen-3-ylsulfanyl)-hexanediamide",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
739,CC(C)(C)NC(=O)[C@@H]1CSCN1C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)COc1ccccc1,"InChI=1S/C26H33N3O5S/c1-26(2,3)28-24(32)21-16-35-17-29(21)25(33)23(31)20(14-18-10-6-4-7-11-18)27-22(30)15-34-19-12-8-5-9-13-19/h4-13,20-21,23,31H,14-17H2,1-3H3,(H,27,30)(H,28,32)/t20-,21-,23-/m0/s1",JYRALUMTCIVLJG-FUDKSRODSA-N,704,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-(2-phenoxyacetamido)-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-2-hydroxy-3-(phenoxyacetyl)amino-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::allophenylnorstatine deriv. 1",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
740,Cc1ccccc1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C27H35N3O5S/c1-18-10-8-9-13-22(18)35-15-23(31)28-20(14-19-11-6-5-7-12-19)24(32)26(34)30-17-36-16-21(30)25(33)29-27(2,3)4/h5-13,20-21,24,32H,14-17H2,1-4H3,(H,28,31)(H,29,33)/t20-,21-,24-/m0/s1",IVIMNZYRNVOORJ-HFMPRLQTSA-N,705,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[2-(2-methylphenoxy)acetamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-2-hydroxy-3-(2-methylphenoxyacetyl)amino-4-phenylbutanoyl]-1,3-thiazolindine-4-carboxamide::allophenylnorstatine deriv. 2",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
741,Cc1cccc(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC[C@H]2C(=O)NC(C)(C)C)c1,"InChI=1S/C27H35N3O5S/c1-18-9-8-12-20(13-18)35-15-23(31)28-21(14-19-10-6-5-7-11-19)24(32)26(34)30-17-36-16-22(30)25(33)29-27(2,3)4/h5-13,21-22,24,32H,14-17H2,1-4H3,(H,28,31)(H,29,33)/t21-,22-,24-/m0/s1",ZCJCABOMUKILOY-FIXSFTCYSA-N,706,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[2-(3-methylphenoxy)acetamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-2-hydroxy-3-(3-methylphenoxyacetyl)amino-4-phenylbutanoyl]-1,3-thiazolindine-4-carboxamide::allophenylnorstatine deriv. 3",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
742,Cc1ccc(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC[C@H]2C(=O)NC(C)(C)C)cc1,"InChI=1S/C27H35N3O5S/c1-18-10-12-20(13-11-18)35-15-23(31)28-21(14-19-8-6-5-7-9-19)24(32)26(34)30-17-36-16-22(30)25(33)29-27(2,3)4/h5-13,21-22,24,32H,14-17H2,1-4H3,(H,28,31)(H,29,33)/t21-,22-,24-/m0/s1",UPOQLBYNLZAKKI-FIXSFTCYSA-N,707,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[2-(4-methylphenoxy)acetamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-2-hydroxy-3-(4-methylphenoxyacetyl)amino-4-phenylbutanoyl]-1,3-thiazolindine-4-carboxamide::allophenylnorstatine deriv. 4",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
743,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C28H37N3O5S/c1-18-10-9-11-19(2)25(18)36-15-23(32)29-21(14-20-12-7-6-8-13-20)24(33)27(35)31-17-37-16-22(31)26(34)30-28(3,4)5/h6-13,21-22,24,33H,14-17H2,1-5H3,(H,29,32)(H,30,34)/t21-,22-,24-/m0/s1",BAEPUUWETTZONO-FIXSFTCYSA-N,708,"(4R)-N-tert-butyl-3-[(2S,3S)-3-[2-(2,6-dimethylphenoxy)acetamido]-2-hydroxy-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-2-hydroxy-3-(2,6-dimethylphenoxyacetyl)amino-2-hydroxy-4-phenylbutanoyl]-1,3-thiazolindine-4-carboxamide::allophenylnorstatine deriv. 5",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
744,CCc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C29H39N3O5S/c1-6-21-14-10-11-19(2)26(21)37-16-24(33)30-22(15-20-12-8-7-9-13-20)25(34)28(36)32-18-38-17-23(32)27(35)31-29(3,4)5/h7-14,22-23,25,34H,6,15-18H2,1-5H3,(H,30,33)(H,31,35)/t22-,23-,25-/m0/s1",OLOASAZQPBKSCT-LSQMVHIFSA-N,709,"(4R)-N-tert-butyl-3-[(2S,3S)-3-[2-(2-ethyl-6-methylphenoxy)acetamido]-2-hydroxy-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-3-(2-ethyl-6-methylphenoxyacetyl)amino-2-hydroxy-4-phenylbutanoyl]-1,3-thiazolindine-4-carboxamide::allophenylnorstatine deriv. 6",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
745,CCCc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C30H41N3O5S/c1-6-11-22-15-10-12-20(2)27(22)38-17-25(34)31-23(16-21-13-8-7-9-14-21)26(35)29(37)33-19-39-18-24(33)28(36)32-30(3,4)5/h7-10,12-15,23-24,26,35H,6,11,16-19H2,1-5H3,(H,31,34)(H,32,36)/t23-,24-,26-/m0/s1",ZRGAMMHOASLEJA-GNKBHMEESA-N,710,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[2-(2-methyl-6-propylphenoxy)acetamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-2-hydroxy-3-(2-methyl-6-propylphenoxyacetyl)amino-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::allophenylnorstatine deriv. 7",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
746,CCc1cccc(CC)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C30H41N3O5S/c1-6-21-14-11-15-22(7-2)27(21)38-17-25(34)31-23(16-20-12-9-8-10-13-20)26(35)29(37)33-19-39-18-24(33)28(36)32-30(3,4)5/h8-15,23-24,26,35H,6-7,16-19H2,1-5H3,(H,31,34)(H,32,36)/t23-,24-,26-/m0/s1",UXIZNKGRWHSJDJ-GNKBHMEESA-N,711,"(4R)-N-tert-butyl-3-[(2S,3S)-3-[2-(2,6-diethylphenoxy)acetamido]-2-hydroxy-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-3-(2,6-diethylpropylphenoxyacetyl)amino-2-hydroxy-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::allophenylnorstatine deriv. 8",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
747,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C30H41N3O5S/c1-19-12-11-13-20(2)25(19)38-17-23(34)31-22(16-21-14-9-8-10-15-21)24(35)28(37)33-18-39-30(6,7)26(33)27(36)32-29(3,4)5/h8-15,22,24,26,35H,16-18H2,1-7H3,(H,31,34)(H,32,36)/t22-,24-,26+/m0/s1",CSWRAOHDICNMPU-LLZJGCNPSA-N,712,"(4R)-N-tert-butyl-3-[(2S,3S)-3-[2-(2,6-dimethylphenoxy)acetamido]-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-3-(2,6-dimethylpropylphenoxyacetyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::JE-1482",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
748,Cc1c(O)cccc1C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C26H33N3O5S/c1-16-18(11-8-12-21(16)30)23(32)27-19(13-17-9-6-5-7-10-17)22(31)25(34)29-15-35-14-20(29)24(33)28-26(2,3)4/h5-12,19-20,22,30-31H,13-15H2,1-4H3,(H,27,32)(H,28,33)/t19-,20-,22-/m0/s1",DBZLZNFYSDUNIS-ONTIZHBOSA-N,713,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzoyl)amino-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::allophenylnorstatine deriv. 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
749,Cc1c(O)cccc1C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C28H37N3O5S/c1-17-19(13-10-14-21(17)32)24(34)29-20(15-18-11-8-7-9-12-18)22(33)26(36)31-16-37-28(5,6)23(31)25(35)30-27(2,3)4/h7-14,20,22-23,32-33H,15-16H2,1-6H3,(H,29,34)(H,30,35)/t20-,22-,23+/m0/s1",CGFVYUGIPISJQG-ACIOBRDBSA-N,714,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzoyl)amino-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::JE-533",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
750,CCc1c(O)cccc1C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C29H39N3O5S/c1-7-19-20(14-11-15-22(19)33)25(35)30-21(16-18-12-9-8-10-13-18)23(34)27(37)32-17-38-29(5,6)24(32)26(36)31-28(2,3)4/h8-15,21,23-24,33-34H,7,16-17H2,1-6H3,(H,30,35)(H,31,36)/t21-,23-,24+/m0/s1",POTILZIEQCOPAG-OEMFJLHTSA-N,715,"(4R)-N-tert-butyl-3-[(2S,3S)-3-[(2-ethyl-3-hydroxyphenyl)formamido]-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::(R)-N-tert-Butyl-3-[(2S,3S)-3-(2-ethyl-3-hydroxybenzoyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::allophenylnorstatine deriv. 12",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
751,Cc1ccccc1CNC(=O)[C@@H]1CSCN1C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1C,"InChI=1S/C30H33N3O5S/c1-19-9-6-7-12-22(19)16-31-29(37)25-17-39-18-33(25)30(38)27(35)24(15-21-10-4-3-5-11-21)32-28(36)23-13-8-14-26(34)20(23)2/h3-14,24-25,27,34-35H,15-18H2,1-2H3,(H,31,37)(H,32,36)/t24-,25-,27-/m0/s1",MMCLAFJWSPFWJN-KLJDGLGGSA-N,716,"(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide::(R)-N-(2-Methylbenzyl)-3-{(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzoyl)amino-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::KNI-764 analog::allophenylnorstatine deriv. 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
752,Cc1ccccc1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1C,"InChI=1S/C32H37N3O5S/c1-20-11-8-9-14-23(20)18-33-30(39)28-32(3,4)41-19-35(28)31(40)27(37)25(17-22-12-6-5-7-13-22)34-29(38)24-15-10-16-26(36)21(24)2/h5-16,25,27-28,36-37H,17-19H2,1-4H3,(H,33,39)(H,34,38)/t25-,27-,28+/m0/s1",CUFQBQOBLVLKRF-RZDMPUFOSA-N,580,"(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide::AG1776::JE-2147::KNI-764",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
753,Cc1c(O)cccc1C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)NCc1ccccc1Cl,"InChI=1S/C31H34ClN3O5S/c1-19-22(13-9-15-25(19)36)28(38)34-24(16-20-10-5-4-6-11-20)26(37)30(40)35-18-41-31(2,3)27(35)29(39)33-17-21-12-7-8-14-23(21)32/h4-15,24,26-27,36-37H,16-18H2,1-3H3,(H,33,39)(H,34,38)/t24-,26-,27+/m0/s1",ZGQZLXSZBYZZLN-DOEKTCAHSA-N,717,"(4R)-N-[(2-chlorophenyl)methyl]-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::(R)-N-(2-Chlorobenzyl)-3-{(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzoyl)amino-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::KNI-764 analog::allophenylnorstatine deriv. 15",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
754,CCc1c(O)cccc1C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)NCc1ccccc1C,"InChI=1S/C33H39N3O5S/c1-5-24-25(16-11-17-27(24)37)30(39)35-26(18-22-13-7-6-8-14-22)28(38)32(41)36-20-42-33(3,4)29(36)31(40)34-19-23-15-10-9-12-21(23)2/h6-17,26,28-29,37-38H,5,18-20H2,1-4H3,(H,34,40)(H,35,39)/t26-,28-,29+/m0/s1",POIJPWBGRRKOEC-PIZZNKLWSA-N,718,"(4R)-3-[(2S,3S)-3-[(2-ethyl-3-hydroxyphenyl)formamido]-2-hydroxy-4-phenylbutanoyl]-5,5-dimethyl-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide::(R)-N-(2-Methylbenzyl)-3-[(2S,3S)-3-(2-ethyl-3-hydroxybenzoyl)amino-2-hydroxy-4-phenylbutanoyl]-5,5-methyl-1,3-thiazolidine-4-carboxamide::JE-1520::KNI-764 analog",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
755,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C35H45N5O6S2/c1-34(2,3)39-32(44)30-35(4,5)48-21-40(30)33(45)29(42)25(17-22-11-8-7-9-12-22)38-31(43)26(20-47-6)37-28(41)19-46-27-14-10-13-23-18-36-16-15-24(23)27/h7-16,18,25-26,29-30,42H,17,19-21H2,1-6H3,(H,37,41)(H,38,43)(H,39,44)/t25-,26-,29-,30+/m0/s1",AHWCYDXQIXZVRK-RPQLRNILSA-N,719,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::CHEMBL231622::KNI-227",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
756,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24-,25-,26-,29-/m0/s1",NJBBLOIWMSYVCQ-VZTVMPNDSA-N,579,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::CHEMBL414640::KNI-272::Kynostatin 272::iQoa-Mta-Apns-Thz-NH-tBu",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
757,CC(C)C[C@]1(N=CC([C@@H](Cc2ccccc2)C(N)=O)C1=O)C1C=N[C@](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)(Cc2ccccc2)C1=O,"InChI=1S/C43H52N4O6/c1-28(2)23-43(37(49)33(26-46-43)32(39(44)51)21-29-15-9-6-10-16-29)34-27-45-42(38(34)50,24-31-19-13-8-14-20-31)25-36(48)35(22-30-17-11-7-12-18-30)47-40(52)53-41(3,4)5/h6-20,26-28,32-36,48H,21-25H2,1-5H3,(H2,44,51)(H,47,52)/t32-,33?,34?,35+,36+,42+,43+/m1/s1",ZXPYRRBCVSDGNH-NILJFMCASA-N,720,"Pyrrolinone deriv. 1::Pyrrolinone inhibitor 1::tert-butyl N-[(2S,3S)-4-[(2S)-2-benzyl-4-[(2S)-4-[(1R)-1-carbamoyl-2-phenylethyl]-2-(2-methylpropyl)-3-oxo-2,3-dihydro-1H-pyrrol-2-yl]-3-oxo-2,3-dihydro-1H-pyrrol-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1, 10
758,CC(C)C[C@]1(N=CC([C@@H](Cc2ccccc2)C(N)=O)C1=O)C1C=N[C@](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCOC2)(Cc2ccccc2)C1=O,"InChI=1S/C43H50N4O7/c1-28(2)22-43(38(49)34(25-46-43)33(40(44)51)20-29-12-6-3-7-13-29)35-26-45-42(39(35)50,23-31-16-10-5-11-17-31)24-37(48)36(21-30-14-8-4-9-15-30)47-41(52)54-32-18-19-53-27-32/h3-17,25-26,28,32-37,48H,18-24,27H2,1-2H3,(H2,44,51)(H,47,52)/t32-,33+,34?,35?,36-,37-,42-,43-/m0/s1",AVDFHCYEKNPTPH-LXDZYXNNSA-N,721,"(3S)-oxolan-3-yl N-[(2S,3S)-4-[(2S)-2-benzyl-4-[(2S)-4-[(1R)-1-carbamoyl-2-phenylethyl]-2-(2-methylpropyl)-3-oxo-2,3-dihydro-1H-pyrrol-2-yl]-3-oxo-2,3-dihydro-1H-pyrrol-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Pyrrolinone deriv. 2::Pyrrolinone inhibitor 2",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1, 1.3
759,CC(C)C[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,"InChI=1S/C39H52N4O6/c1-26(2)21-33(37(47)41-32(35(40)45)24-29-19-13-8-14-20-29)42-36(46)30(22-27-15-9-6-10-16-27)25-34(44)31(23-28-17-11-7-12-18-28)43-38(48)49-39(3,4)5/h6-20,26,30-34,44H,21-25H2,1-5H3,(H2,40,45)(H,41,47)(H,42,46)(H,43,48)/t30-,31+,32+,33+,34+/m1/s1",MURCDOXDAHPNRQ-OWIQAHIBSA-N,751,"CHEMBL289195::Hydroxyethylene dipeptide isostere::L-682,679::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-{[(1S)-1-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1, 0.6
760,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)NC1[C@H](O)Cc2ccccc12,"InChI=1S/C33H40N2O5/c1-33(2,3)40-32(39)34-27(19-23-14-8-5-9-15-23)28(36)21-25(18-22-12-6-4-7-13-22)31(38)35-30-26-17-11-10-16-24(26)20-29(30)37/h4-17,25,27-30,36-37H,18-21H2,1-3H3,(H,34,39)(H,35,38)/t25-,27+,28+,29-,30?/m1/s1",ZJBUCZFZQXPYFC-ZDKASERPSA-N,723,"CHEMBL277908::Pyrrolinone inhibitor 4::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1, 0.3
761,O[C@@H](C[C@@H](Cc1ccccc1)C(=O)NC1[C@H](O)Cc2ccccc12)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1,"InChI=1S/C33H38N2O6/c36-29(28(18-23-11-5-2-6-12-23)34-33(39)41-26-15-16-40-21-26)20-25(17-22-9-3-1-4-10-22)32(38)35-31-27-14-8-7-13-24(27)19-30(31)37/h1-14,25-26,28-31,36-37H,15-21H2,(H,34,39)(H,35,38)/t25-,26+,28+,29+,30-,31?/m1/s1",PKJPLBXKJRGYRL-ZNTXGADESA-N,724,"(3S)-oxolan-3-yl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate::Pyrrolinone deriv. 5::Pyrrolinone inhibitor 5",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1, 0.03
762,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@]1(Cc2ccccc2)N=CC(C2[C@H](O)Cc3ccccc23)C1=O,"InChI=1S/C35H40N2O5/c1-34(2,3)42-33(41)37-28(18-23-12-6-4-7-13-23)30(39)21-35(20-24-14-8-5-9-15-24)32(40)27(22-36-35)31-26-17-11-10-16-25(26)19-29(31)38/h4-17,22,27-31,38-39H,18-21H2,1-3H3,(H,37,41)/t27?,28-,29+,30-,31?,35-/m0/s1",XGMFGBHGPVJDEB-OZFQOWRPSA-N,725,"Boc-Monopyrrolinone Inhibitor::Pyrrolinone deriv. 6::Pyrrolinone inhibitor 6::tert-butyl N-[(2S,3S)-4-[(2S)-2-benzyl-4-[(2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-3-oxo-2,3-dihydro-1H-pyrrol-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1, 11.9
763,O[C@@H](C[C@]1(Cc2ccccc2)N=CC(C2[C@H](O)Cc3ccccc23)C1=O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1,"InChI=1S/C35H38N2O6/c38-30-18-25-13-7-8-14-27(25)32(30)28-21-36-35(33(28)40,19-24-11-5-2-6-12-24)20-31(39)29(17-23-9-3-1-4-10-23)37-34(41)43-26-15-16-42-22-26/h1-14,21,26,28-32,38-39H,15-20,22H2,(H,37,41)/t26-,28?,29-,30+,31-,32?,35-/m0/s1",MDUHYHGYNCJLNY-SWTALMHUSA-N,726,"(3S)-oxolan-3-yl N-[(2S,3S)-4-[(2S)-2-benzyl-4-[(2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-3-oxo-2,3-dihydro-1H-pyrrol-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Pyrrolinone deriv. 7::Pyrrolinone inhibitor 7::Tetrahydrofuranylcarbamate-Monopyrrolinone::monopyrrolinone-based inhibitor (-)-1::monopyrrolinone-based inhibitor 1",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1, 2.0
764,NC(=O)O[C@@H]1Cc2ccccc2C1C1C=N[C@](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]2CCOC2)(Cc2ccccc2)C1=O,"InChI=1S/C36H39N3O7/c37-34(42)46-31-18-25-13-7-8-14-27(25)32(31)28-21-38-36(33(28)41,19-24-11-5-2-6-12-24)20-30(40)29(17-23-9-3-1-4-10-23)39-35(43)45-26-15-16-44-22-26/h1-14,21,26,28-32,40H,15-20,22H2,(H2,37,42)(H,39,43)/t26-,28?,29-,30-,31+,32?,36-/m0/s1",AKZWRTCWNXHHFR-PDIZUQLASA-N,727,"(3S)-oxolan-3-yl N-[(2S,3S)-4-[(2S)-2-benzyl-4-[(2R)-2-(carbamoyloxy)-2,3-dihydro-1H-inden-1-yl]-3-oxo-2,3-dihydro-1H-pyrrol-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Carbamate derivative::Pyrrolinone deriv. 8::Pyrrolinone inhibitor 8::monopyrrolinone-based inhibitor (-)-2::monopyrrolinone-based inhibitor 2",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1, 2.0
765,O[C@@H](C[C@]1(Cc2ccccc2)N=CC(C2CNC(=O)c3ccccc23)C1=O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1,"InChI=1S/C35H37N3O6/c39-31(30(17-23-9-3-1-4-10-23)38-34(42)44-25-15-16-43-22-25)19-35(18-24-11-5-2-6-12-24)32(40)29(21-37-35)28-20-36-33(41)27-14-8-7-13-26(27)28/h1-14,21,25,28-31,39H,15-20,22H2,(H,36,41)(H,38,42)/t25-,28?,29?,30-,31-,35-/m0/s1",RROHLUJAQRVJPX-GHJDJLJMSA-N,728,"(3S)-oxolan-3-yl N-[(2S,3S)-4-[(2S)-2-benzyl-3-oxo-4-(1-oxo-1,2,3,4-tetrahydroisoquinolin-4-yl)-2,3-dihydro-1H-pyrrol-2-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Pyrrolinone deriv. 9::Pyrrolinone inhibitor 9::Tetrahydroisoquinolyl Inhibitor::monopyrrolinone-based inhibitor (+)-3::monopyrrolinone-based inhibitor 3",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1, 5.7
766,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1, 0.36
767,CC(C)[C@H](NC(=O)c1ccc2ccccc2n1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)OCc1ccncc1,"InChI=1S/C41H52N6O5/c1-27(2)37(45-38(49)33-16-15-30-13-9-10-14-32(30)43-33)40(51)44-34(23-28-11-7-6-8-12-28)36(48)25-47-22-19-31(52-26-29-17-20-42-21-18-29)24-35(47)39(50)46-41(3,4)5/h6-18,20-21,27,31,34-37,48H,19,22-26H2,1-5H3,(H,44,51)(H,45,49)(H,46,50)/t31-,34+,35+,36-,37+/m1/s1",RXBWRFDZXRAEJT-SZNOJMITSA-N,729,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-2-hydroxy-3-[(2S)-3-methyl-2-(quinolin-2-ylformamido)butanamido]-4-phenylbutyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::BILA 2011 BS::CHEMBL13134::Palinavir",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4
768,CC(C)[C@H](NC(=O)c1ccc2ccccc2n1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)OCc1ccncc1,"InChI=1S/C41H52N6O5/c1-27(2)37(45-38(49)33-16-15-30-13-9-10-14-32(30)43-33)40(51)44-34(23-28-11-7-6-8-12-28)36(48)25-47-22-19-31(52-26-29-17-20-42-21-18-29)24-35(47)39(50)46-41(3,4)5/h6-18,20-21,27,31,34-37,48H,19,22-26H2,1-5H3,(H,44,51)(H,45,49)(H,46,50)/t31-,34+,35+,36-,37+/m1/s1",RXBWRFDZXRAEJT-SZNOJMITSA-N,729,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-2-hydroxy-3-[(2S)-3-methyl-2-(quinolin-2-ylformamido)butanamido]-4-phenylbutyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::BILA 2011 BS::CHEMBL13134::Palinavir",Dimer of Gag-Pol polyprotein [514-612],Human immunodeficiency virus 2, 10
769,CC(C)(C)NC(=O)[C@@H]1C[C@@H](CCN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)OCc1ccncc1,"InChI=1S/C34H44N4O5/c1-34(2,3)37-32(40)30-21-28(42-23-27-14-17-35-18-15-27)16-19-38(30)22-31(39)29(20-25-10-6-4-7-11-25)36-33(41)43-24-26-12-8-5-9-13-26/h4-15,17-18,28-31,39H,16,19-24H2,1-3H3,(H,36,41)(H,37,40)/t28-,29+,30+,31-/m1/s1",WAHBCPQDHASNLU-QNRWOPMTSA-N,730,"Palinavir deriv. 2::benzyl N-[(2S,3R)-4-[(2S,4R)-2-(tert-butylcarbamoyl)-4-(pyridin-4-ylmethoxy)piperidin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 400
770,CC(C)(C)NC(=O)[C@@H]1C[C@@H](CCN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)COc1ccccc1)OCc1ccncc1,"InChI=1S/C34H44N4O5/c1-34(2,3)37-33(41)30-21-28(42-23-26-14-17-35-18-15-26)16-19-38(30)22-31(39)29(20-25-10-6-4-7-11-25)36-32(40)24-43-27-12-8-5-9-13-27/h4-15,17-18,28-31,39H,16,19-24H2,1-3H3,(H,36,40)(H,37,41)/t28-,29+,30+,31-/m1/s1",SMQRMVSFQHFPRT-QNRWOPMTSA-N,731,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-2-hydroxy-3-(2-phenoxyacetamido)-4-phenylbutyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::Palinavir deriv. 3",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1100
771,CC(C)(C)NC(=O)[C@@H]1C[C@@H](CCN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CCc1ccccc1)OCc1ccncc1,"InChI=1S/C35H46N4O4/c1-35(2,3)38-34(42)31-23-29(43-25-28-16-19-36-20-17-28)18-21-39(31)24-32(40)30(22-27-12-8-5-9-13-27)37-33(41)15-14-26-10-6-4-7-11-26/h4-13,16-17,19-20,29-32,40H,14-15,18,21-25H2,1-3H3,(H,37,41)(H,38,42)/t29-,30+,31+,32-/m1/s1",VFWJLYLCPJFUKE-OKDNLZPVSA-N,732,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-2-hydroxy-4-phenyl-3-(3-phenylpropanamido)butyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::Palinavir deriv. 4",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1400
772,CC(C)(C)NC(=O)[C@@H]1C[C@@H](CCN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CSc1ccccc1)OCc1ccncc1,"InChI=1S/C34H44N4O4S/c1-34(2,3)37-33(41)30-21-27(42-23-26-14-17-35-18-15-26)16-19-38(30)22-31(39)29(20-25-10-6-4-7-11-25)36-32(40)24-43-28-12-8-5-9-13-28/h4-15,17-18,27,29-31,39H,16,19-24H2,1-3H3,(H,36,40)(H,37,41)/t27-,29+,30+,31-/m1/s1",PGASSTKSMMTYHX-CFNXAKABSA-N,733,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-2-hydroxy-4-phenyl-3-[2-(phenylsulfanyl)acetamido]butyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::Palinavir deriv. 5",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 4200
773,CC(C)(C)NC(=O)[C@@H]1C[C@@H](CCN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CCCc1ccccc1)OCc1ccncc1,"InChI=1S/C36H48N4O4/c1-36(2,3)39-35(43)32-24-30(44-26-29-17-20-37-21-18-29)19-22-40(32)25-33(41)31(23-28-13-8-5-9-14-28)38-34(42)16-10-15-27-11-6-4-7-12-27/h4-9,11-14,17-18,20-21,30-33,41H,10,15-16,19,22-26H2,1-3H3,(H,38,42)(H,39,43)/t30-,31+,32+,33-/m1/s1",FXGXHPLBTOAXAD-JDIHBLRXSA-N,734,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-2-hydroxy-4-phenyl-3-(4-phenylbutanamido)butyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::Palinavir deriv. 6",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,>20000
774,CC(C)(C)NC(=O)[C@@H]1C[C@@H](CCN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)\C=C\c1ccccc1)OCc1ccncc1,"InChI=1S/C35H44N4O4/c1-35(2,3)38-34(42)31-23-29(43-25-28-16-19-36-20-17-28)18-21-39(31)24-32(40)30(22-27-12-8-5-9-13-27)37-33(41)15-14-26-10-6-4-7-11-26/h4-17,19-20,29-32,40H,18,21-25H2,1-3H3,(H,37,41)(H,38,42)/b15-14+/t29-,30+,31+,32-/m1/s1",YEPGBKOTJWSVML-WJKUSJKMSA-N,735,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-2-hydroxy-4-phenyl-3-[(2E)-3-phenylprop-2-enamido]butyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::Palinavir deriv. 7",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 11000
775,Cc1ccccc1COC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)OCc1ccncc1,"InChI=1S/C35H46N4O5/c1-25-10-8-9-13-28(25)24-44-34(42)37-30(20-26-11-6-5-7-12-26)32(40)22-39-19-16-29(43-23-27-14-17-36-18-15-27)21-31(39)33(41)38-35(2,3)4/h5-15,17-18,29-32,40H,16,19-24H2,1-4H3,(H,37,42)(H,38,41)/t29-,30+,31+,32-/m1/s1",CFKNTKGMEUMOTC-OKDNLZPVSA-N,736,"(2-methylphenyl)methyl N-[(2S,3R)-4-[(2S,4R)-2-(tert-butylcarbamoyl)-4-(pyridin-4-ylmethoxy)piperidin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Palinavir deriv. 8",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 210
776,Cc1ccccc1CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)OCc1ccncc1,"InChI=1S/C36H48N4O4/c1-26-10-8-9-13-29(26)14-15-34(42)38-31(22-27-11-6-5-7-12-27)33(41)24-40-21-18-30(44-25-28-16-19-37-20-17-28)23-32(40)35(43)39-36(2,3)4/h5-13,16-17,19-20,30-33,41H,14-15,18,21-25H2,1-4H3,(H,38,42)(H,39,43)/t30-,31+,32+,33-/m1/s1",NHVDOABLJWTEDN-JDIHBLRXSA-N,737,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-2-hydroxy-3-[3-(2-methylphenyl)propanamido]-4-phenylbutyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::Palinavir deriv. 9",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2500
777,Cc1ccccc1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)OCc1ccncc1,"InChI=1S/C35H46N4O5/c1-25-10-8-9-13-32(25)44-24-33(41)37-29(20-26-11-6-5-7-12-26)31(40)22-39-19-16-28(43-23-27-14-17-36-18-15-27)21-30(39)34(42)38-35(2,3)4/h5-15,17-18,28-31,40H,16,19-24H2,1-4H3,(H,37,41)(H,38,42)/t28-,29+,30+,31-/m1/s1",BHYLXIUVVRJDMP-QNRWOPMTSA-N,738,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-2-hydroxy-3-[2-(2-methylphenoxy)acetamido]-4-phenylbutyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::Palinavir deriv. 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 120
778,Cc1cccc(C)c1COC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)OCc1ccncc1,"InChI=1S/C36H48N4O5/c1-25-10-9-11-26(2)30(25)24-45-35(43)38-31(20-27-12-7-6-8-13-27)33(41)22-40-19-16-29(44-23-28-14-17-37-18-15-28)21-32(40)34(42)39-36(3,4)5/h6-15,17-18,29,31-33,41H,16,19-24H2,1-5H3,(H,38,43)(H,39,42)/t29-,31+,32+,33-/m1/s1",PCEGWKGFACRWOO-NWAHQLIBSA-N,739,"(2,6-dimethylphenyl)methyl N-[(2S,3R)-4-[(2S,4R)-2-(tert-butylcarbamoyl)-4-(pyridin-4-ylmethoxy)piperidin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Palinavir deriv. 11",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 420
779,Cc1cccc(C)c1CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)OCc1ccncc1,"InChI=1S/C37H50N4O4/c1-26-10-9-11-27(2)31(26)14-15-35(43)39-32(22-28-12-7-6-8-13-28)34(42)24-41-21-18-30(45-25-29-16-19-38-20-17-29)23-33(41)36(44)40-37(3,4)5/h6-13,16-17,19-20,30,32-34,42H,14-15,18,21-25H2,1-5H3,(H,39,43)(H,40,44)/t30-,32+,33+,34-/m1/s1",SNOCIZXDQHKVNO-SBLQOOQRSA-N,740,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-3-[3-(2,6-dimethylphenyl)propanamido]-2-hydroxy-4-phenylbutyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::Palinavir deriv. 12",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2400
780,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)OCc1ccncc1,"InChI=1S/C36H48N4O5/c1-25-10-9-11-26(2)34(25)45-24-33(42)38-30(20-27-12-7-6-8-13-27)32(41)22-40-19-16-29(44-23-28-14-17-37-18-15-28)21-31(40)35(43)39-36(3,4)5/h6-15,17-18,29-32,41H,16,19-24H2,1-5H3,(H,38,42)(H,39,43)/t29-,30+,31+,32-/m1/s1",YNTKPAFJCHPPOK-OKDNLZPVSA-N,741,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-3-[2-(2,6-dimethylphenoxy)acetamido]-2-hydroxy-4-phenylbutyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::Palinavir deriv. 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 7
781,CC(Oc1c(C)cccc1C)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)OCc1ccncc1,"InChI=1S/C37H50N4O5/c1-25-11-10-12-26(2)34(25)46-27(3)35(43)39-31(21-28-13-8-7-9-14-28)33(42)23-41-20-17-30(45-24-29-15-18-38-19-16-29)22-32(41)36(44)40-37(4,5)6/h7-16,18-19,27,30-33,42H,17,20-24H2,1-6H3,(H,39,43)(H,40,44)/t27?,30-,31+,32+,33-/m1/s1",CMBBYMMNBCVVGO-VEAZSMFDSA-N,742,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-3-[2-(2,6-dimethylphenoxy)propanamido]-2-hydroxy-4-phenylbutyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::Palinavir deriv. 14",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 20
782,Cc1c(O)cccc1C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)OCc1ccncc1,"InChI=1S/C34H44N4O5/c1-23-27(11-8-12-30(23)39)32(41)36-28(19-24-9-6-5-7-10-24)31(40)21-38-18-15-26(43-22-25-13-16-35-17-14-25)20-29(38)33(42)37-34(2,3)4/h5-14,16-17,26,28-29,31,39-40H,15,18-22H2,1-4H3,(H,36,41)(H,37,42)/t26-,28+,29+,31-/m1/s1",NKGCIFOXPWDDMH-BTURHGITSA-N,743,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutyl]-4-(pyridin-4-ylmethoxy)piperidine-2-carboxamide::Palinavir deriv. 15",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 12
783,CC(C)(C)NC(=O)[C@@H]1C[C@@H](CCN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)OCc1ccncc1,"InChI=1S/C31H44N4O6/c1-31(2,3)34-29(37)27-18-24(40-20-23-9-13-32-14-10-23)11-15-35(27)19-28(36)26(17-22-7-5-4-6-8-22)33-30(38)41-25-12-16-39-21-25/h4-10,13-14,24-28,36H,11-12,15-21H2,1-3H3,(H,33,38)(H,34,37)/t24-,25+,26+,27+,28-/m1/s1",NUYOEBHSJRCFOD-VNGQLYDISA-N,744,"(3S)-oxolan-3-yl N-[(2S,3R)-4-[(2S,4R)-2-(tert-butylcarbamoyl)-4-(pyridin-4-ylmethoxy)piperidin-1-yl]-3-hydroxy-1-phenylbutan-2-yl]carbamate::Palinavir deriv. 16",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 260
784,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)SCc1ccncc1,"InChI=1S/C36H48N4O4S/c1-25-10-9-11-26(2)34(25)44-23-33(42)38-30(20-27-12-7-6-8-13-27)32(41)22-40-19-16-29(45-24-28-14-17-37-18-15-28)21-31(40)35(43)39-36(3,4)5/h6-15,17-18,29-32,41H,16,19-24H2,1-5H3,(H,38,42)(H,39,43)/t29-,30+,31+,32-/m1/s1",FIWNNAIJMGZTNA-OKDNLZPVSA-N,745,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-3-[2-(2,6-dimethylphenoxy)acetamido]-2-hydroxy-4-phenylbutyl]-4-[(pyridin-4-ylmethyl)sulfanyl]piperidine-2-carboxamide::Palinavir deriv. 17",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.8
785,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)SCc1cccnc1,"InChI=1S/C36H48N4O4S/c1-25-11-9-12-26(2)34(25)44-23-33(42)38-30(19-27-13-7-6-8-14-27)32(41)22-40-18-16-29(45-24-28-15-10-17-37-21-28)20-31(40)35(43)39-36(3,4)5/h6-15,17,21,29-32,41H,16,18-20,22-24H2,1-5H3,(H,38,42)(H,39,43)/t29-,30+,31+,32-/m1/s1",HQARCNFWJWVJSV-OKDNLZPVSA-N,746,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-3-[2-(2,6-dimethylphenoxy)acetamido]-2-hydroxy-4-phenylbutyl]-4-[(pyridin-3-ylmethyl)sulfanyl]piperidine-2-carboxamide::Palinavir deriv. 18",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.7
786,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1CC[C@H](C[C@H]1C(=O)NC(C)(C)C)Sc1ccncc1,"InChI=1S/C35H46N4O4S/c1-24-10-9-11-25(2)33(24)43-23-32(41)37-29(20-26-12-7-6-8-13-26)31(40)22-39-19-16-28(44-27-14-17-36-18-15-27)21-30(39)34(42)38-35(3,4)5/h6-15,17-18,28-31,40H,16,19-23H2,1-5H3,(H,37,41)(H,38,42)/t28-,29+,30+,31-/m1/s1",WVPSCZBMYQIZMS-QNRWOPMTSA-N,747,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-3-[2-(2,6-dimethylphenoxy)acetamido]-2-hydroxy-4-phenylbutyl]-4-(pyridin-4-ylsulfanyl)piperidine-2-carboxamide::Palinavir deriv. 19",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.6
787,Cc1cc(S[C@@H]2CCN(C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)COc3c(C)cccc3C)[C@@H](C2)C(=O)NC(C)(C)C)nc(C)n1,"InChI=1S/C36H49N5O4S/c1-23-12-11-13-24(2)34(23)45-22-32(43)39-29(19-27-14-9-8-10-15-27)31(42)21-41-17-16-28(20-30(41)35(44)40-36(5,6)7)46-33-18-25(3)37-26(4)38-33/h8-15,18,28-31,42H,16-17,19-22H2,1-7H3,(H,39,43)(H,40,44)/t28-,29+,30+,31-/m1/s1",FDYJWNQORWMJFP-QNRWOPMTSA-N,748,"(2S,4R)-N-tert-butyl-1-[(2R,3S)-3-[2-(2,6-dimethylphenoxy)acetamido]-2-hydroxy-4-phenylbutyl]-4-[(2,6-dimethylpyrimidin-4-yl)sulfanyl]piperidine-2-carboxamide::Palinavir deriv. 20",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.5
788,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,"InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1",QWAXKHKRTORLEM-UGJKXSETSA-N,519,"(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::CHEMBL114::Fortovase::Invirase::Ro 31-8959::SQV::Saquinavir",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 8.4
789,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,"InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1",YMARZQAQMVYCKC-OEMFJLHTSA-N,577,"(3S)-oxolan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate::141W94::APV::Agenerase::Amprenavir::CHEMBL116::VX-478",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.6
790,CC(C)C[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,"InChI=1S/C57H70N6O8/c1-38(2)31-47(53(67)60-46(51(58)65)34-41-25-15-8-16-26-41)61-52(66)44(32-39-21-11-6-12-22-39)37-50(64)45(33-40-23-13-7-14-24-40)59-54(68)48(35-42-27-17-9-18-28-42)62-55(69)49(36-43-29-19-10-20-30-43)63-56(70)71-57(3,4)5/h6-30,38,44-50,64H,31-37H2,1-5H3,(H2,58,65)(H,59,68)(H,60,67)(H,61,66)(H,62,69)(H,63,70)/t44-,45+,46+,47+,48+,49+,50+/m1/s1",GYFHTEOWKRLODY-GPBZZYCGSA-N,749,"L-364,505::tert-butyl N-[(1S)-1-{[(1S)-1-{[(2S,3S,5R)-5-benzyl-5-{[(1S)-1-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}-3-hydroxy-1-phenylpentan-2-yl]carbamoyl}-2-phenylethyl]carbamoyl}-2-phenylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.0
791,CC(C)C[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,"InChI=1S/C48H61N5O7/c1-32(2)26-40(45(57)51-39(43(49)55)29-35-22-14-8-15-23-35)52-44(56)37(27-33-18-10-6-11-19-33)31-42(54)38(28-34-20-12-7-13-21-34)50-46(58)41(30-36-24-16-9-17-25-36)53-47(59)60-48(3,4)5/h6-25,32,37-42,54H,26-31H2,1-5H3,(H2,49,55)(H,50,58)(H,51,57)(H,52,56)(H,53,59)/t37-,38+,39+,40+,41+,42+/m1/s1",OKLXJRBROSFVFX-RUPQPXQESA-N,750,"Hydroxyethylene deriv. 1::tert-butyl N-[(1S)-1-{[(2S,3S,5R)-5-benzyl-5-{[(1S)-1-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}-3-hydroxy-1-phenylpentan-2-yl]carbamoyl}-2-phenylethyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 20.0
792,CC(C)C[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,"InChI=1S/C39H52N4O6/c1-26(2)21-33(37(47)41-32(35(40)45)24-29-19-13-8-14-20-29)42-36(46)30(22-27-15-9-6-10-16-27)25-34(44)31(23-28-17-11-7-12-18-28)43-38(48)49-39(3,4)5/h6-20,26,30-34,44H,21-25H2,1-5H3,(H2,40,45)(H,41,47)(H,42,46)(H,43,48)/t30-,31+,32+,33+,34+/m1/s1",MURCDOXDAHPNRQ-OWIQAHIBSA-N,751,"CHEMBL289195::Hydroxyethylene dipeptide isostere::L-682,679::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-{[(1S)-1-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.6
793,CC(C)C[C@H](NC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)CC(C)(C)C)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,"InChI=1S/C40H54N4O5/c1-27(2)21-34(39(49)43-33(37(41)47)24-30-19-13-8-14-20-30)44-38(48)31(22-28-15-9-6-10-16-28)25-35(45)32(23-29-17-11-7-12-18-29)42-36(46)26-40(3,4)5/h6-20,27,31-35,45H,21-26H2,1-5H3,(H2,41,47)(H,42,46)(H,43,49)(H,44,48)/t31-,32+,33+,34+,35+/m1/s1",SSDHDCHQNPWZLQ-DNOAQWIPSA-N,752,"(2R,4S,5S)-2-benzyl-N-[(1S)-1-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}-3-methylbutyl]-5-(3,3-dimethylbutanamido)-4-hydroxy-6-phenylhexanamide::Hydroxyethylene deriv. 3",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 6.0
794,CC(C)C[C@H](NC(=O)[C@H](C\C=C\c1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,"InChI=1S/C41H54N4O6/c1-28(2)24-35(39(49)43-34(37(42)47)26-31-20-13-8-14-21-31)44-38(48)32(23-15-22-29-16-9-6-10-17-29)27-36(46)33(25-30-18-11-7-12-19-30)45-40(50)51-41(3,4)5/h6-22,28,32-36,46H,23-27H2,1-5H3,(H2,42,47)(H,43,49)(H,44,48)(H,45,50)/b22-15+/t32-,33+,34+,35+,36+/m1/s1",INMQYOIMKNCOOR-KXUOSNPDSA-N,753,"Hydroxyethylene deriv. 4::Hydroxyethylene dipeptide isostere 7::tert-butyl N-[(2S,3S,5R)-5-{[(1S)-1-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}-3-hydroxy-1-phenyl-5-[(2E)-3-phenylprop-2-en-1-yl]pentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.15
795,CC(C)CC(NC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)NCCc1ccccc1,"InChI=1S/C38H51N3O5/c1-27(2)23-33(36(44)39-22-21-28-15-9-6-10-16-28)40-35(43)31(24-29-17-11-7-12-18-29)26-34(42)32(25-30-19-13-8-14-20-30)41-37(45)46-38(3,4)5/h6-20,27,31-34,42H,21-26H2,1-5H3,(H,39,44)(H,40,43)(H,41,45)/t31-,32+,33?,34+/m1/s1",DWSUULFDMUNPJU-UVUKXFCASA-N,754,"Hydroxyethylene deriv. 5::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-({3-methyl-1-[(2-phenylethyl)carbamoyl]butyl}carbamoyl)-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 12.0
796,CC(C)CC(NC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C37H49N3O5/c1-26(2)21-32(35(43)38-25-29-19-13-8-14-20-29)39-34(42)30(22-27-15-9-6-10-16-27)24-33(41)31(23-28-17-11-7-12-18-28)40-36(44)45-37(3,4)5/h6-20,26,30-33,41H,21-25H2,1-5H3,(H,38,43)(H,39,42)(H,40,44)/t30-,31+,32?,33+/m1/s1",TZKGOSNDFIBVER-DYRNCJCTSA-N,755,"Hydroxyethylene deriv. 6::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-{[1-(benzylcarbamoyl)-3-methylbutyl]carbamoyl}-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.4
797,CC(C)CC(NC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(N)=O,"InChI=1S/C30H43N3O5/c1-20(2)16-25(27(31)35)32-28(36)23(17-21-12-8-6-9-13-21)19-26(34)24(18-22-14-10-7-11-15-22)33-29(37)38-30(3,4)5/h6-15,20,23-26,34H,16-19H2,1-5H3,(H2,31,35)(H,32,36)(H,33,37)/t23-,24+,25?,26+/m1/s1",FACAUYLYCYUNSS-NNQWSVJYSA-N,756,"Hydroxyethylene deriv. 7::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-[(1-carbamoyl-3-methylbutyl)carbamoyl]-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 12.0
798,CC(C)CCNC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1,"InChI=1S/C29H42N2O4/c1-21(2)16-17-30-27(33)24(18-22-12-8-6-9-13-22)20-26(32)25(19-23-14-10-7-11-15-23)31-28(34)35-29(3,4)5/h6-15,21,24-26,32H,16-20H2,1-5H3,(H,30,33)(H,31,34)/t24-,25+,26+/m1/s1",AAYIGYNCAMMVQJ-ZNZIZOMTSA-N,757,"Hydroxyethylene deriv. 8::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-[(3-methylbutyl)carbamoyl]-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 470
799,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C31H38N2O4/c1-31(2,3)37-30(36)33-27(20-24-15-9-5-10-16-24)28(34)21-26(19-23-13-7-4-8-14-23)29(35)32-22-25-17-11-6-12-18-25/h4-18,26-28,34H,19-22H2,1-3H3,(H,32,35)(H,33,36)/t26-,27+,28+/m1/s1",SDOJFPSFHFRQPP-PKTNWEFCSA-N,758,"CHEMBL277034::Hydroxyethylene deriv. 9::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-(benzylcarbamoyl)-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 111
800,CCC(C)C(NC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C37H49N3O5/c1-6-26(2)33(35(43)38-25-29-20-14-9-15-21-29)40-34(42)30(22-27-16-10-7-11-17-27)24-32(41)31(23-28-18-12-8-13-19-28)39-36(44)45-37(3,4)5/h7-21,26,30-33,41H,6,22-25H2,1-5H3,(H,38,43)(H,39,44)(H,40,42)/t26?,30-,31+,32+,33?/m1/s1",UZBJXXZZZVEMND-JSXCYRQFSA-N,759,"Hydroxyethylene deriv. 10::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-{[1-(benzylcarbamoyl)-2-methylbutyl]carbamoyl}-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.71
801,CCC(C)C(NC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)NCC(O)CO,"InChI=1S/C33H49N3O7/c1-6-22(2)29(31(41)34-20-26(38)21-37)36-30(40)25(17-23-13-9-7-10-14-23)19-28(39)27(18-24-15-11-8-12-16-24)35-32(42)43-33(3,4)5/h7-16,22,25-29,37-39H,6,17-21H2,1-5H3,(H,34,41)(H,35,42)(H,36,40)/t22?,25-,26?,27+,28+,29?/m1/s1",CNNKZGRBCPFNKW-IKGKUSMESA-N,760,"Hydroxyethylene deriv. 11::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-({1-[(2,3-dihydroxypropyl)carbamoyl]-2-methylbutyl}carbamoyl)-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.15
802,CCC(C)C(NC(=O)[C@@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)NCc1nc2ccccc2[nH]1,"InChI=1S/C38H49N5O5/c1-6-25(2)34(36(46)39-24-33-40-29-19-13-14-20-30(29)41-33)43-35(45)28(21-26-15-9-7-10-16-26)23-32(44)31(22-27-17-11-8-12-18-27)42-37(47)48-38(3,4)5/h7-20,25,28,31-32,34,44H,6,21-24H2,1-5H3,(H,39,46)(H,40,41)(H,42,47)(H,43,45)/t25?,28-,31+,32+,34?/m1/s1",BINCYFHKHSPQAO-AUDVFALKSA-N,761,"Hydroxyethylene deriv. 12::tert-butyl N-[(2S,3S,5R)-5-({1-[(1H-1,3-benzodiazol-2-ylmethyl)carbamoyl]-2-methylbutyl}carbamoyl)-5-benzyl-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.07
803,CCC(C)C(NC(=O)[C@H](C\C=C\c1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)NCc1nc2ccccc2[nH]1,"InChI=1S/C40H51N5O5/c1-6-27(2)36(38(48)41-26-35-42-31-22-13-14-23-32(31)43-35)45-37(47)30(21-15-20-28-16-9-7-10-17-28)25-34(46)33(24-29-18-11-8-12-19-29)44-39(49)50-40(3,4)5/h7-20,22-23,27,30,33-34,36,46H,6,21,24-26H2,1-5H3,(H,41,48)(H,42,43)(H,44,49)(H,45,47)/b20-15+/t27?,30-,33+,34+,36?/m1/s1",XETIIHXJGVJJAT-NODMNJIGSA-N,762,"BocPhe[CHOH(CH2)3CH=CHPhCO]IleAMBI::L-687,908::tert-butyl N-[(2S,3S,5R)-5-({1-[(1H-1,3-benzodiazol-2-ylmethyl)carbamoyl]-2-methylbutyl}carbamoyl)-3-hydroxy-1-phenyl-5-[(2E)-3-phenylprop-2-en-1-yl]pentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.03
804,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
805,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639",Dimer of Gag-Pol polyprotein [514-612],Human immunodeficiency virus 2,
806,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,L512I]",Human immunodeficiency virus 1,
807,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,L512V]",Human immunodeficiency virus 1,
808,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,V521I]",Human immunodeficiency virus 1,
809,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,I536L]",Human immunodeficiency virus 1,
810,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,I539L]",Human immunodeficiency virus 1,
811,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,L565M]",Human immunodeficiency virus 1,
812,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,V571I]",Human immunodeficiency virus 1,
813,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,I573V]",Human immunodeficiency virus 1,
814,Oc1c2CCCCCCc2oc(=O)c1[C@@H](C1CC1)c1cccc(NS(=O)(=O)c2ccccc2)c1,"InChI=1S/C27H29NO5S/c29-26-22-13-6-1-2-7-14-23(22)33-27(30)25(26)24(18-15-16-18)19-9-8-10-20(17-19)28-34(31,32)21-11-4-3-5-12-21/h3-5,8-12,17-18,24,28-29H,1-2,6-7,13-16H2/t24-/m0/s1",GDRNWAKVNIROCG-DEOSSOPVSA-N,763,"Cyclooctylpyranonesulfonamide deriv. 8b::N-{3-[(S)-cyclopropyl({4-hydroxy-2-oxo-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-3-yl})methyl]phenyl}benzenesulfonamide::Sulfonamide-Substituted Cyclooctylpyranone deriv. 8h::U-103017 Analog",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
815,Cc1ccccc1S(=O)(=O)Nc1cccc(c1)C(C1CC1)c1c(O)c2CCCCCCc2oc1=O,"InChI=1S/C28H31NO5S/c1-18-9-6-7-14-24(18)35(32,33)29-21-11-8-10-20(17-21)25(19-15-16-19)26-27(30)22-12-4-2-3-5-13-23(22)34-28(26)31/h6-11,14,17,19,25,29-30H,2-5,12-13,15-16H2,1H3",AYZGBDUXVJCUNJ-UHFFFAOYSA-N,764,"Cyclooctylpyranonesulfonamide deriv. 8c::N-{3-[cyclopropyl({4-hydroxy-2-oxo-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-3-yl})methyl]phenyl}-2-methylbenzene-1-sulfonamide::Sulfonamide-Substituted Cyclooctylpyranone deriv. 33a::U-103017 Analog",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
816,Cc1cccc(c1)S(=O)(=O)Nc1cccc(c1)C(C1CC1)c1c(O)c2CCCCCCc2oc1=O,"InChI=1S/C28H31NO5S/c1-18-8-6-11-22(16-18)35(32,33)29-21-10-7-9-20(17-21)25(19-14-15-19)26-27(30)23-12-4-2-3-5-13-24(23)34-28(26)31/h6-11,16-17,19,25,29-30H,2-5,12-15H2,1H3",PDXABVTZQPAMBI-UHFFFAOYSA-N,765,"Cyclooctylpyranonesulfonamide deriv. 8d::N-{3-[cyclopropyl({4-hydroxy-2-oxo-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-3-yl})methyl]phenyl}-3-methylbenzene-1-sulfonamide::Sulfonamide-Substituted Cyclooctylpyranone deriv. 34a::U-103017 Analog",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
817,Cc1ccc(cc1)S(=O)(=O)Nc1cccc(c1)C(C1CC1)c1c(O)c2CCCCCCc2oc1=O,"InChI=1S/C28H31NO5S/c1-18-11-15-22(16-12-18)35(32,33)29-21-8-6-7-20(17-21)25(19-13-14-19)26-27(30)23-9-4-2-3-5-10-24(23)34-28(26)31/h6-8,11-12,15-17,19,25,29-30H,2-5,9-10,13-14H2,1H3",WMWRKGRHVTXXNA-UHFFFAOYSA-N,766,"Cyclooctylpyranonesulfonamide deriv. 8e::N-{3-[cyclopropyl({4-hydroxy-2-oxo-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-3-yl})methyl]phenyl}-4-methylbenzene-1-sulfonamide::Sulfonamide-Substituted Cyclooctylpyranone deriv. 35a::U-103017 Analog",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
818,Oc1c2CCCCCCc2oc(=O)c1[C@@H](C1CC1)c1cccc(NS(=O)(=O)c2ccc(cc2)C#N)c1,"InChI=1S/C28H28N2O5S/c29-17-18-10-14-22(15-11-18)36(33,34)30-21-7-5-6-20(16-21)25(19-12-13-19)26-27(31)23-8-3-1-2-4-9-24(23)35-28(26)32/h5-7,10-11,14-16,19,25,30-31H,1-4,8-9,12-13H2/t25-/m0/s1",VCYQENLVFRTJIC-VWLOTQADSA-N,767,"4-Cyano-N-[3-[cyclopropyl(5,6,7,8,9,10-hexahydro-4-hydroxy-2-oxo-2H-cycloocta[b]pyran-3-yl)methyl]phenyl]-benzenesulfonamide::4-cyano-N-{3-[(S)-cyclopropyl({4-hydroxy-2-oxo-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-3-yl})methyl]phenyl}benzene-1-sulfonamide::U-103,017",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
819,CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O,"InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3",DQDAYGNAKTZFIW-UHFFFAOYSA-N,768,4-hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one::CHEMBL16694::phenprocoumon,Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
820,CCC(c1ccccc1)c1c(O)cc(CCc2ccccc2)oc1=O,"InChI=1S/C22H22O3/c1-2-19(17-11-7-4-8-12-17)21-20(23)15-18(25-22(21)24)14-13-16-9-5-3-6-10-16/h3-12,15,19,23H,2,13-14H2,1H3",OAXPPAUXOZJCFF-UHFFFAOYSA-N,769,4-hydroxy-2-pyrone 6::4-hydroxy-6-(2-phenylethyl)-3-(1-phenylpropyl)-2H-pyran-2-one,Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
821,CCC(Cc1ccccc1)c1cc(O)c(C(CC)c2ccccc2)c(=O)o1,"InChI=1S/C24H26O3/c1-3-18(15-17-11-7-5-8-12-17)22-16-21(25)23(24(26)27-22)20(4-2)19-13-9-6-10-14-19/h5-14,16,18,20,25H,3-4,15H2,1-2H3",HALPINAQGOXQAN-UHFFFAOYSA-N,770,4-hydroxy-6-(1-phenylbutan-2-yl)-3-(1-phenylpropyl)-2H-pyran-2-one::CHEMBL22164::U-96988,Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
822,Oc1c2CCCCCCc2oc(=O)c1C(C1CC1)c1ccccc1,"InChI=1S/C21H24O3/c22-20-16-10-6-1-2-7-11-17(16)24-21(23)19(20)18(15-12-13-15)14-8-4-3-5-9-14/h3-5,8-9,15,18,22H,1-2,6-7,10-13H2",JHWCZVFBDHIFSP-UHFFFAOYSA-N,771,"3-[cyclopropyl(phenyl)methyl]-4-hydroxy-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::CHEMBL16584::Cyclooctylpyranone 4::Cyclooctylpyranone 5d",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
823,CCC(Cc1ccccc1)c1cc(O)c(C(CC)c2ccccc2)c(=O)o1,"InChI=1S/C24H26O3/c1-3-18(15-17-11-7-5-8-12-17)22-16-21(25)23(24(26)27-22)20(4-2)19-13-9-6-10-14-19/h5-14,16,18,20,25H,3-4,15H2,1-2H3",HALPINAQGOXQAN-UHFFFAOYSA-N,770,4-hydroxy-6-(1-phenylbutan-2-yl)-3-(1-phenylpropyl)-2H-pyran-2-one::CHEMBL22164::U-96988,Dimer of Gag-Pol polyprotein [514-612],Human immunodeficiency virus 2,
824,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
825,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
826,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
827,Cc1ccccc1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1C,"InChI=1S/C32H37N3O5S/c1-20-11-8-9-14-23(20)18-33-30(39)28-32(3,4)41-19-35(28)31(40)27(37)25(17-22-12-6-5-7-13-22)34-29(38)24-15-10-16-26(36)21(24)2/h5-16,25,27-28,36-37H,17-19H2,1-4H3,(H,33,39)(H,34,38)/t25-,27-,28+/m0/s1",CUFQBQOBLVLKRF-RZDMPUFOSA-N,580,"(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide::AG1776::JE-2147::KNI-764",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
828,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24-,25-,26-,29-/m0/s1",NJBBLOIWMSYVCQ-VZTVMPNDSA-N,579,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::CHEMBL414640::KNI-272::Kynostatin 272::iQoa-Mta-Apns-Thz-NH-tBu",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
829,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir","Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,D531N]",Human immunodeficiency virus 1,
830,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,D531N]",Human immunodeficiency virus 1,
831,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept","Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,D531N]",Human immunodeficiency virus 1,
832,Cc1ccccc1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1C,"InChI=1S/C32H37N3O5S/c1-20-11-8-9-14-23(20)18-33-30(39)28-32(3,4)41-19-35(28)31(40)27(37)25(17-22-12-6-5-7-13-22)34-29(38)24-15-10-16-26(36)21(24)2/h5-16,25,27-28,36-37H,17-19H2,1-4H3,(H,33,39)(H,34,38)/t25-,27-,28+/m0/s1",CUFQBQOBLVLKRF-RZDMPUFOSA-N,580,"(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide::AG1776::JE-2147::KNI-764","Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,D531N]",Human immunodeficiency virus 1,
833,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24-,25-,26-,29-/m0/s1",NJBBLOIWMSYVCQ-VZTVMPNDSA-N,579,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::CHEMBL414640::KNI-272::Kynostatin 272::iQoa-Mta-Apns-Thz-NH-tBu","Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,D531N]",Human immunodeficiency virus 1,
834,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir","Dimer of Gag-Pol polyprotein [501-599,M537I]",Human immunodeficiency virus 1,
835,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [501-599,M537I]",Human immunodeficiency virus 1,
836,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept","Dimer of Gag-Pol polyprotein [501-599,M537I]",Human immunodeficiency virus 1,
837,Cc1ccccc1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1C,"InChI=1S/C32H37N3O5S/c1-20-11-8-9-14-23(20)18-33-30(39)28-32(3,4)41-19-35(28)31(40)27(37)25(17-22-12-6-5-7-13-22)34-29(38)24-15-10-16-26(36)21(24)2/h5-16,25,27-28,36-37H,17-19H2,1-4H3,(H,33,39)(H,34,38)/t25-,27-,28+/m0/s1",CUFQBQOBLVLKRF-RZDMPUFOSA-N,580,"(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide::AG1776::JE-2147::KNI-764","Dimer of Gag-Pol polyprotein [501-599,M537I]",Human immunodeficiency virus 1,
838,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24-,25-,26-,29-/m0/s1",NJBBLOIWMSYVCQ-VZTVMPNDSA-N,579,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::CHEMBL414640::KNI-272::Kynostatin 272::iQoa-Mta-Apns-Thz-NH-tBu","Dimer of Gag-Pol polyprotein [501-599,M537I]",Human immunodeficiency virus 1,
839,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir","Dimer of Gag-Pol polyprotein [501-599,A572V]",Human immunodeficiency virus 1,
840,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [501-599,A572V]",Human immunodeficiency virus 1,
841,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept","Dimer of Gag-Pol polyprotein [501-599,A572V]",Human immunodeficiency virus 1,
842,Cc1ccccc1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1C,"InChI=1S/C32H37N3O5S/c1-20-11-8-9-14-23(20)18-33-30(39)28-32(3,4)41-19-35(28)31(40)27(37)25(17-22-12-6-5-7-13-22)34-29(38)24-15-10-16-26(36)21(24)2/h5-16,25,27-28,36-37H,17-19H2,1-4H3,(H,33,39)(H,34,38)/t25-,27-,28+/m0/s1",CUFQBQOBLVLKRF-RZDMPUFOSA-N,580,"(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide::AG1776::JE-2147::KNI-764","Dimer of Gag-Pol polyprotein [501-599,A572V]",Human immunodeficiency virus 1,
843,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24-,25-,26-,29-/m0/s1",NJBBLOIWMSYVCQ-VZTVMPNDSA-N,579,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::CHEMBL414640::KNI-272::Kynostatin 272::iQoa-Mta-Apns-Thz-NH-tBu","Dimer of Gag-Pol polyprotein [501-599,A572V]",Human immunodeficiency virus 1,
844,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir","Dimer of Gag-Pol polyprotein [501-599,D531N,M537I]",Human immunodeficiency virus 1,
845,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [501-599,D531N,M537I]",Human immunodeficiency virus 1,
846,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept","Dimer of Gag-Pol polyprotein [501-599,D531N,M537I]",Human immunodeficiency virus 1,
847,Cc1ccccc1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1C,"InChI=1S/C32H37N3O5S/c1-20-11-8-9-14-23(20)18-33-30(39)28-32(3,4)41-19-35(28)31(40)27(37)25(17-22-12-6-5-7-13-22)34-29(38)24-15-10-16-26(36)21(24)2/h5-16,25,27-28,36-37H,17-19H2,1-4H3,(H,33,39)(H,34,38)/t25-,27-,28+/m0/s1",CUFQBQOBLVLKRF-RZDMPUFOSA-N,580,"(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide::AG1776::JE-2147::KNI-764","Dimer of Gag-Pol polyprotein [501-599,D531N,M537I]",Human immunodeficiency virus 1,
848,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24-,25-,26-,29-/m0/s1",NJBBLOIWMSYVCQ-VZTVMPNDSA-N,579,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::CHEMBL414640::KNI-272::Kynostatin 272::iQoa-Mta-Apns-Thz-NH-tBu","Dimer of Gag-Pol polyprotein [501-599,D531N,M537I]",Human immunodeficiency virus 1,
849,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir","Dimer of Gag-Pol polyprotein [501-599,D531N,A572V]",Human immunodeficiency virus 1,
850,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [501-599,D531N,A572V]",Human immunodeficiency virus 1,
851,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept","Dimer of Gag-Pol polyprotein [501-599,D531N,A572V]",Human immunodeficiency virus 1,
852,Cc1ccccc1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1C,"InChI=1S/C32H37N3O5S/c1-20-11-8-9-14-23(20)18-33-30(39)28-32(3,4)41-19-35(28)31(40)27(37)25(17-22-12-6-5-7-13-22)34-29(38)24-15-10-16-26(36)21(24)2/h5-16,25,27-28,36-37H,17-19H2,1-4H3,(H,33,39)(H,34,38)/t25-,27-,28+/m0/s1",CUFQBQOBLVLKRF-RZDMPUFOSA-N,580,"(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide::AG1776::JE-2147::KNI-764","Dimer of Gag-Pol polyprotein [501-599,D531N,A572V]",Human immunodeficiency virus 1,
853,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24-,25-,26-,29-/m0/s1",NJBBLOIWMSYVCQ-VZTVMPNDSA-N,579,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::CHEMBL414640::KNI-272::Kynostatin 272::iQoa-Mta-Apns-Thz-NH-tBu","Dimer of Gag-Pol polyprotein [501-599,D531N,A572V]",Human immunodeficiency virus 1,
854,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir","Dimer of Gag-Pol polyprotein [501-599,M537I,A572V]",Human immunodeficiency virus 1,
855,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [501-599,M537I,A572V]",Human immunodeficiency virus 1,
856,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept","Dimer of Gag-Pol polyprotein [501-599,M537I,A572V]",Human immunodeficiency virus 1,
857,Cc1ccccc1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1C,"InChI=1S/C32H37N3O5S/c1-20-11-8-9-14-23(20)18-33-30(39)28-32(3,4)41-19-35(28)31(40)27(37)25(17-22-12-6-5-7-13-22)34-29(38)24-15-10-16-26(36)21(24)2/h5-16,25,27-28,36-37H,17-19H2,1-4H3,(H,33,39)(H,34,38)/t25-,27-,28+/m0/s1",CUFQBQOBLVLKRF-RZDMPUFOSA-N,580,"(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide::AG1776::JE-2147::KNI-764","Dimer of Gag-Pol polyprotein [501-599,M537I,A572V]",Human immunodeficiency virus 1,
858,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24-,25-,26-,29-/m0/s1",NJBBLOIWMSYVCQ-VZTVMPNDSA-N,579,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::CHEMBL414640::KNI-272::Kynostatin 272::iQoa-Mta-Apns-Thz-NH-tBu","Dimer of Gag-Pol polyprotein [501-599,M537I,A572V]",Human immunodeficiency virus 1,
859,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir","Dimer of Gag-Pol polyprotein [501-599,D531N,M537I,A572V]",Human immunodeficiency virus 1,
860,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [501-599,D531N,M537I,A572V]",Human immunodeficiency virus 1,
861,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept","Dimer of Gag-Pol polyprotein [501-599,D531N,M537I,A572V]",Human immunodeficiency virus 1,
862,Cc1ccccc1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1C,"InChI=1S/C32H37N3O5S/c1-20-11-8-9-14-23(20)18-33-30(39)28-32(3,4)41-19-35(28)31(40)27(37)25(17-22-12-6-5-7-13-22)34-29(38)24-15-10-16-26(36)21(24)2/h5-16,25,27-28,36-37H,17-19H2,1-4H3,(H,33,39)(H,34,38)/t25-,27-,28+/m0/s1",CUFQBQOBLVLKRF-RZDMPUFOSA-N,580,"(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide::AG1776::JE-2147::KNI-764","Dimer of Gag-Pol polyprotein [501-599,D531N,M537I,A572V]",Human immunodeficiency virus 1,
863,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24-,25-,26-,29-/m0/s1",NJBBLOIWMSYVCQ-VZTVMPNDSA-N,579,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::CHEMBL414640::KNI-272::Kynostatin 272::iQoa-Mta-Apns-Thz-NH-tBu","Dimer of Gag-Pol polyprotein [501-599,D531N,M537I,A572V]",Human immunodeficiency virus 1,
864,CC(c1ccccc1)c1c(O)c2CCCCCCc2oc1=O,"InChI=1S/C19H22O3/c1-13(14-9-5-4-6-10-14)17-18(20)15-11-7-2-3-8-12-16(15)22-19(17)21/h4-6,9-10,13,20H,2-3,7-8,11-12H2,1H3",NGTPYSMBKIFYEF-UHFFFAOYSA-N,781,"4-hydroxy-3-(1-phenylethyl)-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::Cyclooctylpyranone 6",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
865,CCC(c1ccccc1)c1c(O)c2CCCCCCc2oc1=O,"InChI=1S/C20H24O3/c1-2-15(14-10-6-5-7-11-14)18-19(21)16-12-8-3-4-9-13-17(16)23-20(18)22/h5-7,10-11,15,21H,2-4,8-9,12-13H2,1H3",UXCLJNSXDNCIIT-UHFFFAOYSA-N,782,"4-hydroxy-3-(1-phenylpropyl)-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::5,6,7,8,9,10-Hexahydro-4-hydroxy-3-( 1-phenylpropyl).W-cycloocta[b]pyran-2-one::CHEMBL275899::Cyclooctylpyranone 4d",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
866,CCCC(c1ccccc1)c1c(O)c2CCCCCCc2oc1=O,"InChI=1S/C21H26O3/c1-2-10-16(15-11-6-5-7-12-15)19-20(22)17-13-8-3-4-9-14-18(17)24-21(19)23/h5-7,11-12,16,22H,2-4,8-10,13-14H2,1H3",FTLZWVIFFLWQIJ-UHFFFAOYSA-N,783,"4-hydroxy-3-(1-phenylbutyl)-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::5,6,7,8,9,l0-Hexahydro-4-hydroxy-3-(l-phenylbutyl)-W-cycloocta[blpyran-2-one::Cyclooctylpyranone 7",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
867,CC(C)C(c1ccccc1)c1c(O)c2CCCCCCc2oc1=O,"InChI=1S/C21H26O3/c1-14(2)18(15-10-6-5-7-11-15)19-20(22)16-12-8-3-4-9-13-17(16)24-21(19)23/h5-7,10-11,14,18,22H,3-4,8-9,12-13H2,1-2H3",SHPVIVQZNPRWJX-UHFFFAOYSA-N,784,"4-hydroxy-3-(2-methyl-1-phenylpropyl)-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::5,6,7,8,9,1O-Hexahydro-4-hydroxy-3-(2-methyl-nylpropyl)-W-cycloocta[b]pyran-2-one::Cyclooctylpyranone 8",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
868,Oc1c2CCCCCCc2oc(=O)c1C(C1CC1)c1ccccc1,"InChI=1S/C21H24O3/c22-20-16-10-6-1-2-7-11-17(16)24-21(23)19(20)18(15-12-13-15)14-8-4-3-5-9-14/h3-5,8-9,15,18,22H,1-2,6-7,10-13H2",JHWCZVFBDHIFSP-UHFFFAOYSA-N,771,"3-[cyclopropyl(phenyl)methyl]-4-hydroxy-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::CHEMBL16584::Cyclooctylpyranone 4::Cyclooctylpyranone 5d",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
869,CCCCC(c1ccccc1)c1c(O)c2CCCCCCc2oc1=O,"InChI=1S/C22H28O3/c1-2-3-13-17(16-11-7-6-8-12-16)20-21(23)18-14-9-4-5-10-15-19(18)25-22(20)24/h6-8,11-12,17,23H,2-5,9-10,13-15H2,1H3",CNSKLJKHQGIUGM-UHFFFAOYSA-N,786,"4-hydroxy-3-(1-phenylpentyl)-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::5,6,7,8,9,10-Hexahydroro-4-hydroxy- 1-phenylpentyl)-W-cycloocta[blpyran-2-one::Cyclooctylpyranone 9",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
870,CC(C)CC(c1ccccc1)c1c(O)c2CCCCCCc2oc1=O,"InChI=1S/C22H28O3/c1-15(2)14-18(16-10-6-5-7-11-16)20-21(23)17-12-8-3-4-9-13-19(17)25-22(20)24/h5-7,10-11,15,18,23H,3-4,8-9,12-14H2,1-2H3",VLJOZQWJEGNYAL-UHFFFAOYSA-N,787,"4-hydroxy-3-(3-methyl-1-phenylbutyl)-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::5,6,7,8,9,1O-Hexahydro-4-hydroxy-3-(3-methyl- l-phe-nylbutyl)-W-cycloocta[b]pyran-2-one::Cyclooctylpyranone 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
871,Oc1c2CCCCCCc2oc(=O)c1C(c1ccccc1)c1ccccc1,"InChI=1S/C24H24O3/c25-23-19-15-9-1-2-10-16-20(19)27-24(26)22(23)21(17-11-5-3-6-12-17)18-13-7-4-8-14-18/h3-8,11-14,21,25H,1-2,9-10,15-16H2",PUBCUSNYSLHTMJ-UHFFFAOYSA-N,788,"3-(Diphenylmethyl)-5,6,7,8,9,1O-hexahydro-4-hydroxy-W-cycloocta[b]pyran-2-one::3-(diphenylmethyl)-4-hydroxy-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::Cyclooctylpyranone 11",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
872,Oc1c2CCCCCCc2oc(=O)c1C(C1CC1)C1CC1,"InChI=1S/C18H24O3/c19-17-13-5-3-1-2-4-6-14(13)21-18(20)16(17)15(11-7-8-11)12-9-10-12/h11-12,15,19H,1-10H2",ASKNXZXTIIAPJQ-UHFFFAOYSA-N,789,"3-(Dicyclopropylmethy1)-5,6,7,8,9,l0-hexahydro-4-droxy-W-cycloocta[blpyran-2-one::3-(dicyclopropylmethyl)-4-hydroxy-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::Cyclooctylpyranone 12",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
873,Oc1c(Cc2ccccc2)c(=O)oc2CCCCCCc12,"InChI=1S/C18H20O3/c19-17-14-10-6-1-2-7-11-16(14)21-18(20)15(17)12-13-8-4-3-5-9-13/h3-5,8-9,19H,1-2,6-7,10-12H2",QWJMOXSHVWEFEX-UHFFFAOYSA-N,790,"3-benzyl-4-hydroxy-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::Cyclooctylpyranone 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
874,Oc1c(CCc2ccccc2)c(=O)oc2CCCCCCc12,"InChI=1S/C19H22O3/c20-18-15-10-6-1-2-7-11-17(15)22-19(21)16(18)13-12-14-8-4-3-5-9-14/h3-5,8-9,20H,1-2,6-7,10-13H2",FOZRPMATVHONKK-UHFFFAOYSA-N,791,"4-hydroxy-3-(2-phenylethyl)-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::Cyclooctylpyranone 14",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
875,Oc1c(CCCc2ccccc2)c(=O)oc2CCCCCCc12,"InChI=1S/C20H24O3/c21-19-16-12-6-1-2-7-14-18(16)23-20(22)17(19)13-8-11-15-9-4-3-5-10-15/h3-5,9-10,21H,1-2,6-8,11-14H2",FFDSQYPZHOARRP-UHFFFAOYSA-N,792,"4-hydroxy-3-(3-phenylpropyl)-2H,5H,6H,7H,8H,9H,10H-cycloocta[b]pyran-2-one::Cyclooctylpyranone 15",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
876,CC(C)(C)NC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)COc1cccc2ccccc12,"InChI=1S/C36H45N5O7S/c1-35(2,3)40-33(46)31-36(4,5)49-21-41(31)34(47)30(44)25(18-22-12-7-6-8-13-22)39-32(45)26(19-28(37)42)38-29(43)20-48-27-17-11-15-23-14-9-10-16-24(23)27/h6-17,25-26,30-31,44H,18-21H2,1-5H3,(H2,37,42)(H,38,43)(H,39,45)(H,40,46)/t25-,26-,30-,31+/m0/s1",UFSMRNQSQSGJII-QYRZKEDASA-N,793,"(2S)-N-[(2S,3S)-4-[(4R)-4-(tert-butylcarbamoyl)-5,5-dimethyl-1,3-thiazolidin-3-yl]-3-hydroxy-4-oxo-1-phenylbutan-2-yl]-2-[2-(naphthalen-1-yloxy)acetamido]butanediamide::KNI-174::Noa-Asn-Apns-Dmt-NH-tBu",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
877,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C35H45N5O6S2/c1-34(2,3)39-32(44)30-35(4,5)48-21-40(30)33(45)29(42)25(17-22-11-8-7-9-12-22)38-31(43)26(20-47-6)37-28(41)19-46-27-14-10-13-23-18-36-16-15-24(23)27/h7-16,18,25-26,29-30,42H,17,19-21H2,1-6H3,(H,37,41)(H,38,43)(H,39,44)/t25-,26-,29-,30+/m0/s1",AHWCYDXQIXZVRK-RPQLRNILSA-N,719,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide::CHEMBL231622::KNI-227",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
878,CSC[C@H](NC(=O)COc1cccc2cnccc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24-,25-,26-,29-/m0/s1",NJBBLOIWMSYVCQ-VZTVMPNDSA-N,579,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(2R)-2-[2-(isoquinolin-5-yloxy)acetamido]-3-(methylsulfanyl)propanamido]-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide::CHEMBL414640::KNI-272::Kynostatin 272::iQoa-Mta-Apns-Thz-NH-tBu",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
879,CC(C)(C)NC(=O)C1CSCN1C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)COc1cccc2ccccc12,"InChI=1S/C34H41N5O7S/c1-34(2,3)38-32(44)26-19-47-20-39(26)33(45)30(42)24(16-21-10-5-4-6-11-21)37-31(43)25(17-28(35)40)36-29(41)18-46-27-15-9-13-22-12-7-8-14-23(22)27/h4-15,24-26,30,42H,16-20H2,1-3H3,(H2,35,40)(H,36,41)(H,37,43)(H,38,44)/t24-,25-,26?,30-/m0/s1",ORRZZPYNUKXKAG-ZNBUKYQUSA-N,794,"(2S)-N-[(2S,3S)-4-[4-(tert-butylcarbamoyl)-1,3-thiazolidin-3-yl]-3-hydroxy-4-oxo-1-phenylbutan-2-yl]-2-[2-(naphthalen-1-yloxy)acetamido]butanediamide::KNI-154::Noa-Asn-Apns-Thz-NH-tBu",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
880,CC(C)CCN(C[C@@H](O)[C@@H]1Cc2ccc(OCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N1)cc2)S(=O)(=O)c1ccc(N)cc1,"InChI=1S/C32H49N5O6S/c1-21(2)16-17-37(44(41,42)26-14-10-24(33)11-15-26)20-29(38)28-19-23-8-12-25(13-9-23)43-18-6-5-7-27(34)31(39)36-30(22(3)4)32(40)35-28/h8-15,21-22,27-30,38H,5-7,16-20,33-34H2,1-4H3,(H,35,40)(H,36,39)/t27-,28-,29+,30-/m0/s1",ZYGJIVAYVQHQAD-ZXYZSCNASA-N,795,"(2R)-2-[(7S,10S,13S)-7-amino-8,11-dioxo-10-(propan-2-yl)-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-13-yl]-N-(4-aminophenyl)-2-hydroxy-N-(3-methylbutyl)ethane-1-sulfonamido::Macrocycle-containing Compound 9a","Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]",Human immunodeficiency virus 1,
881,CC(C)CCN(C[C@@H](O)[C@@H]1Cc2ccc(OCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1)cc2)S(=O)(=O)c1ccc(NC(C)=O)cc1,"InChI=1S/C39H59N5O9S/c1-25(2)20-21-44(54(50,51)31-18-14-29(15-19-31)40-27(5)45)24-34(46)33-23-28-12-16-30(17-13-28)52-22-10-9-11-32(42-38(49)53-39(6,7)8)36(47)43-35(26(3)4)37(48)41-33/h12-19,25-26,32-35,46H,9-11,20-24H2,1-8H3,(H,40,45)(H,41,48)(H,42,49)(H,43,47)/t32-,33-,34+,35-/m0/s1",QQMKKKSPIWRIDH-KMSCUOMXSA-N,796,"Macrocycle-containing Compound 9b::tert-butyl N-[(7S,10S,13S)-13-[(1R)-2-[(4-acetamidobenzene)(3-methylbutyl)sulfonamido]-1-hydroxyethyl]-8,11-dioxo-10-(propan-2-yl)-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-7-yl]carbamate","Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]",Human immunodeficiency virus 1,
882,CC(C)CCN(C[C@@H](O)[C@@H]1Cc2ccc(OCCCC[C@H](NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](C(C)C)C(=O)N1)cc2)S(=O)(=O)c1ccc(N)cc1,"InChI=1S/C37H56N6O9S/c1-23(2)17-18-43(53(50,51)29-15-11-27(38)12-16-29)21-33(46)31-20-26-9-13-28(14-10-26)52-19-7-6-8-30(40-36(48)32(22-44)39-25(5)45)35(47)42-34(24(3)4)37(49)41-31/h9-16,23-24,30-34,44,46H,6-8,17-22,38H2,1-5H3,(H,39,45)(H,40,48)(H,41,49)(H,42,47)/t30-,31-,32-,33+,34-/m0/s1",YAUPSJXHXSEEKT-ALJNDBQTSA-N,797,"(2S)-N-[(7S,10S,13S)-13-[(1R)-2-[(4-aminobenzene)(3-methylbutyl)sulfonamido]-1-hydroxyethyl]-8,11-dioxo-10-(propan-2-yl)-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-7-yl]-2-acetamido-3-hydroxypropanamide::Macrocycle-containing Compound 9c","Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]",Human immunodeficiency virus 1,
883,CCCC[C@@H]1NC(=O)[C@@H](N)CCCCOc2ccc(C[C@H](NC1=O)[C@H](O)CN(CCC(C)C)S(=O)(=O)c1ccc(N)cc1)cc2,"InChI=1S/C33H51N5O6S/c1-4-5-9-29-33(41)37-30(21-24-10-14-26(15-11-24)44-20-7-6-8-28(35)32(40)36-29)31(39)22-38(19-18-23(2)3)45(42,43)27-16-12-25(34)13-17-27/h10-17,23,28-31,39H,4-9,18-22,34-35H2,1-3H3,(H,36,40)(H,37,41)/t28-,29-,30-,31+/m0/s1",ICLGGNKOSYUHKP-XHPANXIASA-N,798,"(2R)-2-[(7S,10S,13S)-7-amino-10-butyl-8,11-dioxo-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-13-yl]-N-(4-aminophenyl)-2-hydroxy-N-(3-methylbutyl)ethane-1-sulfonamido::Macrocycle-containing Compound 9d","Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]",Human immunodeficiency virus 1,
884,CCCC[C@@H]1NC(=O)[C@H](CCCCOc2ccc(C[C@H](NC1=O)[C@H](O)CN(CCC(C)C)S(=O)(=O)c1ccc(NC(C)=O)cc1)cc2)NC(=O)OC(C)(C)C,"InChI=1S/C40H61N5O9S/c1-8-9-12-33-37(48)43-35(36(47)26-45(23-22-27(2)3)55(51,52)32-20-16-30(17-21-32)41-28(4)46)25-29-14-18-31(19-15-29)53-24-11-10-13-34(38(49)42-33)44-39(50)54-40(5,6)7/h14-21,27,33-36,47H,8-13,22-26H2,1-7H3,(H,41,46)(H,42,49)(H,43,48)(H,44,50)/t33-,34-,35-,36+/m0/s1",MVEFGMVKYUWSQO-SKXFTCKDSA-N,799,"Macrocycle-containing Compound 9e::tert-butyl N-[(7S,10S,13S)-10-butyl-13-[(1R)-2-[(4-acetamidobenzene)(3-methylbutyl)sulfonamido]-1-hydroxyethyl]-8,11-dioxo-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-7-yl]carbamate","Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]",Human immunodeficiency virus 1,
885,CCCC[C@@H]1NC(=O)[C@H](CCCCOc2ccc(C[C@H](NC1=O)[C@H](O)CN(CCC(C)C)S(=O)(=O)c1ccc(N)cc1)cc2)NC(C)=O,"InChI=1S/C35H53N5O7S/c1-5-6-9-31-35(44)39-32(33(42)23-40(20-19-24(2)3)48(45,46)29-17-13-27(36)14-18-29)22-26-11-15-28(16-12-26)47-21-8-7-10-30(34(43)38-31)37-25(4)41/h11-18,24,30-33,42H,5-10,19-23,36H2,1-4H3,(H,37,41)(H,38,43)(H,39,44)/t30-,31-,32-,33+/m0/s1",GMZJLQXXVYHTRJ-ZWDYZTTJSA-N,800,"Macrocycle-containing Compound 9f::N-[(7S,10S,13S)-13-[(1R)-2-[(4-aminobenzene)(3-methylbutyl)sulfonamido]-1-hydroxyethyl]-10-butyl-8,11-dioxo-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-7-yl]acetamide","Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]",Human immunodeficiency virus 1,
886,CCCC[C@@H]1NC(=O)[C@H](CCCCOc2ccc(C[C@H](NC1=O)[C@H](O)CN(CCC(C)C)S(=O)(=O)c1ccc(N)cc1)cc2)NC(=O)[C@@H](N)CO,"InChI=1S/C36H56N6O8S/c1-4-5-8-30-36(47)41-32(33(44)22-42(19-18-24(2)3)51(48,49)28-16-12-26(37)13-17-28)21-25-10-14-27(15-11-25)50-20-7-6-9-31(35(46)40-30)39-34(45)29(38)23-43/h10-17,24,29-33,43-44H,4-9,18-23,37-38H2,1-3H3,(H,39,45)(H,40,46)(H,41,47)/t29-,30-,31-,32-,33+/m0/s1",XKWMIPNLKJFKLK-PMUGGPHNSA-N,801,"(2S)-2-amino-N-[(7S,10S,13S)-13-[(1R)-2-[(4-aminobenzene)(3-methylbutyl)sulfonamido]-1-hydroxyethyl]-10-butyl-8,11-dioxo-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-7-yl]-3-hydroxypropanamide::Macrocycle-containing Compound 9g","Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]",Human immunodeficiency virus 1,
887,CCCC[C@@H]1NC(=O)[C@H](CCCCOc2ccc(C[C@H](NC1=O)[C@H](O)CN(CCC(C)C)S(=O)(=O)c1ccc(NC(C)=O)cc1)cc2)NC(=O)[C@H](CO)NC(=O)OC(C)(C)C,"InChI=1S/C43H66N6O11S/c1-8-9-12-34-40(54)47-36(38(52)26-49(23-22-28(2)3)61(57,58)33-20-16-31(17-21-33)44-29(4)51)25-30-14-18-32(19-15-30)59-24-11-10-13-35(39(53)45-34)46-41(55)37(27-50)48-42(56)60-43(5,6)7/h14-21,28,34-38,50,52H,8-13,22-27H2,1-7H3,(H,44,51)(H,45,53)(H,46,55)(H,47,54)(H,48,56)/t34-,35-,36-,37-,38+/m0/s1",AGTAFMHGZWVOJS-OWIVKRMQSA-N,802,"Macrocycle-containing Compound 9h::tert-butyl N-[(1S)-1-{[(7S,10S,13S)-10-butyl-13-[(1R)-2-[(4-acetamidobenzene)(3-methylbutyl)sulfonamido]-1-hydroxyethyl]-8,11-dioxo-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-7-yl]carbamoyl}-2-hydroxyethyl]carbamate","Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]",Human immunodeficiency virus 1,
888,CCCC[C@@H]1NC(=O)[C@H](CCCCOc2ccc(C[C@H](NC1=O)[C@H](O)CN(CCC(C)C)S(=O)(=O)c1ccc(NC(C)=O)cc1)cc2)NC(=O)CCCC,"InChI=1S/C40H61N5O8S/c1-6-8-12-35-40(50)44-36(37(47)27-45(24-23-28(3)4)54(51,52)33-21-17-31(18-22-33)41-29(5)46)26-30-15-19-32(20-16-30)53-25-11-10-13-34(39(49)43-35)42-38(48)14-9-7-2/h15-22,28,34-37,47H,6-14,23-27H2,1-5H3,(H,41,46)(H,42,48)(H,43,49)(H,44,50)/t34-,35-,36-,37+/m0/s1",NIGWUFYZXMGGES-MYOMABOUSA-N,803,"Macrocycle-containing Compound 9i::N-[(7S,10S,13S)-10-butyl-13-[(1R)-2-[(4-acetamidobenzene)(3-methylbutyl)sulfonamido]-1-hydroxyethyl]-8,11-dioxo-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-7-yl]pentanamide","Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]",Human immunodeficiency virus 1,
889,CCCOC[C@@H]1NC(=O)[C@@H](N)CCCCOc2ccc(C[C@H](NC1=O)[C@H](O)CN(CCC(C)C)S(=O)(=O)c1ccc(N)cc1)cc2,"InChI=1S/C33H51N5O7S/c1-4-18-44-22-30-33(41)36-29(20-24-8-12-26(13-9-24)45-19-6-5-7-28(35)32(40)37-30)31(39)21-38(17-16-23(2)3)46(42,43)27-14-10-25(34)11-15-27/h8-15,23,28-31,39H,4-7,16-22,34-35H2,1-3H3,(H,36,41)(H,37,40)/t28-,29-,30-,31+/m0/s1",ZOGAJEOVCPKBPD-XHPANXIASA-N,804,"(2R)-2-[(7S,10S,13S)-7-amino-8,11-dioxo-10-(propoxymethyl)-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-13-yl]-N-(4-aminophenyl)-2-hydroxy-N-(3-methylbutyl)ethane-1-sulfonamido::Macrocycle-containing Compound 9j","Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]",Human immunodeficiency virus 1,
890,CCCOC[C@@H]1NC(=O)[C@H](CCCCOc2ccc(C[C@H](NC1=O)[C@H](O)CN(CCC(C)C)S(=O)(=O)c1ccc(NC(C)=O)cc1)cc2)NC(=O)OC(C)(C)C,"InChI=1S/C40H61N5O10S/c1-8-22-53-26-35-38(49)42-34(36(47)25-45(21-20-27(2)3)56(51,52)32-18-14-30(15-19-32)41-28(4)46)24-29-12-16-31(17-13-29)54-23-10-9-11-33(37(48)43-35)44-39(50)55-40(5,6)7/h12-19,27,33-36,47H,8-11,20-26H2,1-7H3,(H,41,46)(H,42,49)(H,43,48)(H,44,50)/t33-,34-,35-,36+/m0/s1",ZMHLFTWXZHATIC-SKXFTCKDSA-N,805,"Macrocycle-containing Compound 9k::tert-butyl N-[(7S,10S,13S)-13-[(1R)-2-[(4-acetamidobenzene)(3-methylbutyl)sulfonamido]-1-hydroxyethyl]-8,11-dioxo-10-(propoxymethyl)-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-7-yl]carbamate","Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]",Human immunodeficiency virus 1,
891,CC(C)(C)OC(=O)N[C@H](CCN[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)Cc1ccccc1,"InChI=1S/C38H49N5O7/c1-38(2,3)50-37(49)41-29(23-26-13-7-4-8-14-26)21-22-40-32(25-28-17-11-6-12-18-28)36(48)42-30(19-20-33(44)45)35(47)43-31(34(39)46)24-27-15-9-5-10-16-27/h4-18,29-32,40H,19-25H2,1-3H3,(H2,39,46)(H,41,49)(H,42,48)(H,43,47)(H,44,45)/t29-,30+,31+,32+/m1/s1",CBWQRQVEXJTNOT-ZLESDFJESA-N,17351,(4S)-4-[(2S)-2-{[(3S)-3-{[(tert-butoxy)carbonyl]amino}-4-phenylbutyl]amino}-3-phenylpropanamido]-4-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}butanoic acid::CHEMBL215431,Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
892,CC(C)(C)OC(=O)N[C@H](CCN[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)Cc1ccccc1,"InChI=1S/C38H49N5O7/c1-38(2,3)50-37(49)41-29(23-26-13-7-4-8-14-26)21-22-40-32(25-28-17-11-6-12-18-28)36(48)42-30(19-20-33(44)45)35(47)43-31(34(39)46)24-27-15-9-5-10-16-27/h4-18,29-32,40H,19-25H2,1-3H3,(H2,39,46)(H,41,49)(H,42,48)(H,43,47)(H,44,45)/t29-,30+,31+,32+/m1/s1",CBWQRQVEXJTNOT-ZLESDFJESA-N,17351,(4S)-4-[(2S)-2-{[(3S)-3-{[(tert-butoxy)carbonyl]amino}-4-phenylbutyl]amino}-3-phenylpropanamido]-4-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}butanoic acid::CHEMBL215431,"Dimer of Gag-Pol polyprotein [501-599,A572V,V583T,I585V]",Human immunodeficiency virus 1,
893,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,"InChI=1S/C38H50N6O7/c1-38(2,3)51-37(50)44-29(21-25-13-7-4-8-14-25)32(45)24-41-31(23-27-17-11-6-12-18-27)36(49)42-28(19-20-33(39)46)35(48)43-30(34(40)47)22-26-15-9-5-10-16-26/h4-18,28-32,41,45H,19-24H2,1-3H3,(H2,39,46)(H2,40,47)(H,42,49)(H,43,48)(H,44,50)/t28-,29-,30-,31-,32-/m0/s1",SSPOMXWWHDMCTH-XDIGFQIYSA-N,17349,"CHEMBL386758::tert-butyl N-[(2S,3S)-4-{[(1S)-1-{[(1S)-3-carbamoyl-1-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propyl]carbamoyl}-2-phenylethyl]amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
894,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,"InChI=1S/C38H49N5O8/c1-38(2,3)51-37(50)43-29(21-25-13-7-4-8-14-25)32(44)24-40-31(23-27-17-11-6-12-18-27)36(49)41-28(19-20-33(45)46)35(48)42-30(34(39)47)22-26-15-9-5-10-16-26/h4-18,28-32,40,44H,19-24H2,1-3H3,(H2,39,47)(H,41,49)(H,42,48)(H,43,50)(H,45,46)/t28-,29-,30-,31-,32-/m0/s1",MPMUDVMRFYJRLP-XDIGFQIYSA-N,17350,"(4S)-4-[(2S)-2-{[(2S,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-phenylbutyl]amino}-3-phenylpropanamido]-4-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}butanoic acid::CHEMBL386563",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
895,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,Q496K]",Human immunodeficiency virus 1,
896,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept","Dimer of Gag-Pol polyprotein [489-587,Q496K]",Human immunodeficiency virus 1,
897,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,"InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1",QWAXKHKRTORLEM-UGJKXSETSA-N,519,"(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::CHEMBL114::Fortovase::Invirase::Ro 31-8959::SQV::Saquinavir","Dimer of Gag-Pol polyprotein [489-587,Q496K]",Human immunodeficiency virus 1,
898,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir","Dimer of Gag-Pol polyprotein [489-587,Q496K]",Human immunodeficiency virus 1,
899,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,Q496K,L499I,M525I,S526D,M535I,R546K,L552P,A560V,G562S,I573V,L579M,I582L]",Human immunodeficiency virus 1,
900,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept","Dimer of Gag-Pol polyprotein [489-587,Q496K,L499I,M525I,S526D,M535I,R546K,L552P,A560V,G562S,I573V,L579M,I582L]",Human immunodeficiency virus 1,
901,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,"InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1",QWAXKHKRTORLEM-UGJKXSETSA-N,519,"(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::CHEMBL114::Fortovase::Invirase::Ro 31-8959::SQV::Saquinavir","Dimer of Gag-Pol polyprotein [489-587,Q496K,L499I,M525I,S526D,M535I,R546K,L552P,A560V,G562S,I573V,L579M,I582L]",Human immunodeficiency virus 1,
902,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir","Dimer of Gag-Pol polyprotein [489-587,Q496K,L499I,M525I,S526D,M535I,R546K,L552P,A560V,G562S,I573V,L579M,I582L]",Human immunodeficiency virus 1,
903,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,Q496K,I573V]",Human immunodeficiency virus 1,
904,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept","Dimer of Gag-Pol polyprotein [489-587,Q496K,I573V]",Human immunodeficiency virus 1,
905,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,"InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1",QWAXKHKRTORLEM-UGJKXSETSA-N,519,"(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::CHEMBL114::Fortovase::Invirase::Ro 31-8959::SQV::Saquinavir","Dimer of Gag-Pol polyprotein [489-587,Q496K,I573V]",Human immunodeficiency virus 1,
906,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir","Dimer of Gag-Pol polyprotein [489-587,Q496K,I573V]",Human immunodeficiency virus 1,
907,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,517,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide::CHEMBL115::Crixivan::INDINAVIR SULFATE::Indinavir::Indinavir, 19::L-735, 524::MK639","Dimer of Gag-Pol polyprotein [489-587,Q496K,L499I,M525I,S526D,M535I,R546K,L552P,A560V,G562S,L579M,I582L]",Human immunodeficiency virus 1,
908,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,518,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide::AG-1343::CHEMBL584::Nelfinavir::Viracept","Dimer of Gag-Pol polyprotein [489-587,Q496K,L499I,M525I,S526D,M535I,R546K,L552P,A560V,G562S,L579M,I582L]",Human immunodeficiency virus 1,
909,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,"InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1",QWAXKHKRTORLEM-UGJKXSETSA-N,519,"(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide::CHEMBL114::Fortovase::Invirase::Ro 31-8959::SQV::Saquinavir","Dimer of Gag-Pol polyprotein [489-587,Q496K,L499I,M525I,S526D,M535I,R546K,L552P,A560V,G562S,L579M,I582L]",Human immunodeficiency virus 1,
910,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,520,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate::ABT-538::CHEMBL163::Norvir::RTV::Ritonavir","Dimer of Gag-Pol polyprotein [489-587,Q496K,L499I,M525I,S526D,M535I,R546K,L552P,A560V,G562S,L579M,I582L]",Human immunodeficiency virus 1,
911,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CSc1ccc(F)cc1)NS(C)(=O)=O,"InChI=1S/C34H49FN4O5S2/c1-34(2,3)37-33(42)30-19-24-12-8-9-13-25(24)20-39(30)21-31(40)28(18-23-10-6-5-7-11-23)36-32(41)29(38-46(4,43)44)22-45-27-16-14-26(35)15-17-27/h5-7,10-11,14-17,24-25,28-31,38,40H,8-9,12-13,18-22H2,1-4H3,(H,36,41)(H,37,42)/t24-,25+,28-,29+,30-,31+/m0/s1",SLKMGYJMZOWGPU-NUHKNMDZSA-N,806,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3S)-3-[(2S)-3-[(4-fluorophenyl)sulfanyl]-2-methanesulfonamidopropanamido]-2-hydroxy-4-phenylbutyl]-decahydroisoquinoline-3-carboxamide::Saquinavir/Nelfinavir deriv. 10",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 24
912,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)c1ccc(F)cc1)NS(C)(=O)=O,"InChI=1S/C34H49FN4O6S2/c1-34(2,3)37-33(42)30-19-24-12-8-9-13-25(24)20-39(30)21-31(40)28(18-23-10-6-5-7-11-23)36-32(41)29(38-47(4,44)45)22-46(43)27-16-14-26(35)15-17-27/h5-7,10-11,14-17,24-25,28-31,38,40H,8-9,12-13,18-22H2,1-4H3,(H,36,41)(H,37,42)/t24-,25+,28-,29+,30-,31+,46?/m0/s1",WXOMYWCKSSDBHF-OTSXENPMSA-N,807,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3S)-3-[(2S)-3-[(4-fluorobenzene)sulfinyl]-2-methanesulfonamidopropanamido]-2-hydroxy-4-phenylbutyl]-decahydroisoquinoline-3-carboxamide::Saquinavir/Nelfinavir deriv. 11",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.6
913,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)(=O)c1ccc(F)cc1)NS(C)(=O)=O,"InChI=1S/C34H49FN4O7S2/c1-34(2,3)37-33(42)30-19-24-12-8-9-13-25(24)20-39(30)21-31(40)28(18-23-10-6-5-7-11-23)36-32(41)29(38-47(4,43)44)22-48(45,46)27-16-14-26(35)15-17-27/h5-7,10-11,14-17,24-25,28-31,38,40H,8-9,12-13,18-22H2,1-4H3,(H,36,41)(H,37,42)/t24-,25+,28-,29+,30-,31+/m0/s1",VGJJGVNGFKVNSV-NUHKNMDZSA-N,808,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3S)-3-[(2S)-3-[(4-fluorobenzene)sulfonyl]-2-methanesulfonamidopropanamido]-2-hydroxy-4-phenylbutyl]-decahydroisoquinoline-3-carboxamide::LY314163::Saquinavir/Nelfinavir deriv.",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.0
914,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CSc1ccc2ccccc2c1)NS(C)(=O)=O,"InChI=1S/C38H52N4O5S2/c1-38(2,3)40-37(45)34-22-29-16-10-11-17-30(29)23-42(34)24-35(43)32(20-26-12-6-5-7-13-26)39-36(44)33(41-49(4,46)47)25-48-31-19-18-27-14-8-9-15-28(27)21-31/h5-9,12-15,18-19,21,29-30,32-35,41,43H,10-11,16-17,20,22-25H2,1-4H3,(H,39,44)(H,40,45)/t29-,30+,32-,33+,34-,35+/m0/s1",NNBAMFOWJQFHIQ-HHIXDIKQSA-N,809,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3S)-2-hydroxy-3-[(2S)-2-methanesulfonamido-3-(naphthalen-2-ylsulfanyl)propanamido]-4-phenylbutyl]-decahydroisoquinoline-3-carboxamide::Saquinavir/Nelfinavir deriv. 13",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 5.1
915,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)c1ccc2ccccc2c1)NS(C)(=O)=O,"InChI=1S/C38H52N4O6S2/c1-38(2,3)40-37(45)34-22-29-16-10-11-17-30(29)23-42(34)24-35(43)32(20-26-12-6-5-7-13-26)39-36(44)33(41-50(4,47)48)25-49(46)31-19-18-27-14-8-9-15-28(27)21-31/h5-9,12-15,18-19,21,29-30,32-35,41,43H,10-11,16-17,20,22-25H2,1-4H3,(H,39,44)(H,40,45)/t29-,30+,32-,33+,34-,35+,49?/m0/s1",HSGWMHCBWWNMPP-SRYSGFPJSA-N,810,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3S)-2-hydroxy-3-[(2S)-2-methanesulfonamido-3-(naphthalene-2-sulfinyl)propanamido]-4-phenylbutyl]-decahydroisoquinoline-3-carboxamide::CHEMBL49002::Saquinavir/Nelfinavir deriv. 14",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.4
916,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)(=O)c1ccc2ccccc2c1)NS(C)(=O)=O,"InChI=1S/C38H52N4O7S2/c1-38(2,3)40-37(45)34-22-29-16-10-11-17-30(29)23-42(34)24-35(43)32(20-26-12-6-5-7-13-26)39-36(44)33(41-50(4,46)47)25-51(48,49)31-19-18-27-14-8-9-15-28(27)21-31/h5-9,12-15,18-19,21,29-30,32-35,41,43H,10-11,16-17,20,22-25H2,1-4H3,(H,39,44)(H,40,45)/t29-,30+,32-,33+,34-,35+/m0/s1",YLHWBQKQACUIES-HHIXDIKQSA-N,811,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3S)-2-hydroxy-3-[(2S)-2-methanesulfonamido-3-(naphthalene-2-sulfonyl)propanamido]-4-phenylbutyl]-decahydroisoquinoline-3-carboxamide::Saquinavir/Nelfinavir deriv. 15",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.5
917,CC(=O)N[C@H](CS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C39H52N4O6S/c1-26(44)40-34(25-50(48,49)32-19-18-28-14-8-9-15-29(28)21-32)37(46)41-33(20-27-12-6-5-7-13-27)36(45)24-43-23-31-17-11-10-16-30(31)22-35(43)38(47)42-39(2,3)4/h5-9,12-15,18-19,21,30-31,33-36,45H,10-11,16-17,20,22-25H2,1-4H3,(H,40,44)(H,41,46)(H,42,47)/t30-,31+,33-,34+,35-,36+/m0/s1",JCNVJZXOHPISSM-XGRSQTKDSA-N,812,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3S)-3-[(2S)-2-acetamido-3-(naphthalene-2-sulfonyl)propanamido]-2-hydroxy-4-phenylbutyl]-decahydroisoquinoline-3-carboxamide::Saquinavir/Nelfinavir deriv. 16",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.6
918,CC(=O)N[C@H](CS(=O)(=O)c1cccc2cccnc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C38H51N5O6S/c1-25(44)40-31(24-50(48,49)34-18-10-16-27-17-11-19-39-35(27)34)36(46)41-30(20-26-12-6-5-7-13-26)33(45)23-43-22-29-15-9-8-14-28(29)21-32(43)37(47)42-38(2,3)4/h5-7,10-13,16-19,28-33,45H,8-9,14-15,20-24H2,1-4H3,(H,40,44)(H,41,46)(H,42,47)/t28-,29+,30-,31+,32-,33+/m0/s1",DHFIBAHBWAOLNZ-AEAWEUCCSA-N,813,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3S)-3-[(2S)-2-acetamido-3-(quinoline-8-sulfonyl)propanamido]-2-hydroxy-4-phenylbutyl]-decahydroisoquinoline-3-carboxamide::Saquinavir/Nelfinavir deriv. 17",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.7
919,CC(=O)N[C@H](CSCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C36H52N4O4S/c1-25(41)37-31(24-45-23-27-15-9-6-10-16-27)34(43)38-30(19-26-13-7-5-8-14-26)33(42)22-40-21-29-18-12-11-17-28(29)20-32(40)35(44)39-36(2,3)4/h5-10,13-16,28-33,42H,11-12,17-24H2,1-4H3,(H,37,41)(H,38,43)(H,39,44)/t28-,29+,30-,31+,32-,33+/m0/s1",FSZBMUOHARLJDN-AEAWEUCCSA-N,814,"(3S,4aS,8aS)-2-[(2R,3S)-3-[(2S)-3-(benzylsulfanyl)-2-acetamidopropanamido]-2-hydroxy-4-phenylbutyl]-N-tert-butyl-decahydroisoquinoline-3-carboxamide::Saquinavir/Nelfinavir deriv. 18",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 6.0
920,CC(=O)N[C@H](CS(=O)(=O)c1ccc(F)cc1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H45FN4O6S2/c1-21(39)35-27(20-46(43,44)25-12-10-24(34)11-13-25)31(41)36-26(16-22-8-6-5-7-9-22)29(40)19-38-18-23-14-15-45-30(23)17-28(38)32(42)37-33(2,3)4/h5-13,23,26-30,40H,14-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t23-,26+,27-,28+,29-,30+/m1/s1",UJIMFKSBLFMXCG-CCZNUBNBSA-N,815,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3S)-3-[(2S)-2-acetamido-3-[(4-fluorobenzene)sulfonyl]propanamido]-2-hydroxy-4-phenylbutyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 19",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.2
921,CC(=O)N[C@H](CS(=O)(=O)c1ccc(F)cc1)C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C33H45FN4O6S3/c1-21(39)35-27(20-47(43,44)25-12-10-23(34)11-13-25)31(41)36-26(19-46-24-8-6-5-7-9-24)29(40)18-38-17-22-14-15-45-30(22)16-28(38)32(42)37-33(2,3)4/h5-13,22,26-30,40H,14-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t22-,26+,27-,28+,29-,30+/m1/s1",KEAKEWINSNWPIW-UDQVHHHJSA-N,816,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3R)-3-[(2S)-2-acetamido-3-[(4-fluorobenzene)sulfonyl]propanamido]-2-hydroxy-4-(phenylsulfanyl)butyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 20",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.8
922,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2SCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)(=O)c1ccc(F)cc1)NC(=O)C(F)(F)F,"InChI=1S/C33H42F4N4O6S2/c1-32(2,3)40-30(44)26-16-28-21(13-14-48-28)17-41(26)18-27(42)24(15-20-7-5-4-6-8-20)38-29(43)25(39-31(45)33(35,36)37)19-49(46,47)23-11-9-22(34)10-12-23/h4-12,21,24-28,42H,13-19H2,1-3H3,(H,38,43)(H,39,45)(H,40,44)/t21-,24+,25-,26+,27-,28+/m1/s1",GCXUQJZQTKASDY-GQQCNCLLSA-N,817,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3S)-3-[(2S)-3-[(4-fluorobenzene)sulfonyl]-2-(2,2,2-trifluoroacetamido)propanamido]-2-hydroxy-4-phenylbutyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 21",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,<0.2
923,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2SCC[C@@H]2CN1C[C@@H](O)[C@H](CSc1ccccc1)NC(=O)[C@@H](CS(=O)(=O)c1ccc(F)cc1)NC(=O)C(F)(F)F,"InChI=1S/C33H42F4N4O6S3/c1-32(2,3)40-30(44)26-15-28-20(13-14-48-28)16-41(26)17-27(42)24(18-49-22-7-5-4-6-8-22)38-29(43)25(39-31(45)33(35,36)37)19-50(46,47)23-11-9-21(34)10-12-23/h4-12,20,24-28,42H,13-19H2,1-3H3,(H,38,43)(H,39,45)(H,40,44)/t20-,24+,25-,26+,27-,28+/m1/s1",HURRTIMYJDPUGL-GOVMIMJISA-N,818,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3R)-3-[(2S)-3-[(4-fluorobenzene)sulfonyl]-2-(2,2,2-trifluoroacetamido)propanamido]-2-hydroxy-4-(phenylsulfanyl)butyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 22",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 10
924,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2SCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)(=O)c1ccc(F)cc1)NS(C)(=O)=O,"InChI=1S/C32H45FN4O7S3/c1-32(2,3)35-31(40)27-17-29-22(14-15-45-29)18-37(27)19-28(38)25(16-21-8-6-5-7-9-21)34-30(39)26(36-46(4,41)42)20-47(43,44)24-12-10-23(33)11-13-24/h5-13,22,25-29,36,38H,14-20H2,1-4H3,(H,34,39)(H,35,40)/t22-,25+,26-,27+,28-,29+/m1/s1",LYXPKYLWOJGHAC-CMMBNUEMSA-N,819,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3S)-3-[(2S)-3-[(4-fluorobenzene)sulfonyl]-2-methanesulfonamidopropanamido]-2-hydroxy-4-phenylbutyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 23",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.22
925,CC(=O)N[C@H](CS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C37H48N4O6S2/c1-24(42)38-31(23-49(46,47)29-15-14-26-12-8-9-13-27(26)19-29)35(44)39-30(18-25-10-6-5-7-11-25)33(43)22-41-21-28-16-17-48-34(28)20-32(41)36(45)40-37(2,3)4/h5-15,19,28,30-34,43H,16-18,20-23H2,1-4H3,(H,38,42)(H,39,44)(H,40,45)/t28-,30+,31-,32+,33-,34+/m1/s1",HSMOPCIGLSCZAN-LQLDJECCSA-N,820,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3S)-3-[(2S)-2-acetamido-3-(naphthalene-2-sulfonyl)propanamido]-2-hydroxy-4-phenylbutyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 24",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.5
926,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2SCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)(=O)c1ccc2ccccc2c1)NC(=O)C(F)(F)F,"InChI=1S/C37H45F3N4O6S2/c1-36(2,3)43-34(47)30-19-32-26(15-16-51-32)20-44(30)21-31(45)28(17-23-9-5-4-6-10-23)41-33(46)29(42-35(48)37(38,39)40)22-52(49,50)27-14-13-24-11-7-8-12-25(24)18-27/h4-14,18,26,28-32,45H,15-17,19-22H2,1-3H3,(H,41,46)(H,42,48)(H,43,47)/t26-,28+,29-,30+,31-,32+/m1/s1",YADWMKZCMFVWHR-AIFBBKAJSA-N,821,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3S)-2-hydroxy-3-[(2S)-3-(naphthalene-2-sulfonyl)-2-(2,2,2-trifluoroacetamido)propanamido]-4-phenylbutyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 25",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,<0.2
927,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2SCC[C@@H]2CN1C[C@@H](O)[C@H](CSc1ccccc1)NC(=O)[C@@H](CS(=O)(=O)c1ccc2ccccc2c1)NC(=O)C(F)(F)F,"InChI=1S/C37H45F3N4O6S3/c1-36(2,3)43-34(47)30-18-32-25(15-16-51-32)19-44(30)20-31(45)28(21-52-26-11-5-4-6-12-26)41-33(46)29(42-35(48)37(38,39)40)22-53(49,50)27-14-13-23-9-7-8-10-24(23)17-27/h4-14,17,25,28-32,45H,15-16,18-22H2,1-3H3,(H,41,46)(H,42,48)(H,43,47)/t25-,28+,29-,30+,31-,32+/m1/s1",HJFZZDLQFWVWFW-KCCNJYLQSA-N,822,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3R)-2-hydroxy-3-[(2S)-3-(naphthalene-2-sulfonyl)-2-(2,2,2-trifluoroacetamido)propanamido]-4-(phenylsulfanyl)butyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 26",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.8
928,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2SCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)(=O)c1ccc2ccccc2c1)NS(C)(=O)=O,"InChI=1S/C36H48N4O7S3/c1-36(2,3)38-35(43)31-20-33-27(16-17-48-33)21-40(31)22-32(41)29(18-24-10-6-5-7-11-24)37-34(42)30(39-49(4,44)45)23-50(46,47)28-15-14-25-12-8-9-13-26(25)19-28/h5-15,19,27,29-33,39,41H,16-18,20-23H2,1-4H3,(H,37,42)(H,38,43)/t27-,29+,30-,31+,32-,33+/m1/s1",UEIIUHMWGABPPS-CYNCVGHESA-N,823,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3S)-2-hydroxy-3-[(2S)-2-methanesulfonamido-3-(naphthalene-2-sulfonyl)propanamido]-4-phenylbutyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 27",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,<0.2
929,CC(=O)N[C@H](CS(=O)(=O)c1cccc2cccnc12)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN1C[C@H]2CCS[C@H]2C[C@H]1C(=O)NC(C)(C)C,"InChI=1S/C36H47N5O6S2/c1-23(42)38-28(22-49(46,47)32-14-8-12-25-13-9-16-37-33(25)32)34(44)39-27(18-24-10-6-5-7-11-24)30(43)21-41-20-26-15-17-48-31(26)19-29(41)35(45)40-36(2,3)4/h5-14,16,26-31,43H,15,17-22H2,1-4H3,(H,38,42)(H,39,44)(H,40,45)/t26-,27+,28-,29+,30-,31+/m1/s1",CBVONKNRKVRZIS-HLCMLFPZSA-N,824,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3S)-3-[(2S)-2-acetamido-3-(quinoline-8-sulfonyl)propanamido]-2-hydroxy-4-phenylbutyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 28",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.42
930,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2SCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)(=O)c1cccc2cccnc12)NC(=O)C(F)(F)F,"InChI=1S/C36H44F3N5O6S2/c1-35(2,3)43-33(47)27-18-29-24(14-16-51-29)19-44(27)20-28(45)25(17-22-9-5-4-6-10-22)41-32(46)26(42-34(48)36(37,38)39)21-52(49,50)30-13-7-11-23-12-8-15-40-31(23)30/h4-13,15,24-29,45H,14,16-21H2,1-3H3,(H,41,46)(H,42,48)(H,43,47)/t24-,25+,26-,27+,28-,29+/m1/s1",GPEVFYOHNNRULA-IFZRAKSQSA-N,825,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3S)-2-hydroxy-4-phenyl-3-[(2S)-3-(quinoline-8-sulfonyl)-2-(2,2,2-trifluoroacetamido)propanamido]butyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 29",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.21
931,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2SCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)(=O)c1cccc2cccnc12)NS(C)(=O)=O,"InChI=1S/C35H47N5O7S3/c1-35(2,3)38-34(43)28-19-30-25(15-17-48-30)20-40(28)21-29(41)26(18-23-10-6-5-7-11-23)37-33(42)27(39-49(4,44)45)22-50(46,47)31-14-8-12-24-13-9-16-36-32(24)31/h5-14,16,25-30,39,41H,15,17-22H2,1-4H3,(H,37,42)(H,38,43)/t25-,26+,27-,28+,29-,30+/m1/s1",QDNTXUZUWFKCPF-HAYFFOTOSA-N,826,"(3aR,6S,7aS)-N-tert-butyl-5-[(2R,3S)-2-hydroxy-3-[(2S)-2-methanesulfonamido-3-(quinoline-8-sulfonyl)propanamido]-4-phenylbutyl]-octahydrothieno[3,2-c]pyridine-6-carboxamide::Saquinavir/Nelfinavir deriv. 30",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.71
932,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CSc1ccc(F)cc1)NS(C)(=O)=O)C(=O)NC(C)(C)C,"InChI=1S/C29H43FN4O5S2/c1-20(2)17-34(28(37)32-29(3,4)5)18-26(35)24(16-21-10-8-7-9-11-21)31-27(36)25(33-41(6,38)39)19-40-23-14-12-22(30)13-15-23/h7-15,20,24-26,33,35H,16-19H2,1-6H3,(H,31,36)(H,32,37)/t24-,25+,26+/m0/s1",QZDJOQNQPQZWDU-JIMJEQGWSA-N,827,"(2S)-N-[(2S,3R)-4-[(tert-butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-3-[(4-fluorophenyl)sulfanyl]-2-methanesulfonamidopropanamide::Saquinavir/Nelfinavir deriv. 31",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 85
933,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)(=O)c1ccc(F)cc1)NS(C)(=O)=O)C(=O)NC(C)(C)C,"InChI=1S/C29H43FN4O7S2/c1-20(2)17-34(28(37)32-29(3,4)5)18-26(35)24(16-21-10-8-7-9-11-21)31-27(36)25(33-42(6,38)39)19-43(40,41)23-14-12-22(30)13-15-23/h7-15,20,24-26,33,35H,16-19H2,1-6H3,(H,31,36)(H,32,37)/t24-,25+,26+/m0/s1",JKEMJFRUOXJPST-JIMJEQGWSA-N,828,"(2S)-N-[(2S,3R)-4-[(tert-butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-3-[(4-fluorobenzene)sulfonyl]-2-methanesulfonamidopropanamide::Saquinavir/Nelfinavir deriv. 32",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 10
934,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CSc1ccc2ccccc2c1)NS(C)(=O)=O)C(=O)NC(C)(C)C,"InChI=1S/C33H46N4O5S2/c1-23(2)20-37(32(40)35-33(3,4)5)21-30(38)28(18-24-12-8-7-9-13-24)34-31(39)29(36-44(6,41)42)22-43-27-17-16-25-14-10-11-15-26(25)19-27/h7-17,19,23,28-30,36,38H,18,20-22H2,1-6H3,(H,34,39)(H,35,40)/t28-,29+,30+/m0/s1",IWAJOTAOLYGYBV-FRXPANAUSA-N,829,"(2S)-N-[(2S,3R)-4-[(tert-butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-2-methanesulfonamido-3-(naphthalen-2-ylsulfanyl)propanamide::Saquinavir/Nelfinavir deriv. 33",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 50
935,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CS(=O)c1ccc2ccccc2c1)NS(C)(=O)=O)C(=O)NC(C)(C)C,"InChI=1S/C33H46N4O6S2/c1-23(2)20-37(32(40)35-33(3,4)5)21-30(38)28(18-24-12-8-7-9-13-24)34-31(39)29(36-45(6,42)43)22-44(41)27-17-16-25-14-10-11-15-26(25)19-27/h7-17,19,23,28-30,36,38H,18,20-22H2,1-6H3,(H,34,39)(H,35,40)/t28-,29+,30+,44?/m0/s1",OXGKMNBMJKSNRS-FHAUPYODSA-N,830,"(2S)-N-[(2S,3R)-4-[(tert-butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-2-methanesulfonamido-3-(naphthalene-2-sulfinyl)propanamide::Saquinavir/Nelfinavir deriv. 34",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.1
936,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1,"InChI=1S/C31H38N2O4/c1-31(2,3)37-30(36)33-27(20-24-15-9-5-10-16-24)28(34)21-26(19-23-13-7-4-8-14-23)29(35)32-22-25-17-11-6-12-18-25/h4-18,26-28,34H,19-22H2,1-3H3,(H,32,35)(H,33,36)/t26-,27+,28+/m1/s1",SDOJFPSFHFRQPP-PKTNWEFCSA-N,758,"CHEMBL277034::Hydroxyethylene deriv. 9::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-(benzylcarbamoyl)-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 111
937,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)NCCc1ccccc1,"InChI=1S/C32H40N2O4/c1-32(2,3)38-31(37)34-28(22-26-17-11-6-12-18-26)29(35)23-27(21-25-15-9-5-10-16-25)30(36)33-20-19-24-13-7-4-8-14-24/h4-18,27-29,35H,19-23H2,1-3H3,(H,33,36)(H,34,37)/t27-,28+,29+/m1/s1",OGUBVLIFQZTDDU-ULNSLHSMSA-N,832,"Benzocycloalkyl Amines deriv. 2::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-1-phenyl-5-[(2-phenylethyl)carbamoyl]pentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2800
938,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)NC1Cc2ccccc2C1,"InChI=1S/C33H40N2O4/c1-33(2,3)39-32(38)35-29(19-24-14-8-5-9-15-24)30(36)22-27(18-23-12-6-4-7-13-23)31(37)34-28-20-25-16-10-11-17-26(25)21-28/h4-17,27-30,36H,18-22H2,1-3H3,(H,34,37)(H,35,38)/t27-,29+,30+/m1/s1",YTVUVKHREDAUGZ-GGCFSWKVSA-N,833,"Benzocycloalkyl Amines deriv. 3::Benzocycloalkyl Amines deriv. 4::CHEMBL439725::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-(2,3-dihydro-1H-inden-2-ylcarbamoyl)-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 130
939,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)NC1Cc2ccccc2C1,"InChI=1S/C33H40N2O4/c1-33(2,3)39-32(38)35-29(19-24-14-8-5-9-15-24)30(36)22-27(18-23-12-6-4-7-13-23)31(37)34-28-20-25-16-10-11-17-26(25)21-28/h4-17,27-30,36H,18-22H2,1-3H3,(H,34,37)(H,35,38)/t27-,29+,30+/m1/s1",YTVUVKHREDAUGZ-GGCFSWKVSA-N,833,"Benzocycloalkyl Amines deriv. 3::Benzocycloalkyl Amines deriv. 4::CHEMBL439725::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-(2,3-dihydro-1H-inden-2-ylcarbamoyl)-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 19
940,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1CCc2ccccc12,"InChI=1S/C33H40N2O4/c1-33(2,3)39-32(38)35-29(21-24-14-8-5-9-15-24)30(36)22-26(20-23-12-6-4-7-13-23)31(37)34-28-19-18-25-16-10-11-17-27(25)28/h4-17,26,28-30,36H,18-22H2,1-3H3,(H,34,37)(H,35,38)/t26-,28+,29+,30+/m1/s1",PRRJHDLIZGFHHO-ZRJFKUPHSA-N,835,"Benzocycloalkyl Amines deriv. 5::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-[(1S)-2,3-dihydro-1H-inden-1-ylcarbamoyl]-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 21
941,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)NC1CCCc2ccccc12,"InChI=1S/C34H42N2O4/c1-34(2,3)40-33(39)36-30(22-25-15-8-5-9-16-25)31(37)23-27(21-24-13-6-4-7-14-24)32(38)35-29-20-12-18-26-17-10-11-19-28(26)29/h4-11,13-17,19,27,29-31,37H,12,18,20-23H2,1-3H3,(H,35,38)(H,36,39)/t27-,29?,30+,31+/m1/s1",SYHMSAYQDYUEPQ-HCTKOXKRSA-N,836,"Benzocycloalkyl Amines deriv. 6::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-1-phenyl-5-(1,2,3,4-tetrahydronaphthalen-1-ylcarbamoyl)pentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 16
942,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)NC1Cc2ccccc12,"InChI=1S/C32H38N2O4/c1-32(2,3)38-31(37)34-28(19-23-14-8-5-9-15-23)29(35)21-25(18-22-12-6-4-7-13-22)30(36)33-27-20-24-16-10-11-17-26(24)27/h4-17,25,27-29,35H,18-21H2,1-3H3,(H,33,36)(H,34,37)/t25-,27?,28+,29+/m1/s1",HPNWNQXCBHLAEF-QTRRWBPYSA-N,837,"Benzocycloalkyl Amines deriv. 7::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-{bicyclo[4.2.0]octa-1,3,5-trien-7-ylcarbamoyl}-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 22
943,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@@H](O)Cc2ccccc12,"InChI=1S/C33H40N2O5/c1-33(2,3)40-32(39)34-27(19-23-14-8-5-9-15-23)28(36)21-25(18-22-12-6-4-7-13-22)31(38)35-30-26-17-11-10-16-24(26)20-29(30)37/h4-17,25,27-30,36-37H,18-21H2,1-3H3,(H,34,39)(H,35,38)/t25-,27+,28+,29+,30+/m1/s1",ZJBUCZFZQXPYFC-KMMGOQOWSA-N,838,"Benzocycloalkyl Amines deriv. 8::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 259
944,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C33H40N2O5/c1-33(2,3)40-32(39)34-27(19-23-14-8-5-9-15-23)28(36)21-25(18-22-12-6-4-7-13-22)31(38)35-30-26-17-11-10-16-24(26)20-29(30)37/h4-17,25,27-30,36-37H,18-21H2,1-3H3,(H,34,39)(H,35,38)/t25-,27+,28+,29-,30+/m1/s1",ZJBUCZFZQXPYFC-JOFXVPDFSA-N,1030,"CHEMBL296115::L-685,434::Urethane deriv. 1::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.3
945,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1[C@@H](O)Cc2ccccc12,"InChI=1S/C33H40N2O5/c1-33(2,3)40-32(39)34-27(19-23-14-8-5-9-15-23)28(36)21-25(18-22-12-6-4-7-13-22)31(38)35-30-26-17-11-10-16-24(26)20-29(30)37/h4-17,25,27-30,36-37H,18-21H2,1-3H3,(H,34,39)(H,35,38)/t25-,27+,28+,29+,30-/m1/s1",ZJBUCZFZQXPYFC-VQXQMPIVSA-N,840,"Benzocycloalkyl Amines deriv. 10::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 229
946,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@@H](Cc2ccccc12)C(N)=O,"InChI=1S/C34H41N3O5/c1-34(2,3)42-33(41)36-28(19-23-14-8-5-9-15-23)29(38)21-25(18-22-12-6-4-7-13-22)32(40)37-30-26-17-11-10-16-24(26)20-27(30)31(35)39/h4-17,25,27-30,38H,18-21H2,1-3H3,(H2,35,39)(H,36,41)(H,37,40)/t25-,27-,28+,29+,30+/m1/s1",ROOKYLNNFCRHNK-WJBPYKOESA-N,841,"Benzocycloalkyl Amines deriv. 11::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-{[(1R,2R)-2-carbamoyl-2,3-dihydro-1H-inden-1-yl]carbamoyl}-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.8
947,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)[C@H](O)c2ccccc12,"InChI=1S/C33H40N2O6/c1-33(2,3)41-32(40)34-26(19-22-14-8-5-9-15-22)27(36)20-23(18-21-12-6-4-7-13-21)31(39)35-28-24-16-10-11-17-25(24)29(37)30(28)38/h4-17,23,26-30,36-38H,18-20H2,1-3H3,(H,34,40)(H,35,39)/t23-,26+,27+,28+,29-,30+/m1/s1",HKAQGSPFDKETKG-HPZRALQFSA-N,842,"Benzocycloalkyl Amines deriv. 12::CHEMBL419923::tert-butyl N-[(2S,3S,5R)-5-benzyl-5-{[(1S,2S,3R)-2,3-dihydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.1
948,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)[C@H](N)c2ccccc12,"InChI=1S/C33H41N3O5/c1-33(2,3)41-32(40)35-26(19-22-14-8-5-9-15-22)27(37)20-23(18-21-12-6-4-7-13-21)31(39)36-29-25-17-11-10-16-24(25)28(34)30(29)38/h4-17,23,26-30,37-38H,18-20,34H2,1-3H3,(H,35,40)(H,36,39)/t23-,26+,27+,28-,29+,30-/m1/s1",MRLZHJSWDCUIEE-IAPQBRSKSA-N,843,"Benzocycloalkyl Amines deriv. 13::tert-butyl N-[(2S,3S,5R)-5-{[(1S,2R,3R)-3-amino-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-benzyl-3-hydroxy-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.9
949,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccccc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H46N4O8/c1-19(2)23(29(39)33-5)35-31(41)27(43-17-21-13-9-7-10-14-21)25(37)26(38)28(44-18-22-15-11-8-12-16-22)32(42)36-24(20(3)4)30(40)34-6/h7-16,19-20,23-28,37-38H,17-18H2,1-6H3,(H,33,39)(H,34,40)(H,35,41)(H,36,42)/t23-,24-,25+,26+,27+,28+/m0/s1",QHMBKCCJSCSGHG-BQXGFVACSA-N,348,"(2R,3R,4R,5R)-2,5-bis(benzyloxy)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::1-Valine Methylamide deriv. 1::C2-Symmetric Inhibitor 2::C2-symmetric compound 5::CHEMBL105459::Diol-Based HIV-1 protease inhibitor 2",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
950,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(Br)cc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(Br)cc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C32H44Br2N4O8/c1-17(2)23(29(41)35-5)37-31(43)27(45-15-19-7-11-21(33)12-8-19)25(39)26(40)28(46-16-20-9-13-22(34)14-10-20)32(44)38-24(18(3)4)30(42)36-6/h7-14,17-18,23-28,39-40H,15-16H2,1-6H3,(H,35,41)(H,36,42)(H,37,43)(H,38,44)/t23-,24-,25+,26+,27+,28+/m0/s1",FFUDEABEDNGPMU-BQXGFVACSA-N,845,"(2R,3R,4R,5R)-2,5-bis[(4-bromophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::C2-Symmetric inhibitor 3::CHEMBL124139::N1, N6-Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis(4-bromobenzyloxy)-3,4-dihydroxy-hexanediamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
951,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(cc1)-c1ccccc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(cc1)-c1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C44H54N4O8/c1-27(2)35(41(51)45-5)47-43(53)39(55-25-29-17-21-33(22-18-29)31-13-9-7-10-14-31)37(49)38(50)40(44(54)48-36(28(3)4)42(52)46-6)56-26-30-19-23-34(24-20-30)32-15-11-8-12-16-32/h7-24,27-28,35-40,49-50H,25-26H2,1-6H3,(H,45,51)(H,46,52)(H,47,53)(H,48,54)/t35-,36-,37+,38+,39+,40+/m0/s1",BOHAIUZINOMMEV-OYEZVYLDSA-N,846,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis[(4-phenylphenyl)methoxy]hexanediamide::C2-Symmetric inhibitor 4::N1,N6-Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2R,3R,4R,5R)-2,5-bis(4-phenylbenzyloxy)-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
952,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(cc1)-c1cccc(c1)N(=O)=O)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(cc1)-c1cccc(c1)N(=O)=O)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C44H52N6O12/c1-25(2)35(41(53)45-5)47-43(55)39(61-23-27-13-17-29(18-14-27)31-9-7-11-33(21-31)49(57)58)37(51)38(52)40(44(56)48-36(26(3)4)42(54)46-6)62-24-28-15-19-30(20-16-28)32-10-8-12-34(22-32)50(59)60/h7-22,25-26,35-40,51-52H,23-24H2,1-6H3,(H,45,53)(H,46,54)(H,47,55)(H,48,56)/t35-,36-,37+,38+,39+,40+/m0/s1",GNZIXCJETYMUQA-OYEZVYLDSA-N,847,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis({[4-(3-nitrophenyl)phenyl]methoxy})hexanediamide::C2-Symmetric inhibitor 5::N1,N6-Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis[4-(3-nitrophenyl)benzyloxy]-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
953,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(cc1)-c1ccsc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(cc1)-c1ccsc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C40H50N4O8S2/c1-23(2)31(37(47)41-5)43-39(49)35(51-19-25-7-11-27(12-8-25)29-15-17-53-21-29)33(45)34(46)36(40(50)44-32(24(3)4)38(48)42-6)52-20-26-9-13-28(14-10-26)30-16-18-54-22-30/h7-18,21-24,31-36,45-46H,19-20H2,1-6H3,(H,41,47)(H,42,48)(H,43,49)(H,44,50)/t31-,32-,33+,34+,35+,36+/m0/s1",AJZAPEZJWWQJHC-UWNKZCSISA-N,848,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis({[4-(thiophen-3-yl)phenyl]methoxy})hexanediamide::C2-Symmetric inhibitor 6::CHEMBL127214::N1,N6-Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis[4-(3-thienyl)benzyloxy]-3,4-dihydroxyhexanediamide::symmetric/asymmetric inhibitor 7",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
954,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(cc1)-c1cccs1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(cc1)-c1cccs1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C40H50N4O8S2/c1-23(2)31(37(47)41-5)43-39(49)35(51-21-25-11-15-27(16-12-25)29-9-7-19-53-29)33(45)34(46)36(40(50)44-32(24(3)4)38(48)42-6)52-22-26-13-17-28(18-14-26)30-10-8-20-54-30/h7-20,23-24,31-36,45-46H,21-22H2,1-6H3,(H,41,47)(H,42,48)(H,43,49)(H,44,50)/t31-,32-,33+,34+,35+,36+/m0/s1",BUEYISJFODTUIB-UWNKZCSISA-N,849,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis({[4-(thiophen-2-yl)phenyl]methoxy})hexanediamide::C2-Symmetric inhibitor 7::N1,N6-Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis[4-(2-thienyl)benzyloxy]-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
955,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(CCc2ccccc2)cc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(CCc2ccccc2)cc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C48H62N4O8/c1-31(2)39(45(55)49-5)51-47(57)43(59-29-37-25-21-35(22-26-37)19-17-33-13-9-7-10-14-33)41(53)42(54)44(48(58)52-40(32(3)4)46(56)50-6)60-30-38-27-23-36(24-28-38)20-18-34-15-11-8-12-16-34/h7-16,21-28,31-32,39-44,53-54H,17-20,29-30H2,1-6H3,(H,49,55)(H,50,56)(H,51,57)(H,52,58)/t39-,40-,41+,42+,43+,44+/m0/s1",WSIGESKMDUMSIL-LVFDAWRISA-N,850,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis({[4-(2-phenylethyl)phenyl]methoxy})hexanediamide::C2-Symmetric inhibitor 8::CHEMBL441167::N1,N6-Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis[4-(2-phenylethyl)benzyloxy]-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
956,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(cc1)-c1cccnc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(cc1)-c1cccnc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C42H52N6O8/c1-25(2)33(39(51)43-5)47-41(53)37(55-23-27-11-15-29(16-12-27)31-9-7-19-45-21-31)35(49)36(50)38(42(54)48-34(26(3)4)40(52)44-6)56-24-28-13-17-30(18-14-28)32-10-8-20-46-22-32/h7-22,25-26,33-38,49-50H,23-24H2,1-6H3,(H,43,51)(H,44,52)(H,47,53)(H,48,54)/t33-,34-,35+,36+,37+,38+/m0/s1",FOBRXMROTNVGST-CXPJILFNSA-N,851,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis({[4-(pyridin-3-yl)phenyl]methoxy})hexanediamide::C2-Symmetric inhibitor 9::N1,N6-Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis[4-(3-pyridyl)benzyloxy]-3,4-dihydroxyhexanediamide::symmetric/asymmetric inhibitor 8",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
957,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(cc1)-c1ccccn1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(cc1)-c1ccccn1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C42H52N6O8/c1-25(2)33(39(51)43-5)47-41(53)37(55-23-27-13-17-29(18-14-27)31-11-7-9-21-45-31)35(49)36(50)38(42(54)48-34(26(3)4)40(52)44-6)56-24-28-15-19-30(20-16-28)32-12-8-10-22-46-32/h7-22,25-26,33-38,49-50H,23-24H2,1-6H3,(H,43,51)(H,44,52)(H,47,53)(H,48,54)/t33-,34-,35+,36+,37+,38+/m0/s1",KBBBMHGFCVYISD-CXPJILFNSA-N,852,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis({[4-(pyridin-2-yl)phenyl]methoxy})hexanediamide::C2-Symmetric inhibitor 10::CHEMBL127524::N1,N6-Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis[4-(2-pyridyl)benzyloxy]-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
958,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(cc1)-c1nccs1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(cc1)-c1nccs1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C38H48N6O8S2/c1-21(2)27(33(47)39-5)43-35(49)31(51-19-23-7-11-25(12-8-23)37-41-15-17-53-37)29(45)30(46)32(36(50)44-28(22(3)4)34(48)40-6)52-20-24-9-13-26(14-10-24)38-42-16-18-54-38/h7-18,21-22,27-32,45-46H,19-20H2,1-6H3,(H,39,47)(H,40,48)(H,43,49)(H,44,50)/t27-,28-,29+,30+,31+,32+/m0/s1",XISQZIYLHTUXPS-VQKSECAYSA-N,853,"(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis({[4-(1,3-thiazol-2-yl)phenyl]methoxy})hexanediamide::C2-Symmetric inhibitor 11::CHEMBL340116::N1,N6-Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis[4-(2-thiazolyl)benzyloxy]-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
959,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(\C=C\C(=O)OC)cc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(\C=C\C(=O)OC)cc1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C40H54N4O12/c1-23(2)31(37(49)41-5)43-39(51)35(55-21-27-13-9-25(10-14-27)17-19-29(45)53-7)33(47)34(48)36(40(52)44-32(24(3)4)38(50)42-6)56-22-28-15-11-26(12-16-28)18-20-30(46)54-8/h9-20,23-24,31-36,47-48H,21-22H2,1-8H3,(H,41,49)(H,42,50)(H,43,51)(H,44,52)/b19-17+,20-18+/t31-,32-,33+,34+,35+,36+/m0/s1",BIPBOTWHSNMRCV-ZKKZGDMFSA-N,854,"C2-Symmetric inhibitor 12::CHEMBL127045::N1,N6-Bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis{4-[(E)-2-methoxycarbonylethenyl]-benzyloxy}-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
960,CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(cc1)C1CCCC(=O)C1=O)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(cc1)C1CCCC(=O)C1=O)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C,"InChI=1S/C44H58N4O12/c1-23(2)33(41(55)45-5)47-43(57)39(59-21-25-13-17-27(18-14-25)29-9-7-11-31(49)35(29)51)37(53)38(54)40(44(58)48-34(24(3)4)42(56)46-6)60-22-26-15-19-28(20-16-26)30-10-8-12-32(50)36(30)52/h13-20,23-24,29-30,33-34,37-40,53-54H,7-12,21-22H2,1-6H3,(H,45,55)(H,46,56)(H,47,57)(H,48,58)/t29?,30?,33-,34-,37+,38+,39+,40+/m0/s1",FNBWPIBLHMWNLO-SSZBCMKESA-N,855,"(2R,3R,4R,5R)-3,4-dihydroxy-2,5-bis({[4-(2-hydroxy-3-oxocyclohex-1-en-1-yl)phenyl]methoxy})-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]hexanediamide::C2-Symmetric inhibitor 13::CHEMBL338428::N1,N6-Bis[(1S)-2-methyl-1-(methylcarbamoyl)pro-pyl](2R,3R,4R,5R)-2,5-bis[4-(3-cyclohexane-1,2-dionyl)benzyloxy]-3,4-dihydroxyhexanediamide",Dimer of Gag-Pol polyprotein [501-599],Human immunodeficiency virus 1,
961,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)[C@H]1NCc2ccc(OCCCCNC(=O)C(NC1=O)C(C)C)cc2,"InChI=1S/C40H53N5O7/c1-26(2)33-37(47)41-21-11-12-22-51-31-19-17-29(18-20-31)24-42-35(39(49)44-33)36(46)32(23-28-13-7-5-8-14-28)43-38(48)34(27(3)4)45-40(50)52-25-30-15-9-6-10-16-30/h5-10,13-20,26-27,32-36,42,46H,11-12,21-25H2,1-4H3,(H,41,47)(H,43,48)(H,44,49)(H,45,50)/t32-,33?,34-,35+,36?/m0/s1",SFYLJGNBGITWFY-OTXQKLNXSA-N,856,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 22::benzyl N-[(1S)-1-{[(1S,2S)-1-[(9R,12R)-8,11-dioxo-9-(propan-2-yl)-2-oxa-7,10,13-triazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-12-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
962,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)[C@H]1NCc2ccc(OCCOCCNC(=O)C(NC1=O)C(C)C)cc2,"InChI=1S/C40H53N5O8/c1-26(2)33-37(47)41-19-20-51-21-22-52-31-17-15-29(16-18-31)24-42-35(39(49)44-33)36(46)32(23-28-11-7-5-8-12-28)43-38(48)34(27(3)4)45-40(50)53-25-30-13-9-6-10-14-30/h5-18,26-27,32-36,42,46H,19-25H2,1-4H3,(H,41,47)(H,43,48)(H,44,49)(H,45,50)/t32-,33?,34-,35+,36?/m0/s1",FIQBSLXLTLJIQG-OTXQKLNXSA-N,857,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 3::benzyl N-[(1S)-1-{[(1S,2S)-1-[(10R,13R)-9,12-dioxo-10-(propan-2-yl)-2,5-dioxa-8,11,14-triazabicyclo[14.2.2]icosa-1(18),16,19-trien-13-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
963,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)[C@H]1NCc2ccc(OCCOCCOCCNC(=O)C(NC1=O)C(C)C)cc2,"InChI=1S/C42H57N5O9/c1-28(2)35-39(49)43-19-20-53-21-22-54-23-24-55-33-17-15-31(16-18-33)26-44-37(41(51)46-35)38(48)34(25-30-11-7-5-8-12-30)45-40(50)36(29(3)4)47-42(52)56-27-32-13-9-6-10-14-32/h5-18,28-29,34-38,44,48H,19-27H2,1-4H3,(H,43,49)(H,45,50)(H,46,51)(H,47,52)/t34-,35?,36-,37+,38?/m0/s1",BOMYVDPSYNOFDI-KCVBXHHVSA-N,858,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 23::benzyl N-[(1S)-1-{[(1S,2S)-1-[(13R,16R)-12,15-dioxo-13-(propan-2-yl)-2,5,8-trioxa-11,14,17-triazabicyclo[17.2.2]tricosa-1(21),19,22-trien-16-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
964,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)[C@H]1NCc2ccc(OCCOCCOCCOCCNC(=O)C(NC1=O)C(C)C)cc2,"InChI=1S/C44H61N5O10/c1-30(2)37-41(51)45-19-20-55-21-22-56-23-24-57-25-26-58-35-17-15-33(16-18-35)28-46-39(43(53)48-37)40(50)36(27-32-11-7-5-8-12-32)47-42(52)38(31(3)4)49-44(54)59-29-34-13-9-6-10-14-34/h5-18,30-31,36-40,46,50H,19-29H2,1-4H3,(H,45,51)(H,47,52)(H,48,53)(H,49,54)/t36-,37?,38-,39+,40?/m0/s1",LRKUSTGJXNLIKZ-VHJUTDPPSA-N,859,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 24::benzyl N-[(1S)-1-{[(1S,2S)-1-[(16R,19R)-15,18-dioxo-16-(propan-2-yl)-2,5,8,11-tetraoxa-14,17,20-triazabicyclo[20.2.2]hexacosa-1(24),22,25-trien-19-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
965,CC(C)C1NC(=O)[C@H](NCc2ccc(OCCCCNC1=O)cc2)C(O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C,"InChI=1S/C32H46N4O6/c1-21(2)26-29(38)33-17-9-10-18-41-24-15-13-23(14-16-24)20-34-27(30(39)36-26)28(37)25(19-22-11-7-6-8-12-22)35-31(40)42-32(3,4)5/h6-8,11-16,21,25-28,34,37H,9-10,17-20H2,1-5H3,(H,33,38)(H,35,40)(H,36,39)/t25-,26?,27+,28?/m0/s1",AOOUKNIZXIPRPV-JCYSWHRNSA-N,860,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 25::tert-butyl N-[(1S,2S)-1-[(9R,12R)-8,11-dioxo-9-(propan-2-yl)-2-oxa-7,10,13-triazabicyclo[13.2.2]nonadeca-1(17),15,18-trien-12-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
966,CC(C)C1NC(=O)[C@H](NCc2ccc(OCCOCCNC1=O)cc2)C(O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C,"InChI=1S/C32H46N4O7/c1-21(2)26-29(38)33-15-16-41-17-18-42-24-13-11-23(12-14-24)20-34-27(30(39)36-26)28(37)25(19-22-9-7-6-8-10-22)35-31(40)43-32(3,4)5/h6-14,21,25-28,34,37H,15-20H2,1-5H3,(H,33,38)(H,35,40)(H,36,39)/t25-,26?,27+,28?/m0/s1",KVGCZGXPZTZUIK-JCYSWHRNSA-N,861,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 16::tert-butyl N-[(1S,2S)-1-[(10R,13R)-9,12-dioxo-10-(propan-2-yl)-2,5-dioxa-8,11,14-triazabicyclo[14.2.2]icosa-1(18),16,19-trien-13-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
967,CC(C)C1NC(=O)[C@H](NCc2ccc(OCCOCCOCCNC1=O)cc2)C(O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C,"InChI=1S/C34H50N4O8/c1-23(2)28-31(40)35-15-16-43-17-18-44-19-20-45-26-13-11-25(12-14-26)22-36-29(32(41)38-28)30(39)27(21-24-9-7-6-8-10-24)37-33(42)46-34(3,4)5/h6-14,23,27-30,36,39H,15-22H2,1-5H3,(H,35,40)(H,37,42)(H,38,41)/t27-,28?,29+,30?/m0/s1",VWFACMZZIZWUON-ZQTFWZTISA-N,862,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 26::tert-butyl N-[(1S,2S)-1-[(13R,16R)-12,15-dioxo-13-(propan-2-yl)-2,5,8-trioxa-11,14,17-triazabicyclo[17.2.2]tricosa-1(21),19,22-trien-16-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
968,CC(C)C1NC(=O)[C@H](NCc2ccc(OCCOCCOCCOCCNC1=O)cc2)C(O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C,"InChI=1S/C36H54N4O9/c1-25(2)30-33(42)37-15-16-45-17-18-46-19-20-47-21-22-48-28-13-11-27(12-14-28)24-38-31(34(43)40-30)32(41)29(23-26-9-7-6-8-10-26)39-35(44)49-36(3,4)5/h6-14,25,29-32,38,41H,15-24H2,1-5H3,(H,37,42)(H,39,44)(H,40,43)/t29-,30?,31+,32?/m0/s1",HGRKOLDVMGOTDN-KMDJKLILSA-N,863,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 27::tert-butyl N-[(1S,2S)-1-[(16R,19R)-15,18-dioxo-16-(propan-2-yl)-2,5,8,11-tetraoxa-14,17,20-triazabicyclo[20.2.2]hexacosa-1(24),22,25-trien-19-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
969,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)[C@H]1NCc2cccc(OCCCCNC(=O)C(NC1=O)C(C)C)c2,"InChI=1S/C40H53N5O7/c1-26(2)33-37(47)41-20-11-12-21-51-31-19-13-18-30(22-31)24-42-35(39(49)44-33)36(46)32(23-28-14-7-5-8-15-28)43-38(48)34(27(3)4)45-40(50)52-25-29-16-9-6-10-17-29/h5-10,13-19,22,26-27,32-36,42,46H,11-12,20-21,23-25H2,1-4H3,(H,41,47)(H,43,48)(H,44,49)(H,45,50)/t32-,33?,34-,35+,36?/m0/s1",CSURAROSZFOMBV-OTXQKLNXSA-N,864,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 28::benzyl N-[(1S)-1-{[(1S,2S)-1-[(9R,12R)-8,11-dioxo-9-(propan-2-yl)-2-oxa-7,10,13-triazabicyclo[13.3.1]nonadeca-1(18),15(19),16-trien-12-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
970,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)[C@H]1NCc2cccc(OCCOCCNC(=O)C(NC1=O)C(C)C)c2,"InChI=1S/C40H53N5O8/c1-26(2)33-37(47)41-18-19-51-20-21-52-31-17-11-16-30(22-31)24-42-35(39(49)44-33)36(46)32(23-28-12-7-5-8-13-28)43-38(48)34(27(3)4)45-40(50)53-25-29-14-9-6-10-15-29/h5-17,22,26-27,32-36,42,46H,18-21,23-25H2,1-4H3,(H,41,47)(H,43,48)(H,44,49)(H,45,50)/t32-,33?,34-,35+,36?/m0/s1",QCOTVEZNURNOOS-OTXQKLNXSA-N,865,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 20::benzyl N-[(1S)-1-{[(1S,2S)-1-[(10R,13R)-9,12-dioxo-10-(propan-2-yl)-2,5-dioxa-8,11,14-triazabicyclo[14.3.1]icosa-1(19),16(20),17-trien-13-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
971,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)[C@H]1NCc2cccc(OCCOCCOCCNC(=O)C(NC1=O)C(C)C)c2,"InChI=1S/C42H57N5O9/c1-28(2)35-39(49)43-18-19-53-20-21-54-22-23-55-33-17-11-16-32(24-33)26-44-37(41(51)46-35)38(48)34(25-30-12-7-5-8-13-30)45-40(50)36(29(3)4)47-42(52)56-27-31-14-9-6-10-15-31/h5-17,24,28-29,34-38,44,48H,18-23,25-27H2,1-4H3,(H,43,49)(H,45,50)(H,46,51)(H,47,52)/t34-,35?,36-,37+,38?/m0/s1",ZPJNIOPWFOKSJR-KCVBXHHVSA-N,866,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 29::benzyl N-[(1S)-1-{[(1S,2S)-1-[(13R,16R)-12,15-dioxo-13-(propan-2-yl)-2,5,8-trioxa-11,14,17-triazabicyclo[17.3.1]tricosa-1(22),19(23),20-trien-16-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
972,CC(C)C1NC(=O)[C@H](NCc2cccc(OCCCCNC1=O)c2)C(O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C,"InChI=1S/C32H46N4O6/c1-21(2)26-29(38)33-16-9-10-17-41-24-15-11-14-23(18-24)20-34-27(30(39)36-26)28(37)25(19-22-12-7-6-8-13-22)35-31(40)42-32(3,4)5/h6-8,11-15,18,21,25-28,34,37H,9-10,16-17,19-20H2,1-5H3,(H,33,38)(H,35,40)(H,36,39)/t25-,26?,27+,28?/m0/s1",KECRHHMVDCUMCW-JCYSWHRNSA-N,867,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 30::tert-butyl N-[(1S,2S)-1-[(9R,12R)-8,11-dioxo-9-(propan-2-yl)-2-oxa-7,10,13-triazabicyclo[13.3.1]nonadeca-1(18),15(19),16-trien-12-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
973,CC(C)C1NC(=O)[C@H](NCc2cccc(OCCOCCNC1=O)c2)C(O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C,"InChI=1S/C32H46N4O7/c1-21(2)26-29(38)33-14-15-41-16-17-42-24-13-9-12-23(18-24)20-34-27(30(39)36-26)28(37)25(19-22-10-7-6-8-11-22)35-31(40)43-32(3,4)5/h6-13,18,21,25-28,34,37H,14-17,19-20H2,1-5H3,(H,33,38)(H,35,40)(H,36,39)/t25-,26?,27+,28?/m0/s1",BEYIKFKXDNCIOO-JCYSWHRNSA-N,868,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 17::tert-butyl N-[(1S,2S)-1-[(10R,13R)-9,12-dioxo-10-(propan-2-yl)-2,5-dioxa-8,11,14-triazabicyclo[14.3.1]icosa-1(19),16(20),17-trien-13-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
974,CC(C)C1NC(=O)[C@H](NCc2cccc(OCCOCCOCCNC1=O)c2)C(O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C,"InChI=1S/C34H50N4O8/c1-23(2)28-31(40)35-14-15-43-16-17-44-18-19-45-26-13-9-12-25(20-26)22-36-29(32(41)38-28)30(39)27(21-24-10-7-6-8-11-24)37-33(42)46-34(3,4)5/h6-13,20,23,27-30,36,39H,14-19,21-22H2,1-5H3,(H,35,40)(H,37,42)(H,38,41)/t27-,28?,29+,30?/m0/s1",DQRZWWANHBNSDX-ZQTFWZTISA-N,869,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 31::tert-butyl N-[(1S,2S)-1-[(13R,16R)-12,15-dioxo-13-(propan-2-yl)-2,5,8-trioxa-11,14,17-triazabicyclo[17.3.1]tricosa-1(22),19(23),20-trien-16-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
975,CC(C)C1NC(=O)[C@H](NCc2ccc(OCCOCCNC1=O)cc2)C(O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)(C)C,"InChI=1S/C41H55N5O8/c1-27(2)33-37(48)42-20-21-52-22-23-53-31-18-16-29(17-19-31)25-43-34(38(49)45-33)35(47)32(24-28-12-8-6-9-13-28)44-39(50)36(41(3,4)5)46-40(51)54-26-30-14-10-7-11-15-30/h6-19,27,32-36,43,47H,20-26H2,1-5H3,(H,42,48)(H,44,50)(H,45,49)(H,46,51)/t32-,33?,34+,35?,36+/m0/s1",TZULDDUNYAGRDC-KJDUMKRQSA-N,870,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 32::benzyl N-[(1S)-1-{[(1S,2S)-1-[(10R,13R)-9,12-dioxo-10-(propan-2-yl)-2,5-dioxa-8,11,14-triazabicyclo[14.2.2]icosa-1(18),16,19-trien-13-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
976,CC(C)C1NC(=O)[C@H](NCc2ccc(OCCOCCNC1=O)cc2)C(O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CSc1nncn1C)C(C)(C)C,"InChI=1S/C38H54N8O7S/c1-24(2)30-34(49)39-16-17-52-18-19-53-27-14-12-26(13-15-27)21-40-31(35(50)44-30)32(48)28(20-25-10-8-7-9-11-25)42-36(51)33(38(3,4)5)43-29(47)22-54-37-45-41-23-46(37)6/h7-15,23-24,28,30-33,40,48H,16-22H2,1-6H3,(H,39,49)(H,42,51)(H,43,47)(H,44,50)/t28-,30?,31+,32?,33+/m0/s1",FSQSJCNROUMWQT-ADMCGCMZSA-N,871,"(2S)-N-[(1S,2S)-1-[(10R,13R)-9,12-dioxo-10-(propan-2-yl)-2,5-dioxa-8,11,14-triazabicyclo[14.2.2]icosa-1(18),16,19-trien-13-yl]-1-hydroxy-3-phenylpropan-2-yl]-3,3-dimethyl-2-{2-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]acetamido}butanamide::1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 33",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
977,CC(C)C1NC(=O)[C@H](NCc2ccc(OCCOCCNC1=O)cc2)C(O)[C@H](Cc1ccccc1)NC(=O)OC1CCOC1,"InChI=1S/C32H44N4O8/c1-21(2)27-30(38)33-13-15-41-16-17-43-24-10-8-23(9-11-24)19-34-28(31(39)36-27)29(37)26(18-22-6-4-3-5-7-22)35-32(40)44-25-12-14-42-20-25/h3-11,21,25-29,34,37H,12-20H2,1-2H3,(H,33,38)(H,35,40)(H,36,39)/t25?,26-,27?,28+,29?/m0/s1",GAASGBLOUADBCT-POAHTBLISA-N,872,"(3R)-oxolan-3-yl N-[(1S,2S)-1-[(10R,13R)-9,12-dioxo-10-(propan-2-yl)-2,5-dioxa-8,11,14-triazabicyclo[14.2.2]icosa-1(18),16,19-trien-13-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamate::1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 21",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
978,CC(C)C1NC(=O)[C@H](NCc2ccc(OCCOCCOCCNC1=O)cc2)C(O)[C@H](Cc1ccccc1)NC(=O)OC1CCOC1,"InChI=1S/C34H48N4O9/c1-23(2)29-32(40)35-13-15-43-16-17-44-18-19-46-26-10-8-25(9-11-26)21-36-30(33(41)38-29)31(39)28(20-24-6-4-3-5-7-24)37-34(42)47-27-12-14-45-22-27/h3-11,23,27-31,36,39H,12-22H2,1-2H3,(H,35,40)(H,37,42)(H,38,41)/t27?,28-,29?,30+,31?/m0/s1",PWEJSYALDYQGFY-UFSCFTEJSA-N,873,"(3R)-oxolan-3-yl N-[(1S,2S)-1-[(13R,16R)-12,15-dioxo-13-(propan-2-yl)-2,5,8-trioxa-11,14,17-triazabicyclo[17.2.2]tricosa-1(21),19,22-trien-16-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamate::1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 34",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
979,COc1ccc(CN[C@H](C(O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)C)C(=O)NC(C(C)C)C(=O)NCc2nc3ccccc3[nH]2)cc1,"InChI=1S/C45H55N7O7/c1-28(2)38(42(54)47-26-37-48-34-18-12-13-19-35(34)49-37)51-44(56)40(46-25-31-20-22-33(58-5)23-21-31)41(53)36(24-30-14-8-6-9-15-30)50-43(55)39(29(3)4)52-45(57)59-27-32-16-10-7-11-17-32/h6-23,28-29,36,38-41,46,53H,24-27H2,1-5H3,(H,47,54)(H,48,49)(H,50,55)(H,51,56)(H,52,57)/t36-,38?,39-,40+,41?/m0/s1",VDAMGRGIJMNRLL-ILOASLALSA-N,874,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 1::benzyl N-[(1S)-1-{[(2S,3S,4R)-4-{[(1R)-1-[(1H-1,3-benzodiazol-2-ylmethyl)carbamoyl]-2-methylpropyl]carbamoyl}-3-hydroxy-4-{[(4-methoxyphenyl)methyl]amino}-1-phenylbutan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
980,COc1ccc(CN[C@H](C(O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)(C)C)C(=O)N[C@@H]2C(O)Cc3ccccc23)cc1,"InChI=1S/C42H50N4O7/c1-42(2,3)38(46-41(51)53-26-29-15-9-6-10-16-29)40(50)44-33(23-27-13-7-5-8-14-27)37(48)36(43-25-28-19-21-31(52-4)22-20-28)39(49)45-35-32-18-12-11-17-30(32)24-34(35)47/h5-22,33-38,43,47-48H,23-26H2,1-4H3,(H,44,50)(H,45,49)(H,46,51)/t33-,34?,35-,36+,37?,38+/m0/s1",ZVWSWYSIMOZTTG-OWCVLDFASA-N,875,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 2::benzyl N-[(1S)-1-{[(2S,3S,4R)-3-hydroxy-4-{[(1S,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-4-{[(4-methoxyphenyl)methyl]amino}-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1,
981,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)[C@H]1NCc2ccc(OCCOCCNC(=O)C(NC1=O)C(C)C)cc2,"InChI=1S/C40H53N5O8/c1-26(2)33-37(47)41-19-20-51-21-22-52-31-17-15-29(16-18-31)24-42-35(39(49)44-33)36(46)32(23-28-11-7-5-8-12-28)43-38(48)34(27(3)4)45-40(50)53-25-30-13-9-6-10-14-30/h5-18,26-27,32-36,42,46H,19-25H2,1-4H3,(H,41,47)(H,43,48)(H,44,49)(H,45,50)/t32-,33?,34-,35+,36?/m0/s1",FIQBSLXLTLJIQG-OTXQKLNXSA-N,857,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 3::benzyl N-[(1S)-1-{[(1S,2S)-1-[(10R,13R)-9,12-dioxo-10-(propan-2-yl)-2,5-dioxa-8,11,14-triazabicyclo[14.2.2]icosa-1(18),16,19-trien-13-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [514-612],Human immunodeficiency virus 2,
982,CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)[C@H]1NCc2ccc(OCCOCCOCCNC(=O)C(NC1=O)C(C)C)cc2,"InChI=1S/C42H57N5O9/c1-28(2)35-39(49)43-19-20-53-21-22-54-23-24-55-33-17-15-31(16-18-33)26-44-37(41(51)46-35)38(48)34(25-30-11-7-5-8-12-30)45-40(50)36(29(3)4)47-42(52)56-27-32-13-9-6-10-14-32/h5-18,28-29,34-38,44,48H,19-27H2,1-4H3,(H,43,49)(H,45,50)(H,46,51)(H,47,52)/t34-,35?,36-,37+,38?/m0/s1",BOMYVDPSYNOFDI-KCVBXHHVSA-N,858,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 23::benzyl N-[(1S)-1-{[(1S,2S)-1-[(13R,16R)-12,15-dioxo-13-(propan-2-yl)-2,5,8-trioxa-11,14,17-triazabicyclo[17.2.2]tricosa-1(21),19,22-trien-16-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [514-612],Human immunodeficiency virus 2,
983,CC(C)C1NC(=O)[C@H](NCc2ccc(OCCOCCNC1=O)cc2)C(O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)(C)C,"InChI=1S/C41H55N5O8/c1-27(2)33-37(48)42-20-21-52-22-23-53-31-18-16-29(17-19-31)25-43-34(38(49)45-33)35(47)32(24-28-12-8-6-9-13-28)44-39(50)36(41(3,4)5)46-40(51)54-26-30-14-10-7-11-15-30/h6-19,27,32-36,43,47H,20-26H2,1-5H3,(H,42,48)(H,44,50)(H,45,49)(H,46,51)/t32-,33?,34+,35?,36+/m0/s1",TZULDDUNYAGRDC-KJDUMKRQSA-N,870,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 32::benzyl N-[(1S)-1-{[(1S,2S)-1-[(10R,13R)-9,12-dioxo-10-(propan-2-yl)-2,5-dioxa-8,11,14-triazabicyclo[14.2.2]icosa-1(18),16,19-trien-13-yl]-1-hydroxy-3-phenylpropan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate",Dimer of Gag-Pol polyprotein [514-612],Human immunodeficiency virus 2,
984,COc1ccc(CN[C@H](C(O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)C)C(=O)NC(C(C)C)C(=O)NCc2nc3ccccc3[nH]2)cc1,"InChI=1S/C45H55N7O7/c1-28(2)38(42(54)47-26-37-48-34-18-12-13-19-35(34)49-37)51-44(56)40(46-25-31-20-22-33(58-5)23-21-31)41(53)36(24-30-14-8-6-9-15-30)50-43(55)39(29(3)4)52-45(57)59-27-32-16-10-7-11-17-32/h6-23,28-29,36,38-41,46,53H,24-27H2,1-5H3,(H,47,54)(H,48,49)(H,50,55)(H,51,56)(H,52,57)/t36-,38?,39-,40+,41?/m0/s1",VDAMGRGIJMNRLL-ILOASLALSA-N,874,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 1::benzyl N-[(1S)-1-{[(2S,3S,4R)-4-{[(1R)-1-[(1H-1,3-benzodiazol-2-ylmethyl)carbamoyl]-2-methylpropyl]carbamoyl}-3-hydroxy-4-{[(4-methoxyphenyl)methyl]amino}-1-phenylbutan-2-yl]carbamoyl}-2-methylpropyl]carbamate",Dimer of Gag-Pol polyprotein [514-612],Human immunodeficiency virus 2,
985,COc1ccc(CN[C@H](C(O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)(C)C)C(=O)N[C@@H]2C(O)Cc3ccccc23)cc1,"InChI=1S/C42H50N4O7/c1-42(2,3)38(46-41(51)53-26-29-15-9-6-10-16-29)40(50)44-33(23-27-13-7-5-8-14-27)37(48)36(43-25-28-19-21-31(52-4)22-20-28)39(49)45-35-32-18-12-11-17-30(32)24-34(35)47/h5-22,33-38,43,47-48H,23-26H2,1-4H3,(H,44,50)(H,45,49)(H,46,51)/t33-,34?,35-,36+,37?,38+/m0/s1",ZVWSWYSIMOZTTG-OWCVLDFASA-N,875,"1OH-2(Cbz-Tle)3PhPr [14]paracyclophane deriv. 2::benzyl N-[(1S)-1-{[(2S,3S,4R)-3-hydroxy-4-{[(1S,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-4-{[(4-methoxyphenyl)methyl]amino}-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate",Dimer of Gag-Pol polyprotein [514-612],Human immunodeficiency virus 2,
986,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C33H40N2O5/c1-33(2,3)40-32(39)34-27(19-23-14-8-5-9-15-23)28(36)21-25(18-22-12-6-4-7-13-22)31(38)35-30-26-17-11-10-16-24(26)20-29(30)37/h4-17,25,27-30,36-37H,18-21H2,1-3H3,(H,34,39)(H,35,38)/t25-,27+,28+,29-,30+/m1/s1",ZJBUCZFZQXPYFC-JOFXVPDFSA-N,1030,"CHEMBL296115::L-685,434::Urethane deriv. 1::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.35
987,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C40H46N2O6/c1-40(2,3)48-39(46)41-34(23-27-12-6-4-7-13-27)35(43)25-31(38(45)42-37-33-17-11-10-16-30(33)24-36(37)44)22-28-18-20-32(21-19-28)47-26-29-14-8-5-9-15-29/h4-21,31,34-37,43-44H,22-26H2,1-3H3,(H,41,46)(H,42,45)/t31-,34+,35+,36-,37+/m1/s1",LRRAWJHFJBTJSY-SZNOJMITSA-N,877,"L-685,434 deriv. 19::N-(2(R)-Hydroxy-1(S)-indany1)-5(S)-[(tert -butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-(benzyloxy)phenyl]methyl]hexanamide::tert-butyl N-[(2S,3S,5R)-5-{[4-(benzyloxy)phenyl]methyl}-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.18
988,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C33H40N2O6/c1-33(2,3)41-32(40)34-27(18-21-9-5-4-6-10-21)28(37)20-24(17-22-13-15-25(36)16-14-22)31(39)35-30-26-12-8-7-11-23(26)19-29(30)38/h4-16,24,27-30,36-38H,17-20H2,1-3H3,(H,34,40)(H,35,39)/t24-,27+,28+,29-,30+/m1/s1",IXMOCJVKYIUCEJ-BANMPPSNSA-N,1046,"CHEMBL298316::L-685,927::tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-[(4-hydroxyphenyl)methyl]-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.16
989,CC(C)(C)OC(=O)N[C@@H](Cc1ccc(O)cc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C33H40N2O6/c1-33(2,3)41-32(40)34-27(18-22-13-15-25(36)16-14-22)28(37)20-24(17-21-9-5-4-6-10-21)31(39)35-30-26-12-8-7-11-23(26)19-29(30)38/h4-16,24,27-30,36-38H,17-20H2,1-3H3,(H,34,40)(H,35,39)/t24-,27+,28+,29-,30+/m1/s1",XCAIGOGENFFHKM-BANMPPSNSA-N,879,"L-685,434 deriv. 23::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-(4-hydroxyphenyl)-2-(R)-(phenylmethyl)hexanamide::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-(4-hydroxyphenyl)pentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.35
990,CC(C)(C)OC(=O)N[C@@H](Cc1ccc(O)cc1)[C@@H](O)C[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C33H40N2O7/c1-33(2,3)42-32(41)34-27(17-21-10-14-25(37)15-11-21)28(38)19-23(16-20-8-12-24(36)13-9-20)31(40)35-30-26-7-5-4-6-22(26)18-29(30)39/h4-15,23,27-30,36-39H,16-19H2,1-3H3,(H,34,41)(H,35,40)/t23-,27+,28+,29-,30+/m1/s1",OZGPXSDVWSRZFO-QSHKSBDLSA-N,880,"L-685,434 deriv. 24::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-(4-hydroxyphenyl)-2-(R)-[(4-hydroxyphenyl)methyl]hexanamide::tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-(4-hydroxyphenyl)-5-[(4-hydroxyphenyl)methyl]pentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.15
991,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccc(OCCN2CCOCC2)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C39H51N3O7/c1-39(2,3)49-38(46)40-33(24-27-9-5-4-6-10-27)34(43)26-30(37(45)41-36-32-12-8-7-11-29(32)25-35(36)44)23-28-13-15-31(16-14-28)48-22-19-42-17-20-47-21-18-42/h4-16,30,33-36,43-44H,17-26H2,1-3H3,(H,40,46)(H,41,45)/t30-,33+,34+,35-,36+/m1/s1",IYLCQJSWFWQHCD-AIIVFDHXSA-N,881,"L-685,434 derivative::L-689,502::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(4-morpholinyl)ethoxy]phenyl]methl]hexanamide::tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-({4-[2-(morpholin-4-yl)ethoxy]phenyl}methyl)-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.45
992,CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OCCN2CCOCC2)cc1)[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C39H51N3O7/c1-39(2,3)49-38(46)40-33(24-28-13-15-31(16-14-28)48-22-19-42-17-20-47-21-18-42)34(43)26-30(23-27-9-5-4-6-10-27)37(45)41-36-32-12-8-7-11-29(32)25-35(36)44/h4-16,30,33-36,43-44H,17-26H2,1-3H3,(H,40,46)(H,41,45)/t30-,33+,34+,35-,36+/m1/s1",NBGSECDAEROIQJ-AIIVFDHXSA-N,882,"L-685,434 deriv. 30::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-[4-[2-[(4-morpholinyl)ethoxy]phenyl]-2-(R)-(phenylmethyl)hexanamide::tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-{4-[2-(morpholin-4-yl)ethoxy]phenyl}pentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.55
993,CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OCCN2CCOCC2)cc1)[C@@H](O)C[C@@H](Cc1ccc(OCCN2CCOCC2)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C45H62N4O9/c1-45(2,3)58-44(53)46-39(29-33-10-14-37(15-11-33)57-27-21-49-18-24-55-25-19-49)40(50)31-35(43(52)47-42-38-7-5-4-6-34(38)30-41(42)51)28-32-8-12-36(13-9-32)56-26-20-48-16-22-54-23-17-48/h4-15,35,39-42,50-51H,16-31H2,1-3H3,(H,46,53)(H,47,52)/t35-,39+,40+,41-,42+/m1/s1",WGHYNTCTLVBFHI-HATTVXFNSA-N,883,"L-685,434 deriv. 31::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-[4-[2-(4-morpholinyl)ethoxy]phenyl]-2-(R)-[[4-[2-(4-morphholinyl)ethoxy]phenyl]methyl]hexanamide::tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-{4-[2-(morpholin-4-yl)ethoxy]phenyl}-5-({4-[2-(morpholin-4-yl)ethoxy]phenyl}methyl)pentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.9
994,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccc(OCCCN2CCOCC2)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C40H53N3O7/c1-40(2,3)50-39(47)41-34(25-28-10-5-4-6-11-28)35(44)27-31(38(46)42-37-33-13-8-7-12-30(33)26-36(37)45)24-29-14-16-32(17-15-29)49-21-9-18-43-19-22-48-23-20-43/h4-8,10-17,31,34-37,44-45H,9,18-27H2,1-3H3,(H,41,47)(H,42,46)/t31-,34+,35+,36-,37+/m1/s1",LFHRZDUCVKDMRO-SZNOJMITSA-N,884,"L-685,434 deriv. 32::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-[4-[[3-(4-morpholinyl)propyl]oxy]phenyl]-2(R)-(phenylmethyl)hexanamide::tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-({4-[3-(morpholin-4-yl)propoxy]phenyl}methyl)-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.0
995,CN(C)CCOc1ccc(C[C@H](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)cc1,"InChI=1S/C37H49N3O6/c1-37(2,3)46-36(44)38-31(22-25-11-7-6-8-12-25)32(41)24-28(21-26-15-17-29(18-16-26)45-20-19-40(4)5)35(43)39-34-30-14-10-9-13-27(30)23-33(34)42/h6-18,28,31-34,41-42H,19-24H2,1-5H3,(H,38,44)(H,39,43)/t28-,31+,32+,33-,34+/m1/s1",QVYOSIVVMRNXJG-ZVGDERKOSA-N,885,"L-685,434 deriv. 33::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(dimethylamino)ethoxy]phenyl]methl]hexanamide::tert-butyl N-[(2S,3S,5R)-5-({4-[2-(dimethylamino)ethoxy]phenyl}methyl)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 2.1
996,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccc(OCCN2CCCCC2)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C40H53N3O6/c1-40(2,3)49-39(47)41-34(25-28-12-6-4-7-13-28)35(44)27-31(38(46)42-37-33-15-9-8-14-30(33)26-36(37)45)24-29-16-18-32(19-17-29)48-23-22-43-20-10-5-11-21-43/h4,6-9,12-19,31,34-37,44-45H,5,10-11,20-27H2,1-3H3,(H,41,47)(H,42,46)/t31-,34+,35+,36-,37+/m1/s1",GETGSYUVNAQKQG-SZNOJMITSA-N,886,"L-685,434 deriv. 34::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]hexanamide::tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenyl-5-({4-[2-(piperidin-1-yl)ethoxy]phenyl}methyl)pentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.6
997,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccc(OCCN2CCCC2)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C39H51N3O6/c1-39(2,3)48-38(46)40-33(24-27-11-5-4-6-12-27)34(43)26-30(37(45)41-36-32-14-8-7-13-29(32)25-35(36)44)23-28-15-17-31(18-16-28)47-22-21-42-19-9-10-20-42/h4-8,11-18,30,33-36,43-44H,9-10,19-26H2,1-3H3,(H,40,46)(H,41,45)/t30-,33+,34+,35-,36+/m1/s1",KDBIGCDEYFYFCH-AIIVFDHXSA-N,887,"L-685,434 deriv. 35::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]methyl]hexanamide::tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenyl-5-({4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}methyl)pentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 1.8
998,CN1CCN(CCOc2ccc(C[C@H](C[C@H](O)[C@H](Cc3ccccc3)NC(=O)OC(C)(C)C)C(=O)N[C@@H]3[C@H](O)Cc4ccccc34)cc2)CC1,"InChI=1S/C40H54N4O6/c1-40(2,3)50-39(48)41-34(25-28-10-6-5-7-11-28)35(45)27-31(38(47)42-37-33-13-9-8-12-30(33)26-36(37)46)24-29-14-16-32(17-15-29)49-23-22-44-20-18-43(4)19-21-44/h5-17,31,34-37,45-46H,18-27H2,1-4H3,(H,41,48)(H,42,47)/t31-,34+,35+,36-,37+/m1/s1",XJMAXQMSDUBZFJ-SZNOJMITSA-N,888,"L-685,434 deriv. 36::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]methyl]hexanamide::tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-({4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl}methyl)-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.2
999,COCCN(CCOC)CCOc1ccc(C[C@H](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)cc1,"InChI=1S/C41H57N3O8/c1-41(2,3)52-40(48)42-35(26-29-11-7-6-8-12-29)36(45)28-32(39(47)43-38-34-14-10-9-13-31(34)27-37(38)46)25-30-15-17-33(18-16-30)51-24-21-44(19-22-49-4)20-23-50-5/h6-18,32,35-38,45-46H,19-28H2,1-5H3,(H,42,48)(H,43,47)/t32-,35+,36+,37-,38+/m1/s1",OFDNMZCEWPWCDP-MKWZCKROSA-N,889,"L-685,434 deriv. 37::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-[N,N-bis(2-methoxyethyl)amino]ethoxy]phenyl]methyl]hexanamide::tert-butyl N-[(2S,3S,5R)-5-[(4-{2-[bis(2-methoxyethyl)amino]ethoxy}phenyl)methyl]-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.9
1000,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccc(OCCN2CCSCC2)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C39H51N3O6S/c1-39(2,3)48-38(46)40-33(24-27-9-5-4-6-10-27)34(43)26-30(37(45)41-36-32-12-8-7-11-29(32)25-35(36)44)23-28-13-15-31(16-14-28)47-20-17-42-18-21-49-22-19-42/h4-16,30,33-36,43-44H,17-26H2,1-3H3,(H,40,46)(H,41,45)/t30-,33+,34+,35-,36+/m1/s1",ZFGRKMRYECPSSS-AIIVFDHXSA-N,890,"L-685,434 deriv. 38::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(thiamorpholin-4-yl)ethoxy]phenyl]methyl]hexanamide::tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenyl-5-({4-[2-(thiomorpholin-4-yl)ethoxy]phenyl}methyl)pentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.47
1001,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccc(OCCN2CCS(=O)CC2)cc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,"InChI=1S/C39H51N3O7S/c1-39(2,3)49-38(46)40-33(24-27-9-5-4-6-10-27)34(43)26-30(37(45)41-36-32-12-8-7-11-29(32)25-35(36)44)23-28-13-15-31(16-14-28)48-20-17-42-18-21-50(47)22-19-42/h4-16,30,33-36,43-44H,17-26H2,1-3H3,(H,40,46)(H,41,45)/t30-,33+,34+,35-,36+/m1/s1",XLZPJKXMTIWXCM-AIIVFDHXSA-N,891,"L-685,434 deriv. 39::N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(1-oxothiamorpholin-4-yl)ethoxy]phenyl]methyl]hexanamide::tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-({4-[2-(1-oxo-1,4-thiomorpholin-4-yl)ethoxy]phenyl}methyl)-1-phenylpentan-2-yl]carbamate",Dimer of Gag-Pol polyprotein [489-587],Human immunodeficiency virus 1, 0.07
